SUPPLEMENT

FY2025 — Annual financial statements

FY2025PDF · 155 pages9.9 MB
Annual financial
statements
for the year ended 30 June 2025

-- 1 of 155 --

How we report
to our
stakeholders
Group Annual Financial
Statements
Group audited consolidated
annual financial results for
Discovery Limited, the Embedded
Value Statement and Five-year
Review.
* Copyright and trademarks are owned by the
Institute of Directors in South Africa (IoDSA)
NPC and all of its rights are reserved.
Integrated Annual Report
Our primary report to our
shareholders, providers of financial
capital and other key stakeholders,
detailing how we created, preserved
or eroded value during the year.
Climate Report
Discovery’s approach to climate
change and climate-related
disclosures regarding governance,
strategy, risk management, and
metrics and targets.
Remuneration Report
Outlines our remuneration policy and
implementation approach, along with
factors influencing our remuneration-
related decisions.
Annual financial results
presentation and booklet
Sustainability Report
An overview of the Group’s
performance against our Integrated
Sustainability Framework and, where
appropriate, against relevant
standards and frameworks.
Governance Report
Outlines the Group’s governance
philosophy, leadership and compliance
with the King Report on Corporate
Governance for South Africa, 2016
(King IVTM
)*.
Tax Transparency Report
Communicates material tax disclosure
information to demonstrate our
commitment to tax transparency and
operating as a force for good through
our tax contributions.
Notice of Annual General Meeting
(AGM)

-- 2 of 155 --

DIRECTORS’ RESPONSIBILITY TO THE SHAREHOLDERS OF DISCOVERY LIMITED
AND ITS SUBSIDIARIES (DISCOVERY OR THE GROUP)
The directors of Discovery are required by the Companies Act,
No. 71 of 2008, as amended (Companies Act), to maintain
adequate accounting records and to prepare financial
statements for each financial year that fairly present the state
of affairs of Discovery at the end of the financial year and the
results and cash flows for the period. In preparing the
accompanying Annual Financial Statements, IFRS Accounting
Standards have been used, and reasonable estimates have
been made. The Annual Financial Statements incorporate full
and responsible disclosure, in line with Discovery’s philosophy
on corporate governance.
The directors have reviewed Discovery’s budget and cash flow
forecast for the year to 30 June 2026. On the basis of this
review, and in light of the current financial position and
available cash resources, the directors have no reason to
believe that Discovery will not be a going concern for the
foreseeable future. The going concern basis has therefore
been adopted in preparing the Annual Financial Statements.
The directors are responsible for Discovery’s systems of
internal control, which include internal financial controls in the
various subsidiaries that are designed to provide reasonable,
but not absolute, assurance against material misstatement
and loss. Discovery maintains internal financial controls to
provide assurance regarding:
■ Safeguarding of assets against unauthorised use or
disposition, and
■ The maintenance of proper accounting records, written or
electronic and the reliability of financial information used
within the business, or for the publication thereof, including
submissions to the Companies and Intellectual Property
Commission (CIPC).
The controls contain self-monitoring mechanisms, and actions
are taken to correct deficiencies as they are identified. Even an
effective system of internal control, no matter how well
designed, has inherent limitations, including the possibility of
circumvention and the overriding of controls. An effective
system of control therefore aims to provide reasonable
assurance with respect to the reliability of financial
information and, in particular, the presentation of Annual
Financial Statements.
To the best of their knowledge and belief, based on the above,
the directors are satisfied that no material breakdown in the
operation of the systems of internal control and procedures
has occurred during the year under review.
Discovery’s external auditors, KPMG Inc. and Deloitte &
Touche, have audited the Annual Financial Statements and
their unmodified report appears on pages 8 to 12.
The Annual Financial Statements of Discovery for the year
ended 30 June 2025, which appear on pages 17 to 285
have been approved by the Board of Directors on
10 September 2025, and are signed on its behalf by:
Mark Tucker
Chairperson
Adrian Gore
Group Chief Executive
Directors’ responsibility statement
for the year ended 30 June 2025
1
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
Contents
 
Consolidated financial statements
1 	Directors’ responsibility statement
2 	Group Chief Executive and Group Chief Financial Officer’s internal
financial control responsibility statement
2 	Certificate by the Company Secretary
3 	Report of the Discovery Limited Audit Committee
8 	Independent auditors’ report
13 	Directors’ report
18 	Group statement of financial position
19 	Group income statement
20 	Group statement of other comprehensive income
21 	Group statement of cash flows
22 	Group statement of changes in equity
24 	Notes to the Group annual financial statements
Discovery Limited
Registration number
1999/007789/06 	Discovery Limited
215 	Company statement of financial position
216 	Company income statement
216 	Company statement of other comprehensive income
217 	Company statement of cash flows
218 	Company statement of changes in equity
219 	Notes to the Company annual financial statements
Annexures
244 	Annexure A – Group structure
247 	Annexure B – Group accounting policies
282 	Annexure C – Directorate
286 	Annexure D – Unaudited analysis of shareholders
287 	Annexure E – Embedded value statement
300 	Annexure F – Unaudited five-year review
301 	Glossary
BASIS OF PREPARATION
The consolidated and separate Annual Financial Statements have been prepared in accordance with JSE Limited (JSE) Listings
Requirements, IFRS® Accounting Standards as issued by the International Accounting Standards Board (IFRS Accounting Standards), the
South African Institute of Chartered Accountants (SAICA) Financial Reporting Guides as issued by the Accounting Practices Committee,
Financial Pronouncements as issued by the Financial Reporting Standards Council (FRSC), and the requirements of the South African
Companies Act. They have been prepared in accordance with the going concern principle using the historical cost basis, except where
otherwise stated in the accounting policies (refer Annexure B).
The Annual Financial Statements have been prepared under the supervision of Deon Viljoen CA(SA), Group Chief Financial Officer. The
Annual Financial Statements are reviewed by management, the Discovery Limited Audit Committee and Board, and are audited by the
external auditors of the Group.
The embedded value statements have been prepared by Peter Bolink (FASSA) and supervised by Andrew Rayner (FASSA, FIA).
A copy of the set of annual consolidated and separate financial statements with the signatures of the directors is available at the
Company’s registered office through a secure electronic manner, at the election of the person requesting inspection.
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
D 	1

-- 3 of 155 --

After due, careful, and proper consideration, in accordance with the JSE Listings Requirements 3.84(k), each of the directors, whose names
are stated below, hereby confirm that:
■ The Annual Financial Statements set out on pages 17 to 285 fairly present, in all material respects, the financial position, financial
performance and cash flows of the issuer in terms of IFRS;
■ To the best of our knowledge and belief, no facts have been omitted or untrue statements made that would make the Annual Financial
Statements false or misleading;
■ Internal financial controls have been put in place to ensure that material information relating to Discovery Limited and its consolidated
subsidiaries have been provided to effectively prepare the financial statements of the issuer;
■ The internal financial controls are adequate and effective and can be relied upon in compiling the Annual Financial Statements, having
fulfilled our role and function as executive directors with primary responsibility for implementation and execution of controls;
■ Where we are not satisfied, we have disclosed to the Discovery Limited Audit Committee and the auditors any deficiencies in design and
operational effectiveness of the internal financial controls, and have remediated or taken steps to remedy the deficiencies; and
■ We are not aware of any fraud involving directors.
Adrian Gore 	Deon Viljoen
Group Chief Executive 	Group Chief Financial Officer
10 September 2025 	10 September 2025
Certificate by the Company Secretary
for the year ended 30 June 2025
It is hereby certified in terms of section 88(2)(e) of the Companies Act, that Discovery Limited has, for the year ended 30 June 2025, lodged
with the Companies and Intellectual Property Commission (CIPC) all such returns as are required by a public company in terms of this Act
and that all such returns are true, correct and up to date.
Ayanda Ceba
Company Secretary
10 September 2025
Group Chief Executive and Group Chief Financial
Officer’s internal financial control responsibility
statement
for the year ended 30 June 2025
2
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
The Discovery Limited Audit Committee (DLAC) is pleased to present its report for the financial year ended 30 June 2025. This report has
been prepared in accordance with the requirements of the South African Companies Act, 71 of 2008, as amended (Companies Act), the King
Report on Corporate Governance™ for South Africa, 2016 (King IV™), and the JSE Listings Requirements. DLAC has carried out its duties in
accordance with its Terms of Reference as mandated by the Board. This report outlines how DLAC discharged its statutory obligations
during the year under review, including consideration of significant matters and focus areas to ensure the integrity of the Group’s financial
reporting.
ROLE OF THE COMMITTEE
The primary role of DLAC is to provide independent challenge and oversight of the Group’s financial results, as well as over the disclosure of
relevant financial and non-financial information. In fulfilling this role, DLAC evaluates the adequacy and effectiveness of accounting policies
and satisfies itself that significant estimates and judgements made by management in preparing the financial results are sound and
reasonable. In addition, DLAC assesses the effectiveness of internal financial controls, oversees the financial and corporate reporting
processes, monitors the independence and effectiveness of the joint external auditors and recommends their appointment to
shareholders. The scope of DLAC extends to all activities of the Discovery Limited Group and its subsidiaries, both locally and
internationally.
COMPOSITION AND GOVERNANCE
DLAC is chaired by an Independent Non-executive Director and comprises at least three skilled and experienced Independent
Non-executive Directors. Members are appointed annually by the Board of Directors and their appointments are subsequently
confirmed by shareholders at the Discovery Group’s Annual General Meeting.
DLAC members meet the requirements to serve on an audit committee as defined by section 94(7) of the Companies Act and collectively
provide an appropriate balance and diversity of knowledge, financial expertise, and experience necessary to discharge their responsibilities
effectively.
The table below sets out the membership, qualifications, and attendance of DLAC members during the year:
Committee member 	Qualifications
Appointment to
committee
Number of meetings
attended
D Macready (Chairperson) 	BCom (Hons), CTA, CA (SA), SEP, IDP 	February 2020 	4 out of 4
LM Chiume 	BCom Business Finance and Economics 	September 2023 	4 out of 4
MW Hlahla 	BA Economics (Hons), MA, Advanced
Management Programme
August 2021 	4 out of 4
KC Ramon 	BCompt (Hons), CA(SA), SEP 	September 2023 	4 out of 4
M Schreuder 	BCom (Hons), FIA, FASSA 	February 2021 	4 out of 4
In addition to their responsibilities on DLAC, members serve on other key Board committees to ensure collective and integrated oversight
of matters across the Discovery Group, as shown below:
Committee member
Actuarial
committee
Remuneration
committee
Risk and compliance
committee
Social and Ethics
committee
Technology
working group
D Macready 	x 	x
LM Chiume 	x
MW Hlahla 	x 	x
KC Ramon 	x 	x
M Schreuder 	x 	x 	x
The Board Chairperson and other Non-executive Directors can attend DLAC meetings upon request. The Group Chief Executive, Group
Chief Financial Officer (CFO), Actuarial Committee Chairperson and Executive Directors attend DLAC meetings, or parts thereof, by invitation
only. DLAC also invites other members of management to attend meetings to provide deeper insights into specific issues or areas of
the Group.
Report of the Discovery Limited Audit Committee
for the year ended 30 June 2025
3
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
3	2

-- 4 of 155 --

EFFECTIVENESS REVIEW
During the year, DLAC conducted an independent review of its effectiveness. The review provided positive feedback and confirmed that
DLAC is well managed, thorough, proactive, and appropriately resourced to deliver on its mandate.
MEETING CYCLE FOR THE YEAR
Committee meetings 	DLAC convened four scheduled meetings during the year, as well as four ad hoc meetings specifically
to consider the Group’s Annual Financial Statements, results, and annual reporting suite.
Management engagements 	The DLAC Chairperson meets regularly with the Group CFO, the Heads of the Actuarial, Risk and
Compliance functions, and, as necessary, with executive management.
Auditor engagements 	The Group’s internal and external auditors have direct access to the DLAC Chairperson, including
closed sessions without management present, on any matters they consider relevant to fulfilling
DLAC’s responsibilities. In addition, the Chairperson meets regularly with the internal and external
auditors before each meeting and at other times as required.
Regulatory engagements 	DLAC participated in the annual bilateral and trilateral meetings convened with the respective
regulatory bodies.
Subsidiary Audit
Committee engagements
The DLAC Chairperson meets regularly with the individual Chairpersons of the Subsidiary Audit
Committees and can attend their subsidiary meetings as an invitee. Subsidiary Chairpersons are
formally invited to give feedback to the DLAC during reporting periods on subsidiary significant
matters.
Feedback to the Discovery
Board
Following the meetings and engagements outlined above, the DLAC Chairperson reports to the
Discovery Board on DLAC’s activities and matters discussed, highlighting any areas requiring attention
or action.
Annual General Meeting 	The DLAC Chairperson attends Annual General Meetings and is available to respond to any questions
concerning matters within DLAC’s mandate.
KEY FOCUS AREAS FOR FY2025
ASSESSING THE EFFECTIVENESS OF THE GROUP GOVERNANCE FRAMEWORK
DLAC is satisfied that the Group Governance Framework continues to enhance and strengthen the governance and oversight of
subsidiaries within the broader Discovery multinational operations, whilst upholding Discovery’s common purpose, values, and Shared-
value model.
DLAC observed the further maturation of the Subsidiary Audit Committees established under the framework implemented in FY2023,
reflecting steady progress in embedding consistent governance practices and reporting across the Group.
EMBEDDING IFRS 17 AND NEW IFRS ACCOUNTING STANDARDS
In the first year following the transition to IFRS 17, DLAC focused on monitoring Discovery’s integration of the standard into business-as-
usual activities with particular emphasis on internal model governance, system improvements, financial reporting controls and the
strengthening of both internal and external assurance processes.
Restatement of prior period error
The maturation of the IFRS 17 governance models led to the identification of an isolated error arising on transition, which affected prior
periods and resulted in a restatement as set out in Note 7.5 of the Annual Financial Statements.
DLAC reviewed the cause of the error, assessed the effectiveness of the control environment, and considered the proposed adjustment. It
also obtained independent assurance from the external auditors to confirm that the changes were implemented appropriately. DLAC
requested a thorough review of IFRS 17 model governance and best practice. In addition, DLAC considered the related disclosures in the
financial statements and the necessary communication with regulatory bodies.
JSE Proactive monitoring IFRS 17 thematic review
In line with general oversight practice when significant new standards are adopted; the JSE selected Discovery’s FY2024 Annual Financial
Statements, together with those of other major insurers, for its thematic review of IFRS 17 related disclosures.
DLAC noted, in consultation with both management and external auditors, that the common themes and matters highlighted by the JSE
had already been considered in the preparation of Discovery’s financial statements. While the JSE review did not result in material
comments, selected enhancements were made to the IFRS 17 disclosures in the FY2025 Annual Financial Statements. DLAC takes comfort
from the overall quality of the existing disclosures and welcomes any enhancements which further strengthened comparability and clarity
for stakeholders.
Report of the Discovery Limited Audit Committee continued
for the year ended 30 June 2025
4
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
KEY FOCUS AREAS FOR FY2025 continued
ASSESSING THE EFFECTIVENESS OF THE GROUP GOVERNANCE FRAMEWORK continued
IFRS 18 PRESENTATION AND DISCLOSURE IN FINANCIAL STATEMENTS
In April 2024, the International Accounting Standards Board published IFRS 18 Presentation and Disclosure in Financial Statements, which
will supersede IAS 1 Presentation of Financial Statements. IFRS 18 will be effective for Discovery from 1 July 2027. The standard aims to
improve how companies communicate in their financial statements, particularly information about financial performance in the statement
of profit or loss.
Discovery will establish a formal project office in the next financial year to manage the transition to IFRS 18, including assessing the detailed
implications, process and system changes required for successful implementation.
REVIEWING DISCOVERY’S ESG FINANCIAL REPORTING PRACTICES
During the year, DLAC continued its review of the Group’s ESG financial reporting practices, benchmarking these against industry-leading
standards, regulatory requirements and emerging global trends. This included oversight of the implementation of IFRS S1, which outlines
general sustainability-related disclosure requirements and IFRS S2, which specifies climate-related disclosure requirements as well as
compliance with guidance notes issued by the South African Prudential Authority. DLAC also monitored Discovery’s progress in meeting
these evolving reporting requirements and reviewed the assurance processes supporting the Group’s disclosure obligations.
Discovery’s Climate and Environment Steering Committee, comprising representatives from several business functions, meets monthly at a
Group level to manage and drive climate-related transformation. The Committee oversees the implementation of TCFD recommendations
and compliance with related reporting requirements, particularly in the Climate Report and Sustainability Report. During the year,
Discovery also published its Net Zero Transition Plan, which sets out the Group’s pathway to achieving net zero carbon emissions by 2050.
EVALUATING THE EFFECTIVENESS OF GROUP INTERNAL AUDIT AND APPROPRIATENESS
OF THE INSOURCING MODEL
DLAC annually reviews the skills, capacity and effectiveness of the Group Internal Audit (GIA) function, with an independent external
assessment conducted at least every five years. During the current year under review, DLAC’s assessment focused on the efficacy of the
current operating model, considering the adequacy of in-house skills, experience and capacity relative to our co-sourcing, which leverages
external consultants and subject-matter experts for specialised technical assignments. The review also considered coverage against the
audit plan, the risk universe, quality assurance practices, the rating methodology as well as the charter and organisational independence
of GIA.
IMPROVING SHAREHOLDER REPORTING
During the year, DLAC considered holistically the disclosures of IFRS Financial Statements for information in segment reporting alongside
other non-IFRS measures and other management defined performance measures e.g. Annualised Premium Income and other revenue,
Embedded Value and other Group Shareholder Value metrics. DLAC is also satisfied with the segmental enhancements together with the
transparency and consistency in the application of the metrics. DLAC will continue to monitor the quality of shareholder reporting and any
future developments such as the new requirements of the forthcoming IFRS 18.
FINANCIAL, LEGAL, COMPLIANCE AND REGULATORY REPORTING FOR FY2025
DLAC receives regular reports from the Group CFO covering financial performance, budgets, forecasts, long-term plans, capital
expenditure, financial reporting controls, and the adequacy of management information. DLAC reviewed and was satisfied with the
expertise, resources, and experience of the Finance function, including the Group CFO.
As part of its annual work plan, DLAC considered management’s assessment of the JSE Proactive Monitoring Report 2024. The review
confirmed that Discovery’s Annual Financial Statements appropriately addressed the JSE’s findings, with no amendments required.
DLAC also reviewed reports from the Social and Ethics Committee on compliance with Discovery’s Code of Conduct, ethics standards, and
legal and regulatory obligations. DLAC is satisfied that there were no material breaches or instances of non-compliance during the year.
KEY AUDIT MATTERS
Each year, DLAC assesses the key audit matters (KAMs) identified by the Group’s external auditors and considers the related judgements
and estimates in the Annual Financial Statements. The FY2025 KAMs raised by the joint auditors were addressed as follows:
Key Audit Matter 	How DLAC responded
Valuation of assets and
liabilities arising from
insurance contracts
DLAC reviewed reports from the Group Chief Actuary and the external auditors on actuarial
assumptions and basis changes. DLAC evaluated the appropriateness of these assumptions and
noted that the Annual Financial Statements set out the significant judgements and estimates
involved.
OTHER SIGNIFICANT MATTERS CONSIDERED
In addition to the above KAMs, DLAC also focused on:
■ The impairment assessment of specified assets under IAS 36, including goodwill relating to Discovery Bank, VitalityHealth, VitalityLife, and
material associate investments. DLAC was satisfied there was no risk of impairment of any material assets.
■ The recognition and measurement of deferred tax assets arising from unutilised assessed tax losses. DLAC considered the
appropriateness of the measurement and was satisfied with the level of prudence applied in the recognition process.
Report of the Discovery Limited Audit Committee continued
for the year ended 30 June 2025
5
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
5	4

-- 5 of 155 --

ANNUAL FINANCIAL STATEMENTS, ACCOUNTING PRACTICES AND
REPORTING PROCESSES
DLAC reviewed the accounting policies of all entities included in the Group’s consolidated Annual Financial Statements and is satisfied that
they are appropriate, consistently applied and compliant with IFRS Accounting Standards. DLAC also confirmed that Discovery has robust
financial reporting procedures to ensure access to all information required for the preparation of the financial statements. DLAC is satisfied
that the Group remains a going concern and that the financial statements were prepared on this basis. DLAC further considered the
accounting treatments of material or unusual transactions and related judgements.
During the year, DLAC focused on the following financial reporting matters to ensure the integrity and fairness of reported information:
■ Considered significant accounting transactions, actuarial and tax judgements and assumptions, including the KAMs reported by the
external auditors, and was satisfied with how these were addressed.
■ Reviewed financial information in the Group’s trading statements and interim and year-end results announcements to confirm the
accuracy and integrity of external disclosures.
■ Evaluated the consistent application of accounting policies in respect of insurance reserves, including enhancements arising from the
JSE IFRS 17 thematic review.
■ Oversaw the correction of the prior period restatement and assessed the adequacy of related disclosures in the financial statements.
DLAC receives and addresses any complaints or whistleblowing matters related to accounting practices, internal audit, the content or
auditing of financial statements or internal financial controls. No such matters were raised during FY2025.
In respect of the Integrated Annual Report, DLAC evaluated management’s judgements and reporting decisions and is satisfied that all
material matter disclosures were appropriately included. DLAC also reviewed financial and non-financial information, forward-looking
statements, and sustainability disclosures, including:
■ The Sustainability Report, with a focus on data sources, metrics, methodologies, and narrative.
■ The level of internal and external assurance obtained on ESG reporting and disclosures, including work plans and procedures.
■ The Climate Report, with particular emphasis on the disclosure of climate-related risks, opportunities, and financial implications.
EXTERNAL AUDIT
DLAC is responsible to appoint, approve the annual audit budget, and oversee the Group’s independent joint external auditors, KPMG and
Deloitte. During the year, DLAC:
■ Assessed the independence and objectivity of KPMG and Deloitte and is satisfied that both firms operate independently of Discovery,
with internal governance processes supporting their claims to independence.
■ Reviewed the accreditation of the individual audit partners responsible for audit sign-off, as well as the most recent Independent
Regulatory Board for Auditors (IRBA) inspection reports and assessed the suitability of the audit firms and individuals in accordance with
paragraphs 3.84(g)(iii) of the JSE Listings Requirements and 7.3(e)(iii) of the JSE Debt and Specialist Securities Listings Requirements.
■ Approved the engagement letter, terms, audit plan, focus areas, and budgeted audit fees for FY2025 following consultation with
executive management and considered the allocation of work between the joint auditors.
■ Engaged regularly through the DLAC Chairperson with the lead partners from both firms to discuss the audit plan, scope, key focus areas
and findings, including reliance, where appropriate on Group Internal Audit.
■ Received reports from the external auditors on the audit of the Group’s Annual Financial Statements, critical accounting estimates and
judgements, cross-reviews, and the Summary of Audit Differences. DLAC noted the unqualified independent auditors’ report for
Discovery Limited and the Group.
DLAC maintains a formal policy governing non-audit services provided by the joint auditors, which includes a cap whereby such services
may not exceed 25% of each auditor’s audit fee. The DLAC Chairperson pre-approves the nature and scope of any non-audit services in line
with this policy, and DLAC reviews the schedule of approved services annually. For the year ended 30 June 2025, the total value of non-audit
services performed by Deloitte was less than 1% of their audit fee, while KPMG rendered no non-audit services.
In accordance with section 94(8) of the Companies Act and considering the requirements of King IV™, the JSE Listings Requirements, and
broader guidance to audit committees, DLAC is satisfied with the performance and quality of the external audit, the audit firms and the
lead partners for the year ended 30 June 2025.
The appointment of KPMG and Deloitte as joint auditors for the year ending 30 June 2026 will be tabled at the Annual General Meeting
scheduled for November 2025.
GROUP INTERNAL AUDIT
The GIA function provides independent and objective assurance that the Group’s governance processes – including professional ethics, risk
management and systems of internal control – are adequate and effective. The Chief Audit Executive (CAE) reports functionally to the DLAC
Chairperson and administratively to the Group CFO.
During the year, DLAC assessed the independence, effectiveness, and performance of the CAE and GIA function, as well as the adequacy
of audit resources, and found them satisfactory. In assessing the quality and delivery of the internal audit plan, DLAC:
■ Reviewed and approved the internal audit plan, challenging its focus, risk-based approach and relevance.
■ Approved the Group-wide internal audit rating methodology, dispute resolution process and escalation protocol.
■ Noted the results of the IFC and financial reporting controls (FRC) audits conducted by GIA.
■ Reviewed significant issues raised by internal audit and the adequacy of corrective actions taken.
■ Considered the external auditors’ annual assessment of GIA under ISA 610, reaffirming the extent of reliance that could be placed on its work.
■ Reviewed and approved the Internal Audit Charter in 2025, noting that the 2024 review was deferred to November 2024 pending
implementation of the new Global Institute of Internal Audit Standards.
DLAC is satisfied that GIA continues to demonstrate high levels of professional objectivity and ethics in carrying out its mandate.
Report of the Discovery Limited Audit Committee continued
for the year ended 30 June 2025
6
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
OTHER MATTERS CONSIDERED
DLAC oversees the design and implementation of sound risk management and internal control systems. During the year DLAC considered
assessments of the Group’s internal control, governance, risk management and combined assurance processes and is satisfied that these
systems were effective.
COMBINED ASSURANCE
The Group’s Combined Assurance model provides an integrated approach across risk and compliance, external and internal audit,
corporate finance functions and the actuarial committees. DLAC reviewed the model, which is applied throughout the Group and is
satisfied that it appropriately addresses Discovery’s risks. The model continues to mature, as reflected in more efficient planning, improved
coordination between audit, compliance and risk functions and the delivery of more effective assurance outcomes. Management regards
Combined Assurance as a key component of the Group’s broader risk mitigation framework.
INTERNAL FINANCIAL CONTROLS AND FINANCIAL REPORTING CONTROLS
Discovery maintains a strong risk culture, supported by effective internal financial controls (IFCs) to ensure the integrity and reliability of its
financial reporting. DLAC assists the Board in evaluating the adequacy and effectiveness of IFCs, accounting controls, and financial
reporting controls (FRCs). In doing so, DLAC considers reports from external audit, GIA, and management, including GIA’s formal
documented review of the design, implementation, and effectiveness of IFCs and FRCs. In FY2025, GIA focused particularly on updating
controls related to IFRS 17.
Discovery successfully completed the fifth year of the IFC attestation process under paragraph 3.84(k) of the JSE Listings Requirements.
Deficiencies in the design or operating effectiveness of IFCs identified through the three lines of defence were reported to DLAC, which
considered management’s responses, including remediation, compensating controls and additional review procedures. DLAC noted and
supported the positive attestations of the Group Chief Executive and Group CFO.
Based on these reviews, DLAC is satisfied that Discovery’s IFCs and FRCs operated effectively and provided reliable financial information,
resulting in a fair presentation of the Group’s financial performance in the Annual Financial Statements.
KEY FOCUS AREAS FOR FY2026
DLAC has identified the following areas of focus for the forthcoming financial year:
■ Reviewing financial reporting processes, including changes to the JSE Listings Requirements.
■ Monitoring Discovery’s response to forthcoming amendments to IFRS Accounting Standards, in particular IFRS 18
■ Considering enhancements to shareholder value and return metrics
■ Continuing to strengthen Discovery’s ESG financial reporting practices and benchmarking, with particular focus on implementation of the
IFRS Sustainability Disclosure Standards
■ Placing greater thematic focus on automation in financial reporting, together with benchmarking best practice in model risk governance
and IT general controls
■ Overseeing the ongoing revision of the Combined Assurance model to improve Group-wide coordination, effectiveness, and efficiency of
assurance activities.
CONCLUSION
DLAC is satisfied that it has complied with all statutory duties and those delegated by the Board under its Terms of Reference.
DLAC reviewed Discovery Limited’s consolidated and separate financial statements for the year ended 30 June 2025 and, based on the
information provided, is satisfied that Discovery complies, in all material respects, with the requirements of the Companies Act and IFRS
Accounting Standards. DLAC recommended the Annual Financial Statements to the Board for approval and the Board subsequently
approved them. The Annual Financial Statements will be presented for discussion at the forthcoming Annual General Meeting.
D Macready
Chairperson: Discovery Limited Audit Committee
10 September 2025
Report of the Discovery Limited Audit Committee continued
for the year ended 30 June 2025
7
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
7	6

-- 6 of 155 --

TO THE SHAREHOLDERS OF DISCOVERY LIMITED
REPORT ON THE AUDIT OF THE CONSOLIDATED AND SEPARATE FINANCIAL
STATEMENTS
OPINION
We have audited the consolidated and separate financial statements of Discovery Limited (the group and company) set out on pages 17 to
285, which comprises of:
■ the Group and Company statements of financial position as at 30 June 2025;
■ the Group and Company income statements for the year then ended;
■ the Group and Company statements of other comprehensive income for the year then ended;
■ the Group and Company statements of cash flows for the year then ended;
■ the Group and Company statements of changes in equity for the year then ended and
■ the notes to the Group and Company financial statements (including Annexures A and C), including a summary of material accounting
policies (Annexure B).
In our opinion, the consolidated and separate financial statements present fairly, in all material respects, the consolidated and separate
financial position of Discovery Limited as at 30 June 2025, and its consolidated and separate financial performance and consolidated and
separate cash flows for the year then ended, in accordance with IFRS® Accounting Standards as issued by the International Accounting
Standards Board (IFRS Accounting Standards) and the requirements of the South African Companies Act.
BASIS FOR OPINION
We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are
further described in the Auditors’ Responsibilities for the Audit of the Consolidated and Separate Financial Statements section of our report.
We are independent of the Group and Company in accordance with the Independent Regulatory Board for Auditors’ Code of Professional
Conduct for Registered Auditors (IRBA Code) and other independence requirements applicable to performing audits of financial statements
in South Africa. We have fulfilled our other ethical responsibilities in accordance with the IRBA Code and in accordance with other ethical
requirements applicable to performing audits in South Africa. The IRBA Code is consistent with the corresponding sections of the
International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International
Independence Standards). We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our
opinion.
In terms of the IRBA Rule on Enhanced Auditor Reporting for the Audit of Financial Statements of Public Interest Entities, published in
Government Gazette No. 49309 dated 15 September 2023 (EAR Rule) we report:
FINAL MATERIALITY
The audit was influenced by our application of materiality. We define materiality as the magnitude of a misstatement in the consolidated
and separate financial statements that makes it probable that the economic decisions of a reasonably knowledgeable person would be
changed or influenced. We use materiality both in planning the nature and extent of our audit work and in evaluating the effect of
misstatements, both individually and in the aggregate, on the consolidated and separate financial statements as a whole.
Based on our professional judgement, we determined certain quantitative thresholds and overlaid qualitative considerations for materiality
for the consolidated and separate financial statements as a whole as follows:
Group 	Company
Overall materiality 	R641 million 	R248 million
How we determined it 	4.7% of profit before tax from continuing
operations (PBT)
0.5% of total assets
Rationale for the materiality
benchmark and percentage
applied
We identified PBT as the most appropriate
benchmark to determine materiality given
that it is a key performance metric for users
and a common benchmark for returns
generated by listed entities.
We identified total assets as the most appropriate
benchmark to determine materiality given that the
Discovery is an investment holding entity.
The percentages applied to the benchmarks were based on our professional judgement after
consideration of qualitative factors that impact both the group and company.
Independent auditors’ report
for the year ended 30 June 2025
8
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
GROUP AUDIT SCOPE
We tailored the scope of our audit to enable us to provide an opinion on the consolidated financial statements as a whole, considering the
structure of the Group, the accounting processes and controls, and the industry in which the Group operates.
We have performed risk assessment procedures to determine which of the Group’s components are likely to include risks of material
misstatement to the consolidated financial statements and we determined the type of work needed to be performed at those components
to address the risks. Our judgements included assessing the size of the components, nature of assets, liabilities, and transactions within the
components as well as specific risks.
In total we identified fifteen components requiring an audit response. Of those, we identified two components at which audit procedures
were performed on the entire financial information of the component, either because audit evidence was needed to be obtained on all or a
significant proportion of the component’s financial information, or that the components included pervasive risks of material misstatement
to the consolidated financial statements. For the remaining thirteen components, our audit procedures were focused on certain classes of
transactions, account balances and / or disclosures in which we considered risks of material misstatement to have been identified. For the
remaining financial information where audit procedures were not performed, we performed analytical procedures at the Group to assess
the risk of a material misstatement in the remaining financial information.
In respect of the scoped in components where audit procedures were performed, fifteen components contributed 93.6% of the Group’s
operating profit before tax and 94.5% of total assets.
Based on our risk assessment procedures, we have determined that there is a less than reasonable possibility of a material misstatement
in the remaining financial information not subject to further audit procedures.
We considered the scope of the audit, as communicated to the audit committee, to be an appropriate basis for our audit opinion.
KEY AUDIT MATTERS
Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the consolidated and
separate financial statements of the current period. These matters were addressed in the context of our audit of the consolidated and
separate financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
The key audit matters below relate to the consolidated financial statements only. We have determined that there are no key audit matters
to communicate in our report in respect of the separate financial statements.
In terms of the EAR Rule, we are required to report the outcome of audit procedures or key observations with respect to the key audit
matters and these are included below.
Valuation of assets and liabilities arising from insurance contracts issued
Refer to policy 12 of Annexure B – Group accounting policies Section 02 and Section 07, note 7.5 in the notes to the Group financial
statements.
Key audit matter 	How the matter was addressed in our audit
As at 30 June 2025, the Group held assets arising from insurance
contracts issued to the value of R 48 047 million (2024: R37 339
million (restated)) and liabilities arising from insurance contracts
issued to the value of R118 878 million (2024: R105 070 million).
Assets and liabilities arising from insurance contracts issued are
measured in accordance with IFRS 17 Insurance Contracts
(IFRS 17). Within these assets and liabilities arising from
insurance contracts issued, the key audit matter relates to the
following aggregated groups of insurance contracts where
management’s application of the significant judgements, inputs,
assumptions and estimates is the most complex:
■ SA Life (Risk) with a net asset of R23 002 million (2024: R17 846
million net asset (restated))
■ SA Invest (Risk) with a net liability value of R23 580 million
(2024: R24 565 million net liability (restated)),
■ SA Invest (Participating) with a net liability value of R88 150
million (2024: R73 721 million net liability),
■ UK Life (Risk) with a net asset value of R20 180 million (2024:
R15 269 million net asset)
as disaggregated in note 2.2 within section 02 to the Group
financial statements. These insurance contracts are underwritten
by Discovery Life in South Africa and Vitality Life in the United
Kingdom.
The primary audit procedures performed to address the key audit
matter, with support from our actuarial specialists, included the
following:
■ Gaining an understanding of the Group’s actuarial internal
control environment and governance, including the functioning
of the Group’s Actuarial Committee and testing the design and
implementation of key controls.
■ Performing a risk assessment of the key judgements and
assumptions impacting the valuation of insurance contracts by
assessing the level of complexity and judgement related to the
respective actuarial estimates and assumptions.
■ Evaluating the appropriateness of the valuation methodologies
applied by the Group to determine the value of assets and
liabilities arising from insurance contracts. In doing so, we
considered the principles and accuracy of the Group’s models
against the requirements of IFRS 17 and acceptable industry
standards.
■ For a sample of model changes impacting the fulfilment
cashflows, assessing these changes against the requirements of
IFRS 17 by interrogating the model logic and code.
■ Assessing the appropriateness of the method applied in
determining the RA as well as the release of the RA against the
requirements of IFRS 17.
■ For the CSM model specifically, comparing the output of our
recalculations to management’s calculations and obtaining an
understanding of any differences.
Independent auditors’ report continued
for the year ended 30 June 2025
9
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
9	8

-- 7 of 155 --

Valuation of assets and liabilities arising from individual life insurance contracts issued
continued
Refer to policy 12 of Annexure B – Group accounting policies, Section 02 and Section 07, note 7.3.3, in the notes to the group financial
statements.
Key audit matter 	How the matter was addressed in our audit
These balances include estimates and judgement in the
determination of fulfilment cash flows (FCF), specifically the
present value of future cash flows (PVFCF), as well as the risk
adjustment for non-financial risk (RA). Also included in the
balances are the Contractual Services Margin (CSM).
The most significant judgments, inputs, assumptions, and
estimates made in determining the value of the assets and
liabilities arising from insurance contracts relate to determining
the FCF and the CSM. Changes to these significant judgements,
inputs, assumptions and estimates may result in a material
change to the valuation of the insurance contract assets and
liabilities due to the long duration of the underlying contracts
and the unpredictability of the insured events. The key
assumptions include:
■ mortality and morbidity rates;
■ surrender and lapse rates;
■ discount rates and investment returns;
■ expense assumptions; and
■ the coverage units used to determine the CSM recognised for
services provided.
We refer to note 7.5.1 which provides detail of a restatement due
to a coding error that required significant auditor attention
during the audit.
We considered the valuation of assets and liabilities arising from
insurance contracts issued including the restatement to be a key
audit matter in our audit of the financial statements, as it
involved complex and subjective judgements about future
events, including policyholder behaviour and economic
conditions that required judgement to be applied.
■ Challenging management with respect to the appropriateness of
all significant assumptions adopted in the determination of the
valuation of assets and liabilities arising from insurance
contracts issued. This was performed by comparing these
assumptions to the results of historical actuarial experience
investigations conducted by management, including
benchmarking these assumptions against life insurance industry
trends to determine whether they are reasonable and
supportable.
■ For a sample of management’s experience investigations,
assessing the reasonability of the past experience adjustments
by tracing back to policyholder contracts and actual cash flows.
■ For a sample of policyholder data, testing the completeness and
accuracy of the underlying data inputs by agreeing the inputs to
supporting documentation for use in determining the insurance
contract assets/liabilities.
■ We evaluated the appropriateness of the disclosures made in
relation to the assets and liabilities arising from insurance
contracts issued in section 02 to the Group financial statements
in terms of the requirements of IFRS 17.
As it relates the restatement, we:
■ Evaluated the correction of the code to ensure that the final code
applied met the requirements of IFRS 17. Thereafter, we
obtained the corrected data outputs produced using the final
code and recalculated the CSM for all historic periods restated.
We also evaluated the OCI and earnings impact for all historic
periods restated against our expectations, and
■ Evaluated the appropriateness of the disclosures impacted by
the restatement.
■ Based on the above procedures performed, we did not identify
any matters requiring further consideration in concluding on the
valuation of the assets and liabilities arising from insurance
contracts issued and accompanying restatements.
OTHER INFORMATION
The directors are responsible for the other information. The other information comprises the information included in the document titled
“Discovery Annual Financial Statements for the year ended 30 June 2025”, which includes the Directors’ Report, the Report of the Discovery
Limited Audit Committee, and the Certificate by the Company Secretary, as required by the Companies Act of South Africa, which we
obtained prior to the date of this auditors’ report, and the document titled “Discovery Integrated Annual Report for the year ended 30 June
2025” which is expected to be made available to us after that date. The other information does not include the consolidated and separate
financial statements and our auditors’ report thereon.
Our opinion on the consolidated and separate financial statements does not cover the other information and we do not and will not
express an audit opinion or any form of assurance conclusion thereon.
In connection with our audit of the consolidated and separate financial statements, our responsibility is to read the other information and,
in doing so, consider whether the other information is materially inconsistent with the consolidated and separate financial statements, or
our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed, we
conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in
this regard.
Independent auditors’ report continued
for the year ended 30 June 2025
10
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
RESPONSIBILITIES OF THE DIRECTORS FOR THE CONSOLIDATED AND SEPARATE
FINANCIAL STATEMENTS
The directors are responsible for the preparation and fair presentation of the consolidated and separate financial statements, in
accordance with IFRS® Accounting Standards and the requirements of the South African Companies Act, and for such internal control as
the directors determine is necessary to enable the preparation of consolidated and separate financial statements that are free from
material misstatement, whether due to fraud or error.
In preparing the consolidated and separate financial statements, the directors are responsible for assessing the Group and the Company’s
ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the Group and/or the Company or to cease operations, or have no realistic
alternative but to do so.
AUDITORS’ RESPONSIBILITIES FOR THE AUDIT OF THE CONSOLIDATED AND SEPARATE
FINANCIAL STATEMENTS
Our objectives are to obtain reasonable assurance about whether the consolidated and separate financial statements as a whole are free
from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable
assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material
misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate,
they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated and separate
financial statements.
As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional scepticism throughout the audit.
We also:
■ Identify and assess the risks of material misstatement of the consolidated and separate financial statements, whether due to fraud or
error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to
provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting
from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
■ Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the group and the Discovery ’s internal control.
■ Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made
by the directors.
■ Conclude on the appropriateness of the directors’ use of the going concern basis of accounting and based on the audit evidence
obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group and/or the
Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in
our auditors’ report to the related disclosures in the consolidated and separate financial statements or, if such disclosures are
inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report.
However, future events or conditions may cause the Group and/or Company to cease to continue as a going concern.
■ Evaluate the overall presentation, structure and content of the consolidated and separate financial statements, including the disclosures,
and whether the consolidated and separate financial statements represent the underlying transactions and events in a manner that
achieves fair presentation.
■ Plan and perform the Group audit to obtain sufficient appropriate audit evidence regarding the financial information of the entities or
business units within the Group as a basis for forming an opinion on the consolidated financial statements. We are responsible for the
direction, supervision and review of the audit work performed for the purposes of the group audit. We remain solely responsible for our
audit opinion.
We communicate with the directors regarding, among other matters, the planned scope and timing of the audit and significant audit
findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide the directors with a statement that we have complied with relevant ethical requirements regarding independence and
communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where
applicable, actions taken to eliminate threats or safeguards applied.
From the matters communicated with the directors, we determine those matters that were of most significance in the audit of the
consolidated and separate financial statements of the current period and are therefore the key audit matters. We describe these matters in
our auditors’ report, unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we
determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be
expected to outweigh the public interest benefits of such communication.
Independent auditors’ report continued
for the year ended 30 June 2025
11
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
11	10

-- 8 of 155 --

REPORT ON OTHER LEGAL AND REGULATORY REQUIREMENTS
In terms of the IRBA Rule published in Government Gazette Number 39475 dated 4 December 2015, we report that this is the second year
KPMG Inc. and Deloitte & Touche have been the joint auditors of Discovery Limited.
Prior to the commencement of the joint audit relationship with Deloitte & Touche, KPMG Inc. audited Discovery Limited jointly with
PricewaterhouseCoopers Inc. for two years.
KPMG Inc. 	Deloitte & Touche
Registered Auditor 	Registered Auditors
Per: Mark Danckwerts 	Per: Stephen Munro
Chartered Accountant (SA) 	Chartered Accountant (SA)
Registered Auditor 	Registered Auditor
Director 	Partner
KPMG Crescent 	5 Magwa Crescent
85 Empire Road 	Waterfall City
Parktown 	2090
2193
10 September 2025 	10 September 2025
Independent auditors’ report continued
for the year ended 30 June 2025
12
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
NATURE OF BUSINESS
Discovery Limited (the Company) is listed on the JSE and is a global integrated financial services organisation specialising in health
insurance, life assurance, wellness, investments and savings, short-term insurance, and banking.
Discovery’s purpose and ambition are achieved through a pioneering business model that incentivises people to be healthier and enhances
and protects their lives.
Our unique and sophisticated Vitality Shared-value model delivers better health and value for clients, superior actuarial dynamics for the
insurer, and a healthier society. It is a powerful platform of integrated assets and capabilities, which has positioned us well to respond to
the following key trends :
■ a focus on health, wellness and resilience (nature of risk)
■ accelerated use of technology and increased digitisation (technology)
■ increased importance of purpose and trust (social responsibility)
■ rising healthcare costs and resources strain (demographics)
YEAR UNDER REVIEW
Discovery Group achieved strong growth across its operations in the year ended 30 June 2025, evidenced by a 29% growth in normalised
operating profit to R15 210 million and significant growth in cash conversion, now at 77%. Headline earnings and normalised headline
earnings both increased by 30%, to R9 625 million and R9 781 million, respectively, resulting in the normalised return on equity increasing
to 15.4%, from 13.5% in the prior year.
The Group delivered a strong performance in an environment characterised by increased geopolitical complexities and uncertainty around
global policy shifts and trade tensions. In the year under review, economic growth remained below potential in many regions in which the
Group operates, although interest rate reductions provided a better backdrop for investment markets. Risks remain elevated, however the
acceleration of technological and demographic trends underpin the relevance of the Group’s Vitality Shared-value model and unique data,
positioning the Group uniquely for continued growth.
SALIENT GROUP RESULTS FOR THE YEAR ENDED 30 JUNE 2025
Unit 	June 2025 	June 2024 	Change
Group earnings1
Normalised profit from operations 	R million 	15 210 	11 761 	29%
Profit attributable to ordinary shareholders 	R million 	9 471 	7 468 	27%
Normalised headline earnings 	R million 	9 781 	7 511 	30%
Headline earnings 	R million 	9 625 	7 384 	30%
Basic earnings per share 	Cents 	1 402.2 	1 110.3 	26%
Basic headline earnings per share 	Cents 	1 447.0 	1 117.0 	30%
Basic normalised headline earnings per share 	Cents 	1 470.4 	1 136.2 	29%
Returns, cash conversion and dividends
Normalised return on equity1 	% 	15.4 	13.5
Annualised return on opening embedded value (RoEV) 	% 	15.7 	13.2
Cash conversion1,2 	% 	77 	65
Growth drivers
Income from non-insurance business lines2 	R million 	6 643 	5 906 	12%
New business annualised premium income (API) 2 	R million 	26 486 	26 958 	(2)%
Financial position and embedded value
Net asset value1 	R million 	65 699 	54 451 	21%
Embedded value 	R million 	126 554 	110 354 	15%
Basic embedded value per share 	R 	189.85 	166.95 	14%
Financial leverage ratio (FLR)1 	% 	16.8 	20.3
1 Prior year restated refer to note 7.5.1.
2 Refer to Annexure A of “Audited Results and cash dividend declaration for the year ended 30 June 2025; New business API increased 8% when excluding Sasolmed in prior
year.
Directors’ report
for the year ended 30 June 2025
13
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
13	12

-- 9 of 155 --

STRONG IN-PERIOD PERFORMANCE FROM BOTH COMPOSITES AND FINANCIAL
RESILIENCE IN AN UNCERTAIN ENVIRONMENT
Discovery has emerged strongly from its cycle of significant investment, which focused on creating new avenues for long-term growth. This
has positioned the Group for a new distinct phase of scaled organic growth, with focused execution through its recently formed global
composite, Vitality, and its domestic business, Discovery South Africa.
Over the year, the Group continued to execute its growth strategy, delivering 29% growth in normalised profit from operations. Headline
and normalised headline earnings both increased by 30%, delivering a normalised return on equity of 15.4%, up from 13.5% in the prior
year.
The Group’s embedded value increased to R126.6 billion, a 15.7% RoEV. This included an increasing contribution from non-covered
businesses and robust experience variances over the year, with positive contributions from each business, reflecting the competitive
dynamics of the Shared-value Insurance model. The movement in exchange rates and economic basis assumptions were favourable in
aggregate.
Total new business API declined 2%, but increased 8% when excluding the large Sasolmed take-on in the prior year, with stronger growth
delivered in Vitality. The Group focused on deliberate and disciplined pricing strategies and back-book retention, both leveraging the Vitality
Shared-value Insurance model to optimise margins and returns. This has impacted new business growth in some businesses, compounded
by macroeconomic challenges.
Capital ratios remained strong across every regulated business and liquidity at each regulated entity, as well as at the centre, remained well
in excess of the required buffers. Debt across the Group decreased over the year and the FLR reduced to 16.8%. Ping An Health Insurance
(PAHI) paid its second consecutive annual dividend, at a 35% payout ratio (previously 30%), and the Group’s cash conversion ratio increased
to 77% of after-tax normalised operating profit, compared with 65% in the prior year, notwithstanding the strong growth in normalised
profit from operations.
BUSINESS-UNIT PERFORMANCE
R million
Normalised
profit from
operations
June 2025
% change
(Current year
vs prior year)
New business
API
June 2025
% change
(Current year
vs prior year)
Discovery Health 	4 259 	7% 	9 573 	(14%)
Discovery Life 	5 525 	14% 	3 203 	(10%)
Discovery Invest 	1 987 	29% 	3 430 	4%
Discovery Insure1 	817 	229% 	1 361 	(2%)
Discovery Bank 	(68) 	(85%)
Other initiatives and central costs 	(515) 	91% 	546 	33%
Discovery SA 	12 005 	22% 	18 113 	(8%)
VitalityHealth 	1 188 	173% 	2 851 	3%
VitalityLife 	637 	70% 	2 499 	28%
Vitality Network 	554 	4%
VHI – Ping An Health Insurance (PAHI) 	1 206 	7% 	3 023 	22%
VHI – Other 	(291) 	(25%)
Other initiatives and central costs2 	(89) 	(54%)
Vitality (UK and VG) composite 	3 205 	70% 	8 373 	16%
Normalised profit from operations 	15 210 	29%
New business API3 	26 486 	(2%)
1 Includes Discovery Insure’s share of equity accounted profits of its associates.
2 In the prior year Vitality other initiatives and central costs include closure costs of VitalityInvest.
3 New business API increased 8% when excluding Sasolmed in prior period.
WITHIN THE COMPOSITES:
DISCOVERY SOUTH AFRICA
Discovery South Africa delivered 22% growth in normalised profit from operations, reflecting a compelling contribution from each business
in the composite. Excellent levels of customer engagement drove strong claims experience and retention across the franchise. A resulting
increased Vitality benefit utilisation, and successful launch of the new HealthyFood partner, added to various additional one-off costs at the
centre, both of which are expected to ameliorate in FY2026.
■ Discovery Bank continued to deliver high-quality growth. Total clients increased by 30%, advances by 39% and deposits by 26%, resulting
in strong revenue growth, and its first profitable period during the second half of the financial year, ahead of plan.
■ Discovery Health’s operating profit increased 7%, with further investment into technology, innovation and AI to drive continued
innovation around the Shared-value model and to deepen efficiencies.
■ Discovery Life’s normalised operating profit increased 14% mainly driven by an exceptional claims experience. New business declined
10% in total and 2% for Individual Life, maintaining its leading market share but in a soft affluent retail protection market.
■ Discovery Invest delivered a 29% increase in normalised operating profit given strong growth in the value of assets under management
and certain one-off benefits.
■ Discovery Insure successfully executed pricing and claims management initiatives which, combined with benign weather conditions,
resulted in significant improvement in the claims ratio and a 229% increase in operating profits.
Directors’ report continued
for the year ended 30 June 2025
14
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
VITALITY
Vitality generated 70% growth in normalised profit from operations, reflecting the excellent progress made in restructuring all the global
operations into a focused single business over the past nine months, and particularly strong growth in the UK.
■ VitalityHealth’s profits increased 173%, driven by effective pricing actions, a stabilising claims environment and rigorous claims and
expense management.
■ VitalityLife's operating profit recovered strongly, increasing 70%, with new business growing 28% driven by the effective execution of the
Shared-value Insurance model.
■ Ping An Health Insurance (PAHI) delivered a strong operating and investment result, to generate a 22% increase in pre-tax profit, not
withstanding a sizable COVID-19 reserve release in the prior year. Discovery's equity- accounted share, after tax and costs, increased by a
lower 7%, following the prior year benefit of a tax gain.
■ Vitality Network’s model gained significant traction with integrated new business API by partners increasing 24% to almost US$2 billion.
Earnings growth was lower, at 4% (7% in US$), reflecting lower solutions revenues and additional expenditure during the year.
■ VHI-Other losses improved 25% to R291 million, following lower losses in Vitality USA and the successful integration of WellSpark Health.
SHARE CAPITAL
Details of the authorised and issued share capital, together with details of shares issued during the year, are set out in section 2 to the
Company Annual Financial Statements.
OWNERSHIP
For details of shareholders, refer to Annexure D.
GROUP STRUCTURE
The Company is directly and indirectly the holding company of subsidiaries and investments as set out in Annexure A. In addition, Discovery
is required to consolidate certain unit trusts that are deemed to be under the Group’s control in terms of IFRS 10 Consolidated Financial
Statements. These are also set out in Annexure A.
DIVIDENDS
Details of dividends paid and declared are set out in section 7.4.1 to the Annual Financial Statements.
CAPITAL
SOLVENCY AND LIQUIDITY TESTS
The directors have performed the requisite solvency and liquidity tests where required by the Companies Act as amended and concluded
that Discovery meets the solvency and liquidity requirements.
STATUTORY CAPITAL REQUIREMENTS
With effect from 1 July 2018, the Insurance Act 18 of 2017 (Insurance Act) and the related Prudential Standards were implemented in
South Africa. Discovery Life and Discovery Insure are regulated under the Insurance Act, while VitalityHealth and VitalityLife are regulated
under the European Solvency II regulatory regime, which was implemented from 1 January 2016. The values below are estimated based on
information extracted from the audited Annual Financial Statements.
June 2025 	June 2024
Statutory capital requirements 	Cover 	Statutory capital requirements 	Cover
Discovery Life 	R23 479 million 	1.9 times 	R22 365 million 	1.8 times
Discovery Insure 	R1 112 million 	2.1 times 	R1 222 million 	1.6 times
VitalityHealth 	£126 million 	1.8 times 	£116 million 	1.6 times
(R3 072 million) 	(R2 670 million)
VitalityLife 	£383 million 	2.0 times 	£350 million 	2.0 times
(R9 322 million) 	(R8 070 million)
Discovery Bank’s common equity tier 1 (CET1) ratio is 16.31% (FY2024: 17.63%). In addition, the Bank holds an internal management buffer
to cater for future unexpected growth and volatility in risk weighted exposures, as well as an estimation risk buffer.
Directors’ report continued
for the year ended 30 June 2025
15
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
15	14

-- 10 of 155 --

DIRECTORS AND PRESCRIBED OFFICERS
The following were directors and prescribed officers of the Company during the current financial year:
Executive directors 	Independent non-executive directors
A Gore (Group Chief Executive) 	ME Tucker (Chairperson) 	M Schreuder
B Swartzberg 	LM Chiume 	BA van Kralingen
DM Viljoen (Group Chief Financial Officer) 	WM Hlahla
FN Khanyile
D Macready
KC Ramon
Prescribed officers 	Non-executive directors
HD Kallner 	R Farber
NS Koopowitz
Mr TT Mboweni, an independent non-executive of Discovery, passed away on 12 October 2024.
Ms VN Fakude has been appointed as an independent non-executive director with effect from 1 September 2025.
DIRECTORS’ INTERESTS
Details of the directors’ emoluments, participation in share incentive schemes and interests in the Company are reflected in Annexure C.
No material contracts involving directors’ interests were entered into in the current year. The directors had no interest in any third party or
company responsible for managing any of the business activities of Discovery.
INDEMNIFICATION AND INSURANCE OF DIRECTORS AND OFFICERS
The Company entered into agreements to indemnify its directors to the extent permitted by law against all liabilities, including legal costs,
incurred by the director in connection with or as a consequence of the director acting in any capacity, including as an authorised
representative of a Group company. During the financial year, the Company paid insurance premiums in respect of a Directors and Officers
Liability insurance contract, which insures directors and officers of the Company against certain liabilities arising in the course of their
duties to the Company or Group companies. As such disclosure is prohibited under the terms of the contract, details of the nature of the
liabilities covered and the amount of premium paid are not disclosed, .
COMPANY SECRETARY
Ayanda Ceba is the Group Company Secretary
Registered office 	Postal address
1 Discovery Place 	PO Box 786722
Sandton 	Sandton
2196 	2146
BORROWING POWERS
The directors may exercise all the powers of the Company to borrow money. In terms of the Memorandum of Incorporation, the borrowing
powers of the Company are unlimited. In terms of the Insurance Act, both Discovery Life and Discovery Insure may not encumber assets or
directly or indirectly borrow.
EVENTS AFTER THE REPORTING DATE
Refer to Group note 7.4 for a list of the events after reporting date.
AUDITORS
KPMG Inc. and Deloitte & Touche are current joint external auditors. The appointment of external auditors will be proposed at the Annual
General Meeting of shareholders in accordance with section 90(1) of the Companies Act.
Directors’ report continued
for the year ended 30 June 2025
16
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
17
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
Primary
financial
statements
17	16

-- 11 of 155 --

R million 	Notes
Group
2025
Restated
Group
20241
Restated
Group 1 July
20231
Assets
Goodwill 	5.3 	5 429 	5 292 	5 406
Intangible assets 	5.4 	7 542 	7 239 	7 064
Property and equipment 	5.5 	3 266 	3 581 	3 910
Assets arising from insurance contracts issued 	2.2 	48 047 	37 339 	30 224
Assets arising from reinsurance contracts held 	2.2 	962 	837 	604
Deferred tax asset 	5.9.1 	4 886 	5 631 	6 370
Assets arising from contracts with customers 	5.6 	3 722 	2 598 	2 221
Investment in equity-accounted investees 	5.7 	8 989 	8 189 	7 398
Financial assets
– Loans and advances to customers at amortised cost 	3.3 	8 513 	6 028 	4 702
– Investments at amortised cost 	3.3 	12 812 	11 100 	9 910
– Investments at fair value through other comprehensive income 	14 	– 	–
– Investments at fair value through profit or loss 	3.3 	193 776 	165 671 	152 515
– Derivative financial instruments at fair value through profit or loss 	3.4 	63 	43 	119
Contract receivables and other receivables 	5.8 	7 368 	6 729 	5 684
Non-current assets held for sale 	5.5.1 	62 	136 	–
Current tax asset 	31 	250 	41
Cash and cash equivalents 	3.6 	21 968 	18 971 	19 171
TOTAL ASSETS 	327 450 	279 634 	255 339
Equity
Capital and reserves
Ordinary share capital and share premium 	4.3 	11 358 	10 667 	10 351
Perpetual preference share capital 	4.4 	779 	779 	779
Other reserves 	4 921 	2 176 	1 562
Retained earnings 	48 646 	40 829 	34 546
Equity attributable to equity holders of the Company 	65 704 	54 451 	47 238
Non-controlling interest 	(5) 	– 	4
TOTAL EQUITY 	65 699 	54 451 	47 242
Liabilities
Liabilities arising from insurance contracts issued 	2.2 	118 878 	105 070 	94 660
Liabilities arising from reinsurance contracts held 	2.2 	9 121 	5 396 	4 819
Deferred tax liability 	5.9.1 	8 755 	6 975 	5 788
Contract liabilities to customers 	5.6 	1 516 	512 	656
Third-party interest in consolidated funds 	35 932 	31 456 	28 346
Financial liabilities
– Borrowings at amortised cost 	3.7 	20 046 	21 662 	20 586
– Other financial payables at amortised cost 	3.9 	9 148 	8 007 	8 568
– Deposits from customers 	3.10 	23 326 	18 467 	14 333
– Investment contracts at fair value through profit or loss 	3.8 	32 188 	25 710 	28 903
– Derivative financial instruments at fair value through profit or loss 	3.4 	135 	31 	20
Provisions 	5.10 	– 	449 	187
Other payables 	5.10 	2 333 	1 216 	1 066
Current tax liability 	373 	232 	165
TOTAL LIABILITIES 	261 751 	225 183 	208 097
TOTAL EQUITY AND LIABILITIES 	327 450 	279 634 	255 339
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Group statement of financial position
as at 30 June 2025
18
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
R million 	Notes
Group
2025
Restated
Group
20241
Insurance revenue 	2.12 	57 713 	52 130
Insurance service expenses 	5.11.1 	(49 028) 	(46 117)
Net expenses from reinsurance contracts 	(1 306) 	(915)
Insurance service result 	7 379 	5 098
Net financial result from insurance finance income and expense 	(13 088) 	(7 293)
– Net finance expense from insurance contracts 	2.13 	(12 665) 	(6 950)
– Net finance expense from reinsurance contracts 	2.13 	(423) 	(343)
Investment income using the effective interest rate method 	998 	860
Net fair value gains on financial assets at fair value through profit or loss 	3.11 	25 818 	16 245
Fair value adjustment to liabilities under investment contracts 	(3 810) 	(2 142)
Third party interest: fair value adjustment to liabilities under investment contracts 	(4 394) 	(2 873)
Other gains on financial instruments 	(9) 	5
Net insurance and investment results 	12 894 	9 900
Fee income from administration businesses 	5.6.1 	14 326 	13 596
Vitality income 	5.6.1 	5 322 	4 655
Net banking fee and commission income 	1 695 	1 398
– Banking fee and commission income 	5.6.1 	2 238 	1 872
– Banking fee and commission expense 	(543) 	(474)
Net bank interest and similar income 	966 	779
– Bank interest and similar income using the effective interest rate 	2 203 	1 840
– Bank interest and similar expense using the effective interest rate 	(1 237) 	(1 061)
Other income 	1 832 	1 380
Non-insurance revenue and income 	24 141 	21 808
Net income 	37 035 	31 708
Non-insurance acquisition costs 	(384) 	(491)
Expected credit losses 	(279) 	(183)
Marketing and administration expenses 	5.11.3 	(21 765) 	(19 644)
Impairment of goodwill 	(20) 	–
Operating profit 	14 587 	11 390
(Loss)/gain on dilution and disposal of equity-accounted investments 	(32) 	22
Share of net profits from equity-accounted investments 	1 215 	975
Profit before financing and income tax 	15 770 	12 387
Interest expenses on borrowings and lease liabilities 	3.12 	(2 087) 	(2 036)
Foreign exchange losses 	5.12 	(36) 	(87)
Profit before income tax 	13 647 	10 264
Income tax expense 	5.9.2 	(4 089) 	(2 715)
Profit for the year 	9 558 	7 549
Profit attributable to:
– Ordinary shareholders 	9 471 	7 468
– Preference shareholders 	93 	91
– Non-controlling interest 	(6) 	(10)
9 558 	7 549
Earnings per share for profit attributable to ordinary shareholders of the company
during the year (cents):
– Basic 	1.2.2 	1 402.2 	1 110.3
– Diluted 	1.2.2 	1 394.9 	1 103.7
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Group income statement
for the year ended 30 June 2025
19
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
19	18

-- 12 of 155 --

R million
Group
2025
Restated
Group
20241
Profit for the year 	9 558 	7 549
Income and expenses that will be reclassified to profit or loss when specific conditions are met:
Currency translation differences 	998 	(823)
Unrealised gains/(losses) 	1 032 	(846)
Tax on unrealised (gains)/losses 	(34) 	23
Cash flow hedges 	(104) 	(61)
– Unrealised losses 	(106) 	(65)
– Gains reclassified to profit or loss 	2 	4
Net finance income/(expense) from insurance contracts issued 	2 186 	1 701
– Unrealised income/(expense) 	2 961 	2 265
– Tax on unrealised (income)/expense 	(775) 	(564)
Net finance (expense)/income from reinsurance contracts held 	(282) 	(221)
– Unrealised (expense)/income 	(382) 	(290)
– Tax on unrealised expense/(income) 	100 	69
Share of other comprehensive income from equity-accounted investments 	(120) 	(236)
– Change in fair value of debt instruments at fair value through other comprehensive income 	16 	45
– Currency translation differences 	(136) 	(281)
Total income and expenses that will be reclassified to profit or loss when specific
conditions are met 	2 678 	360
Income and expenses that will not be reclassified to profit or loss:
Equity instruments held at fair value through other comprehensive income 	(2) 	–
– Change in fair value of equity instruments at fair value through other comprehensive income 	(2) 	–
– Tax on change in fair value of equity instruments at fair value through other comprehensive income 	* 	–
Share of other comprehensive income from equity-accounted investments 	23 	17
– Change in fair value of equity instruments at fair value through other comprehensive income 	23 	17
Total income and expenses that will not be reclassified to profit or loss 	21 	17
Other comprehensive income for the year, net of tax 	2 699 	377
Total comprehensive income for the year 	12 257 	7 926
Attributable to:
– Ordinary shareholders 	12 169 	7 839
– Preference shareholders 	93 	91
– Non-controlling interest 	(5) 	(4)
Total comprehensive income for the year 	12 257 	7 926
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
* Amount is less than R500 000.
Group statement of other comprehensive income
for the year ended 30 June 2025
20
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
R million 	Notes
Group
2025
Restated
Group
20241
Cash flows from operating activities 	8 667 	2 733
Cash generated from operations 	6.2.1 	1 289 	3 976
Interest received 	2 955 	2 325
Interest paid 	6.2.4 	(2 877) 	(2 627)
Taxation paid 	6.2.2 	(1 867) 	(1 522)
Net movement in operating assets and liabilities 	9 167 	581
– Increase in operating assets 	6.2.1.1 	(11 060) 	(3 224)
– Increase in operating liabilities 	6.2.1.2 	20 227 	3 805
Cash flows from investing activities 	(1 823) 	(1 886)
Purchase of property and equipment 	(294) 	(414)
Proceeds from disposal of property and equipment 	3 	29
Purchase of intangible assets 	(1 682) 	(1 789)
Acquisition of business and subsidiaries net of cash 	(316) 	–
Additional investment in equity-accounted investments 	(24) 	(17)
Dividends from equity-accounted investments 	490 	305
Cash flows from financing activities 	(4 016) 	(780)
Purchase of treasury shares 	– 	(131)
Dividends paid to ordinary shareholders 	(1 614) 	(1 178)
Dividends paid to preference shareholders 	(93) 	(91)
Proceeds from borrowings 	6.2.3 	3 264 	2 005
Repayment of borrowings 	6.2.3 	(5 573) 	(1 385)
Net increase in cash and cash equivalents 	2 828 	67
Cash and cash equivalents at beginning of the year 	18 965 	19 138
Effects of exchange rate changes on cash and cash equivalents 	173 	(240)
Cash and cash equivalents at end of the year 	3.6 	21 966 	18 965
Reconciliation to statement of financial position
Cash and cash equivalents 	21 968 	18 971
Bank overdraft included in borrowings at amortised cost 	(2) 	(6)
Cash and cash equivalents at end of the year 	3.6 	21 966 	18 965
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Group statement of cash flows
for the year ended 30 June 2025
21
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
21	20

-- 13 of 155 --

R million
Attributable to equity holders of the Company 	Attributable to equity holders of the Company
Share capital
and share
premium
Perpetual
preference
share capital
Share-based
payment
reserve
Investment
reserve1
Insurance
finance
reserve
Foreign
currency
translation
reserve
Hedging
reserve
Retained
earnings 	Total
Non-
controlling
interest 	Total Equity
Year ended 30 June 2025
At beginning of the year 	10 667 	779 	1 433 	81 	(4 832) 	5 514 	(20) 	40 829 	54 451 	– 	54 451
Total comprehensive income for the year 	– 	93 	– 	37 	1 904 	861 	(104) 	9 471 	12 262 	(5) 	12 257
Profit for the year 	– 	93 	– 	– 	– 	– 	– 	9 471 	9 564 	(6) 	9 558
Other comprehensive income 	– 	– 	– 	37 	1 904 	861 	(104) 	– 	2 698 	1 	2 699
Transactions with owners 	691 	(93) 	47 	– 	– 	– 	– 	(1 654) 	(1 009) 	– 	(1 009)
Share issue 	626 	– 	– 	– 	– 	– 	– 	(23) 	603 	– 	603
Increase in treasury shares 	(626) 	– 	– 	– 	– 	– 	– 	– 	(626) 	– 	(626)
Delivery of treasury shares 	691 	– 	(674) 	– 	– 	– 	– 	(17) 	– 	– 	–
Employee share option schemes:
– Value of employee services, net of tax 	– 	– 	721 	– 	– 	– 	– 	– 	721 	– 	721
Dividends paid to preference shareholders 	– 	(93) 	– 	– 	– 	– 	– 	– 	(93) 	– 	(93)
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	– 	– 	– 	(1 614) 	(1 614) 	– 	(1 614)
At end of the year 	11 358 	779 	1 480 	118 	(2 928) 	6 375 	(124) 	48 646 	65 704 	(5) 	65 699
Year ended 30 June 2024
At beginning of the year 	10 351 	779 	1 190 	19 	(3 184) 	6 624 	41 	33 900 	49 720 	4 	49 724
– Prior period error adjustments2 	– 	– 	– 	– 	(3 128) 	– 	– 	646 	(2 482) 	– 	(2 482)
Restated balance at beginning of the year 	10 351 	779 	1 190 	19 	(6 312) 	6 624 	41 	34 546 	47 238 	4 	47 242
Total comprehensive income for the year 	– 	91 	– 	62 	1 480 	(1 110) 	(61) 	7 468 	7 930 	(4) 	7 926
Profit for the year 	– 	91 	– 	– 	– 	– 	– 	7 468 	7 559 	(10) 	7 549
Other comprehensive income 	– 	– 	– 	62 	1 480 	(1 110) 	(61) 	– 	371 	6 	377
Transactions with owners 	316 	(91) 	243 	– 	– 	– 	– 	(1 185) 	(717) 	– 	(717)
Share issue 	432 	– 	– 	– 	– 	– 	– 	– 	432 	– 	432
Increase in treasury shares 	(563) 	– 	– 	– 	– 	– 	– 	– 	(563) 	– 	(563)
Delivery of treasury shares 	447 	– 	(440) 	– 	– 	– 	– 	(7) 	– 	– 	–
Employee share option schemes:
– Value of employee services, net of tax 	– 	– 	683 	– 	– 	– 	– 	– 	683 	– 	683
Dividends paid to preference shareholders 	– 	(91) 	– 	– 	– 	– 	– 	– 	(91) 	– 	(91)
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	– 	– 	– 	(1 178) 	(1 178) 	– 	(1 178)
At end of the year 	10 667 	779 	1 433 	81 	(4 832) 	5 514 	(20) 	40 829 	54 451 	– 	54 451
1 This relates to fair value adjustments on those equity instruments designated at fair value through other comprehensive income (FVOCI) and those debt instruments
measured at FVOCI, in terms of IFRS 9 Financial Instruments.
2 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Group statement of changes in equity
for the year ended 30 June 2025
22 	23
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
23	22

-- 14 of 155 --

Notes to the Group annual financial statements
for the year ended 30 June 2025
SECTION 01
Operating Segment and earnings
■ Segment information
■ Earnings, headline earnings and normalised earnings
SECTION 02
Insurance and reinsurance
contracts and management of
insurance risk
■ Introduction and overview
■ Insurance and reinsurance contract disclosures and
reconciliations including Net investment result
■ Management of insurance risk
SECTION 03
Financial instruments and
management of financial risk
■ Introduction and overview
■ Financial instrument disclosures and reconciliations
■ (All financial assets, financial liabilities, cash and cash
equivalents, finance costs)
■ Management of financial risk
SECTION 04
Equity, Share-based payments and
related parties
■ Introduction and overview
■ Ordinary share capital and share premium
■ Perpetual preference share capital
■ Share-based payments and long-term incentives
■ Related parties
SECTION 05
Other assets, liabilities, equity-
accounted investments and
items of income and expense
■ Introduction and overview
■ Other investments, assets and liabilities
■ Goodwill
■ Intangibles assets
■ Property and equipment
■ Assets and liabilities arising from contracts
with customers
■ Investments in equity-accounted investees
■ Contract receivables and other receivables
■ Income tax
■ Other payables and provisions
■ Revenue, income and expense
■ Revenue
■ Marketing and administration expenses
■ Foreign exchange gains or losses
■ Income tax expense
SECTION 06
Cash flows information
Introduction and overview
Cash flow information
■ Cash generated from operations
■ Taxation paid
■ Movement of borrowings
■ Interest paid
■ Dividends received
SECTION 07
Other disclosures
■ Introduction and overview
■ Capital commitments
■ Events after reporting period
■ Restatement
24
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 01
OPERATING
SEGMENT AND
EARNINGS
Description of segments and segment
information
Earnings, headline earnings and
normalised earnings
25
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
25	24

-- 15 of 155 --

SECTION 1: OPERATING SEGMENT AND EARNINGS
1.1 	SEGMENT INFORMATION
Discovery’s operating segments are reported in a manner consistent with the internal reporting provided to the chief operating
decision-maker (CODM). The CODM has been identified as the Group Executive Committee who makes strategic decisions
regarding these businesses.
An operating segment is a component of an entity:
(a) That engages in business activities from which it may earn revenues and incur expenses, including revenues and expenses
relating to transactions with other components of the same entity.
(b) Whose operating results are regularly reviewed by the entity’s CODM to make decisions about resources to be allocated to
the segment and assess its performance; and
(c) For which discrete financial information is available.
An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations
may be operating segments before earning revenues.
Discovery will report separately information about an operating segment that meets any of the following quantitative
thresholds:
(a) Its reported revenue, including both sales to external customers and intersegment sales or transfers, is 10 percent or more
of the combined revenue, internal and external, of all operating segments.
(b) The absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount, of (i) the
combined reported profit of all operating segments that did not report a loss and (ii) the combined reported loss of all
operating segments that reported a loss; and
(c) Its assets are 10 percent or more of the combined assets of all operating segments.
Operating segments that do not meet any of the quantitative thresholds may be considered reportable, and separately
disclosed, if management believes that information about the segment would be useful to users of the financial statements.
Discovery may combine information about operating segments that do not meet the quantitative thresholds with information
about other operating segments that do not meet the quantitative thresholds to produce a reportable segment only if the
operating segments have similar economic characteristics.
The Group has identified its reportable segments based on a combination of products and services offered to customers and the
location of the markets served.
Notes to the group annual financial statements
for the year ended 30 June 2025
26
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.1 	SEGMENT INFORMATION continued
The following summary describes the operations of each of the Group’s reportable segments:
Notes to the group annual financial statements continued
for the year ended 30 June 2025
27
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SA HEALTH
■ Administers and provides managed care services
to medical schemes in South Africa.
■ Renders administration services to other business
segments within the Group.
■ Together with Medical Services Organisation
International (MSO), a subsidiary company,
delivers health insurance, healthcare risk
management and third-party administration
services within rest of Africa markets.
■ Offers non-medical scheme-related products
such as Gap Cover for unexpected medical costs
and Flexicare – which provides quality, affordable
access to primary healthcare for employees
unable to access medical scheme benefits.
SA INVEST
Offers, through a range of investment fund choices,
including Discovery managed unit trusts, a
comprehensive and flexible range of investment
choices. These products are sold through a number of
investment wrappers, including Discovery Life policies,
and are offered to individuals in South Africa.
SA LIFE
Offers a range of insurance and financial solutions to
the Group’s clients against the financial impact of
lifestyle-changing events in South Africa. This
segment also includes Corporate and Employee
Benefits (CEB), which comprises the Group Risk,
Umbrella and HealthyCompany offerings.
SA INSURE
Offers a range of personal line insurance (motor,
building, household content and portable
possessions) to the Group’s SA clients against the
financial impact of loss or damage. The segment also
includes SA Insure’s equity-accounted interests
including Cambridge Mobile Telematics (CMT).
SA BANK
Offers retail banking solutions, including deposits
and loans and advances, to clients in the South
African market. The Bank is still in a start-up phase.
UK HEALTH
Offers consumer-engaged private medical
insurance products to employer groups and
individuals in the UK. All contracts in this segment
are short-term insurance contracts.
UK LIFE
Offers a risk-only life assurance product. All
contracts in this segment are long-term assurance
contracts offered to both employer groups and
individuals in the UK.
Includes those businesses that are not operating segments, as well as those operating segments that do not
meet the qualitative thresholds for separate reporting. It includes:
■ Discovery SA:
– SA Vitality, which offers health and lifestyle benefits with selected partners to the Group’s SA clients.
– SA Insure commercial: provides commercial short-term risk insurance products to the South African
market. Discovery announced that it is exiting this business with all remaining covers terminated by
31 August 2024.
– SA Distribution: provides sales and distribution services in respect of all SA products.
– Discovery Central Services: performing various shared services, treasury and administrative functions
to entities within the Discovery Group.
– Other new group initiatives: including Discovery Green, as well as unallocated central costs.
■ Vitality:
– Vitality Corporate Services (VCSL): provides administration, distribution and management services for
entities within the UK Composite.
– Vitality Health International, leverages Discovery Health and Vitality’s intellectual property to create
strategic partnerships through equity-accounted interests in health insurance and health technology
and solutions businesses, which includes the equity-accounted interests in Ping An Health Insurance
and Amplify Health.
– Vitality Network: which provides a Vitality platform to international insurance businesses.
– Includes immaterial interests in equity-accounted interests, UK Invest (closed down), as well as
unallocated central costs.
27	26

-- 16 of 155 --

SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.1 	SEGMENT INFORMATION continued
The Group Executive Committee assesses the performance of the reportable segments based on normalised profit/loss from
operations. Items that are excluded from normalised profit/loss from operations are separately disclosed in the segment
information to reconcile to the segment results and Group income statement. The segment information is presented on the
same basis as reported to the CODM.
The segment total is then adjusted for accounting reclassifications and entries required to produce results compliant with the
IFRS Accounting Standards, i.e. IFRS reporting adjustments. These adjustments include the following:
(a) Unit trusts that the Group controls in terms of IFRS 10 Consolidated Financial Statements are consolidated into Discovery’s
results for IFRS purposes. The IFRS reporting adjustments include the effects of consolidating the unit trusts into Discovery’s
results, effectively being the income and expenses relating to units held by third parties.
(b) The effects of eliminating intercompany transactions on consolidation and normalised operating profit adjustments; and
(c) The effects of reclassifying items to align to the IFRS Group income statement.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
28
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.1 	SEGMENT INFORMATION continued
Changes from 1 July 2024
1. In response to the IFRIC decision on the presentation of material items of revenue and expenses for segment information,
Discovery’s internal enhancements to financial reporting, and observations from the JSE Proactive Monitoring process,
Discovery Group has expanded its segment disclosure. In particular, the adjustments take into account the information
reviewed by the CODM as well as the required disclosures of specified transactions included in the measurement of
normalised profit from operations, in compliance with IFRS 8.23.
As a result, Discovery has implemented the following changes:
■ To reflect material items of income and expense, marketing and administration expenses have been disaggregated to
separately present staff costs, which represent a material component of these expenses. The staff costs shown in the
segment are net of allocations to the insurance service expense. A separate note (1.1.2) has been included in the segment
information for this disclosure.
■ Discovery has included a separate note (1.1.1) to clearly present items of revenue and other income arising from internal
transactions with other segments.
To implement the changes as disclosed in note 1.1.1. for internal transactions, Discovery has revised the presentation of
intersegment charges, recoveries, revenues, and income:
■ Prior to 1 July 2024 – Intercompany recoveries, recharges, other income, and intercompany revenues were offset within
marketing and administration expenses, with the net expense reflected in the segment.
■ Effective from 1 July 2024 – The presentation of these items within segment information now aligns more closely with the
financial statements of the respective business lines.
■ These changes have been enabled through the new financial reporting system and required significant development to
ensure the accuracy of the information. As permitted by IFRS 8.29, prior-year segment information has not been restated
due to the cost and effort required to reperform the changes for the prior period. Refer to Note 1.1.1 for further details,
ensuring that the results for the year ended 30 June 2025 are comparable to those for the year ended 30 June 2024.
2. Prior to 1 July 2024, VCSL was included as part of the UK Health segment alongside Vitality Health. Effective from 1 July 2024
(with restatement of comparative information), VCSL, as the central services company within the UK, has been excluded
from the UK Health segment and instead included in All other segments. This treatment aligns VCSL with the treatment of
Discovery Central Services. This change, together with the other changes noted earlier, had no impact on the normalised
profit from operations for the UK Health segment as well as no impact in All other segments.
3. The CODM has revised their view of SA Bank costs related to health and lifestyle benefits to align more closely with the
treatment in Discovery Bank’s separate statutory accounts. These costs were previously disclosed within marketing and
administration expenses and are now included within the Net banking fee and commission income of SA Bank. The
comparative information has been restated accordingly to reflect this revised treatment resulting in a decrease of
R328 million in the Net banking and commission income, with an equal and opposite decrease in marketing and
administration expenses. This change in management view had no resultant change in the Group income statement.
4. Prior to 1 July 2024, the Group Risk portfolio of the CEB business was included within the SA Life segment, while the
remainder of the CEB business was reported under All other segments in the segment information. To reflect the
operational and managerial alignment of CEB with SA Life’s business activities and internal reporting structure, the
remainder of CEB business was reclassified to the SA Life segment effective from 1 July 2024.The comparative information
has been restated accordingly, resulting in a R67 million decrease in SA Life’s normalised profit from operations, with a
corresponding increase in All other segments. The change has no impact on the Group’s normalised profit from operations.
5. Prior to 1 July 2024, Vitality Drive International (VDI) was included under All other segments. Effective from 1 July 2024 (with
no restatement of comparative information), VDI has been reclassified to the SA Insure segment. This reflects the strategic
integration of VDI within Discovery Insure’s international expansion and incentive-based behaviour programme, aligning the
reporting structure with operational responsibility and performance oversight. Discovery Insure’s previously published
normalised profit from operations has not been restated as the effect was immaterial in the prior period.
6. From 1 July 2024, SA Invest amended the presentation of specified income tax expenses within its business line to improve
the usefulness of the information provided and to enhance comparability with peers in the market. Within its normalised
profit from operations, SA Invest now includes tax expenses specific to policyholder tax funds that are directly chargeable to,
or recoverable from, policyholders. These are also often referred to as ‘policyholder taxes’ or ‘contract holder taxes’. The
comparative information has been restated to reflect this revised presentation.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
29
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
29	28

-- 17 of 155 --

SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.1 	SEGMENT INFORMATION continued
R million 	Notes
SA
Health
SA
Life
SA
Invest
SA
Insure
SA
Bank
UK
Health
UK
Life
All other
segments
Segment
total
IFRS
reporting
adjustments
IFRS
total
30 June 2025
Income statement
Insurance revenue 	518 	19 149 	4 560 	6 217 	– 	19 124 	8 050 	95 	57 713 	– 	57 713
– Contracts measured under the General measurement model/Variable fee approach 	– 	15 419 	4 560 	– 	– 	– 	8 050 	– 	28 029 	– 	28 029
– Contracts measured under Premium allocation approach 	518 	3 730 	– 	6 217 	– 	19 124 	– 	95 	29 684 	– 	29 684
Insurance service expenses 	(362) 	(15 512) 	(2 676) 	(5 499) 	– 	(17 292) 	(7 595) 	(92) 	(49 028) 	– 	(49 028)
– Claims and benefits 	(216) 	(11 375) 	(608) 	(3 000) 	– 	(11 300) 	(3 681) 	(51) 	(30 231) 	– 	(30 231)
– Insurance service expense and other 	(66) 	(1 795) 	(1 057) 	(1 597) 	– 	(3 981) 	(879) 	(37) 	(9 412) 	– 	(9 412)
– Insurance acquisition cash flows 	(80) 	(2 342) 	(1 011) 	(902) 	– 	(2 011) 	(3 035) 	(4) 	(9 385) 	– 	(9 385)
Tax specific to policyholder tax funds1 	– 	– 	(97) 	– 	– 	– 	– 	– 	(97) 	97 	–
Insurance service result (pre-reinsurance) 	156 	3 637 	1 787 	718 	– 	1 832 	455 	3 	8 588 	97 	8 685
Net expenses from reinsurance contracts 	(1) 	(1 021) 	– 	(112) 	– 	(3) 	(165) 	(4) 	(1 306) 	– 	(1 306)
– Reinsurance expense 	(2) 	(3 838) 	– 	(130) 	– 	(5) 	(8 839) 	(34) 	(12 848) 	– 	(12 848)
– Insurance claims recovered from reinsurers 	1 	2 817 	– 	18 	– 	2 	8 674 	30 	11 542 	– 	11 542
Insurance service result 	155 	2 616 	1 787 	606 	– 	1 829 	290 	(1) 	7 282 	97 	7 379
Net financial result from insurance finance income and expense 	– 	2 466 	(15 831) 	(20) 	– 	– 	417 	– 	(12 968) 	(120) 	(13 088)
– Net finance income/(expense) from insurance contracts 	– 	2 590 	(15 831) 	(20) 	– 	– 	716 	– 	(12 545) 	(120) 	(12 665)
– Net finance expense from reinsurance contracts 	– 	(124) 	– 	– 	– 	– 	(299) 	– 	(423) 	– 	(423)
Investment income using the effective interest rate method 	11 	15 	75 	268 	– 	179 	81 	17 	646 	352 	998
Net fair value gains on financial instruments at fair value through profit or loss 	29 	3 537 	17 058 	11 	52 	70 	– 	– 	20 757 	5 061 	25 818
Fair value adjustments to liabilities under investment contracts2 	– 	(2 961) 	(905) 	– 	– 	– 	– 	– 	(3 866) 	56 	(3 810)
Third-party interest: fair value adjustments to liabilities under investment contracts 	– 	– 	– 	– 	– 	– 	– 	– 	– 	(4 394) 	(4 394)
Intersegment funding 	– 	362 	(362) 	– 	– 	– 	– 	– 	– 	– 	–
Other losses on financial instruments 	– 	– 	– 	– 	(9) 	– 	– 	– 	(9) 	– 	(9)
Net insurance and investment results 	195 	6 035 	1 822 	865 	43 	2 078 	788 	16 	11 842 	1 052 	12 894
Fee income from administration businesses 	1.1.1 	9 766 	188 	1 260 	– 	– 	35 	– 	3 185 	14 434 	(108) 	14 326
Vitality income 	– 	– 	– 	– 	– 	31 	267 	5 575 	5 873 	(551) 	5 322
Net banking fee and commission income 	– 	– 	– 	– 	1 373 	– 	– 	(77) 	1 296 	399 	1 695
– Banking fee and commission income 	– 	– 	– 	– 	2 238 	– 	– 	– 	2 238 	– 	2 238
– Banking fee and commission expense 	– 	– 	– 	– 	(865) 	– 	– 	(77) 	(942) 	399 	(543)
Net banking interest and similar income 	– 	– 	– 	– 	965 	– 	– 	– 	965 	1 	966
– Banking interest and similar income using the effective interest rate 	– 	– 	– 	– 	2 203 	– 	– 	– 	2 203 	– 	2 203
– Banking interest and similar expense using the effective interest rate 	– 	– 	– 	– 	(1 238) 	– 	– 	– 	(1 238) 	1 	(1 237)
Other income 	1.1.1 	1 838 	119 	1 	79 	69 	19 	– 	14 591 	16 716 	(14 884) 	1 832
Non-insurance revenue and income 	11 604 	307 	1 261 	79 	2 407 	85 	267 	23 274 	39 284 	(15 143) 	24 141
Net income 	11 799 	6 342 	3 083 	944 	2 450 	2 163 	1 055 	23 290 	51 126 	(14 091) 	37 035
Non-insurance acquisition costs 	– 	– 	(395) 	– 	– 	– 	– 	(294) 	(689) 	305 	(384)
Expected credit losses 	– 	– 	– 	– 	(279) 	– 	– 	– 	(279) 	– 	(279)
Marketing and administration expenses 	1.1.2 	(7 540) 	(817) 	(701) 	(213) 	(2 239) 	(975) 	(424) 	(23 305) 	(36 214) 	14 449 	(21 765)
Share of net profits from equity-accounted investments 	– 	– 	– 	86 	– 	– 	6 	1 174 	1 266 	(51) 	1 215
Normalised profit/(loss) from operations 	1.2 	4 259 	5 525 	1 987 	817 	(68) 	1 188 	637 	865 	15 210 	612 	15 822
Investment income earned on shareholder investments and cash 	98 	31 	13 	7 	– 	– 	– 	203 	352 	(352) 	–
Intercompany investment income 	– 	– 	– 	– 	– 	– 	– 	1 351 	1 351 	(1 351) 	–
Net fair value gains/(losses) on financial assets at fair value through profit or loss 	– 	51 	54 	– 	– 	– 	– 	– 	105 	(105) 	–
(Loss)/gain from dilution of equity accounted investments 	– 	– 	– 	(32) 	– 	– 	– 	– 	(32) 	– 	(32)
Impairment of goodwill 	(20) 	– 	– 	– 	– 	– 	– 	– 	(20) 	– 	(20)
Amortisation of intangibles from business combinations 	– 	– 	– 	(51) 	– 	– 	– 	(71) 	(122) 	122 	–
Market rentals related to Head Office building adjusted for finance costs and
depreciation 	– 	– 	– 	– 	– 	– 	– 	(72) 	(72) 	72 	–
Restructuring costs 	– 	– 	– 	– 	– 	– 	– 	(80) 	(80) 	80 	–
Interest expenses on borrowings and lease liabilities 	(2) 	(1) 	– 	– 	– 	(18) 	(201) 	(1 588) 	(1 810) 	(277) 	(2 087)
Intercompany finance expenses on borrowings 	(447) 	– 	– 	– 	– 	– 	(444) 	(460) 	(1 351) 	1 351 	–
Foreign exchange (losses)/gains 	(5) 	(14) 	(5) 	– 	– 	– 	1 	(13) 	(36) 	– 	(36)
Profit/(loss) before income tax 	3 883 	5 592 	2 049 	741 	(68) 	1 170 	(7) 	135 	13 495 	152 	13 647
Income tax expense 	(1 046) 	(1 508) 	(793) 	(216) 	25 	(311) 	(62) 	(26) 	(3 937) 	(152) 	(4 089)
Profit/(loss) for the year 	2 837 	4 084 	1 256 	525 	(43) 	859 	(69) 	109 	9 558 	– 	9 558
Profit attributable to:
– Ordinary shareholders 	2 843 	4 084 	1 256 	525 	(43) 	859 	(69) 	16 	9 471 	– 	9 471
– Preference shareholders 	– 	– 	– 	– 	– 	– 	– 	93 	93 	– 	93
– Non-controlling interest 	(6) 	– 	– 	– 	– 	– 	– 	– 	(6) 	– 	(6)
1 Tax specific to policyholder tax funds is reallocated from the income tax expense line. This includes taxes that are directly chargeable to the policyholder under insurance contracts, with a corresponding change in the policyholder fund values, which are included within the insurance revenue line.
2 The value is reflected net of contract holder taxes, which are taxes directly chargeable to the contract holder. There is a corresponding change in the contract holder value, which is included in the fair value measurement.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
30 	31
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
31	30

-- 18 of 155 --

SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.1 	SEGMENT INFORMATION continued
R million 	Notes
SA
Health
SA
Life
SA
Invest
SA
Insure
SA
Bank
UK
Health
UK
Life
All other
segments
Segment
total
IFRS
reporting
adjustments
IFRS
total
30 June 2024 Restated1
Income statement
Insurance revenue 	435 	17 522 	4 360 	5 737 	– 	16 474 	6 904 	698 	52 130 	– 	52 130
– Contracts measured under the General measurement model/Variable fee approach 	– 	14 014 	4 360 	– 	– 	– 	6 904 	– 	25 278 	– 	25 278
– Contracts measured under Premium allocation approach 	435 	3 508 	– 	5 737 	– 	16 474 	– 	698 	26 852 	– 	26 852
Insurance service expenses 	(341) 	(15 207) 	(2 671) 	(5 471) 	– 	(15 456) 	(6 217) 	(754) 	(46 117) 	– 	(46 117)
– Claims and benefits 	(224) 	(12 104) 	(462) 	(3 540) 	– 	(9 562) 	(3 098) 	(472) 	(29 462) 	– 	(29 462)
– Insurance service expense and other 	(54) 	(1 096) 	(1 148) 	(1 069) 	– 	(4 127) 	(509) 	(135) 	(8 138) 	– 	(8 138)
– Insurance acquisition cash flows 	(63) 	(2 007) 	(1 061) 	(862) 	– 	(1 767) 	(2 610) 	(147) 	(8 517) 	– 	(8 517)
Tax specific to policyholder tax funds2 	(85) 	(85) 	85 	–
–
Insurance service result (pre-reinsurance) 	94 	2 315 	1 604 	266 	– 	1 018 	687 	(56) 	5 928 	85 	6 013
Net income/(expenses) from reinsurance contracts 	(1) 	(458) 	– 	(24) 	– 	(8) 	(408) 	(16) 	(915) 	– 	(915)
– Reinsurance expense 	(1) 	(3 692) 	– 	(474) 	– 	(8) 	(5 738) 	(275) 	(10 188) 	– 	(10 188)
– Insurance claims recovered from reinsurers 	– 	3 234 	– 	450 	– 	– 	5 330 	259 	9 273 	– 	9 273
Insurance service result 	93 	1 857 	1 604 	242 	– 	1 010 	279 	(72) 	5 013 	85 	5 098
Net financial result from insurance finance income and expense 	– 	2 626 	(9 850) 	– 	– 	– 	231 	– 	(6 993) 	(300) 	(7 293)
– Net finance income/(expense) from insurance contracts 	– 	2 821 	(9 850) 	– 	– 	– 	379 	– 	(6 650) 	(300) 	(6 950)
– Net finance expense from reinsurance contracts 	– 	(195) 	– 	– 	– 	– 	(148) 	– 	(343) 	– 	(343)
Investment income using the effective interest rate method 	– 	32 	49 	209 	– 	175 	65 	12 	542 	318 	860
Net fair value (losses)/gains on financial instruments at fair value through profit or loss 	(6) 	2 420 	10 098 	1 	1 	60 	– 	(48) 	12 526 	3 719 	16 245
Fair value adjustments to liabilities under investment contracts3 	– 	(1 450) 	(749) 	– 	– 	– 	– 	46 	(2 153) 	11 	(2 142)
Third-party interest: fair value adjustments to liabilities under investment contracts 	– 	– 	– 	– 	– 	– 	– 	– 	– 	(2 873) 	(2 873)
Intersegment funding 	(13) 	(282) 	282 	13 	– 	– 	– 	– 	– 	– 	–
Other gains and losses on financial instruments 	– 	– 	– 	– 	5 	– 	– 	– 	5 	– 	5
Net investment and financial results 	74 	5 203 	1 434 	465 	6 	1 245 	575 	(62) 	8 940 	960 	9 900
Fee income from administration businesses 	1.1.1 	9 233 	155 	1 215 	– 	– 	31 	– 	2 962 	13 596 	– 	13 596
Vitality income 	1.1.1 	– 	– 	– 	– 	– 	23 	264 	4 368 	4 655 	– 	4 655
Net banking fee and commission income 	– 	– 	– 	– 	1 039 	– 	– 	31 	1 070 	328 	1 398
– Banking fee and commission income 	– 	– 	– 	– 	1 795 	– 	– 	– 	1 795 	77 	1 872
– Banking fee and commission expense 	– 	– 	– 	– 	(756) 	– 	– 	31 	(725) 	251 	(474)
Net banking interest and similar income 	– 	– 	– 	– 	779 	– 	– 	– 	779 	– 	779
– Banking interest and similar income using the effective interest rate 	– 	– 	– 	– 	1 840 	– 	– 	– 	1 840 	– 	1 840
– Banking interest and similar expense using the effective interest rate 	– 	– 	– 	– 	(1 061) 	– 	– 	– 	(1 061) 	– 	(1 061)
Other income 	1.1.1 	1 173 	3 	– 	16 	– 	22 	– 	106 	1 320 	60 	1 380
Non-insurance revenue and income 	10 406 	158 	1 215 	16 	1 818 	76 	264 	7 467 	21 420 	388 	21 808
Net income 	10 480 	5 361 	2 649 	481 	1 824 	1 321 	839 	7 405 	30 360 	1 348 	31 708
Non-insurance acquisition costs 	– 	– 	(383) 	– 	– 	– 	– 	(108) 	(491) 	– 	(491)
Expected credit losses 	– 	– 	– 	– 	(183) 	– 	– 	– 	(183) 	– 	(183)
Marketing and administration expenses 	1.1.2 	(6 508) 	(523) 	(727) 	(282) 	(2 095) 	(886) 	(470) 	(7 459) 	(18 950) 	(694) 	(19 644)
Share of net profits from equity-accounted investments 	– 	– 	– 	49 	– 	– 	6 	970 	1 025 	(50) 	975
Normalised profit/(loss) from operations 	1.2 	3 972 	4 838 	1 539 	248 	(454) 	435 	375 	808 	11 761 	604 	12 365
Investment income earned on shareholder investments and cash 	120 	27 	16 	– 	– 	– 	– 	155 	318 	(318) 	–
Intercompany investment income 	– 	– 	– 	– 	– 	– 	– 	1 046 	1 046 	(1 046) 	–
Net fair value gains/(losses) on financial assets at fair value through profit or loss 	– 	87 	75 	– 	– 	– 	– 	– 	162 	(162) 	–
Gain/(Loss) from dilution and disposal of equity accounted investments 	– 	– 	– 	22 	– 	– 	– 	– 	22 	– 	22
Amortisation of intangibles from business combinations 	– 	– 	– 	(49) 	– 	– 	– 	(56) 	(105) 	105 	–
Market rentals related to Head Office building adjusted for finance costs and depreciation 	– 	– 	– 	– 	– 	– 	– 	(105) 	(105) 	105 	–
Restructuring costs 	– 	– 	– 	– 	– 	– 	– 	(48) 	(48) 	48 	–
Interest expenses on borrowings and lease liabilities 	(2) 	(1) 	– 	– 	– 	(17) 	(217) 	(1 513) 	(1 750) 	(286) 	(2 036)
Intercompany finance expenses on borrowings 	(412) 	– 	– 	– 	– 	– 	(464) 	(170) 	(1 046) 	1 046 	–
Foreign exchange gains/(losses) 	(6) 	(11) 	(20) 	– 	– 	– 	– 	(50) 	(87) 	– 	(87)
Profit/(loss) before income tax 	3 672 	4 940 	1 610 	221 	(454) 	418 	(306) 	67 	10 168 	96 	10 264
Income tax expense 	(987) 	(1 334) 	(273) 	(58) 	171 	(29) 	25 	(134) 	(2 619) 	(96) 	(2 715)
Profit/(loss) for the year 	2 685 	3 606 	1 337 	163 	(283) 	389 	(281) 	(67) 	7 549 	– 	7 549
Profit attributable to:
– Ordinary shareholders 	2 695 	3 606 	1 337 	163 	(283) 	389 	(281) 	(158) 	7 468 	– 	7 468
– Preference shareholders 	– 	– 	– 	– 	– 	– 	– 	91 	91 	– 	91
– Non-controlling interest 	(10) 	– 	– 	– 	– 	– 	– 	– 	(10) 	– 	(10)
1 The comparative information has been restated due to (1) correction of a prior period error as discussed in note 7.5 as well as (2) those changes noted in
items 2 (VCSL Branch), 3 (SA Bank costs of specified benefits), 4 (CEB Business) and 6 (SA Invest specified income tax expenses) as discussed in the introduction
to Segment information “Changes from 1 July 2024”.
2 Tax specific to policyholder tax funds is reallocated from the income tax expense line. This includes taxes that are directly chargeable to the policyholder
under insurance contracts, with a corresponding change in the policyholder fund values, which are included within the insurance revenue line.
3 The value is reflected net of contract holder taxes, which are taxes directly chargeable to the contract holder. There is a corresponding change in the contract holder value, which is included in the fair value measurement.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
32 	33
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
33	32

-- 19 of 155 --

SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.1 	SEGMENT INFORMATION continued
1.1.1 	Revenues and income with other operating segments
The net income presented within each respective segment includes the following items of revenue and income derived from
transactions with other operating segments of the Group:
R million
SA
Health
SA
Life
SA
Invest
SA
Insure
SA
Bank
UK
Health
UK
Life
All other
segments
Segment
total
30 June 2025
Fee income from administration businesses 	– 	– 	– 	– 	– 	– 	– 	94 	94
Vitality income 	– 	– 	– 	– 	– 	– 	– 	551 	551
Other income 	235 	130 	1 	64 	69 	94 	– 	14 784 	15 377
Total 	235 	130 	1 	64 	69 	94 	– 	15 429 	16 022
1.1.2 	Material items of expenses
Additional information on material items of expenses included within the marketing and administration expenses:
R million
SA
Health
SA
Life
SA
Invest
SA
Insure
SA
Bank
UK
Health
UK
Life
All other
segments
Segment
total
30 June 2025
Depreciation and amortisation 	(174) 	(1) 	(24) 	(1) 	(368) 	– 	(58) 	(1 273) 	(1 899)
Derecognition of intangible assets and property and equipment 	– 	(43) 	– 	(52) 	– 	– 	(1) 	(45) 	(141)
Impairment of intangible assets and property and equipment 	(20) 	(28) 	– 	(18) 	– 	(79) 	– 	– 	(145)
Staff costs 	(3 038) 	(284) 	(262) 	(95) 	(984) 	– 	– 	(8 062) 	(12 725)
Other expenses1 	(4 308) 	(461) 	(415) 	(47) 	(887) 	(896) 	(365) 	(13 925) 	(21 304)
Total: Marketing and administration expenses 	(7 540) 	(817) 	(701) 	(213) 	(2 239) 	(975) 	(424) 	(23 305) 	(36 214)
30 June 2024
Depreciation and amortisation 	(171) 	– 	(17) 	(43) 	(339) 	(5) 	(49) 	(1 276) 	(1 900)
Derecognition of intangible assets and property and equipment 	– 	– 	– 	(16) 	– 	– 	– 	(39) 	(55)
Impairment of intangible assets and property and equipment 	– 	– 	– 	– 	– 	(13) 	– 	(9) 	(22)
Staff costs 	(2 625) 	(212) 	(210) 	(71) 	(911) 	– 	– 	(7 486) 	(11 515)
Other expenses1 	(3 712) 	(311) 	(500) 	(152) 	(845) 	(868) 	(421) 	1 351 	(5 458)
Total: Marketing and administration expenses 	(6 508) 	(523) 	(727) 	(282) 	(2 095) 	(886) 	(470) 	(7 459) 	(18 950)
1 Included in SA Health other expenses are IT systems and consumables of R1 576 million (2024: R1 488 million)
Changes since 1 July 2024: As noted earlier, Discovery changed the presentation of intercompany recoveries, recharges, other
income and intercompany revenues. If the information for the year ended 30 June 2025 was presented on a similar basis to the
results for the year ended 30 June 2024, the ‘Total: Marketing and administration expenses’ would have been reduced by the
value equal to the ‘Total’ as disclosed in Note 1.1.1.
34 	35
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
35	34

-- 20 of 155 --

SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.2 	EARNINGS, HEADLINE EARNINGS AND NORMALISED HEADLINE EARNINGS
continued
1.2.1 	Normalised profit from operations
The following table shows the main components of the normalised profit from operations for the year ended 30 June 2025:
R million
Group
2025
Restated
Group
20241
%
Change
Discovery Health 	4 259 	3 972 	7 %
Discovery Life 	5 525 	4 838 	14 %
Discovery Invest 	1 987 	1 539 	29 %
Discovery Insure – Personal lines 	817 	248 	229 %
Discovery Bank 	(68) 	(454) 	(85) %
Other initiatives and central costs* 	(515) 	(269) 	91 %
Normalised profit from Discovery SA 	12 005 	9 874 	22 %
VitalityHealth 	1 188 	435 	173 %
VitalityLife 	637 	375 	70 %
Closure costs of VitalityInvest* 	– 	(75) 	(100) %
Vitality Health International – Ping An Health Insurance* 	1 206 	1 124 	7 %
Vitality Health International – Other* 	(291) 	(386) 	(25) %
Vitality Network* 	554 	533 	4 %
Other initiatives and central costs* 	(89) 	(119) 	(25) %
Normalised profit from Vitality 	3 205 	1 887 	70 %
Normalised profit from operations 	15 210 	11 761 	29 %
* Presented in ‘All other segments’ on the Segment information disclosure note in section 1.1.
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
36
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.2 	EARNINGS, HEADLINE EARNINGS AND NORMALISED HEADLINE EARNINGS
continued
1.2.2 	Earnings, Headline Earnings and Normalised Headline Earnings
Notes
Group
2025
Restated
Group
20241
Number of shares used in calculation
Weighted number of shares in issue ('000) 	665 168 	661 071
Diluted weighted number of shares ('000) 	668 715 	665 016
Earnings per share (cents):
– basic 	1 402.2 	1 110.3
– diluted 	1 394.9 	1 103.7
Headline earnings per share (cents):
– basic 	1 447.0 	1 117.0
– diluted 	1 439.4 	1 110.4
Normalised headline earnings per share (cents):
– basic 	1 470.4 	1 136.2
– diluted 	1 462.8 	1 129.5
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES (‘000)
Issued ordinary shares at 1 July 	4.3 	661 021 	658 424
Effect of share options exercised and vesting of share awards 	4 147 	2 647
Weighted average number of ordinary shares at 30 June (basic) 	665 168 	661 071
Effect of share options exercised and vesting of share awards 	3 547 	3 945
Weighted-average number of ordinary shares at 30 June (diluted) 	668 715 	665 016
EARNINGS RECONCILIATION (R million)
Profit attributable to the ordinary shareholders 	9 471 	7 468
Adjusted for:
– Profit attributable to non-forfeitable dividend share plan 	(144) 	(128)
Basic earnings attributable to the ordinary shareholders 	9 327 	7 340
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
37
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
37	36

-- 21 of 155 --

SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.2 	EARNINGS, HEADLINE EARNINGS AND NORMALISED HEADLINE EARNINGS
continued
1.2.2 	Earnings, Headline Earnings and Normalised Headline Earnings continued
HEADLINE EARNINGS RECONCILIATION
Headline earnings per share is disclosed per the JSE Listings Requirements and is calculated in accordance with the circular titled
Headline Earnings issued by SAICA, as amended from time to time. Headline earnings per share is based on the net profit after
tax attributable to ordinary shareholders adjusted for items of a capital nature and the weighted average number of ordinary
shares in issue.
R million
Group 2025 	Restated Group 20241
Gross 	Tax 	Net 	Gross 	Tax 	Net
Basic earnings attributable to the
ordinary shareholders 	9 327 	7 340
Adjusted for:
IFRS 3: Goodwill impairment 	20 	– 	20 	– 	– 	–
IFRS 5: Impairment - NCAHFS 	79 	– 	79 	– 	– 	–
IAS 16: Gain on disposal of property
and equipment 	(1) 	– 	(1) 	(1) 	– 	(1)
IAS 16: Loss on derecognition
of property and equipment 	11 	(3) 	8 	10 	(3) 	7
IAS 16: Impairment of property
and equipment 	– 	– 	– 	14 	– 	14
IAS 38: Loss on derecognition
of intangible assets 	131 	(19) 	112 	45 	(10) 	35
IAS 38: Impairment of intangibles 	65 	(10) 	55 	8 	(2) 	6
IAS 28: Loss/(gain) on dilution and
disposal of equity-accounted
investments 	32 	(7) 	25 	(22) 	5 	(17)
Headline earnings
(basic and diluted) 	9 625 	7 384
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
38
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 1: OPERATING SEGMENT AND EARNINGS continued
1.2 	EARNINGS, HEADLINE EARNINGS AND NORMALISED HEADLINE EARNINGS
continued
1.2.2 	Earnings, Headline earnings and Normalised Headline Earnings
NORMALISED HEADLINE EARNINGS RECONCILIATION
Normalised headline earnings is calculated per Discovery’s policy as set out in the Accounting Policies in Annexure B.
Management considers that Normalised headline earnings is an appropriate alternative performance measure to enhance the
comparability and understanding of the financial performance of the Group.
R million
Group 2025 	Restated Group 20241
Gross 	Tax 	Net 	Gross 	Tax 	Net
Headline earnings 	9 625 	7 384
Adjusted for:
– Gain arising from the recognition
of deferred tax asset resulting
from assessed loss: Initial
recognition 	– 	(9) 	(9) 	– 	– 	–
– Amortisation of intangible assets
arising from business
combinations 	71 	(18) 	53 	56 	(15) 	41
– Restructuring costs 	80 	(19) 	61 	48 	(11) 	37
Adjustments attributable to equity-
accounted investments:
– Amortisation of intangible assets
arising from business
combinations 	51 	– 	51 	49 	– 	49
Normalised headline earnings
(basic and diluted) 	9 781 	7 511
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
39
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
39	38

-- 22 of 155 --

SECTION 02
INSURANCE AND
REINSURANCE
CONTRACTS AND
MANAGEMENT OF
INSURANCE RISK
Introduction and overview
Insurance and reinsurance contract
disclosures and reconciliations
including Net investment result
Management of insurance risk
40
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK
2.1 	INTRODUCTION AND OVERVIEW
This section provides information on the group’s core insurance business as well as disclosures that enable the assessment of
the effect of insurance and reinsurance contracts held on the Group statement of financial position, Group income statement,
Group statement of other comprehensive income and Group statement of cash flows. In addition to the disclosures in terms of
IFRS 17 Insurance Contracts (IFRS 17), this section will also provide information on how the Group manages the risks arising
because of insurance contracts.
To assist the users of the financial statements in understanding the insurance and reinsurance disclosures, Section 2 disclosures
have been re-presented for the following:
1. The Discovery SA Life and Invest (Risk) (GMM) portfolio has been split into two separate portfolios — SA Life (Risk) (GMM)
and SA Invest (Risk) (GMM). This change is purely a re-presentation of the information, with no impact on the total values
reported in the SA Life and SA Invest disclosures.
By presenting SA Life (Risk) (GMM) and SA Invest (Risk) (GMM) separately, the users of the financial statements can better
understand the distinct performance and financial impact of each portfolio during the reporting period.
2. The net investment note has been updated to provide a granular breakdown of the key components driving the interest
accretion as presented in profit or loss and OCI. The change is aimed at providing the users of the financial statements a
better understanding of the detailed interest accretion components.
3. The comparative disclosures for the Discovery SA Life (Risk)(GMM) portfolio has been restated due to a correction of a prior
period error, refer to note 7.5 for more detail. Refer to the index summary table for all the notes that have been restated.
R million
Group
June
2025
Restated
Group
June
20243
Assets
Assets arising from insurance contracts issued3 	48 047 	37 339
Assets arising from reinsurance contracts held 	962 	837
Equity
Other reserves1,2,3 	(2 928) 	(4 832)
Liabilities
Liabilities arising from insurance contracts issued 	118 878 	105 070
Liabilities arising from reinsurance contracts held 	9 121 	5 396
1 The other reserves balance relates to the insurance finance reserve only.
2 The insurance finance reserve has a cumulative debit balance, and therefore represents a reduction of total equity.
3 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
R million
Group
June
2025
Restated
Group
June
20241
Insurance revenue 	57 713 	52 130
Insurance service expenses 	(49 028) 	(46 117)
Net expenses from reinsurance contracts 	(1 306) 	(915)
Insurance service result 	7 379 	5 098
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Refer to section 2.19 for the detailed analysis of the insurance risk and management thereof.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
41
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
41	40

-- 23 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.1 	INTRODUCTION AND OVERVIEW continued
The following disclosures enable the user to assess the effect of insurance contracts issued and reinsurance contracts held on
Discovery’s financial position, financial performance and cash flows. In addition to the disclosures on significant judgements and
estimates above, the following disclosures provide a quantitative summary of the amount recognised in the financial statements.
IFRS 17 requires that in determining the level at which an aggregated group of insurance contracts can provide useful
information to the user, Discovery considers:
■ The type of contract which would consider the nature of the product and the measurement model.
■ The geographical areas may expose the entity to different sets of risks, even for similar products.
■ Reportable segments.
Having applied the guidance, Discovery has aggregated its portfolios for the disclosures as set out below.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
42
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SA Life (Risk) | GMM
(Life: Individual Life, Dollar LifePlan,
Health Protection Plans, Standalone Global Educator)
SA Invest (Risk) | GMM
(Guaranteed endowments)
SA Invest (Participating) | VFA
(Unit-linked invest products, Unit-linked insurance
products and Discovery Retirement Optimiser)
SA Life and Invest: Group Life and other | PAA
(Group Risk, Funeral and other including Discovery Card
Protector, Standalone Cancer Protector and LifeDrive)
SA Insure and other | PAA
(Personal and Commercial lines, GAP and Trauma Cover,
Travel Cover and AfricaHealth)
UK Life (Risk) | GMM
(Own Licence and PAC book)
UK Health | PAA
(Private Medical Insurance)
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.1 	INTRODUCTION AND OVERVIEW continued
For the accounting policies relevant to the recognition and measurement of Insurance contracts issued and Reinsurance
contracts held, refer Annexure B policy 12. The following index is a summary of all the quantitative disclosures set out in the
notes:
Note 	Description
Analysis of
financial
position
2.2 Summary of insurance contracts issued and
reinsurance contracts held1,2
The note summarises the total value of insurance
and reinsurance contracts held across the disclosed
portfolios, showing separately those insurance and
reinsurance contracts in a net liability or net asset
position.
2.3 Insurance acquisition assets 	The note provides a movement in the Insurance
acquisition assets, reflecting the movement in the
capitalised initial acquisition cash flows of the
VitalityHealth portfolio.
Reconciliation of insurance contracts
Analysis by remaining coverage and incurred claims
2.4 GMM
2.4.1 SA Life (Risk)1,2
2.4.2 SA Invest (Risk)1,2
2.4.3 UK Life (Risk)
2.6 VFA
2.6.1 SA Invest (Participating)
2.8 PAA
2.8.1 SA Life: Group Life and other
2.8.2 SA Insure and other
2.8.3 UK Health
Reconciliation of reinsurance contracts
Analysis by remaining coverage and incurred claims
2.9 GMM
2.9.1 SA Life (Risk)
2.9.2 UK Life (Risk)
2.11 PAA
2.11.1 SA Life: Group Life and other
2.11.2 SA Insure and other
2.11.3 UK Health
The notes provide a detailed reconciliation of
disclosed portfolios showing the build-up of:
■ The liability for remaining coverage (LRC) reflects
Discovery’s obligation for the unexpired portion
of the coverage period. For contracts measured
using the simplified approach, LRC includes the
unearned premium.
■ The liability of incurred claims (LIC) reflects
Discovery’s obligation to cover the insured events
that have occurred.
Reconciliation of insurance contracts
Analysis by measurement component
2.5 GMM
2.5.1 SA Life (Risk)1,2
2.5.2 SA Invest (Risk)1,2
2.5.3 UK Life (Risk)
2.7 VFA
2.7.1 SA Invest (Participating)
Reconciliation of reinsurance contracts
Analysis by measurement component
2.10 GMM
2.10.1 SA Life (Risk)
2.10.2 UK Life (Risk)
The notes provide a detailed reconciliation of
disclosed portfolios showing the build-up of the
measurement components, namely:
■ Estimates of the present value of expected
fulfilment cash flows.
■ The Risk adjustment.
■ The Contractual service margin reflects unearned
profit. The CSM is further separated to reflect
how the CSM was calculated at transition, being
modified retrospectively or fully retrospectively.
1 The note has been re-presented for the split of the Discovery SA Life and Invest (Risk) (GMM) portfolio. Refer to item 1 noted in the introduction of Section 2.1.
2 The comparative information has been restated due to correction of a prior period error. Refer to item 4 noted in the introduction of section 2.1.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
43
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
43	42

-- 24 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.1 	INTRODUCTION AND OVERVIEW continued
Note 	Description
Analysis of
income
statement
2.12 Insurance revenue1,2 	The note provides a breakdown of the makeup of insurance
revenue for each disclosed portfolio business unit.
For those contracts not measured using the PAA approach,
the amount reflects the provision of services and the recovery
of insurance acquisition cash flows. The provision of services
is represented by the change in the LRC, namely:
■ CSM recognised during the period for the service provided.
■ The change in the Risk adjustment for non-financial risk.
■ Expected claims and insurance services expenses.
■ Experience adjustments.
2.13 Net investment result1,2,3 	The note provides a holistic view of the following:
■ The investment returns on financial assets held.
■ The insurance and reinsurance finance income and
expenses, including the amounts recognised in profit or
loss and other comprehensive income (OCI).
Additional
information
2.14 Effect of contracts initially
recognised in the year:
2.14.1 Effects of insurance contracts
initially recognised in the year1
.
2.14.2 Effect of reinsurance contracts
initially recognised in the year1
.
The notes provide a breakdown of the contracts initially
recognised during the period for each disclosed portfolio
business unit.
■ For insurance contracts, differentiate between profitable
contracts recognised with CSM and onerous contracts.
■ Reinsurance contracts reflect contracts originated with and
without the loss-recovery component.
2.15 Contractual service margin1,3
. 	The note provides, for each disclosed portfolio business unit,
the expected recognition of CSM, with interest accretion over
the lifetime of the group of insurance contracts.
The note also sets out the release of accumulated IFIE OCI
balances into profit or loss.
2.16 OCI run-off3 	The note provides, for each disclosed portfolio business unit,
the expected run-off of the IFIE reserve, with interest accretion
over the lifetime of the group of insurance contracts.
2.17 Claims development 	The note provides, for the annuity type benefits, the
comparison between actual in-period claims and previous
estimates of the claims amount.
2.18 Significant accounting estimates,
judgements in applying accounting
policies
The note provides the significant accounting estimates,
judgements in applying accounting polices 12 on the
insurance contracts.
Insurance
related
disclosures
included in
other notes
Claims and benefit 	The note provides, for each disclosed portfolio business unit,
the net claims and policyholder’s benefit.
Refer to note 5.11.4
Expenses 	The note provides an analysis of all expenses, highlighting
those that are insurance related. Refer to note 5.11
1 The note has been re-presented for the split of the Discovery SA Life and Invest (Risk) (GMM) portfolio. Refer to item 1 noted in the introduction of section 2.1.
2 The note has been re-presented to provide a granular breakdown of interest accretion components. Refer to item 3 noted in the introduction of section 2.1.
3 The comparative information has been restated due to correction of a prior period error. Refer to item 4 noted in the introduction of section 2.1.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
44
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.1 	INTRODUCTION AND OVERVIEW continued
Definitions and Abbreviations
The following abbreviations and terms are commonly used within the accounting policy:
Abbreviations 	Meaning
CSM 	Contractual Service Margin
DISCOVERY 	Discovery Group
DPF 	Direct Participation Features
DRO 	Discovery Retirement Optimiser
EFCF 	Expected Fulfilment Cash Flows
FINANCIAL RISK 	The risk of a possible future change in one or more of a specified interest rate, financial instrument
price, commodity price, currency exchange rate, index of prices or rates, credit rating or credit index
or other variable, provided in the case of a non-financial variable that the variable is not specific to a
party to the contract.
GMM 	General Measurement Model
IACF 	Initial Acquisition Cash Flows
IFIE 	Insurance finance income and expense comprises the change in the carrying amount of the group
of insurance contracts arising from:
the effect of the time value of money and changes in the time value of money, and the effect of
financial risk and changes in financial risk
IFRS Accounting
Standards
IFRS® Accounting Standards
IFRS 17 	IFRS 17 Insurance Contracts (effective for Discovery post 1 July 2023)
IFRS 17 margins 	IFRS 17 margins refers to the contractual service margin plus the risk adjustment
ISE 	Insurance Service Expenses
LIC 	Liability for Incurred Claims
LRC 	Liability for Remaining Coverage
OCI 	Other Comprehensive Income
PAA 	Premium Allocation Approach
VFA 	Variable Fee Approach
Notes to the group annual financial statements continued
for the year ended 30 June 2025
45
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
45	44

-- 25 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.2 	SUMMARY OF INSURANCE CONTRACTS ISSUED AND REINSURANCE
CONTRACTS HELD
Group
R million (Assets)/Liabilities 	Navigation
SA
Life
Risk
(GMM)
SA
Invest
Risk
(GMM)
UK Life
Risk
(GMM)
SA Invest
Partici-
pating
(VFA)
SA Life:
Group Life
and other
(PAA)
SA Insure
and other
(PAA)
UK
Health
(PAA) 	Total
Year ended 30 June 2025
Insurance Contracts 	A = D + E 	(23 002) 	23 580 	(20 180) 	88 150 	6 414 	734 	(4 865) 	70 831
Reinsurance Contracts 	B = F 	370 	– 	8 751 	– 	(865) 	(84) 	(13) 	8 159
Total 	C = A +B 	(22 632) 	23 580 	(11 429) 	88 150 	5 549 	650 	(4 878) 	78 990
Insurance contracts issued
Assets arising from
insurance contracts
– Insurance contract balances 	(23 002) 	– 	(20 180) 	– 	– 	– 	884 	(42 298)
– Assets for insurance
acquisition cash flows 	– 	– 	– 	– 	– 	– 	(5 749) 	(5 749)
Total 	D 	(23 002) 	– 	(20 180) 	– 	– 	– 	(4 865) (48 047)
Liabilities arising from
insurance contracts
– Insurance contract balances 	– 	23 580 	– 	88 150 	6 414 	734 	– 118 878
Total 	E 	– 	23 580 	– 	88 150 	6 414 	734 	– 118 878
Reinsurance contracts held
Reinsurance contract assets 	– 	– 	– 	– 	(865) 	(84) 	(13) 	(962)
Reinsurance contract liabilities 	370 	– 	8 751 	– 	– 	– 	– 	9 121
Total 	F 	370 	– 	8 751 	– 	(865) 	(84) 	(13) 	8 159
Year ended 30 June 2024
Insurance Contracts 	(17 846) 	24 565 	(15 269) 	73 721 	5 888 	896 	(4 224) 	67 731
Reinsurance Contracts 	126 	– 	5 270 	– 	(685) 	(139) 	(13) 	4 559
Total 	(17 720) 	24 565 	(9 999) 	73 721 	5 203 	757 	(4 237) 	72 290
Insurance contracts issued
Assets arising from
insurance contracts
– Insurance contract balances 	(17 846) 	– 	(15 269) 	– 	– 	– 	683 	(32 432)
– Assets for insurance
acquisition cash flows 	– 	– 	– 	– 	– 	– 	(4 907) 	(4 907)
Total 	(17 846) 	– 	(15 269) 	– 	– 	– 	(4 224) (37 339)
Liabilities arising from
insurance contracts
– Insurance contract balances 	– 	24 565 	– 	73 721 	5 888 	896 	– 105 070
– 	24 565 	– 	73 721 	5 888 	896 	– 105 070
Reinsurance contracts held
Reinsurance contract assets 	– 	– 	– 	– 	(685) 	(139) 	(13) 	(837)
Reinsurance contract liabilities 	126 	– 	5 270 	– 	– 	– 	– 	5 396
Total 	126 	– 	5 270 	– 	(685) 	(139) 	(13) 	4 559
Cross reference to related
notes of insurance
contracts issued
– Analysis by remaining
coverage and incurred
claims 	2.4.1 	2.4.2 	2.4.3 	2.6.1 	2.8.1 	2.8.2 	2.8.3
– Analysis by measurement
component 	2.5.1 	2.5.2 	2.5.3 	2.7.1
– Assets for insurance
acquisition cash flows 	2.3
Cross reference to related
notes of reinsurance
contracts held
– Analysis by remaining
coverage and incurred
claims 	2.9.1 	2.9.2 	2.11.1 	2.11.2 	2.11.3
– Analysis by measurement
component 	2.10.1 	2.10.2
Notes to the group annual financial statements continued
for the year ended 30 June 2025
46
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.3 	MOVEMENT IN ASSET FOR INSURANCE ACQUISITION CASH FLOWS
Group
R million
UK
Health (PAA)
Year ended 30 June 2025
Balance at the beginning of the year 	4 907
Amounts incurred during the year 	1 786
Amounts derecognised and included in the measurement of insurance contracts 	(1 235)
Effect of movements in exchange rates 	291
Balance at the end of the year 	5 749
Year ended 30 June 2024
Balance at the beginning of the year 	4 544
Amounts incurred during the year 	1 659
Amounts derecognised and included in the measurement of insurance contracts 	(1 111)
Effect of movements in exchange rates 	(185)
Balance at the end of the year 	4 907
Balance as at 30 June 2025
Presented in assets arising from insurance contracts 	5 749
Balance as at 30 June 2024
Presented in assets arising from insurance contracts 	4 907
The following table sets out when the Group expects to derecognise assets for insurance acquisition cash flows after the
reporting date.
Group
R million
UK
Health (PAA)
30 June 2025
Year 1 	1 107
Years 1 to 2 	921
Years 3 to 5 	2 238
Years 6 to 10 	1 483
> 10 years 	–
5 749
30 June 2024
Year 1 	950
Years 1 to 2 	787
Years 3 to 5 	1 912
Years 6 to 10 	1 258
> 10 years
4 907
Notes to the group annual financial statements continued
for the year ended 30 June 2025
47
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
47	46

-- 26 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.4 	RECONCILIATION OF INSURANCE CONTRACTS – GMM
2.4.1 	SA Life (Risk)
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Liabilities for Remaining
Coverage
Liabilities for
Incurred
Claims 	Total
Liabilities for Remaining
Coverage
Liabilities for
Incurred
Claims 	Total
Group
R million
Excluding
loss
component
Loss
component
Excluding
loss component
Loss
component	(Assets)/Liabilities 	Navigation
Opening assets arising from insurance
contracts issued 	(26 406) 	941 	7 619 	(17 846) 	(22 596) 	1 319 	6 621 	(14 656)
Net balance at beginning of the
year 	A 	(26 406) 	941 	7 619 	(17 846) 	(22 596) 	1 319 	6 621 	(14 656)
Changes in the income statement
and OCI
Insurance revenue transitional split
Contracts under the modified
retrospective approach 	(382) 	– 	– 	(382) 	(381) 	– 	– 	(381)
All other contracts 	(15 037) 	– 	– 	(15 037) 	(13 633) 	– 	– 	(13 633)
B 	(15 419) 	– 	– 	(15 419) 	(14 014) 	– 	– 	(14 014)
Insurance service expenses
Incurred claims and other insurance
service expenses 	– 	– 	10 120 	10 120 	– 	– 	10 559 	10 559
Amortised assets for insurance
acquisition cash flows 	2 163 	– 	– 	2 163 	1 838 	– 	– 	1 838
Adjustment to liability for incurred
claims 	– 	– 	6 	6 	– 	– 	37 	37
Losses and reversal of losses on
onerous contracts 	– 	143 	– 	143 	– 	(410) 	– 	(410)
C 	2 163 	143 	10 126 	12 432 	1 838 	(410) 	10 596 	12 024
Investment components 	D 	– 	– 	– 	– 	– 	– 	– 	–
Insurance service result 	E = B + C + D 	(13 256) 	143 	10 126 	(2 987) 	(12 176) 	(410) 	10 596 	(1 990)
Net finance expenses from insurance
contracts 	F 	(5 232) 	24 	437 	(4 771) 	(3 488) 	32 	416 	(3 040)
Net changes to income statement
and OCI 	G = E + F 	(18 488) 	167 	10 563 	(7 758) 	(15 664) 	(378) 	11 012 	(5 030)
Cash Flows
Premiums received 	15 334 	– 	– 	15 334 	14 359 	– 	– 	14 359
Insurance acquisition cash flows 	(2 423) 	– 	– 	(2 423) 	(2 505) 	– 	– 	(2 505)
Claims and other directly attributable
expenses paid 	– 	– 	(10 309) 	(10 309) 	– 	– 	(10 014) 	(10 014)
Total cash flows 	H 	12 911 	– 	(10 309) 	2 602 	11 854 	– 	(10 014) 	1 840
Net balance at the end of the year 	J = A + G + H 	(31 983) 	1 108 	7 873 	(23 002) 	(26 406) 	941 	7 619 	(17 846)
Closing assets arising from insurance
contracts issued 	(31 983) 	1 108 	7 873 	(23 002) 	(26 406) 	941 	7 619 	(17 846)
Net balance at the end of the year 	(31 983) 	1 108 	7 873 	(23 002) 	(26 406) 	941 	7 619 	(17 846)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
48 	49
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
49	48

-- 27 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.4 	RECONCILIATION OF INSURANCE CONTRACTS – GMM continued
2.4.2 	SA Invest (Risk)
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Liabilities for Remaining
Coverage
Liabilities for
Incurred
Claims 	Total
Liabilities for Remaining
Coverage
Liabilities for
Incurred
Claims 	Total
Group
R million
(Assets)/Liabilities 	Navigation
Excluding
loss
component
Loss
component
Excluding
loss component
Loss
component
Opening liabilities arising from
insurance contracts issued 	24 370 	195 	– 	24 565 	22 236 	185 	– 	22 421
Net balance at beginning of the
year 	A 	24 370 	195 	– 	24 565 	22 236 	185 	– 	22 421
Changes in the income statement
and OCI
Insurance revenue transitional split
All other contracts 	(1 203) 	– 	– 	(1 203) 	(1 031) 	– 	– 	(1 031)
B 	(1 203) 	– 	– 	(1 203) 	(1 031) 	– 	– 	(1 031)
Insurance service expenses
Incurred claims and other insurance
service expenses 	– 	– 	607 	607 	– 	– 	450 	450
Amortised assets for insurance
acquisition cash flows 	225 	– 	– 	225 	304 	– 	– 	304
Losses and reversal of losses on
onerous contracts 	– 	(8) 	– 	(8) 	– 	21 	– 	21
C 	225 	(8) 	607 	824 	304 	21 	450 	775
Investment components 	D 	(7 337) 	– 	7 337 	– 	(5 242) 	– 	5 242 	–
Insurance service result 	E = B + C + D 	(8 315) 	(8) 	7 944 	(379) 	(5 969) 	21 	5 692 	(256)
Net finance expenses from insurance
contracts 	F 	2 897 	31 	– 	2 928 	2 352 	(11) 	– 	2 341
Net changes to income statement
and OCI 	G = E + F 	(5 418) 	23 	7 944 	2 549 	(3 617) 	10 	5 692 	2 085
Cash Flows
Premiums received 	4 581 	– 	– 	4 581 	5 960 	– 	– 	5 960
Insurance acquisition cash flows 	(171) 	– 	– 	(171) 	(209) 	– 	– 	(209)
Claims and other directly attributable
expenses paid 	– 	– 	(7 944) 	(7 944) 	– 	– 	(5 692) 	(5 692)
Total cash flows 	H 	4 410 	– 	(7 944) 	(3 534) 	5 751 	– 	(5 692) 	59
Net balance at the end of the year 	J = A + G + H 	23 362 	218 	– 	23 580 	24 370 	195 	– 	24 565
Closing assets arising from insurance
contracts issued 	23 362 	218 	– 	23 580 	24 370 	195 	– 	24 565
Net balance at the end of the year 	23 362 	218 	– 	23 580 	24 370 	195 	– 	24 565
Notes to the group annual financial statements continued
for the year ended 30 June 2025
50 	51
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
51	50

-- 28 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.4 	RECONCILIATION OF INSURANCE CONTRACTS – GMM continued
2.4.3 	UK Life (Risk)
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Liabilities for Remaining
Coverage
Liabilities for
Incurred
Claims 	Total
Liabilities for Remaining
Coverage
Liabilities for
Incurred
Claims 	Total
Group
R million
(Assets)/Liabilities 	Navigation
Excluding
loss
component
Loss
component
Excluding
loss component
Loss
component
Opening assets arising from insurance
contracts issued 	(22 202) 	5 140 	1 793 	(15 269) 	(19 017) 	5 327 	1 631 	(12 059)
Net balance at beginning of the
year 	A 	(22 202) 	5 140 	1 793 	(15 269) 	(19 017) 	5 327 	1 631 	(12 059)
Changes in the income statement
and OCI
Insurance revenue transitional split
All other contracts 	(8 050) 	– 	– 	(8 050) 	(6 904) 	– 	– 	(6 904)
B 	(8 050) 	– 	– 	(8 050) 	(6 904) 	– 	– 	(6 904)
Insurance service expenses
Incurred claims and other insurance
service expenses 	– 	– 	4 193 	4 193 	– 	– 	3 453 	3 453
Amortised assets for insurance
acquisition cash flows 	3 035 	– 	– 	3 035 	2 610 	– 	– 	2 610
Losses and reversal of losses on
onerous contracts 	– 	367 	– 	367 	– 	154 	– 	154
C 	3 035 	367 	4 193 	7 595 	2 610 	154 	3 453 	6 217
Investment components 	D 	496 	– 	(496) 	– 	46 	– 	(46) 	–
Insurance service result 	E = B + C + D 	(4 519) 	367 	3 697 	(455) 	(4 248) 	154 	3 407 	(687)
Net finance expenses from insurance
contracts 	F 	(1 737) 	(182) 	– 	(1 919) 	(2 625) 	(137) 	– 	(2 762)
Net changes to income statement
and OCI 	G = E + F 	(6 256) 	185 	3 697 	(2 374) 	(6 873) 	17 	3 407 	(3 449)
Cash Flows
Premiums received 	8 263 	– 	– 	8 263 	7 807 	– 	– 	7 807
Insurance acquisition cash flows 	(6 441) 	– 	– 	(6 441) 	(4 929) 	– 	– 	(4 929)
Claims and other directly attributable
expenses paid 	– 	– 	(3 375) 	(3 375) 	– 	– 	(3 178) 	(3 178)
Total cash flows 	H 	1 822 	– 	(3 375) 	(1 553) 	2 878 	– 	(3 178) 	(300)
Effect of movements in exchange rates 	I 	(1 384) 	289 	111 	(984) 	810 	(204) 	(67) 	539
Net balance at the end of the year 	J = A + G + H + I 	(28 020) 	5 614 	2 226 	(20 180) 	(22 202) 	5 140 	1 793 	(15 269)
Closing assets arising from insurance
contracts issued 	(28 020) 	5 614 	2 226 	(20 180) 	(22 202) 	5 140 	1 793 	(15 269)
Net balance at the end of the year 	(28 020) 	5 614 	2 226 	(20 180) 	(22 202) 	5 140 	1 793 	(15 269)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
52 	53
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
53	52

-- 29 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.5 	RECONCILIATION OF INSURANCE CONTRACTS – GMM
2.5.1 	SA Life (Risk)
ANALYSIS BY MEASUREMENT COMPONENT
2025 	2024
Group
R million
(Assets)/Liabilities
Estimates of
PVFCF
RA for
non- financial
Risk
CSM
Total
Estimates of
PVFCF
RA for
non–financial
Risk
CSM
Total	Navigation
Other
contracts
Other
contracts
Opening assets arising from insurance
contracts issued 	(54 499) 	7 811 	28 842 	(17 846) 	(52 454) 	6 960 	30 838 	(14 656)
Net balance at beginning of the
year 	A 	(54 499) 	7 811 	28 842 	(17 846) 	(52 454) 	6 960 	30 838 	(14 656)
Changes in the income statement
and OCI
Changes that relate to current
services
CSM recognised for services provided 	– 	– 	(1 862) 	(1 862) 	– 	– 	(1 800) 	(1 800)
Change in Risk Adjustment for non-
financial risk that
relates to expired risk 	– 	(642) 	– 	(642) 	– 	(593) 	– 	(593)
Experience adjustments 	(724) 	– 	– 	(724) 	656 	– 	– 	656
Changes that relate to future services
Contracts initially recognised in the
period 	(1 647) 	395 	1 286 	34 	(1 888) 	402 	1 522 	36
Changes in estimates that adjust CSM 	4 046 	(362) 	(3 684) 	– 	4 024 	369 	(4 393) 	–
Changes in estimates that result in
onerous contract
losses or reversal of losses 	202 	(14) 	– 	188 	(337) 	(9) 	(6) 	(352)
Servicing expenses and commission
for onerous
contracts 	13 	– 	– 	13 	26 	– 	– 	26
Changes that relate to past services
Adjustment to liability for incurred
claims 	– 	6 	– 	6 	– 	37 	– 	37
Insurance service result 	B 	1 890 	(617) 	(4 260) 	(2 987) 	2 481 	206 	(4 677) 	(1 990)
Net finance expenses from insurance
contracts 	C 	(8 647) 	1 163 	2 713 	(4 771) 	(6 366) 	645 	2 681 	(3 040)
Net changes to income statement
and OCI 	D = B + C 	(6 757) 	546 	(1 547) 	(7 758) 	(3 885) 	851 	(1 996) 	(5 030)
Cash flows 	E 	2 602 	– 	– 	2 602 	1 840 	– 	– 	1 840
Net balance at the end of the year 	G = A + D + E 	(58 654) 	8 357 	27 295 	(23 002) 	(54 499) 	7 811 	28 842 	(17 846)
Closing assets arising from insurance
contracts issued 	(58 654) 	8 357 	27 295 	(23 002) 	(54 499) 	7 811 	28 842 	(17 846)
Net balance at the end of the year 	(58 654) 	8 357 	27 295 	(23 002) 	(54 499) 	7 811 	28 842 	(17 846)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
54 	55
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
55	54

-- 30 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.5 	RECONCILIATION OF INSURANCE CONTRACTS – GMM continued
2.5.2 	SA Invest (Risk)
ANALYSIS BY MEASUREMENT COMPONENT
2025 	2024
Group
R million
(Assets)/Liabilities
Estimates of
PVFCF
RA for
non- financial
Risk
CSM
Total
Estimates of
PVFCF
RA for
non-financial
Risk
CSM
Total	Navigation
Other
contracts
Other
contracts
Opening liabilities arising from
insurance contracts issued 	23 489 	135 	941 	24 565 	21 521 	86 	814 	22 421
Net balance at beginning of the
year 	A 	23 489 	135 	941 	24 565 	21 521 	86 	814 	22 421
Changes in the income statement
and OCI
Changes that relate to current
services
CSM recognised for services provided 	– 	– 	(395) 	(395) 	– 	– 	(295) 	(295)
Change in Risk Adjustment for non-
financial risk that
relates to expired risk 	– 	(38) 	– 	(38) 	– 	(23) 	– 	(23)
Experience adjustments 	32 	– 	– 	32 	7 	– 	– 	7
Changes that relate to future services
Contracts initially recognised in the
period 	(266) 	25 	245 	4 	(369) 	27 	365 	23
Changes in estimates that adjust CSM 	49 	17 	(66) 	– 	15 	11 	(26) 	–
Changes in estimates that result in
onerous contract losses or reversal of
losses 	(5) 	23 	– 	18 	22 	10 	– 	32
Servicing expenses and commission
for onerous contracts 	– 	– 	– 	– 	– 	– 	– 	–
Changes that relate to past services
Adjustment to liability for incurred
claims 	– 	– 	– 	– 	– 	– 	– 	–
Insurance service result 	B 	(190) 	27 	(216) 	(379) 	(325) 	25 	44 	(256)
Net finance expenses from insurance
contracts 	C 	2 805 	28 	95 	2 928 	2 234 	24 	83 	2 341
Net changes to income statement
and OCI 	D = B + C 	2 615 	55 	(121) 	2 549 	1 909 	49 	127 	2 085
Cash flows 	E 	(3 534) 	– 	– 	(3 534) 	59 	– 	– 	59
Net balance at the end of the year 	G = A + D + E 	22 570 	190 	820 	23 580 	23 489 	135 	941 	24 565
Closing liabilities arising from
insurance contracts issued 	22 570 	190 	820 	23 580 	23 489 	135 	941 	24 565
Net balance at the end of the year 	22 570 	190 	820 	23 580 	23 489 	135 	941 	24 565
Notes to the group annual financial statements continued
for the year ended 30 June 2025
56 	57
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
57	56

-- 31 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.5 	RECONCILIATION OF INSURANCE CONTRACTS – GMM continued
2.5.3 	UK Life (Risk)
ANALYSIS BY MEASUREMENT COMPONENT
2025 	2024
Group
R million
(Assets)/Liabilities
Estimates of
PVFCF
RA for non-
financial
Risk
CSM
Total
Estimates of
PVFCF
RA for non-
financial
Risk
CSM
Total	Navigation
Other
contracts
Other
contracts
Opening assets arising from insurance
contracts issued 	(30 819) 	2 239 	13 311 	(15 269) 	(27 886) 	2 020 	13 807 	(12 059)
Net balance at beginning of the
year 	A 	(30 819) 	2 239 	13 311 	(15 269) 	(27 886) 	2 020 	13 807 	(12 059)
Changes in the income statement
and OCI
Changes that relate to current
services
CSM recognised for services provided 	– 	– 	(1 332) 	(1 332) 	– 	– 	(1 242) 	(1 242)
Change in Risk Adjustment for non-
financial risk that
relates to expired risk 	– 	(246) 	– 	(246) 	– 	(209) 	– 	(209)
Experience adjustments 	362 	– 	– 	362 	224 	– 	– 	224
Changes that relate to future services
Contracts initially recognised in
the period 	(2 192) 	471 	2 128 	407 	(1 573) 	368 	1 482 	277
Changes in estimates that adjust CSM 	(164) 	(2) 	166 	– 	447 	(3) 	(444) 	–
Changes in estimates that result in
onerous contract losses or reversal
of losses 	345 	9 	– 	354 	224 	39 	– 	263
Insurance service result 	B 	(1 649) 	232 	962 	(455) 	(678) 	195 	(204) 	(687)
Net finance expenses from insurance
contracts 	C 	(2 178) 	(39) 	298 	(1 919) 	(3 108) 	107 	239 	(2 762)
Net changes to income statement
and OCI 	D = B + C 	(3 827) 	193 	1 260 	(2 374) 	(3 786) 	302 	35 	(3 449)
Cash flows 	E 	(1 553) 	– 	– 	(1 553) 	(300) 	– 	– 	(300)
Effect of movements in exchange rates 	F 	(1 892) 	130 	778 	(984) 	1 153 	(83) 	(531) 	539
Net balance at the end of the year 	G = A + D + E + F 	(38 091) 	2 562 	15 349 	(20 180) 	(30 819) 	2 239 	13 311 	(15 269)
Closing assets arising from insurance
contracts issued 	(38 091) 	2 562 	15 349 	(20 180) 	(30 819) 	2 239 	13 311 	(15 269)
Net balance at the end of the year 	(38 091) 	2 562 	15 349 	(20 180) 	(30 819) 	2 239 	13 311 	(15 269)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
58 	59
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
59	58

-- 32 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.6 	RECONCILIATION OF INSURANCE CONTRACTS – VFA
2.6.1 	SA Invest (Participating)
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Liabilities for Remaining
Coverage (LRC) 	Liabilities for
Incurred
Claims
(LIC) 	Total
Liabilities for Remaining
Coverage (LRC) 	Liabilities for
Incurred
Claims
(LIC) 	Total
Group
R million
(Assets)/Liabilities 	Navigation
Excluding
loss
component
Loss
component
Excluding
loss component
Loss
component
Opening liabilities arising from
insurance contracts issued 	73 598 	123 	– 	73 721 	66 236 	72 	– 	66 308
Net balance at beginning of the
year 	A 	73 598 	123 	– 	73 721 	66 236 	72 	– 	66 308
Changes in the income statement
and OCI
Insurance revenue transitional split
Contracts under the modified
retrospective approach 	(2 690) 	– 	– 	(2 690) 	(3 157) 	– 	– 	(3 157)
Other contracts 	(667) 	– 	– 	(667) 	(172) 	– 	– 	(172)
B 	(3 357) 	– 	– 	(3 357) 	(3 329) 	– 	– 	(3 329)
Insurance service expenses
Incurred claims and other insurance
service expenses 	– 	– 	1 056 	1 056 	– 	– 	999 	999
Experience adjustments adjusting CSM 	(16) 	(2) 	– 	(18) 	86 	46 	– 	132
Amortised assets for insurance
acquisition cash flows 	781 	– 	– 	781 	758 	– 	– 	758
Losses and reversal of losses on
onerous contracts 	– 	30 	– 	30 	– 	5 	– 	5
C 	765 	28 	1 056 	1 849 	844 	51 	999 	1 894
Investment components 	D 	(12 062) 	– 	12 062 	– 	(11 577) 	– 	11 577 	–
Insurance service result 	E = B + C + D 	(14 654) 	28 	13 118 	(1 508) 	(14 062) 	51 	12 576 	(1 435)
Net finance expenses from insurance
contracts 	F 	13 024 	– 	– 	13 024 	7 810 	– 	– 	7 810
Net changes to income statement
and OCI 	G = E + F 	(1 630) 	28 	13 118 	11 516 	(6 252) 	51 	12 576 	6 375
Cash Flows
Premiums received 	16 829 	– 	– 	16 829 	14 294 	– 	– 	14 294
Insurance acquisition cash flows 	(798) 	– 	– 	(798) 	(680) 	– 	– 	(680)
Claims and other directly attributable
expenses paid 	– 	– 	(13 118) 	(13 118) 	– 	– 	(12 576) 	(12 576)
Total cash flows 	H 	16 031 	– 	(13 118) 	2 913 	13 614 	– 	(12 576) 	1 038
Net balance at the end of the year 	J = A + G + H 	87 999 	151 	– 	88 150 	73 598 	123 	– 	73 721
Closing liabilities arising from
insurance contracts issued 	87 999 	151 	– 	88 150 	73 598 	123 	– 	73 721
Net balance at the end of the year 	87 999 	151 	– 	88 150 	73 598 	123 	– 	73 721
Notes to the group annual financial statements continued
for the year ended 30 June 2025
60 	61
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
61	60

-- 33 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.7 	RECONCILIATION OF INSURANCE CONTRACTS – VFA
2.7.1 	SA Invest (Participating)
ANALYSIS BY MEASUREMENT COMPONENT
2025 	2024
Estimates of
PVFCF
RA for non-
financial
Risk
CSM
Total
Estimates of
PVFCF
RA for non-
financial
Risk
CSM
Total
Group
R million
(Assets)/Liabilities 	Navigation
Transition:
Modified
retro-
spective
Other
contracts
Transition:
Modified
retro-
spective
Other
contracts
Opening liabilities arising from
insurance contracts issued 	66 642 	773 	5 275 	1 031 	73 721 	59 328 	912 	5 430 	638 	66 308
Net balance at beginning
of the year 	A 	66 642 	773 	5 275 	1 031 	73 721 	59 328 	912 	5 430 	638 	66 308
Changes in the income statement
and OCI
Changes that relate to current
services
CSM recognised for services provided 	– 	– 	(1 058) 	(266) 	(1 324) 	– 	– 	(1 080) 	(142) 	(1 222)
Change in Risk Adjustment for
non-financial risk that relates
to expired risk 	– 	(186) 	– 	– 	(186) 	– 	(212) 	– 	– 	(212)
Experience adjustments 	(96) 	– 	56 	(22) 	(62) 	(93) 	– 	63 	1 	(29)
Changes that relate to future services
Contracts initially recognised in
the period 	(764) 	89 	– 	732 	57 	(510) 	70 	– 	490 	50
Changes in estimates that adjust CSM 	(357) 	99 	202 	56 	– 	289 	(83) 	(122) 	(84) 	–
Changes in estimates that result in
onerous contract losses or reversal
of losses 	6 	1 	– 	– 	7 	(23) 	1 	– 	– 	(22)
Insurance service result 	B 	(1 211) 	3 	(800) 	500 	(1 508) 	(337) 	(224) 	(1 139) 	265 	(1 435)
Net finance expenses from
insurance contracts 	C 	11 855 	67 	902 	200 	13 024 	6 613 	85 	984 	128 	7 810
Net changes to income statement
and OCI 	D = B + C 	10 644 	70 	102 	700 	11 516 	6 276 	(139) 	(155) 	393 	6 375
Cash flows 	E 	2 913 	– 	– 	– 	2 913 	1 038 	– 	– 	– 	1 038
Net balance at the end of the year 	G = A + D + E 	80 199 	843 	5 377 	1 731 	88 150 	66 642 	773 	5 275 	1 031 	73 721
Closing liabilities arising from
insurance contracts issued 	80 199 	843 	5 377 	1 731 	88 150 	66 642 	773 	5 275 	1 031 	73 721
Net balance at the end of the year 	80 199 	843 	5 377 	1 731 	88 150 	66 642 	773 	5 275 	1 031 	73 721
Notes to the group annual financial statements continued
for the year ended 30 June 2025
62 	63
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
63	62

-- 34 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.8 	RECONCILIATION OF INSURANCE CONTRACTS – PAA
2.8.1 	SA Life: Group risk and other
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Liabilities
for Remaining
Coverage
Liabilities for Incurred Claims
Total
Liabilities
for Remaining
Coverage
Liabilities for Incurred Claims
Total
Group
R million
(Assets)/Liabilities 	Navigation
Estimates of
PVFCF
RA for non-
financial
risk
Estimates of
PVFCF
RA for non-
financial
risk
Opening liabilities arising from
insurance contracts issued 	(142) 	5 932 	98 	5 888 	(162) 	5 167 	104 	5 109
Net balance at beginning of the
year 	A 	(142) 	5 932 	98 	5 888 	(162) 	5 167 	104 	5 109
Insurance revenue 	B 	(3 738) 	– 	– 	(3 738) 	(3 517) 	(3 517)
Insurance service expenses
Incurred claims and other insurance
service expenses 	– 	2 914 	(11) 	2 903 	– 	3 028 	(32) 	2 996
Gross claims and insurance service
expenses 	– 	2 914 	(11) 	2 903 	– 	3 028 	(32) 	2 996
Salvages 	– 	– 	– 	– 	– 	– 	– 	–
Amortisation of assets for insurance
acquisition cash flows 	180 	– 	– 	180 	169 	– 	– 	169
Adjustment to liability for incurred
claims 	– 	– 	– 	– 	– 	– 	19 	19
C 	180 	2 914 	(11) 	3 083 	169 	3 028 	(13) 	3 184
Insurance service result 	D = B + C 	(3 558) 	2 914 	(11) 	(655) 	(3 348) 	3 028 	(13) 	(333)
Net finance expenses from insurance
contracts issued 	E 	– 	401 	21 	422 	– 	329 	7 	336
Net changes to statement of profit
or loss and OCI 	F = D +E 	(3 558) 	3 315 	10 	(233) 	(3 348) 	3 357 	(6) 	3
Cash flows
Premiums received 	3 768 	– 	– 	3 768 	3 537 	– 	– 	3 537
Insurance acquisition cash flows 	(179) 	– 	– 	(179) 	(169) 	– 	– 	(169)
Claims and other directly attributable
expenses paid 	– 	(2 830) 	– 	(2 830) 	– 	(2 592) 	– 	(2 592)
Gross claims and insurance service
expenses paid 	– 	(2 830) 	– 	(2 830) 	– 	(2 592) 	– 	(2 592)
Salvages 	– 	– 	– 	– 	– 	– 	– 	–
Total cash flows 	G 	3 589 	(2 830) 	– 	759 	3 368 	(2 592) 	– 	776
Net balance at the end of year 	K = A + F + G 	(111) 	6 417 	108 	6 414 	(142) 	5 932 	98 	5 888
Closing liabilities arising from
insurance contracts issued 	(111) 	6 417 	108 	6 414 	(142) 	5 932 	98 	5 888
Net balance at the end of year 	(111) 	6 417 	108 	6 414 	(142) 	5 932 	98 	5 888
Notes to the group annual financial statements continued
for the year ended 30 June 2025
64 	65
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
65	64

-- 35 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.8 	RECONCILIATION OF INSURANCE CONTRACTS – PAA continued
2.8.2 	SA Insure and other
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Liabilities
for Remaining
Coverage
Liabilities for Incurred Claims
Total
Liabilities
for Remaining
Coverage
Liabilities for Incurred Claims
Total
Group
R million
(Assets)/Liabilities 	Navigation
Estimates of
PVFCF
RA for non-
financial
risk
Estimates of
PVFCF
RA for non-
financial
risk
Opening liabilities arising from
insurance contracts issued 	19 	863 	14 	896 	52 	758 	12 	822
Net balance at beginning of the
year 	A 	19 	863 	14 	896 	52 	758 	12 	822
Insurance revenue 	B 	(6 822) 	– 	– 	(6 822) 	(6 861) 	– 	– 	(6 861)
Insurance service expenses
Incurred claims and other insurance
service expenses 	– 	4 976 	9 	4 985 	– 	5 445 	5 	5 450
Gross claims and insurance service
expenses 	– 	5 407 	9 	5 416 	– 	5 904 	5 	5 909
Salvages 	– 	(431) 	– 	(431) 	– 	(459) 	– 	(459)
Amortisation of assets for insurance
acquisition cash flows1 	986 	– 	– 	986 	1 053 	– 	– 	1 053
Adjustment to liability for incurred
claims 	– 	(11) 	(8) 	(19) 	– 	61 	2 	63
C 	986 	4 965 	1 	5 952 	1 053 	5 506 	7 	6 566
Insurance service result 	D = B + C 	(5 836) 	4 965 	1 	(870) 	(5 808) 	5 506 	7 	(295)
Net finance expenses from insurance
contracts issues 	E 	– 	19 	1 	20 	– 	– 	– 	–
Net changes to statement of profit
or loss and OCI 	F = D+E 	(5 836) 	4 984 	2 	(850) 	(5 808) 	5 506 	7 	(295)
Cash flows
Premiums received 	6 893 	– 	– 	6 893 	6 827 	– 	– 	6 827
Insurance acquisition cash flows 	(986) 	(17) 	– 	(1 003) 	(1 053) 	(21) 	– 	(1 074)
Claims and other directly attributable
expenses paid 	– 	(5 205) 	– 	(5 205) 	– 	(5 378) 	(5) 	(5 383)
Gross claims and insurance service
expenses paid 	– 	(5 670) 	– 	(5 670) 	– 	(5 825) 	(5) 	(5 830)
Salvages 	– 	465 	– 	465 	– 	447 	– 	447
Total cash flows 	G 	5 907 	(5 222) 	– 	685 	5 774 	(5 399) 	(5) 	370
Effect of movements in exchange rates 	H 	2 	1 	– 	3 	1 	(2) 	– 	(1)
Net balance at the end of year 	K = A + F + G + H 	92 	626 	16 	734 	19 	863 	14 	896
Closing liabilities arising from
insurance contracts issued 	92 	626 	16 	734 	19 	863 	14 	896
Net balance at the end of year 	92 	626 	16 	734 	19 	863 	14 	896
Notes to the group annual financial statements continued
for the year ended 30 June 2025
66 	67
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
67	66

-- 36 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.8 	RECONCILIATION OF INSURANCE CONTRACTS – PAA continued
2.8.3 	UK Health
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Liabilities
for Remaining
Coverage
Liabilities for Incurred Claims
Total
Liabilities
for Remaining
Coverage
Liabilities for Incurred Claims
Total
Group
R million
(Assets)/Liabilities 	Navigation
Estimates of
PVFCF
RA for non-
financial
risk
Estimates of
PVFCF
RA for non-
financial
risk
Opening assets arising from insurance
contracts issued 	(426) 	1 080 	29 	683 	(372) 	1 350 	57 	1 035
Net balance at beginning of the
year 	A 	(426) 	1 080 	29 	683 	(372) 	1 350 	57 	1 035
Insurance revenue 	B 	(19 124) 	– 	– 	(19 124) 	(16 474) 	– 	– 	(16 474)
Insurance service expenses
Incurred claims and other insurance
service expenses 	– 	15 280 	1 	15 281 	– 	13 713 	(26) 	13 687
Gross claims and insurance
service expenses 	– 	15 280 	1 	15 281 	– 	13 713 	(26) 	13 687
Salvages 	– 	– 	– 	– 	– 	– 	– 	–
Amortisation of assets for insurance
acquisition cash flows 	2 011 	– 	– 	2 011 	1 767 	– 	– 	1 767
Losses and reversal of losses on
onerous contracts 	– 	– 	– 	– 	– 	– 	– 	–
C 	2 011 	15 280 	1 	17 292 	1 767 	13 713 	(26) 	15 454
Insurance service result 	D = B + C 	(17 113) 	15 280 	1 	(1 832) 	(14 707) 	13 713 	(26) 	(1 020)
Net changes to statement of profit
or loss and OCI 	F = D 	(17 113) 	15 280 	1 	(1 832) 	(14 707) 	13 713 	(26) 	(1 020)
Cash flows
Premiums received 	19 306 	– 	– 	19 306 	16 502 	– 	– 	16 502
Insurance acquisition cash flows 	(906) 	– 	– 	(906) 	(755) 	– 	– 	(755)
Claims and other directly attributable
expenses paid 	– 	(15 175) 	– 	(15 175) 	– 	(13 936) 	– 	(13 936)
Gross claims and insurance service
expenses paid 	– 	(15 175) 	– 	(15 175) 	– 	(13 936) 	– 	(13 936)
Salvages 	– 	– 	– 	– 	– 	– 	– 	–
Total cash flows 	G 	18 400 	(15 175) 	– 	3 225 	15 747 	(13 936) 	– 	1 811
Allocation from assets for insurance
acquisition cash flows to group of
insurance contracts 	H 	(1 235) 	– 	– 	(1 235) 	(1 111) 	– 	– 	(1 111)
Effect of movements in exchange rates 	I 	(22) 	62 	3 	43 	17 	(47) 	(2) 	(32)
Net balance at the end of year
K = A + F + G +
H + I 	(396) 	1 247 	33 	884 	(426) 	1 080 	29 	683
Closing assets arising from insurance
contracts issued 	(396) 	1 247 	33 	884 	(426) 	1 080 	29 	683
Net balance at the end of year 	(396) 	1 247 	33 	884 	(426) 	1 080 	29 	683
Notes to the group annual financial statements continued
for the year ended 30 June 2025
68 	69
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
69	68

-- 37 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.9 	RECONCILIATION OF REINSURANCE CONTRACTS – GMM
2.9.1 	SA Life (Risk)
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Total
Assets for Remaining
Coverage (ARC)
Assets for
Incurred
Claims (AIC) 	Total
Assets for Remaining
Coverage (ARC)
Assets for
Incurred
Claims (AIC)
Group
R million
(Assets)/Liabilities 	Navigation
Excluding loss
recovery
component
Loss recovery
component
Excluding loss
recovery
component
Loss recovery
component
Opening liabilities arising from
reinsurance contracts held 	2 649 	(168) 	(2 355) 	126 	3 027 	(202) 	(2 258) 	567
Net balance at beginning
of the year 	A 	2 649 	(168) 	(2 355) 	126 	3 027 	(202) 	(2 258) 	567
Changes in the income statement
and OCI
Allocation of reinsurance
premiums paid 	3 549 	– 	– 	3 549 	3 387 	– 	– 	3 387
Amounts recoverable from reinsurers
Recoveries of incurred claims and
other insurance service expenses 	– 	– 	(2 526) 	(2 526) 	– 	– 	(3 002) 	(3 002)
Recoveries and reversals of recoveries
of losses on onerous underlying
contracts 	– 	(7) 	– 	(7) 	– 	39 	– 	39
Adjustments to assets for
incurred claims 	– 	– 	(1) 	(1) 	– 	– 	(10) 	(10)
B 	3 549 	(7) 	(2 527) 	1 015 	3 387 	39 	(3 012) 	414
Net expenses from reinsurance
contracts 	C = B 	3 549 	(7) 	(2 527) 	1 015 	3 387 	39 	(3 012) 	414
Net finance expenses from
reinsurance contracts 	D 	531 	1 	(123) 	409 	177 	(5) 	(106) 	66
Net changes to income statement
and OCI 	E = B + D 	4 080 	(6) 	(2 650) 	1 424 	3 564 	34 	(3 118) 	480
Cash Flows
Premiums paid 	(3 970) 	– 	– 	(3 970) 	(3 942) 	– 	– 	(3 942)
Claims recovered 	– 	– 	2 790 	2 790 	– 	– 	3 021 	3 021
Total cash flows 	F 	(3 970) 	– 	2 790 	(1 180) 	(3 942) 	– 	3 021 	(921)
Net balance at the end of the year 	G = A +E + F 	2 759 	(174) 	(2 215) 	370 	2 649 	(168) 	(2 355) 	126
Closing liabilities arising from
reinsurance contracts held 	2 759 	(174) 	(2 215) 	370 	2 649 	(168) 	(2 355) 	126
Net balance at the end of the year 	2 759 	(174) 	(2 215) 	370 	2 649 	(168) 	(2 355) 	126
Notes to the group annual financial statements continued
for the year ended 30 June 2025
70 	71
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
71	70

-- 38 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.9 	RECONCILIATION OF REINSURANCE CONTRACTS – GMM continued
2.9.2 	UK Life (Risk)
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Assets for Remaining
Coverage (ARC)
Assets for
Incurred
Claims (AIC) 	Total
Assets for Remaining
Coverage (ARC)
Assets for
Incurred Claims
(AIC) 	Total
Group
R million
(Assets)/Liabilities 	Navigation
Excluding loss
recovery
component
Loss recovery
component
Excluding loss
recovery
component
Loss recovery
component
Opening liabilities arising from
reinsurance contracts held 	9 280 	(2 189) 	(1 821) 	5 270 	7 862 	(2 348) 	(1 262) 	4 252
Net balance at beginning of the
year 	A 	9 280 	(2 189) 	(1 821) 	5 270 	7 862 	(2 348) 	(1 262) 	4 252
Changes in the income statement
and OCI
Allocation of reinsurance
premiums paid 	8 839 	– 	– 	8 839 	5 738 	– 	– 	5 738
Amounts recoverable from reinsurers
Recoveries of incurred claims and
other insurance service expenses 	– 	– 	(8 474) 	(8 474) 	– 	– 	(5 349) 	(5 349)
Recoveries and reversals of recoveries
of losses on onerous underlying
contracts 	– 	(200) 	– 	(200) 	– 	18 	– 	18
Adjustments to assets for
incurred claims 	– 	– 	– 	– 	– 	– 	– 	–
B 	8 839 	(200) 	(8 474) 	165 	5 738 	18 	(5 349) 	407
Net expenses from reinsurance
contracts 	C = B 	8 839 	(200) 	(8 474) 	165 	5 738 	18 	(5 349) 	407
Net finance expenses from
reinsurance contracts 	D 	408 	44 	– 	452 	564 	52 	– 	616
Net changes to income statement
and OCI 	E = B + D 	9 247 	(156) 	(8 474) 	617 	6 302 	70 	(5 349) 	1 023
Cash Flows
Premiums paid 	(5 102) 	– 	– 	(5 102) 	(4 547) 	– 	– 	(4 547)
Claims recovered 	– 	– 	7 562 	7 562 	– 	– 	4 730 	4 730
Total cash flows 	F 	(5 102) 	– 	7 562 	2 460 	(4 547) 	– 	4 730 	183
Effect of movements in exchange rates 	G 	664 	(128) 	(132) 	404 	(337) 	89 	60 	(188)
Net balance at the end of the year 	H= A +E +F + G 	14 089 	(2 473) 	(2 865) 	8 751 	9 280 	(2 189) 	(1 821) 	5 270
Closing liabilities arising from
reinsurance contracts held 	14 089 	(2 473) 	(2 865) 	8 751 	9 280 	(2 189) 	(1 821) 	5 270
Net balance at the end of the year 	14 089 	(2 473) 	(2 865) 	8 751 	9 280 	(2 189) 	(1 821) 	5 270
Notes to the group annual financial statements continued
for the year ended 30 June 2025
72 	73
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
73	72

-- 39 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.10 	RECONCILIATION OF REINSURANCE CONTRACTS – GMM
2.10.1 	SA Life (Risk)
ANALYSIS BY MEASUREMENT COMPONENT
2025 	2024
Estimates of
PVFCF
RA for non-
financial
Risk
CSM
Total
Estimates of
PVFCF
RA for non-
financial
Risk
CSM
Total
Group
R million
(Assets)/Liabilities 	Navigation
Transition:
Modified
retro-
spective
Other
contracts
Transition:
Modified
retro-
spective
Other
contracts
Opening liabilities arising from
reinsurance contracts held 	5 899 	(703) 	(100) 	(4 970) 	126 	6 094 	(698) 	(80) 	(4 749) 	567
Net balance at beginning of the
year 	A 	5 899 	(703) 	(100) 	(4 970) 	126 	6 094 	(698) 	(80) 	(4 749) 	567
Changes in the income statement
and OCI
Changes that relate to current
services
CSM recognised for services provided 	– 	– 	6 	319 	325 	– 	– 	6 	338 	344
Change in Risk Adjustment for
non-financial risk that relates
to expired risk 	– 	73 	– 	– 	73 	– 	71 	– 	– 	71
Experience adjustments 	624 	– 	– 	– 	624 	(12) 	– 	– 	– 	(12)
Changes that relate to future services 	– 	–
Contracts initially recognised in
the period 	187 	(21) 	– 	(172) 	(6) 	202 	(22) 	– 	(186) 	(6)
Changes in estimates that adjust CSM 	(897) 	76 	3 	839 	21 	16 	– 	(16) 	40 	40
Changes in estimates that relate to
losses and reversal of losses on
underlying contracts 	(19) 	(2) 	– 	– 	(21) 	(17) 	4 	– 	– 	(13)
Changes that relate to past services
Adjustment to assets for incurred
claims 	– 	(1) 	– 	– 	(1) 	– 	(10) 	– 	– 	(10)
Net expenses from reinsurance
contracts held 	B 	(105) 	125 	9 	986 	1 015 	189 	43 	(10) 	192 	414
Net finance income from reinsurance
contracts 	C 	1 035 	(93) 	(13) 	(520) 	409 	537 	(48) 	(10) 	(413) 	66
Net changes to income statement
and OCI 	D = B + C 	930 	32 	(4) 	466 	1 424 	726 	(5) 	(20) 	(221) 	480
Cash flows 	E 	(1 180) 	– 	– 	– 	(1 180) 	(921) 	– 	– 	– 	(921)
Effect of movements in exchange rates 	F 	– 	– 	– 	– 	– 	– 	– 	– 	– 	–
Net balance at the end of the year 	G = A + D +
E + F 	5 649 	(671) 	(104) 	(4 504) 	370 	5 899 	(703) 	(100) 	(4 970) 	126
Closing liabilities arising from
reinsurance contracts held 	5 649 	(671) 	(104) 	(4 504) 	370 	5 899 	(703) 	(100) 	(4 970) 	126
Net balance at the end of the year 	5 649 	(671) 	(104) 	(4 504) 	370 	5 899 	(703) 	(100) 	(4 970) 	126
Notes to the group annual financial statements continued
for the year ended 30 June 2025
74 	75
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
75	74

-- 40 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.10. 	RECONCILIATION OF REINSURANCE CONTRACTS – GMM continued
2.10.2 	UK Life (Risk)
ANALYSIS BY MEASUREMENT COMPONENT
2025 	2024
Estimates of
PVFCF
RA for
non- financial
Risk
CSM
Total
Estimates of
PVFCF
RA for
non-financial
Risk
CSM
Total
Group
R million
(Assets)/Liabilities 	Navigation
Other
contracts
Other
contracts
Opening liabilities arising from
reinsurance contracts held 	11 460 	(471) 	(5 719) 	5 270 	9 701 	(429) 	(5 020) 	4 252
Net balance at beginning of the
year 	A 	11 460 	(471) 	(5 719) 	5 270 	9 701 	(429) 	(5 020) 	4 252
Changes in the income statement
and OCI
Changes that relate to current
services
CSM recognised for services provided 	– 	– 	636 	636 	– 	– 	495 	495
Change in Risk Adjustment for
non-financial risk that relates
to expired risk 	– 	25 	– 	25 	– 	24 	– 	24
Experience adjustments 	(130) 	– 	– 	(130) 	22 	– 	– 	22
Changes that relate to future services
Contracts initially recognised in
the period 	1 574 	(76) 	(1 782) 	(284) 	1 193 	(65) 	(1 318) 	(190)
Changes in estimates that adjust CSM 	333 	(2) 	(331) 	– 	(30) 	(2) 	33 	1
Changes in estimates that relate to
losses and reversal of losses on
underlying contracts 	(81) 	(4) 	– 	(85) 	63 	(8) 	– 	55
Net expenses from reinsurance
contracts held 	B 	1 696 	(57) 	(1 477) 	162 	1 248 	(51) 	(790) 	407
Net finance income from reinsurance
contracts 	C 	598 	34 	(180) 	452 	743 	(8) 	(119) 	616
Net changes to income statement
and OCI 	D = B + C 	2 294 	(23) 	(1 657) 	614 	1 991 	(59) 	(909) 	1 023
Cash flows 	E 	2 460 	– 	– 	2 460 	183 	– 	– 	183
Effect of movements in exchange rates 	F 	809 	(27) 	(375) 	407 	(415) 	17 	210 	(188)
Net balance at the end of the year 	G = A + D + E + F 	17 023 	(521) 	(7 751) 	8 751 	– 	11 460 	(471) 	(5 719) 	5 270
Closing liabilities arising from
reinsurance contracts held 	17 023 	(521) 	(7 751) 	8 751 	11 460 	(471) 	(5 719) 	5 270
Net balance at the end of the year 	17 023 	(521) 	(7 751) 	8 751 	11 460 	(471) 	(5 719) 	5 270
Notes to the group annual financial statements continued
for the year ended 30 June 2025
76 	77
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
77	76

-- 41 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.11 	RECONCILIATION OF REINSURANCE CONTRACTS – PAA
2.11.1 	SA Life: Group Life and other
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Asset for Incurred Claims 	Asset for Incurred Claims
Group
R million
(Assets)/Liabilities 	Navigation
Asset for
Remaining
Coverage
Estimates
of PVFCF
RA for
non-financial
risk 	Total
Asset for
Remaining
Coverage
Estimates
of PVFCF
RA for
non-financial
risk 	Total
Opening assets arising from
reinsurance contracts held 	159 	(830) 	(14) 	(685) 	398 	(910) 	(17) 	(529)
Net balance at beginning of
the year 	A 	159 	(830) 	(14) 	(685) 	398 	(910) 	(17) 	(529)
Changes in the statement of
profit or loss and OCI
Reinsurance premiums expense 	290 	– 	– 	290 	305 	– 	– 	305
Claims recovered from reinsurer 	– 	(286) 	3 	(283) 	– 	(265) 	4 	(261)
Net finance income from reinsurance
contracts held 	– 	(53) 	(3) 	(56) 	– 	(48) 	(1) 	(49)
Net changes to statement of profit
or loss and OCI 	B 	290 	(339) 	– 	(49) 	305 	(313) 	3 	(5)
Cash Flows
Premiums paid net of commissions 	(388) 	– 	– 	(388) 	(544) 	– 	– 	(544)
Reinsurance recoveries 	– 	257 	– 	257 	– 	393 	– 	393
Total cash flows 	C 	(388) 	257 	– 	(131) 	(544) 	393 	– 	(151)
Net balance at end of the year 	D = A + B + C 	61 	(912) 	(14) 	(865) 	159 	(830) 	(14) 	(685)
Closing assets arising from
reinsurance contracts held 	61 	(912) 	(14) 	(865) 	159 	(830) 	(14) 	(685)
Net balance at end of the year 	61 	(912) 	(14) 	(865) 	159 	(830) 	(14) 	(685)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
78 	79
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
79	78

-- 42 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.11 	RECONCILIATION OF REINSURANCE CONTRACTS – PAA continued
2.11.2 	SA Insure and other
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Asset for Incurred Claims 	Asset for Incurred Claims
Group
R million
(Assets)/Liabilities 	Navigation
Asset for
Remaining
Coverage
Estimates of
PVFCF
RA for non-
financial
risk 	Total
Asset for
Remaining
Coverage
Estimates of
PVFCF
RA for non-
financial
risk 	Total
Opening assets arising from
reinsurance contracts held 	916 	(1 053) 	(2) 	(139) 	776 	(845) 	(2) 	(71)
Net balance at beginning of the
year 	A 	916 	(1 053) 	(2) 	(139) 	776 	(845) 	(2) 	(71)
Changes in the statement of profit
or loss and OCI
Net expenses from reinsurance
contracts held 	– 	– 	– 	– 	– 	– 	– 	–
Reinsurance premiums expense 	162 	– 	– 	162 	732 	– 	– 	732
Recoveries and reversals of recoveries
of losses on onerous
underlying contracts 	– 	– 	– 	– 	– 	– 	– 	–
Claims recovered from reinsurer 	– 	(49) 	2 	(47) 	– 	(706) 	– 	(706)
Net changes to statement of profit
or loss and OCI 	B 	162 	(49) 	2 	115 	732 	(706) 	– 	26
Cash Flows
Premiums paid net of commissions 	(1 045) 	– 	– 	(1 045) 	(592) 	– 	– 	(592)
Other attributable expenses 	– 	– 	– 	– 	–
Reinsurance recoveries 	– 	985 	– 	985 	– 	498 	– 	498
Total cash flows 	C 	(1 045) 	985 	– 	(60) 	(592) 	498 	– 	(94)
Net balance at end of the year 	D = A +B + C 	33 	(117) 	– 	(84) 	916 	(1 053) 	(2) 	(139)
Closing assets arising from
reinsurance contracts held 	33 	(117) 	– 	(84) 	916 	(1 053) 	(2) 	(139)
Net balance at end of the year 	33 	(117) 	– 	(84) 	916 	(1 053) 	(2) 	(139)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
80 	81
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
81	80

-- 43 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.11 	RECONCILIATION OF REINSURANCE CONTRACTS – PAA continued
2.11.3 	UK Health
ANALYSIS BY REMAINING COVERAGE AND INCURRED CLAIMS
2025 	2024
Asset for Incurred Claims 	Asset for Incurred Claims
Group
R million
(Assets)/Liabilities 	Navigation
Asset for
Remaining
Coverage
Estimates of
PVFCF
RA for non-
financial
risk 	Total
Asset for
Remaining
Coverage
Estimates of
PVFCF
RA for non-
financial
risk 	Total
Opening assets arising from
reinsurance contracts held 	(4) 	(7) 	(2) 	(13) 	8 	(9) 	(3) 	(4)
Net balance at beginning of the
year 	A 	(4) 	(7) 	(2) 	(13) 	8 	(9) 	(3) 	(4)
Changes in the statement of profit
or loss and OCI
Reinsurance premiums expense 	5 	– 	– 	5 	(2) 	– 	– 	(2)
Claims recovered from reinsurer 	– 	(3) 	1 	(2) 	– 	2 	1 	3
Net changes to statement of profit
or loss and OCI 	B 	5 	(3) 	1 	3 	(2) 	2 	1 	1
Cash Flows
Premiums paid net of commissions 	(4) 	– 	– 	(4) 	(10) 	– 	– 	(10)
Reinsurance recoveries 	– 	1 	– 	1 	– 	– 	– 	–
Total cash flows 	C 	(4) 	1 	– 	(3) 	(10) 	– 	– 	(10)
Net balance at end of the year 	D = A +B + C 	(3) 	(9) 	(1) 	(13) 	(4) 	(7) 	(2) 	(13)
Closing assets arising from
reinsurance contracts held 	(3) 	(9) 	(1) 	(13) 	(4) 	(7) 	(2) 	(13)
Net balance at end of the year 	(3) 	(9) 	(1) 	(13) 	(4) 	(7) 	(2) 	(13)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
82 	83
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
83	82

-- 44 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.12 	INSURANCE REVENUE
The following tables present an analysis of the insurance revenue recognised in the period.
Group
R million
Income/(expense)
SA Life Risk
(GMM)
SA Invest
Risk (GMM)
SA
Invest
Participating
(VFA)
SA Life: Group
life and other
(PAA)
SA Insure and
other
(PAA)
UK Life Risk
(GMM)1
UK Health
(PAA) 	Total
Year ended 30 June 2025
Contracts not measured under the PAA
Amounts relating to changes in liabilities for remaining coverage 	13 257 	975 	2 574 	– 	– 	5 014 	– 	21 820
– CSM recognised for services provided 	1 862 	395 	1 324 	– 	– 	1 332 	– 	4 913
– Change in risk adjustment for non-financial risk for risk expired 	640 	36 	167 	– 	– 	239 	– 	1 082
– Expected incurred claims and other insurance service expenses 	10 712 	502 	986 	– 	– 	3 565 	– 	15 765
– Experience adjustments 	43 	42 	97 	– 	– 	(122) 	– 	60
Recovery of insurance acquisition cash flows 	2 162 	228 	783 	– 	– 	3 036 	– 	6 209
Contracts not measured under the PAA 	15 419 	1 203 	3 357 	– 	– 	8 050 	– 	28 029
Contracts measured under the PAA 	– 	– 	– 	3 738 	6 822 	– 	19 124 	29 684
Total insurance revenue 	15 419 	1 203 	3 357 	3 738 	6 822 	8 050 	19 124 	57 713
Year ended 30 June 2024
Contracts not measured under the PAA
Amounts relating to changes in liabilities for remaining coverage 	12 176 	727 	2 572 	– 	– 	4 294 	– 	19 769
– CSM recognised for services provided 	1 800 	295 	1 222 	– 	– 	1 241 	– 	4 558
– Change in risk adjustment for non-financial risk for risk expired 	589 	22 	201 	– 	– 	201 	– 	1 013
– Expected incurred claims and other insurance service expenses 	9 880 	370 	1 074 	– 	– 	3 146 	– 	14 470
– Experience adjustments 	(93) 	40 	75 	– 	– 	(294) 	– 	(272)
Recovery of insurance acquisition cash flows 	1 838 	304 	757 	– 	– 	2 610 	– 	5 509
Contracts not measured under the PAA 	14 014 	1 031 	3 329 	– 	– 	6 904 	– 	25 278
Contracts measured under the PAA 	– 	– 	– 	3 517 	6 861 	– 	16 474 	26 852
Total insurance revenue 	14 014 	1 031 	3 329 	3 517 	6 861 	6 904 	16 474 	52 130
Notes to the group annual financial statements continued
for the year ended 30 June 2025
84 	85
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
85	84

-- 45 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.13 	NET INVESTMENT RESULT
The following table analyses the Group’s net investment result in profit or loss and OCI.
Group
R million
Income/(expense)
SA Life Risk
(GMM)
SA Invest
Risk (GMM)
SA Invest
Participating
(VFA)
SA Life:
Group Life
and other
(PAA)
SA Insure
and other
immaterial
(PAA)
UK Life Risk
(GMM)
UK Health
(PAA)
Other
businesses 	Total
Year ended 30 June 2025
Investment return
Interest revenue from financial assets not measured at FVTPL 	3 	– 	– 	– 	5 	76 	154 	760 	998
Net gains on FVTPL investments 	29 	2 986 	13 130 	503 	– 	– 	70 	9 100 	25 818
Total investment return 	32 	2 986 	13 130 	503 	5 	76 	224 	9 860 	26 816
Movement in investment contract liabilities 	(3 810) 	(3 810)
Movement in third party interests in consolidated funds 	(4 394) 	(4 394)
Finance income/(expenses) from insurance contracts
Amounts recognised in profit or loss 	3 087 	(2 928) 	(13 024) 	(496) 	(20) 	716 	– 	– 	(12 665)
– Changes in fair value of underlying items of direct participation contracts 	– 	– 	(13 024) 	– 	– 	– 	– 	– 	(13 024)
– Interest accreted to the CSM 	(3 475) 	(95) 	(1 101) 	– 	– 	(258) 	– 	– 	(4 929)
– Interest on FCF and other finance (income)/expenses 	6 562 	(1 838) 	1 101 	(496) 	(20) 	974 	– 	– 	6 283
– Effect of changes in interest rates and other financial assumptions 	– 	(995) 	– 	– 	– 	– 	– 	– 	(995)
– Effect of movements in exchange rates 	– 	– 	– 	– 	– 	– 	– 	– 	–
Amounts recognised in OCI 	1 684 	– 	– 	74 	– 	1 203 	– 	– 	2 961
– Interest accreted to the CSM 	731 	– 	– 	– 	– 	(40) 	– 	– 	691
– Interest on FCF and other finance (income)/expenses 	(2 465) 	– 	– 	81 	– 	1 061 	– 	– 	(1 323)
– Effect of changes in interest rates and other financial assumptions 	2 309 	– 	– 	(10) 	– 	125 	– 	– 	2 424
– Effect of changing FCF at current rates when adjusting the CSM at rates on initial recognition 	1 151 	– 	– 	– 	– 	57 	– 	– 	1 208
– Effect of movements in exchange rates 	(42) 	– 	– 	3 	– 	– 	– 	– 	(39)
Net finance expenses from insurance contracts 	4 771 	(2 928) 	(13 024) 	(422) 	(20) 	1 919 	– 	– 	(9 704)
Finance income/(expenses) from reinsurance contracts
Amounts recognised in profit or loss 	(188) 	– 	– 	64 	– 	(299) 	– 	– 	(423)
– Interest accreted to the CSM 	509 	– 	– 	– 	– 	156 	– 	– 	665
– Interest on FCF and other finance (income)/expenses 	(697) 	– 	– 	64 	– 	(455) 	– 	– 	(1 088)
– Effect of changes in interest rates and other financial assumptions 	– 	– 	– 	– 	– 	– 	– 	– 	–
– Effect of movements in exchange rates 	– 	– 	– 	– 	– 	– 	– 	– 	–
Amounts recognised in OCI 	(221) 	– 	– 	(8) 	– 	(153) 	– 	– 	(382)
– Interest accreted to the CSM 	(44) 	– 	– 	– 	– 	24 	– 	– 	(20)
– Interest on FCF and other finance (income)/expenses 	291 	– 	– 	(8) 	– 	(260) 	– 	– 	23
– Effect of changes in interest rates and other financial assumptions 	(229) 	– 	– 	3 	– 	12 	– 	– 	(214)
– Effect of changing FCF at current rates when adjusting the CSM at rates on initial recognition 	(242) 	– 	– 	– 	– 	71 	– 	– 	(171)
– Effect of movements in exchange rates 	3 	– 	– 	(3) 	– 	– 	– 	– 	–
Net finance Income from reinsurance contracts 	(409) 	– 	– 	56 	– 	(452) 	– 	– 	(805)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
86 	87
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
87	86

-- 46 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.13 	NET INVESTMENT RESULT continued
The following table analyses the Group’s net investment result in profit or loss and OCI.
Group
R million
Income/(expense)
SA Life Risk
(GMM)
SA Invest
Risk (GMM)
SA Invest
Participating
(VFA)
SA Life:
Group Life
and other
(PAA)
SA Insure
and other
immaterial
(PAA)
UK Life Risk
(GMM)
UK Health
(PAA)
Other
businesses 	Total
Year ended 30 June 2024
Investment return
Interest revenue from financial assets not measured at FVTPL 	22 	– 	– 	– 	234 	58 	160 	386 	860
Net gains on FVTPL investments 	(113) 	2 356 	7 843 	506 	1 	– 	60 	5 592 	16 245
Total investment return 	(91) 	2 356 	7 843 	506 	235 	58 	220 	5 978 	17 105
Movement in investment contract liabilities 	(2 142) 	(2 142)
Movement in third party interests in consolidated funds 	(2 873) 	(2 873)
Finance income/(expenses) from insurance contracts
Amounts recognised in profit or loss 	3 278 	(2 341) 	(7 810) 	(458) 	– 	379 	– 	– 	(6 952)
– Changes in fair value of underlying items of direct participation contracts 	– 	– 	(7 789) 	– 	– 	– 	– 	– 	(7 789)
– Interest accreted to the CSM 	(3 397) 	(83) 	(1 112) 	– 	– 	(208) 	– 	– 	(4 800)
– Interest on FCF and other finance (income)/expenses 	6 675 	(1 876) 	1 091 	(458) 	– 	587 	– 	– 	6 019
– Effect of changes in interest rates and other financial assumptions 	– 	(382) 	– 	– 	– 	– 	– 	– 	(382)
– Effect of movements in exchange rates 	– 	– 	– 	– 	– 	– 	– 	– 	–
Amounts recognised in OCI 	(238) 	– 	– 	122 	– 	2 383 	– 	– 	2 267
– Interest accreted to the CSM 	662 	– 	– 	– 	– 	(31) 	– 	– 	631
– Interest on FCF and other finance (income)/expenses 	(2 478) 	– 	– 	77 	– 	1 056 	– 	– 	(1 345)
– Effect of changes in interest rates and other financial assumptions 	381 	– 	– 	40 	– 	1 402 	– 	– 	1 823
– Effect of changing FCF at current rates when adjusting the CSM at rates on initial recognition 	1 242 	– 	– 	– 	– 	(44) 	– 	– 	1 198
– Effect of movements in exchange rates 	(45) 	– 	– 	5 	– 	– 	– 	– 	(40)
Net finance expenses from insurance contracts 	3 040 	(2 341) 	(7 810) 	(336) 	– 	2 762 	– 	– 	(4 685)
Finance income/(expenses) from reinsurance contracts
Amounts recognised in profit or loss 	(259) 	– 	– 	64 	– 	(148) 	– 	– 	(343)
– Interest accreted to the CSM 	477 	– 	– 	– 	– 	100 	– 	– 	577
– Interest on FCF and other finance (income)/expenses 	(736) 	– 	– 	64 	– 	(248) 	– 	– 	(920)
– Effect of changes in interest rates and other financial assumptions 	– 	– 	– 	– 	– 	– 	– 	– 	–
– Effect of movements in exchange rates 	– 	– 	– 	– 	– 	– 	– 	– 	–
Amounts recognised in OCI 	193 	– 	– 	(15) 	– 	(468) 	– 	– 	(290)
– Interest accreted to the CSM 	(48) 	– 	– 	– 	– 	18 	– 	– 	(30)
– Interest on FCF and other finance (income)/expenses 	206 	– 	– 	(12) 	– 	(346) 	– 	– 	(152)
– Effect of changes in interest rates and other financial assumptions 	(88) 	– 	– 	2 	– 	(166) 	– 	– 	(252)
– Effect of changing FCF at current rates when adjusting the CSM at rates on initial recognition 	121 	– 	– 	– 	– 	26 	– 	– 	147
– Effect of movements in exchange rates 	2 	– 	– 	(5) 	– 	– 	– 	– 	(3)
Net finance Income from reinsurance contracts 	(66) 	– 	– 	49 	– 	(616) 	– 	– 	(633)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
88 	89
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
89	88

-- 47 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.14 	EFFECTS OF CONTRACT INITIALLY RECOGNISED IN THE YEAR
2.14.1 	Effect of insurance contracts initially recognised in the year
Group
R million
Assets/(Liabilities)
Profitable contracts issued 	Onerous contracts issued
Total
SA Life Risk
(GMM)
SA Invest
Risk (GMM)
SA Invest
Participating
(VFA)
UK Life Risk
(GMM)
SA Life
Risk (GMM)
SA Invest
Risk
(GMM)
SA Invest
Participating
(VFA)
UK Life Risk
(GMM)
Year ended 30 June 2025
Insurance acquisition cash flows 	(1 465) 	(160) 	(567) 	(4 956) 	(112) 	(11) 	(87) 	(1 276) 	(8 634)
Claims and other insurance service expenses payable 	(2 050) 	(3 640) 	(9 543) 	(7 284) 	(180) 	(215) 	(840) 	(2 918) 	(26 670)
Estimates of present value of cash outflows 	(3 515) 	(3 800) 	(10 110) 	(12 240) 	(292) 	(226) 	(927) 	(4 194) 	(35 304)
Estimates of present value of cash inflows 	5 176 	4 063 	10 913 	14 760 	278 	229 	888 	3 866 	40 173
Risk adjustment for non-financial risk 	(375) 	(18) 	(71) 	(392) 	(20) 	(7) 	(18) 	(79) 	(980)
CSM 	(1 286) 	(245) 	(732) 	(2 128) 	– 	– 	– 	– 	(4 391)
Losses recognised on initial recognition 	– 	– 	– 	– 	(34) 	(4) 	(57) 	(407) 	(502)
Year ended 30 June 2024
Insurance acquisition cash flows 	(1 290) 	(192) 	(421) 	(3 766) 	(111) 	(16) 	(113) 	(1 022) 	(6 931)
Claims and other insurance service expenses payable 	(2 564) 	(4 652) 	(5 973) 	(4 994) 	(268) 	(377) 	(1 834) 	(2 090) 	(22 752)
Estimates of present value of cash outflows 	(3 854) 	(4 844) 	(6 394) 	(8 760) 	(379) 	(393) 	(1 947) 	(3 112) 	(29 683)
Estimates of present value of cash inflows 	5 758 	5 226 	6 940 	10 549 	363 	380 	1 911 	2 897 	34 024
Risk adjustment for non-financial risk 	(382) 	(16) 	(56) 	(307) 	(21) 	(11) 	(14) 	(62) 	(868)
CSM 	(1 522) 	(366) 	(490) 	(1 482) 	– 	– 	– 	– 	(3 860)
Losses recognised on initial recognition 	– 	– 	– 	– 	(37) 	(24) 	(50) 	(277) 	(387)
2.14.2 	Effect of reinsurance contracts initially recognised in the year
Group
R million
Assets/(Liabilities)
Group of contracts with
a net cost on initial
recognition1
Total
SA Life Risk
(GMM)
UK Life Risk
(GMM)
Year ended 30 June 2025
Estimates of present value of cash outflows 	(1 032) 	(13 919) 	(14 951)
Estimates of present value of cash inflows 	845 	12 345 	13 190
Risk adjustment for non-financial Risk 	21 	76 	97
Income recognised on initial recognition (for offset) 	(6) 	(284) 	(290)
CSM 	(172) 	(1 782) 	(1 954)
Year ended 30 June 2024
Estimates of present value of cash outflows 	(1 134) 	(9 103) 	(10 237)
Estimates of present value of cash inflows 	932 	7 910 	8 842
Risk adjustment for non-financial Risk 	22 	65 	87
Income recognised on initial recognition (for offset) 	(6) 	(190) 	(196)
CSM 	(186) 	(1 318) 	(1 504)
1 Group of contracts with a net cost on initial recognition refers to those reinsurance contracts with a CSM on initial recognition, that will reflect as a future
cost relative to the insurance contract CSM that will release as future revenue.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
90 	91
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
91	90

-- 48 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.15 	CONTRACTUAL SERVICE MARGIN
The following table sets out when the Group expects to recognise the remaining CSM in profit or loss after the reporting date for
contracts not measured under the PAA. The CSM release remains stable, aligning with the service provided to policyholders. As
the expected services are delivered in a relatively linear fashion, the aggregated time bands for the CSM maturity analysis
reflects a broadly linear release pattern.
Group
R million
Assets/(Liabilities)
Year of expected release of the CSM
Total	< 1 year
1 to 2
years
3 to 5
years
6 to 10
years
10 to 20
years 	>20 years
Assets arising from insurance
contract issued
Year ended 30 June 2025
SA Life Risk (GMM)
Balance at beginning of
the period 	27 295 	28 001 	28 905 	32 815 	43 215 	74 434 	27 295
Accretion of interest 	2 686 	2 874 	9 926 	21 822 	66 824 	325 941 	430 073
Recognised in income
statement 	(1 980) 	(1 970) 	(6 016) 	(11 422) 	(35 605) 	(400 375) 	(457 368)
Balance at end of the period 	28 001 	28 905 	32 815 	43 215 	74 434 	– 	–
SA Invest Risk (GMM)
Balance at beginning of
the period 	820 	576 	363 	113 	139 	176 	820
Accretion of interest 	76 	58 	84 	90 	245 	278 	831
Recognised in income
statement 	(320) 	(271) 	(334) 	(64) 	(208) 	(454) 	(1 651)
Balance at end of the period 	576 	363 	113 	139 	176 	– 	–
SA Invest Participating (VFA)
Balance at beginning of
the period 	7 108 	6 707 	6 323 	5 618 	5 637 	4 049 	7 108
Accretion of interest 	1 041 	1 075 	3 357 	7 048 	13 139 	1 054 	26 714
Recognised in income
statement 	(1 442) 	(1 459) 	(4 062) 	(7 029) 	(14 727) 	(5 103) 	(33 822)
Balance at end of the period 	6 707 	6 323 	5 618 	5 637 	4 049 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	15 349 	14 265 	13 276 	10 738 	7 381 	2 911 	15 349
Accretion of interest 	330 	302 	782 	1 014 	1 190 	676 	4 294
Recognised in income
statement 	(1 414) 	(1 291) 	(3 320) 	(4 371) 	(5 660) 	(3 587) 	(19 643)
Balance at end of the period 	14 265 	13 276 	10 738 	7 381 	2 911 	– 	–
Total balance at beginning
of year 	50 572
Notes to the group annual financial statements continued
for the year ended 30 June 2025
92
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.15 	CONTRACTUAL SERVICE MARGIN continued
Group
R million
Assets/(Liabilities)
Year of expected release of the CSM
Total	< 1 year
1 to 2
years
3 to 5
years
6 to 10
years
10 to 20
years 	>20 years
Assets arising from insurance
contract issued
Year ended 30 June 2024
SA Life Risk (GMM)
Balance at beginning of the
period 	28 842 	29 596 	30 570 	34 772 	46 035 	81 593 	28 842
Accretion of interest 	2 699 	2 892 	10 027 	22 331 	71 111 	393 524 	502 584
Recognised in income statement 	(1 945) 	(1 918) 	(5 825) 	(11 068) 	(35 553) 	(475 117) 	(531 426)
Balance at end of the period 	29 596 	30 570 	34 772 	46 035 	81 593 	– 	–
SA Invest Risk (GMM)
Balance at beginning of
the period 	941 	635 	423 	110 	136 	173 	941
Accretion of interest 	86 	61 	93 	89 	240 	244 	813
Recognised in income statement 	(392) 	(273) 	(406) 	(62) 	(204) 	(417) 	(1 754)
Balance at end of the period 	635 	423 	110 	137 	172 	– 	–
SA Invest Risk (VFA)1
Balance at beginning of
the period 	6 306 	6 048 	5 770 	5 627 	6 227 	5 072 	6 306
Accretion of interest 	1 057 	1 088 	3 912 	8 349 	16 006 	1 660 	32 072
Recognised in income statement 	(1 315) 	(1 366) 	(4 055) 	(7 749) 	(17 161) 	(6 732) 	(38 378)
Balance at end of the period 	6 048 	5 770 	5 627 	6 227 	5 072 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	13 312 	12 347 	11 471 	9 232 	6 276 	2 367 	13 312
Accretion of interest 	249 	227 	586 	749 	827 	411 	3 049
Recognised in income statement 	(1 214) 	(1 103) 	(2 825) 	(3 705) 	(4 736) 	(2 778) 	(16 361)
Balance at end of the period 	12 347 	11 471 	9 232 	6 276 	2 367 	– 	–
Total balance at beginning
of year 	49 401
1 The CSM run-off note has been restated to address an issue with part of the reserve which was previously recognised entirely in Year 1. There is no impact on
overall CSM values, but the timing of recognition has been updated to provide an accurate allocation of CSM release over the appropriate service periods.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
93
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
93	92

-- 49 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.15 	CONTRACTUAL SERVICE MARGIN continued
The following table sets out when the Group expects to recognise the remaining CSM in profit or loss after the reporting date for
contracts not measured under the PAA.
Group
R million
(Assets)/Liabilities
Year of expected release of the CSM
Total	< 1 year
1 to 2
years
3 to 5
years
6 to 10
years
10 to 20
years 	>20 years
Liabilities arising from
reinsurance contracts held
Year ended 30 June 2025
SA Life Risk (GMM)
Balance at beginning of
the period 	4 608 	4 704 	4 839 	5 353 	6 388 	8 992 	4 608
Accretion of interest 	428 	449 	1 498 	3 031 	8 084 	32 536 	46 026
Recognised in income
statement 	(332) 	(314) 	(984) 	(1 996) 	(5 480) 	(41 528) 	(50 634)
Balance at end of the period 	4 704 	4 839 	5 353 	6 388 	8 992 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	7 751 	7 246 	6 781 	5 589 	4 002 	1 732 	7 751
Accretion of interest 	211 	191 	491 	649 	818 	477 	2 837
Recognised in income
statement 	(716) 	(656) 	(1 683) 	(2 236) 	(3 088) 	(2 209) 	(10 588)
Balance at end of the period 	7 246 	6 781 	5 589 	4 002 	1 732 	– 	–
Total balance at beginning
of year 	12 359
Year ended 30 June 2024
SA Life Risk (GMM)
Balance at beginning of
the period 	5 070 	5 169 	5 298 	5 861 	7 051 	10 273 	5 070
Accretion of interest 	457 	480 	1 601 	3 269 	8 974 	40 606 	55 387
Recognised in income
statement 	(358) 	(351) 	(1 038) 	(2 079) 	(5 752) 	(50 879) 	(60 457)
Balance at end of the period 	5 169 	5 298 	5 861 	7 051 	10 273 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	5 719 	5 337 	4 986 	4 084 	2 882 	1 193 	5 719
Accretion of interest 	141 	126 	317 	408 	489 	268 	1 749
Recognised in income
statement 	(523) 	(477) 	(1 219) 	(1 610) 	(2 178) 	(1 461) 	(7 468)
Balance at end of the period 	5 337 	4 986 	4 084 	2 882 	1 193 	– 	–
Total balance at beginning
of year 	10 789
Notes to the group annual financial statements continued
for the year ended 30 June 2025
94
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.16 	INSURANCE FINANCE RESERVE – EXPECTED RUN-OFF PROFILE
The following table sets out when the Group expects to recognise the remaining insurance finance income and expense reserve
after the reporting date for contracts not measured under the PAA and the long-term claims in the Group Life business.
Group
R million
Cumulative debit balance/
(Cumulative credit balance)
Year of expected run-off of the IFIE reserve
Total	< 1 year
1 to 2
years
3 to 5
years
6 to 10
years
10 to 20
years 	>20 years
Assets/liabilities arising from
insurance contract issued
Year ended 30 June 2025
SA Life Risk (GMM)
Balance at beginning of
the period 	9 464 	11 588 	13 788 	20 747 	27 038 	7 549 	9 464
Movement in IFIE reserve 	2 124 	2 200 	6 959 	6 291 	(19 489) 	(7 549) 	(9 464)
Balance at end of the period 	11 588 	13 788 	20 747 	27 038 	7 549 	– 	–
SA Life: Group Life and other
(PAA)
Balance at beginning of
the period 	(411) 	(522) 	(626) 	(934) 	(1 184) 	(321) 	(411)
Movement in IFIE reserve 	(111) 	(104) 	(308) 	(250) 	863 	321 	411
Balance at end of the period 	(522) 	(626) 	(934) 	(1 184) 	(321) 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	(3 764) 	(4 154) 	(4 381) 	(5 004) 	(5 750) 	(4 896) 	(3 764)
Movement in IFIE reserve 	(390) 	(227) 	(623) 	(746) 	854 	4 896 	3 764
Balance at end of the period 	(4 154) 	(4 381) 	(5 004) 	(5 750) 	(4 896) 	– 	–
Total balance at beginning
of year 	5 289
Year ended 30 June 2024
SA Life Risk (GMM)
Balance at beginning of
the period 	11 147 	13 068 	15 150 	20 206 	21 989 	(10 991) 	11 147
Movement in IFIE reserve 	1 921 	2 082 	5 056 	1 784 	(32 981) 	10 991 	(11 147)
Balance at end of the period 	13 068 	15 150 	20 206 	21 990 	(10 992) 	– 	–
SA Life: Group Life and other
(PAA)
Balance at beginning of
the period 	(337) 	(466) 	(601) 	(935) 	(1 229) 	(46) 	(337)
Movement in IFIE reserve 	(129) 	(135) 	(334) 	(294) 	1 183 	46 	337
Balance at end of the period 	(466) 	(601) 	(935) 	(1 229) 	(46) 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	(2 385) 	(3 010) 	(3 378) 	(3 877) 	(4 145) 	(3 276) 	(2 385)
Movement in IFIE reserve 	(625) 	(368) 	(499) 	(268) 	869 	3 276 	2 385
Balance at end of the period 	(3 010) 	(3 378) 	(3 877) 	(4 145) 	(3 276) 	– 	–
Total balance at beginning
of year 	8 425
Notes to the group annual financial statements continued
for the year ended 30 June 2025
95
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
95	94

-- 50 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.16 	INSURANCE FINANCE RESERVE – EXPECTED RUN-OFF PROFILE continued
The following table sets out when the Group expects to recognise the remaining reinsurance finance income and expense
reserve after the reporting date for contracts not measured under the PAA and the long-term claims in the Group Life business.
Group
R million
Cumulative credit balance/
(Cumulative debit balance)
Year of expected run-off of the IFIE reserve
Total	< 1 year
1 to 2
years
3 to 5
years
6 to 10
years
10 to 20
years 	>20 years
Liabilities arising from
reinsurance contracts from
reinsurance contracts held
Year ended 30 June 2025
SA Life Risk (GMM)
Balance at beginning of
the period 	1 330 	1 476 	1 617 	2 014 	2 200 	536 	1 330
Movement in IFIE reserve 	146 	141 	397 	186 	(1 664) 	(536) 	(1 330)
Balance at end of the period 	1 476 	1 617 	2 014 	2 200 	536 	– 	–
SA Life Group Risk (PAA)
Balance at beginning of
the period 	(52) 	(64) 	(74) 	(102) 	(117) 	(24) 	(52)
Movement in IFIE reserve 	(12) 	(10) 	(28) 	(15) 	93 	24 	52
Balance at end of the period 	(64) 	(74) 	(102) 	(117) 	(24) 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	39 	(8) 	6 	(20) 	(154) 	(250) 	39
Movement in IFIE reserve 	(47) 	14 	(26) 	(134) 	(96) 	250 	(39)
Balance at end of the period 	(8) 	6 	(20) 	(154) 	(250) 	– 	–
Total balance at beginning
of year 	1 317
Year ended 30 June 2024
SA Life Risk (GMM)
Balance at beginning of
the period 	1 552 	1 739 	1 935 	2 350 	2 452 	66 	1 552
Movement in IFIE reserve 	187 	196 	415 	102 	(2 386) 	(66) 	(1 552)
Balance at end of the period 	1 739 	1 935 	2 350 	2 452 	66 	– 	–
SA Life Group Risk (PAA)
Balance at beginning of
the period 	(44) 	(61) 	(79) 	(123) 	(162) 	(7) 	(44)
Movement in IFIE reserve 	(17) 	(18) 	(44) 	(39) 	155 	7 	44
Balance at end of the period 	(61) 	(79) 	(123) 	(162) 	(7) 	– 	–
UK Life Risk (GMM)
Balance at beginning of
the period 	187 	6 	(64) 	(103) 	(143) 	(153) 	187
Movement in IFIE reserve 	(181) 	(70) 	(39) 	(39) 	(10) 	153 	(186)
Balance at end of the period 	6 	(64) 	(103) 	(142) 	(153) 	– 	1
Total balance at beginning
of year 	1 695
Notes to the group annual financial statements continued
for the year ended 30 June 2025
96
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.17 	CLAIMS DEVELOPMENT
Given the insurance risks underwritten by the Group and the timely settlement of valid claims, uncertain claims which extend
beyond 12 months are limited to certain annuity payments only.
Some insurance claims, such as Income Continuation Benefits (ICB), are settled through regular annuity benefit payments that
may span several years. The initial claim for ICB contracts is established at the date of the disability event, however, the full
extent of the annuity payments remains subject to ongoing insurance events, such as future mortality, and may also vary due to
morbidity outcomes. Nevertheless, once the insured event has occurred, the future benefit payments for these products can be
estimated with a high degree of certainty,
Total claims and benefits for the financial year ended 30 June 2025 was R30 231 million (30 June 2024: R29 462 million). Total ICB
annuity claims and benefits for the same period was R1 136 million or 3.8% of total claims and benefits (30 June 2024: R1 401
million or 4.8% of total claims). Due to the uncertainty in claims development being immaterial, no further information is
disclosed.
The following table outlines the total ICB for incurred claims reconciled with the aggregate carrying amount of the groups of
insurance contracts.
Estimate of cumulative claims
Group
R million
Expected gross
of reinsurance
claim payments
Expected net
of reinsurance
claim payments
Year ended 30 June 2025
Total annuity ICB for incurred claims 	18 513 	15 067
Effect of discounting 	(8 980) 	(7 338)
Risk adjustment 	126 	100
Other claims settled within 1 year 	4 738 	3 429
Total liabilities for incurred claims in the Statement of financial position 	14 397 	11 258
Included in the LIC balance for the following portfolios:
SA Life (Risk) | GMM 	7 873 	5 658
SA Life: Group Life and Other | PAA 	6 524 	5 600
Year ended 30 June 2024
Total annuity ICB for incurred claims 	18 840 	15 269
Effect of discounting 	(9 920) 	(8 062)
Risk adjustment 	121 	94
Other claims settled within 1 year 	4 608 	3 149
Total liabilities for incurred claims in the Statement of financial position 	13 649 	10 450
Included in the LIC balance for the following portfolios:
SA Life (Risk) |GMM 	7 619 	5 264
SA Life: Group Life and Other | PAA 	6 030 	5 186
Notes to the group annual financial statements continued
for the year ended 30 June 2025
97
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
97	96

-- 51 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.18 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES
In preparing the Annual Financial Statements, estimates, assumptions, and judgements are made that could materially affect
the reported amounts of assets and liabilities within the next financial year. Accounting estimates and judgements are
regularly reviewed and are based on historical experience, current best estimates, and expectations of future outcomes as well
as anticipated changes in the environment. The following represents the most material key assumptions applied by
management in preparing these Annual Financial Statements.
I. 	INSURANCE CONTRACTS SCOPE AND GROUPING
DEFINITION AND CLASSIFICATION
a. Definition
IFRS 17 does not specify what significant insurance risk is. Discovery’s policy defines significant insurance risk as follows:
The possibility that the present value of losses arising on the insurance contract exceeds 10% of the present value of
income and receipts collected when applying a worst-case scenario upon the inception of the insurance contract.
b. Classification
Eligibility for VFA
Within Discovery, the unit-linked insurance products offered by Discovery Life are examples of insurance contracts with
direct participation features. The VFA is used to measure insurance contracts with direct participating features.
Discovery exercises judgement in determining whether the VFA eligibility criteria are met at initial recognition. Judgement
is applied for the following eligibility criteria to use VFA:
■ Discovery expects to pay to the policyholder an amount equal to a substantial share of the fair value returns on the
underlying items and
■ Discovery expects a substantial proportion of any change in the amounts to be paid to the policyholder to vary with the
change in fair value of the underlying items.
Within Discovery, a “substantial share” and “substantial proportion” is deemed to represent a proportion that exceeds 50%
as a rebuttable presumption.
UNIT OF ACCOUNT, AGGREGATION AND RECOGNITION OF INSURANCE AND REINSURANCE CONTRACTS
Discovery uses judgement to determine at what level of granularity Discovery has reasonable and supportable information
that is sufficient to conclude that all contracts within a set are sufficiently homogeneous.
For GMM and VFA business Discovery assesses the profitability of each contract at initial recognition for allocation of that
contract to either the profitable, profitable-at-risk or onerous group of insurance contracts. For reinsurance contracts, the
profitability at initial recognition is either profitable, profitable-at-risk or net gain on reinsurance contracts.
Discovery performs stress testing on portfolios measured using GMM/VFA. The stresses are modelled at the policy
inception date and may differ between portfolios but will correspond to the most significant non-financial stresses
currently run as part of the risk appetite work. If any policy that was originally determined to be profitable becomes
onerous under any of the three additional stresses calculated, that policy is classified as profitable-at-risk.
JUDGEMENTS TO DETERMINE THE CONTRACT BOUNDARIES OF POLICIES WITHIN THE PAC ARRANGEMENT
The PAC arrangement is designed for UK Life to assume full economic exposure, including returns and insurance risk, of
the underlying insurance contracts. Accordingly, as UK Life has taken on this risk, it was granted full control over
underwriting decisions for underlying new contracts written under the arrangement. Based on the legal rights and
obligations, UK Life has exposure to monthly insurance contracts under this arrangement with PAC i.e. although new
underlying life insurance contracts could be sold at any time, policy inception occurred only on a monthly basis, consistent
with Discovery’s other life insurance business lines. Exercising judgement under IFRS 17, the contract with PAC has been
modelled using groups of contracts comprising annual groups of insurance contracts written.
II. CONTRACTS MEASURED UNDER THE GMM AND VFA
Discovery provides detailed qualitative information about the inputs, assumptions, and estimation techniques that are
considered significant and material for measuring insurance and reinsurance contracts. Where applicable, Discovery also
provides quantitative information. However, detailed disclosure of quantitative information is not provided when it is
impracticable to do so. This impracticality may arise due to one or a combination of the following reasons:
■ The assumptions are set at a highly granular level to support the unique dynamic underwriting approach used in the
product design. The quantitative inputs are therefore extensive.
■ The dynamic underwriting approach leads to assumptions which are interdependent therefore the quantitative inputs in
one category may be misleading or misinterpreted if not considered together with other assumptions and inputs.
■ The assumptions are partly derived from internal data which is commercially sensitive and impacts Discovery’s
competitive position.
III. EXPECTED FULFILMENT CASH FLOWS (EFCF)
In line with the requirements of IFRS 17, Discovery applies judgement to determine which cash flows within the boundary
of insurance contracts relate directly to the fulfilment of the contracts, including the extent to which fixed and variable
overheads are directly attributable to fulfilling insurance contracts.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
98
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.18 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
Discovery primarily uses deterministic projections to estimate the present value of future cash flows. The following
assumptions were used when estimating future cash flows:
The assumptions used are best estimate assumptions, with the addition of a margin for risk in the assumption being allowed
for in the risk adjustment.
A. MORTALITY AND MORBIDITY
Assumptions of future mortality and morbidity experience are derived from reinsurers and industry data and compared to
actual past experience. Where appropriate, the assumptions are adjusted to reflect actual past experience or for expected
changes in future experience.
The assumptions are modified for each policy based on actual data from underwriting performed on the policy and
compared against standard industry tables for reasonability. The key mortality and morbidity assumptions are reviewed
and benchmarked against the industry to ensure the reasonability of assumptions for Discovery Life. An adjustment to the
standard mortality and morbidity assumptions is made to reflect the expected impact of engagement in the Vitality
programme. It has been observed that higher rates of engagement result in lower mortality and morbidity claims.
For VitalityLife the mortality assumptions are set using mortality tables published by the Continuous Mortality Investigation
(CMI), a subsidiary of the Institute and Faculty of Actuaries, and using the CMI projection model to allow for future
mortality improvements. Where appropriate, the assumptions are adjusted to reflect actual past experience or for
expected changes in future experience. Morbidity assumptions are derived from reinsurer and industry data where
available and adjusted for actual past experience where appropriate. An adjustment to the standard mortality and
morbidity assumptions is made to reflect the expected impact of engagement in the Vitality programme and the
policyholder’s level of physical activity.
A possible increase in mortality rates increases estimates of future cash outflows and thus decreases the CSM. For a
sensitivity analysis, refer to Section 2.19.3.
The sensitivity of the policyholder liabilities due to changes in mortality and morbidity assumptions are set out in section
2.19.3.1 and 2.19.3.2.
B. ASSUMPTIONS ON LAPSE AND SURRENDER RATES
Lapse and surrender rates are based on actual past experience where available. The lapse analysis is done by considering
the in–force duration of policies. For durations longer than actual data, lapse rates are set based on expectations of future
experience based on internal and external expert advice as well as available industry benchmarking. The lapse experience
investigation covers at least the last two years of lapse experience to identify trends.
Lapse and surrender assumptions are varied between different types of policies where the lapse experience is expected to
differ significantly. Allowance is made for the estimated impact of the economic environment. For Discovery Life and
VitalityLife, an adjustment is made to the lapse assumptions to reflect the expected impact of engagement in the Vitality
programme because it has been observed that higher rates of engagement result in lower lapses.
Possible increases in lapse and surrender rates could increase or decrease estimates of future cash outflows and thus
decrease or increase the CSM, depending on the product specifics.
The lapse and surrender rates are assumed to range between 2.8% and 17.6% for the SA Life Risk (GMM) portfolio (2024:
2.5% to 18.4%), up to 3.0% for the SA Invest Risk (GMM) portfolio (2024: up to 3.0%), between 2.3% and 11.0% for the SA
Invest Participating (VFA) portfolios (2024: 2.2% to 11.9%), and between 1.4% and 11.0% for the UK Life Risk (GMM) portfolio
(2024: 1.6% to 11.9%). The disclosed ranges for the GMM portfolios represent the API-weighted average assumptions and
for the VFA portfolio represent asset-weighted assumptions. Both are based on the in-force book exposure over the past
12 months and reflect the key attributes considered in setting assumptions. The ranges exclude funeral business, policies
cancelled from inception, policy alterations, and, for the VFA portfolio, paid-up assumptions.
The sensitivity of the policyholder assets and liabilities due to changes in lapse rate assumptions are set out in section
2.19.3.1 and 2.19.3.2.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
99
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
99	98

-- 52 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.18 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
C. DISCOUNT RATES AND INVESTMENT RETURNS
Discount rate
The bottom-up approach was used to derive the discount rate for the cash flows of portfolios with no tangible asset
backing. Under this approach, the discount rate is determined as the risk-free yield, adjusted for differences in liquidity
characteristics of the insurance contracts sold, where applicable.
The adjustment for the liquidity should reflect the contract’s liquidity from the policyholder’s perspective, i.e., it should
consider both the explicit and implicit impediments for the policyholder to terminate the contract.
From Discovery’s perspective, there is an immaterial liquidity risk on the life insurance portfolio given that the products:
■ do not charge a surrender penalty on lapse. There is no direct impediment for the policyholder to lapse their contract.
■ most policyholders select age-based premium escalation patterns – this provides a broad match between the increase
in premium and the escalating risk over time, leading to a significantly lower implicit impediment to lapse their contract
as value does not accumulate to the extent it would in a level-premium contract for example.
For Discovery, the risk-free yield curve will be ‘current’ and reflect the risk-free yield curve derived on the last day of the
reporting period. The nominal risk-free yield curve is used to discount nominal cash flows, while real cash flows are discounted
using the real risk-free yield curve.
Risk-free rates are determined by reference to the market interest rates in the currency of the underlying cash flows for the
groups of contracts.
The yield curves that were used to discount the estimates of future cash flows that do not vary based on the returns of the
underlying items are as follows:
R million 	< 1 year
1 to 2
years
3 to 5
years
6 to 10
years
10 to 20
years >20 years
30 June 2025
Insurance contract cash flows
SA Life (Risk) | GMM 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
SA Invest (Risk) | GMM 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
SA Invest (Participating) |VFA 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
UK Life (Risk) | GMM 	3.8 % 	3.7 % 	3.6 % 	3.8 % 	4.3 % 	4.1 %
SA Life: Group Life | PAA 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
Reinsurance contract cash flows
SA Life (Risk) | GMM 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
SA Invest (Risk) | GMM 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
SA Invest (Participating) |VFA 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
UK Life (Risk) | GMM 	3.8 % 	3.7 % 	3.6 % 	3.8 % 	4.3 % 	4.1 %
SA Life: Group Life | PAA 	7.6 % 	7.9 % 	8.6 % 	10.2 % 	12.6 % 	12.2 %
30 June 2024
Insurance contract cash flows
SA Life (Risk) | GMM 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
SA Invest (Risk) | GMM 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
SA Invest (Participating) |VFA 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
UK Life (Risk) | GMM 	4.9% 	4.7% 	4.2% 	3.9% 	4.0% 	3.6%
SA Life: Group Life | PAA 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
Reinsurance contract cash flows
SA Life (Risk) | GMM 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
SA Invest (Risk) | GMM 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
SA Invest (Participating) |VFA 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
UK Life (Risk) | GMM 	4.9% 	4.7% 	4.2% 	3.9% 	4.0% 	3.6%
SA Life: Group Life | PAA 	8.5% 	8.6% 	9.5% 	11.3% 	13.4% 	12.6%
Notes to the group annual financial statements continued
for the year ended 30 June 2025
100
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.18 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
Discovery Life
To determine the risk-free rate in South Africa, the daily nominal and real yield curves produced and published daily by the
Discovery Bank Treasury function. These curves are consistent with the current market value of South African Government
Bond issuances, and consistent with observable current market prices.
Discovery Life considers for inclusion all bonds included in the GOVI index while applying exclusion criteria designed to only
include homogeneous bonds within the curve construction. Negotiable Certificates of Deposit are also used making
appropriate adjustments to allow for credit risk.
The South African Government does not issue bonds across all maturities which implicitly creates the need to interpolate
between various securities and extrapolate beyond the last liquid bond used in the construction of the yield curve.
The sensitivity of the policyholder liabilities due to changes in real curve assumptions are set outset out in section 2.4.3.1 and
2.4.3.2.
Vitality Life
To determine the risk-free rate in the UK, the nominal and yield curves are produced and published daily by the European
Insurance and Occupational Pensions Authority (EIOPA).
D. EXPENSE ASSUMPTIONS
IFRS 17 does not specify a methodology for attributing directly attributable fixed overhead expenses to the respective
groups of insurance contracts and to individual policies. It requires that the methods used be systematic and rational.
Discovery has applied judgement in developing its methodology and has consistently applied this methodology period-to-
period, except as noted below.
Estimates of future expenses relating to fulfilment of contracts in the scope of IFRS 17 are based on the results of the latest
expense and budget information. Expenses comprise expenses directly attributable to the groups of contracts including an
allocation of fixed and variable overheads.
Expenses are considered non-recurring when they relate to the start-up of a new business area or when they are material
and are specific to an event that is not expected to occur in the future.
The allocation of expenses between initial and renewal is based on the latest expense analysis, where expenses are
directly allocated based on the function performed. Where an expense could relate to both initial and renewal functions,
the expenses are allocated proportionately based on estimates of the functions performed.
Per Discovery’s policy, expenses are projected to increase in line with consumer price inflation. Non-recurring expenses are
excluded from the expense analysis used to derive the assumption.
The sensitivity of the policyholder liabilities due to changes in expense assumptions are set out in section 2.4.3.1 and
2.4.3.2.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
101
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
101	100

-- 53 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.18 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
CONTRACTUAL SERVICE MARGIN
The CSM is a component of the asset or liability for the group of insurance contracts that represents the future unearned
profit. The CSM of a group of contracts is recognised in profit or loss to reflect services provided in each year based on the
number of coverage units provided in the year.
The determination of coverage units requires significant judgements due to consideration of the quantity of the benefits
provided, the expected coverage period and time value of money for each contract. The coverage units are reviewed and
updated at each reporting date.
The quantity of services provided by insurance contracts may include insurance coverage, investment-return services and
investment-related services, as applicable. Discovery determines the quantity of the benefits provided under each contract as
follows:
Portfolio 	Benefit type
Measurement
model 	Risk Management
Insurance contracts
SA Life (Risk), SA Invest
(Risk) and UK life (Risk)
Lump sum benefits
paid on death,
disability or
disablement and
survival
GMM
For contracts where coverage for an
insured event is provided, the quantity of
benefits is considered to be the maximum
amount payable under each insurance
contract at each point in time. For
contracts where the company provides
investment-return services on insurance
contracts in Invest without direct
participation features, it is assumed that
the company provides an equal service to
all policyholders in the generation of an
investment return for each policyholder.
Annuity-type payment
on death of disability
The expected maximum amount at risk at
each point in time.
SA Invest (Participating) 	Investment linked
insurance contracts.
VFA
The coverage unit should allow for the
coverage provided for the insured event as
well as the management of the underlying
items on behalf of the policyholder. On VFA
contracts, the determination of the
coverage unit is primarily dependent on
the investment services provided under the
contract given this constitutes the majority
of the service provided to policyholders
over the lifetime of the contract.
Reinsurance contracts
SA Life (Risk) and UK life
(Risk)
Quota share
reinsurance
GMM
Same basis as underlying insurance
contract
Excess of loss and stop
loss reinsurance
Expected amount of underlying claims to
be covered in each period
Notes to the group annual financial statements continued
for the year ended 30 June 2025
102
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.18 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES continued
For GMM contracts, Discovery has elected to allow for the real time value of money in the equal allocation of CSM to coverage
units:
■ For Discovery Life and VitalityLife’s life insurance policies this is allowed for implicitly by assuming that the same coverage is
provided in real terms over time. Practically this is achieved by projecting benefits with a 0% CPI rate solely for the
determination of the coverage units.
■ For Discovery Life’s guaranteed endowment and annuity business modelled using the GMM approach, this is allowed for by
explicitly discounting the coverage units at the real rate of return.
For VFA contracts, Discovery’s chosen approach is to allow for the nominal time value of money in the equal allocation of CSM
to coverage units.
RISK ADJUSTMENT
When applying a confidence level technique, the first step in the process is to calculate the best estimate reserve, where there
is an equal chance that the actual amount needed to pay future claims will be higher or lower than the calculated best
estimate. The risk adjustment is then calculated such that there is a specified percentage probability that the reserves will be
sufficient to cover future claims. For Discovery, the determination of specified percentage is set out in Accounting policy 12.2.
and 12.3.3.
III. CONTRACTS MEASURED UNDER THE PAA
INSURANCE ACQUISITION CASH FLOWS
Discovery uses judgement in determining the initial and renewal periods for which the insurance acquisition cash flows are
attributed to groups. For VitalityHealth, the initial and subsequent renewal period is set at ten years.
In the current and prior year, Discovery did not identify any facts and circumstances indicating that the assets for
insurance acquisition cash flows may be impaired.
RISK ADJUSTMENT
For contracts measured under the PAA, the explicit risk adjustment for non-financial risk is estimated to measure the LIC.
The risk adjustment will be determined by applying a confidence level technique. For Discovery, the determination of
specified percentage is set out in Accounting policy 12.2. and 12.4.1.
REINSURANCE
All prospective liabilities are valued gross of reinsurance and then adjusted for the expected effect of reinsurance. For
liabilities arising from insurance contracts, a specific allowance is made for reinsurance recoveries.
The Global Linkage Benefit is fully reinsured. The cost of the future reinsurance is dependent on the cost at which the
reinsurer can buy assets to match the liability under this benefit. Assumptions are made around the cost at which the
reinsurer can purchase these benefits based on the current and historical costs of these assets.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
103
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
103	102

-- 54 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK
Discovery’s accounting policy to recognise and measure insurance contracts can be viewed in Annexure B, Accounting policy 12.
Discovery issues both short-term and long-term contracts that transfer significant insurance risk. Such contracts may also
transfer financial risk. An insurance contract is a contract in which Discovery as the issuer and/or insurer accepts significant
insurance risk from the policyholder by agreeing to compensate the policyholder if a specified uncertain future event (the
insured event) adversely affects the policyholder.
The insurance risk includes mortality and morbidity risk for life insurance contracts, as well as non-life risk from events such as
fire or accident arising under general insurance contracts. As such, Discovery is exposed to the uncertainty surrounding the
timing and severity of such claims.
Discovery has aggregated groups of insurance and reinsurance contracts into portfolios, first based on geographical areas and
subsequently based on measurement models and materiality. Based on the aggregation bases steps, Discovery will aggregate
insurance and reinsurance contracts in the following manner:
Contracts measured under the GMM and VFA
■ Individual life insurance: These contracts insure against a comprehensive spectrum of risks, including life cover, severe illness,
disability and income continuation cover.
■ Investment products with insurance risk: These contracts attract insurance risk arising from additional benefits offered which
mostly insure against mortality or morbidity risks.
Contracts measured under PAA
■ Health insurance: These contracts insure policyholders against healthcare-related claims.
■ Short-term insurance: These monthly contracts insure policyholders against a comprehensive spectrum of short-term risks
including, but not limited to, motor vehicle, household, business, property and liability cover.
■ Group life insurance: These contracts insure against a comprehensive spectrum of protection benefits on a group basis. Life
cover, severe illness, disability and income continuation benefits are offered.
Discovery issues insurance contracts, insurance linked investment contracts and unit-linked insurance contracts that provide
investors with interests in collective investment schemes managed by the Group. The nature and extent of the underwriting and
financial risks arising from these contracts are determined by the contract design. The risks are evaluated for risk management
purposes in conjunction with the risks mitigated by related reinsurance contracts and the risks arising from financial assets held
to fund the settlement of the liabilities.
Risk management objectives and policies for mitigating insurance risk
The Group manages insurance risk through the following mechanisms:
■ Reinsurance, which is used to limit Discovery’s exposure to large single claims and catastrophes. When selecting a reinsurer,
consideration is given to those companies that provide high security using rating information from both public and private
sources.
■ An agreed risk preference for all risk types, including those relating to insurance.
■ The diversification of business over several classes of insurance and large numbers of uncorrelated individual risks, by which
the Group seeks to reduce variability in loss experience.
■ The maintenance and use of information management systems, which provide current data on the risks to which the business
is exposed and the quantification of such risks.
■ Actuarial models, which use the above information to calculate premiums and monitor decrements and claims patterns.
■ Past experience and statistical methods are used.
■ Guidelines for concluding insurance contracts and assuming insurance risks. These include underwriting principles and
product pricing procedures.
■ Discovery manages its exposure to risks arising from insurance contracts in terms of its risk management framework and
holds regulatory and economic capital for protection against adverse experience.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
104
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
The following summarises the risk associated with the various insurance contracts offered by Discovery, and how Discovery
manages these risks.
Type of risk 	Nature of risk 	How Discovery manages the risk
Lapse and
surrender risk
Policyholders have the option to discontinue or
reduce contributions at any time.
Accordingly, there is a risk of financial loss due to
the withdrawal rate, lapses or premium reductions
(with associated reduced cover) being higher than
expected.
Contracts not measured under the PAA model
SA Life and Invest (Risk) and UK Life (Risk)
Future earnings on individual life plans are
dependent on the number of policies remaining in
future years and thus future earnings are
dependent on the lapse rate.
SA Life and Invest (Participating)
Future earnings arising from Invest plans are
dependent on the value of assets under
management and thus future earnings are
dependent on the withdrawal and surrender rate.
For investment products with insurance risk there
is a risk that the surrender value may exceed the
policy value, net of expenses, at early durations.
Contracts measured under the PAA model
For contracts measured under the PAA approach
there is a risk of reduced profits arising from
higher than expected withdrawals at early
durations of policies, resulting in acquisition costs
not being recovered.
Product design
Products are designed to be sustainable in the long
term. New product offerings are made available to
existing policyholders as far as possible to prevent
lapse and re-entry risk.
Integration between different product offerings
across Discovery enhances the value proposition of
the overall package of products from Discovery.
Commission claw back
Discovery predominantly distributes via
independent brokers, intermediaries and tied
agents. Commissions are clawed back from
intermediaries where a policy lapses within a
specified timeframe since inception.
Experience monitoring
Lapse experience is monitored on a monthly basis
and data is analysed to establish possible trends
for which management action can be taken.
Proactive conservation
Targeted conservation campaigns are run
proactively.
For example, financial advisors are notified of
clients that do not have certain features on their
policies that are correlated with good persistency.
Financial advisors are thus encouraged to add such
features.
Modelling and
data risk
Actuarial liabilities are calculated using complex
discounted cash flow models. There is a risk that
the models do not accurately project the policy
cash flows in the future.
The models rely on data from the administration
system, and there is thus a further risk that the
data does not accurately reflect the policies being
valued.
Contracts that are short-term have simplified
models, reducing modelling risk.
The risk is controlled using specialist actuarial
software that is widely used and accepted in the
life insurance industry throughout the world. This
is tailored for Discovery. A detailed analysis of
change is completed on key metrics and serves as
a control on models, data and assumption
changes. Any material unexplained variances are
investigated and resolved where necessary.
The original actuarial models were tested and
verified using an independent but identical parallel
model. Any changes made are externally and
independently reviewed.
The data for the model is extracted from modern
administration systems and subjected to detailed
checks together with high-level reasonability
checks. Data is checked at each valuation date.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
105
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
105	104

-- 55 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Capital adequacy
Requirements and
protection against
adverse
experiences
There is a risk that future premiums, investment
returns and estimates used to calculate liabilities
are insufficient to provide for variations in actual
future experience.
Insurance liabilities are calculated using best
estimates plus the addition of various margins
to avoid premature recognition of profits and
to provide for a buffer against future adverse
experiences. In addition, Discovery maintains
shareholder capital to meet substantial
deviations in experience beyond those
provided for in the liability calculations.
For discussion on how Discovery manages its
capital adequacy requirements, refer to note
2.19.6
Liquidity risk 	Liquidity risk is the risk that an entity will
encounter difficulty in meeting obligations
associated with insurance liabilities due to
insufficient cash being available to meet
commitments as and when they become due. This
is exacerbated by timing mismatches between
assets and liabilities.
For discussion on how Discovery manages its
liquidity risk related to insurance contracts,
refer to note 2.3.1
Concentration risk 	Claims experience risk
There is a risk that a concentration of risk can lead
to worse than expected experience. The
concentration risk is the highest in group business,
since assured lives live in the same geographical
location and generally work in the same industry
or at the same location.
Discovery has a well-diversified book of
business by source of new business and
spread across brokers and agents.
Furthermore, the claims experience risk is
mitigated through catastrophe reinsurance.
Withdrawal concentration risk
There is a financial risk of the withdrawal of a block
of policies written by a single independent
intermediary.
Policy wording/
legal risk
There is a risk that Discovery could be financially
exposed to obligations that differ from
expectations and are not adequately provided for.
The risk could also arise from legal proceedings.
The risk is managed when new products are
developed, and all policy wording is reviewed
by legal advisors and external advice is
obtained where necessary to ensure that
terms and conditions are clearly defined and
unambiguous.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
106
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Regulatory risk 	The risk of not complying with laws, regulations,
rules, related self-regulatory organisation
standards and investment management mandates.
This also includes regulatory change risk and the
impact of implementing the required regulatory
changes.
Although Discovery endeavours to design
insurance and financial solutions which meet the
requirements of the current regulations in force,
the risk does exist that changes in the regulations
or the interpretation of the regulations, over time
may result in the current products not fully
complying with the regulations in force in future.
This risk is managed through constantly
seeking legal advice on new product
developments. Further, all insurance products
issued by Discovery have to be approved,
including approval from a market conduct
perspective. Depending on the business line,
these are approved either by the Head of the
Actuarial Function or Actuarial Committee.
Discovery is a member of industry-wide bodies
that engage in discussions with policymakers
and regulators.
Discovery’s compliance department enhances
regulatory compliance through audits and by
monitoring developments in the regulatory
environment
Tax risk 	Tax risk is the risk that the actual future tax liability
is different from what is currently expected,
resulting in contracts being incorrectly priced.
Tax risk also represents potential changes in the
interpretation or application of prevailing tax
legislation applicable to either policyholders or
shareholders, resulting in higher taxes reducing
profitability, or increasing shareholder tax
burdens.
The group’s internal tax resources monitor the
impact of changes in tax legislation, participate
in discussions with the tax legislator to
comment on changes in legislation and are
involved in the development of new products.
External tax advice is obtained as required.
Expense risk 	Expense risk is the risk of actual expenses and
expense inflation being higher than expected. It
covers the risk of loss or adverse change in
insurance liabilities due to adverse variation in the
expenses incurred in servicing insurance and
reinsurance contracts.
Expenses are monitored monthly against
budgeted expenses. Any deviation from the
budget is investigated, reported and where
necessary, remedial action is taken.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
107
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
107	106

-- 56 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Reputational risk 	Reputational risk is the risk of negative market
reaction towards Discovery practices, associations
and market conduct.
Discovery Life offers policies that integrate with the
product offerings within the Discovery Group. The
reputational risk to Discovery Life is thus extended
to the reputational risk of the entire Discovery
Group.
Reputational risk is carefully monitored.
Decisions to repudiate claims are reviewed by
a review committee comprising of a senior
underwriter and claims assessor,
representatives of the legal department and
the medical team, as well as a compliance
officer.
Marketing material and policy wording are
reviewed and designed to be clear and
unambiguous to avoid creating unreasonable
policyholder expectations.
All products are approved prior to launch, by
either the Head of the Actuarial Function or
Actuarial Committee, depending on the
business line. Approval is obtained prior to
launch from a market conduct perspective.
Mismatching and
market risk
Mismatching is the risk that insurance related cash
outflows (for example, benefit payments,
administration expenses) do not match expected
future cash inflows (predominately future
premiums).
Mismatching risk can also arise when movements
in assets and liabilities are out of line given
changes in market risk, meaning equity price risk,
interest rate risk or currency risk.
For assets arising from insurance contracts,
Discovery covers the insurance related
outflows by expected future cash inflows
(predominately future premiums).
For liabilities arising from insurance contracts,
the insurance related cash outflows are
matched with a combination of a release of
policyholder assets (net of retained fees),
investment return on these assets and cash
inflows.
For further discussion on how Discovery
manages this risk, refer to the following notes:
■ For mismatching risk, refer note 2.19.1
■ For interest rate risk, refer note 2.19.4; and
■ For currency risk, refer note 2.19.5
Notes to the group annual financial statements continued
for the year ended 30 June 2025
108
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Contracts measured not under the PAA approach
Underwriting risk 	The risk that the actual experience
relating to mortality, longevity, disability
and medical (morbidity) will deviate
negatively from the expected
experience used in the pricing of
solutions and valuation of policy
liabilities.
Financial underwriting is applied to ensure that the
policyholder can justify the amount of cover applied for.
Premium loadings and exclusions are applied where high
risks are identified.
Monthly internal quality assurance audits are performed
on underwriting to minimise the risk of incorrect
underwriting decisions.
Underwriting risk
– mortality and
morbidity risk
Mortality and Morbidity risk
There is a risk that actual mortality and
morbidity experience is higher than
expected. This could arise as a result of
the number of claims or the value of
claims being higher than expected.
Mortality risk refers to the death of
policyholder earlier than expected and
morbidity risk is the risk of a critical
illness diagnosis earlier than expected.
Experience monitoring
Experience investigations are conducted and corrective
action is taken where adverse experience is noted.
Experience monitoring is done on at least a quarterly
basis, and in some business lines monthly.
Reinsurance
Reinsurance protects against volatility in claims
experience and against an accumulation of risk.
Reinsurance is further utilised on a facultative basis if
uncertainty exists over the terms that should be offered
to a particular risk.
In addition, reinsurers provide specialist advice when
designing new products.
Underwriting risk
– selection risk
Selection risk is the risk that worse risks
than expected are attracted, and these
risks are then charged inadequate
premiums.
Selection risk could also lead to higher-
than-expected mortality and morbidity
experience on individual life plans or
lower mortality on guaranteed annuity
policies.
Product design and pricing
Products are carefully designed to minimise adverse
selection. Rating factors are applied to standard premium
rates to differentiate between different levels of risk.
Product integration between the different product
offerings in Discovery helps to attract healthier lives than
average in the market, leading to positive selection. The
product integration incentivises engagement in the
Vitality programme, which has a positive impact on risk
experience.
Discovery and VitalityLife is unique due to its Vitality
programme as policyholders are provided access to
several services and benefits that encourage healthy
lifestyle choices and are awarded Vitality points, which
ultimately determine their Vitality status. The claims,
lapse and premium assumptions within the valuation of
insurance contract assets and liabilities are specifically
impacted by the Vitality status of the policyholder.
However, because of the shared value design the
business is hedged to a large extent against extreme
adverse financial impacts resulting from policyholder
behaviour change.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
109
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
109	108

-- 57 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Contracts measured under the PAA approach
Underwriting –
Insurance risk
The principal risk is that the frequency
and/or severity of claims are greater
than expected. Insurance events are, by
their nature, random and the actual
number and size of events during any
one year may vary from those
estimated and experienced in prior
periods.
Experience monitoring
Across both premiums and claims, recent actual
experience is compared against financial forecasts, with
any deviations investigated. The results provide a
feedback loop into the overall pricing approach, enabling
Discovery to react quickly to any changes in behaviour.
Product design and pricing
Group Life business is reviewed on a contract-by-
contract basis, with the review period never exceeding
two years.
Discovery Life predominantly operates in the high end of
the South African insurance market where the risk of HIV/
AIDS is lower than for the South African market as a
whole. The impact of HIV/AIDS is considered and allowed
for during the product development and pricing. The HIV
risk is implicitly allowed for based on rates which are set
guided by overall claims experience and reinsurer input
(including HIV but also other claim causes).
For VitalityHealth new business is written in accordance
with approved pricing assumptions. Underwriting criteria
is defined and aligned to the approved pricing
assumptions.
Existing business is managed through the annual
repricing of policies at renewal on a risk-related basis.
Discovery Insure aims to manage risk through
diversifying the pool of insured risks by establishing a
balanced portfolio of insurance risks over a wide
geographical area. Short-term insurance risks are priced
on an individual basis; therefore, a minimal cross-subsidy
exists between risks.
Discovery Insure uses telematic devices to manage risks
related to motor vehicle cover.
Underwriting –
Exposure relating
to catastrophe
events
Natural and non-natural disasters could
result in increased claims experience
which could result in underwriting
losses.
The Group sets out the total aggregate exposure that it is
prepared to accept in certain territories to a range of
events, such as natural catastrophes. The aggregate
position is reviewed annually. The Group uses a number
of modelling tools to monitor aggregation and to simulate
catastrophe losses in order to measure the effectiveness
of the reinsurance programmes and the net exposure of
the Group.
Underwriting –
Reinsurance risk
Reinsurance risk is the risk that the
reinsurance cover placed is inadequate
and/or inefficient relative to the Group’s
risk management strategy and
objectives.
Discovery Insure mitigates its insurance risk through its
reinsurance programme, which is structured to protect
the company against material losses to either a single
insured risk or a group of insured risks in the case of a
catastrophe where there would tend to be a
concentration of insured risks.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
110
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.1 	Liquidity Risk
2.19.1.1 CONTRACTS WITH LONG-TERM EXPOSURES
Currently, Discovery Life’s and VitalityLife’s expected outflows are mostly long-term, and the main liquidity requirement is to
fund acquisition expenses on new business and unexpected fluctuations in benefit payments. As discussed in note 3.13.4.3,
Discovery invests primarily in liquid financial assets.
For Discovery Life, large sums assured above a defined retention level are reinsured, providing stability in claims experienced
and further reducing liquidity risk.
There is a need to meet liquidity requirements arising from Discovery Invest’s Guaranteed Plan book. Liquidity requirements are
managed to ensure a liquidity buffer is maintained to meet potential outflows if exit rates are higher than expected. The liquidity
risk on the existing portfolio is thus relatively small.
VitalityLife also receives partial financing for new business strain from financing reinsurance treaties with reinsurers.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
111
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
111	110

-- 58 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.1 	Liquidity Risk continued
2.19.1.2 CONTRACTS NOT MEASURED UNDER THE PAA MODEL
2.19.1.2.1 MATURITY ANALYSIS
The following table shows a maturity analysis of discounted cash flows for participating insurance contracts and risk insurance
and reinsurance contracts, which reflects the dates on which the cash flows are expected to occur. This analysis does not include
the liability for remaining coverage for contracts measured under the PAA. The maturity analysis for insurance- linked
investment contracts and unit-linked insurance contracts reflects the contractual maturity dates. The majority of insurance-
linked investment contracts and unit-linked insurance contracts are open ended and have no fixed maturity date. These
contracts are included in the one year or less category.
R million
(Assets)/Liabilities 	Total 	< 1 year 	Years 1 to 2 	Years 2 to 3 	Years 3 to 4 	Years 4 to 5 	Years 6 to 10 	Years 10 to 20 	>20 years
30 June 2025
Insurance contract cash flows
Assets arising from insurance contracts 	(96 747) 	(3 935) 	(7 839) 	(7 075) 	(6 242) 	(5 657) 	(24 571) 	(26 469) 	(14 959)
– SA Life (Risk) 	(58 655) 	17 	(3 392) 	(3 275) 	(2 883) 	(2 642) 	(13 477) 	(17 793) 	(15 210)
– UK Life (Risk) 	(38 092) 	(3 952) 	(4 447) 	(3 800) 	(3 359) 	(3 015) 	(11 094) 	(8 676) 	251
Liabilities arising from insurance contracts 	109 113 	13 203 	11 504 	10 717 	10 973 	10 157 	21 488 	22 298 	8 773
– SA Invest (Risk) 	22 570 	5 223 	3 634 	3 566 	3 925 	2 627 	1 729 	1 419 	447
– SA Invest (Participating) 	80 126 	5 911 	7 076 	6 503 	6 508 	7 079 	18 436 	20 319 	8 294
– SA Life Group Risk and Other (PAA) 	6 417 	2 069 	794 	648 	540 	451 	1 323 	560 	32
Reinsurance contract cash flows
Assets arising from insurance contracts 	(913) 	(368) 	(110) 	(87) 	(71) 	(58) 	(159) 	(57) 	(3)
– SA Life Group Risk and Other (PAA) 	(913) 	(368) 	(110) 	(87) 	(71) 	(58) 	(159) 	(57) 	(3)
Liabilities arising from insurance contracts 	22 672 	2 812 	3 456 	2 954 	2 578 	2 168 	5 233 	2 603 	868
– SA Life (Risk) 	5 650 	(132) 	516 	502 	482 	468 	1 653 	1 420 	741
– UK Life (Risk) 	17 022 	2 944 	2 940 	2 452 	2 096 	1 700 	3 580 	1 183 	127
30 June 2024
Insurance contract cash flows
Assets arising from insurance contracts 	(85 317) 	(1 760) 	(6 643) 	(6 123) 	(5 639) 	(4 960) 	(21 237) 	(23 795) 	(15 160)
– SA Life (Risk) 	(54 498) 	864 	(3 113) 	(3 115) 	(2 987) 	(2 554) 	(12 174) 	(16 297) 	(15 122)
– UK Life (Risk)1 	(30 819) 	(2 624) 	(3 530) 	(3 008) 	(2 652) 	(2 406) 	(9 063) 	(7 498) 	(38)
Liabilities arising from insurance contracts 	96 107 	13 723 	10 732 	8 561 	8 543 	8 852 	18 497 	19 640 	7 559
– SA Invest (Risk)2 	23 488 	7 482 	4 475 	2 939 	2 835 	3 097 	1 298 	1 028 	334
– SA Invest (Participating)2 	66 687 	4 316 	5 514 	5 016 	5 206 	5 341 	15 996 	18 103 	7 195
– SA Life Group Risk and Other (PAA) 	5 932 	1 925 	743 	606 	502 	414 	1 203 	509 	30
Reinsurance contract cash flows
Assets arising from insurance contracts 	(830) 	(315) 	(108) 	(85) 	(68) 	(54) 	(147) 	(51) 	(2)
– SA Life Group Risk and Other (PAA) 	(830) 	(315) 	(108) 	(85) 	(68) 	(54) 	(147) 	(51) 	(2)
Liabilities arising from insurance contracts 	17 358 	1 727 	3 086 	2 008 	1 717 	1 474 	3 851 	2 439 	1 056
– SA Life (Risk) 	5 898 	(366) 	522 	495 	491 	465 	1 803 	1 518 	970
– UK Life (Risk) 1 	11 460 	2 093 	2 564 	1 513 	1 226 	1 009 	2 048 	921 	86
1 The comparative information has been restated to exclude non-cash flow items (risk adjustment and CSM) and present maturity analysis of the expected cash flows.
2 The comparative information has been restated to correctly present the expected cash flows within the correct maturity time bands. The correction did not affect the measurement of insurance contract liabilities or profit and loss.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
112 	113
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
113	112	112

-- 59 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.1 	Liquidity Risk continued
2.19.1.2 CONTRACTS NOT MEASURED UNDER THE PAA MODEL continued
2.19.1.2.1 MATURITY ANALYSIS continued
The amounts from insurance contract liabilities noted in the maturity table above include amounts payable on demand. The
amounts that are payable on demand are set out below.
For the unit-linked and similar investment-linked insurance contracts where the policyholder has the option to terminate or
transfer their contracts at any time and the policyholder receives money back, the money payable to the policyholder is referred
to as the amounts payable on demand. The termination or transfer of the insurance contract will be at the discretion of the
policyholder.
Amounts payable on demand excludes the amounts payable on a valid claim event. The SA Life and Invest (Risk) and UK Life
(Risk) insurance contracts have no amounts payable on demand.
R million
2025 	2024
Amount
payable on
demand
Amount
payable on
demand
SA Invest (Participating) 	91 235 	78 071
2.19.1.3 CONTRACTS MEASURED UNDER THE PAA MODEL
SA INSURE AND OTHER
Discovery Insure holds the majority of working and solvency capital in cash or near cash instruments to minimise liquidity risk.
Large sums assured above a defined retention level are reinsured, providing stability in claims experience and further reducing
the liquidity risk. Catastrophe reinsurance further reduces this risk.
UK HEALTH
VitalityHealth maintains sufficient liquid assets to meet short-term liabilities and to allow for the initial cash flow strain when
writing new business. Currently, VitalityHealth’s expected liabilities are mostly short-term, and the main liquidity requirement is
to fund acquisition expenses on new business, with the existing book mature enough to generate sufficient liquidity to cover
cash flow strain of writing consistent levels of new business.
2.19.2 	Concentration of insurance risk
Discovery manages concentration risk through various mechanisms and monitors the opportunities for mitigating actions. Such
mechanisms include:
■ underwriting principles and product pricing procedures.
■ reinsurance.
■ the diversification of business over several classes of insurance and large numbers of uncorrelated individual risks.
SA LIFE AND INVEST (RISK AND GROUP LIFE)
Discovery Life maintains a well-diversified portfolio of policies. Reinsurance is further used to protect against the concentration
of risk. Catastrophe reinsurance protects against the accumulation of claims from a single event, within a period of time and
area of a limited radius, for example, an airplane crash. The catastrophe reinsurance for Discovery Life covers single event
disasters for up to R1 100 million, where the net of reinsurance impact is greater than R55 million. For its biggest four group
schemes, a further layer of catastrophe reinsurance cover of R4 200 million in excess of R1 155 million is in place.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
114
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.2 	Concentration of insurance risk continued
2.19.2.1 SA LIFE RISK (GMM)
Reinsurance removes the exposure to large individual claims. The following graph demonstrates that the distribution of policies
by sum assured is shifted towards lower sum assured due to the reinsurance cover.
2025 Distribution of Sums Retained: Before and after reinsurance (Sum retained – Rm)
Before reinsurance 	After reinsurance
0 – 0.5 	0.5 – 1.0 	1 – 1.5 	1.5 – 2.0 	2.0 – 2.5 	2.5 – 3.0 	3.0 – 3.5 	3.5 – 4.0 	4.0 – 4.5 	4.5 – 5.0 	>5.0
–
20 000
40 000
60 000
80 000
100 000
120 000
2024 Distribution of Sums Retained: Before and after reinsurance (Sum retained – Rm)
Before reinsurance 	After reinsurance
0 – 0.5 	0.5 – 1.0 	1 – 1.5 	1.5 – 2.0 	2.0 – 2.5 	2.5 – 3.0 	3.0 – 3.5 	3.5 – 4.0 	4.0 – 4.5 	4.5 – 5.0 	>5.0
–
20 000
40 000
60 000
80 000
100 000
120 000
2.19.2.2 SA LIFE AND INVEST: GROUP RISK AND OTHER (PAA)
2025 Distribution of Sums Retained: Before and after reinsurance (Sum retained – Rm)
Before reinsurance 	After reinsurance
0 - 0.5 	0.5 - 1 	1 - 1.5 	1.5 - 2 	2 - 2.5 	2.5 - 3 	3 - 3.5 	3.5 - 4 	4 - 4.5 	4.5 - 5 	>5
–
50 000
100 000
150 000
200 000
2024 Distribution of Sums Retained: Before and after reinsurance (Sum retained – Rm)
Before reinsurance 	After reinsurance
0 - 0.5 	0.5 - 1 	1 - 1.5 	1.5 - 2 	2 - 2.5 	2.5 - 3 	3 - 3.5 	3.5 - 4 	4 - 4.5 	4.5 - 5 	>5
–
50 000
100 000
150 000
200 000
Notes to the group annual financial statements continued
for the year ended 30 June 2025
115
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
Number of lives
Number of lives
Reinsurance results in a reduction in exposure to large individual
sums-at-risk, leading to this transfer from large to small case sizes
Reinsurance results in a reduction in exposure to large individual
sums-at-risk, leading to this transfer from large to small case sizes
Number of lives
115	114

-- 60 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.2 	Concentration of insurance risk continued
2.19.2.3 UK LIFE (RISK) (GMM)
VitalityLife maintains a well-diversified portfolio of policies. Reinsurance removes the exposure to large individual claims. The
following graph demonstrates that the distribution of policies by sum assured is shifted towards lower sum assured due to the
reinsurance cover. The profile is largely the same as the prior period, although a shift towards higher sums assured due to
annual benefit increases and inflationary impacts on new business was observed as expected.
2025 Distribution of Sums Retained: Before and after reinsurance (Sum retained – GBP’000)
Before reinsurance 	After reinsurance
0 – 25 	25 – 50 	50 – 75 	75 – 100 	100 – 125 	125 – 150 150 – 175 	175 – 200 200 – 225 	225 – 250 	>250
–
50 000
100 000
150 000
200 000
250 000
300 000
2024 Distribution of Sums Retained: Before and after reinsurance (Sum retained – GBP’000)
Before reinsurance 	After reinsurance
0 – 25 	25 – 50 	50 – 75 	75 – 100 	100 – 125 	125 – 150 150 – 175 	175 – 200 200 – 225 	225 – 250 	>250
–
50 000
100 000
150 000
200 000
250 000
300 000
UK HEALTH (PAA)
VitalityHealth has the risk of single large medical expense claims arising abroad or multiple small travel claims due to a single
event, which could cause losses. To manage these risks, VitalityHealth holds a reinsurance policy specifically on travel benefits,
which can help cover the concentration risks from these events. The threshold for a potential claim on the reinsurance for either
of these reasons is GBP250 000.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
116
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Number of lives	Number of lives
Number of lives	Number of lives
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.2 	Concentration of insurance risk continued
SA INSURE AND OTHER (PAA)
There is a risk that a concentration of risk can lead to a worse-than-expected claims experience. To manage this concentration
of insurance risk, Discovery has entered a catastrophe excess of loss reinsurance treaty that would limit the loss of the Group
to pre-determined levels following the occurrence of a localised catastrophe in that area.
Discovery Insure has a concentration of policyholders in the main metropolitan areas such as Johannesburg, Pretoria, Cape
Town and Durban. A catastrophic flood, hail, fire or earthquake would result in disproportionate losses in these areas, given the
accumulation of risk. Catastrophe reinsurance is used to limit the size of such losses and their impact on the underwriting result.
2.19.3 	Underwriting risk-sensitivity analysis
The financial impact of the key risks that Discovery is exposed to can be demonstrated by considering the sensitivity of the
financial results to a hypothetical change in the underlying assumptions or prevailing market conditions.
Although the sensitivities demonstrate the impact of a change in assumption, the results generally cannot be extrapolated to
demonstrate the impact on future earnings and earnings forecasts.
For each sensitivity illustrated, all other assumptions have been left unchanged. No allowance has been made for any
management action, for example, premium increases, to react to the worse-than-expected experience.
The sensitivities shown below consider a change in the long-term assumption used in the projection model. The following
sensitivities are provided under insurance risk:
■ Lapse and surrender rates: The lapse, surrender and withdrawal rates are increased or decreased across all policies and
investment plans;
■ Long-term investment return and inflation: A parallel shift is assumed in the yield curve. The investment return, inflation,
renewal expense inflation, and inflation-linked premium increases are adjusted consistently;
■ Renewal expenses: Renewal expense per policy is increased or decreased across all policies and investment plans;
■ Mortality and morbidity: The mortality rate, disability rate and severe illness rates are increased and decreased across all
policies and investment plans; and
■ Real rate returns: The assumed real rate curve is increased or decreased across all policies and investment plans.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
117
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
117	116

-- 61 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.3 	Underwriting risk-sensitivity analysis continued
2.19.3.1 SENSITIVITY ANALYSIS – ASSETS ARISING FROM INSURANCE CONTRACTS
The sensitivity analysis below considers how the CSM, profit or loss and equity would have increased (decreased) given
illustrative changes to key assumptions. This analysis presents the sensitivities both before and after risk mitigation by
reinsurance and assumes that all other variables remain constant. The results do not include the impact of any management
actions which may be taken under these scenarios.
For portfolios where Discovery has elected to disaggregate insurance finance income or expenses between profit or loss and
other comprehensive income (OCI), the movement in equity under each scenario is not necessarily equivalent to the change in
profit or loss, with the difference between the two being reflected in a change in the OCI balance. Consideration also needs to
be given to items of asymmetry. Positive and negative assumption changes may have non-linear impacts on profit and loss due
to the impact on items such as the loss component on onerous contracts.
R million
(Decrease)/Increase
SA Life (Risk) 	SA Life (Risk) 	UK Life (Risk)
CSM 	Profit or loss 	Equity 	CSM 	Profit or loss 	Equity
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Base: June 2025 assumptions
Lapse and surrender rates +10% (e.g. from x% to 1.1x%)1 	(6 837) 	(6 645) 	(1 367) 	(1 304) 	464 	497 	(1 622) 	(1 262) 	412 	294 	122 	(33)
Lapse and surrender rates -10% (e.g. from x% to 0.9x%) 	9 244 	8 991 	660 	630 	(1 412) 	(1 405) 	1 723 	1 402 	(587) 	(494) 	(134) 	(27)
Investment return and inflation -1% (e.g. from 5% to 4%) 	– 	– 	(2) 	(1) 	1 510 	1 365 	– 	– 	(115) 	(128) 	(543) 	(921)
Investment return and inflation +1% (from 5% to 6%) 	– 	– 	3 	2 	(1 395) 	(1 262) 	– 	– 	(16) 	(13) 	132 	487
Expense assumption +10% 	(467) 	(473) 	(72) 	(67) 	(54) 	(49) 	(416) 	(415) 	(313) 	(313) 	(173) 	(172)
Expense assumption -10% 	472 	478 	71 	65 	50 	45 	427 	470 	308 	275 	164 	130
Mortality and morbidity +10% 	(7 800) 	(5 914) 	(2 638) 	(1 859) 	(818) 	(527) 	(4 025) 	(1 289) 	(2 117) 	(811) 	(981) 	(591)
Mortality and morbidity -10% 	10 215 	7 991 	877 	692 	(651) 	(508) 	4 215 	1 327 	2 056 	789 	867 	572
Real curve -1% and inflation +1% 	– 	– 	6 	5 	3 668 	3 462 	– 	– 	(17) 	(16) 	554 	490
Real curve +1% and inflation –1% 	– 	– 	(2) 	(2) 	(2 942) 	(2 766) 	– 	– 	(112) 	(125) 	(697) 	(642)
Base: June 2024 assumptions
Lapse and surrender rates +10% (e.g. from x% to 1.1x%)1 	(7 095) 	(6 808) 	(1 070) 	(1 048) 	1 132 	1 097 	(1 169) 	(944) 	407 	306 	65 	(29)
Lapse and surrender rates -10% (e.g. from x% to 0.9x%) 	9 085 	8 780 	516 	494 	(1 769) 	(1 739) 	1 362 	1 137 	(536) 	(462) 	(166) 	(85)
Investment return and inflation -1% (e.g. from 5% to 4%) 	1 	1 	(26) 	(26) 	1 346 	1 191 	– 	– 	– 	– 	(610) 	(810)
Investment return and inflation +1% (from 5% to 6%) 	(1) 	– 	17 	16 	(1 193) 	(1 064) 	– 	– 	– 	– 	248 	443
Expense assumption +10% 	(467) 	(468) 	(92) 	(90) 	(1) 	– 	(350) 	(366) 	(260) 	(248) 	(152) 	(139)
Expense assumption -10% 	569 	570 	41 	39 	(2) 	(3) 	355 	370 	249 	237 	148 	135
Mortality and morbidity +10% 	(8 445) 	(6 383) 	(2 594) 	(2 033) 	(20) 	64 	(3 618) 	(1 261) 	(1 749) 	(668) 	(800) 	(482)
Mortality and morbidity -10% 	10 225 	8 013 	866 	648 	(934) 	(766) 	3 797 	1 332 	1 718 	677 	696 	441
Real curve -1% and inflation +1% 	1 	1 	(35) 	(35) 	3 644 	3 371 	1 	1 	– 	– 	468 	405
Real curve +1% and inflation –1% 	– 	– 	(3) 	(3) 	(2 846) 	(2 626) 	(1) 	(1) 	– 	– 	(542) 	(486)
1 SA Life and Invest (Risk): an increase in lapse rates on risk policies erodes value (as demonstrated by the CSM impact). Due to differences in the discount
rates used to measure the impact of changes in fulfilment cashflows (at current rates) and the CSM (at initial recognition rates), the impacts between the
two are not consistent and may lead to instances where the net equity position is a gain, although the overall balance sheet position has deteriorated.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
118 	119
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
119	118

-- 62 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.3 	Underwriting risk-sensitivity analysis continued
2.19.3.2 SENSITIVITY ANALYSIS – LIABILITIES ARISING FROM INSURANCE CONTRACTS
The table below analyses how the CSM, profit or loss and equity would have increased (decreased) if changes in underwriting
risk variables that were reasonably possible at the reporting date had occurred. This analysis presents the sensitivities both
before and after risk mitigation by reinsurance and assumes that all other variables remain constant.
R million
(Decrease)/Increase)
SA Invest (Risk) 	SA Invest (Participating) 	SA Life Group Risk and Other
CSM 	Profit or loss 	Equity 	CSM 	Profit or loss 	Equity 	Profit or loss 	Equity
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Gross of
reinsurance
Gross of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Base: June 2025
assumptions
Lapse and surrender rates +10%
(e.g. from x% to 1.1x%) 	– 	– 	4 	4 	4 	4 	(335) 	(29) 	(29) 	– 	– 	– 	–
Lapse and surrender rates -10% (e.g.
from x% to 0.9x%) 	– 	– 	(4) 	(4) 	(4) 	(4) 	361 	25 	25 	– 	– 	– 	–
Investment return and inflation -1%
(e.g. from 5% to 4%) 	– 	– 	(812) 	(812) 	(812) 	(812) 	7 	(6) 	(6) 	– 	– 	27 	23
Investment return and inflation +1%
(from 5% to 6%) 	– 	– 	738 	738 	738 	738 	(7) 	6 	6 	– 	– 	(35) 	(30)
Expense assumption +10% 	(3) 	(3) 	(6) 	(6) 	(6) 	(6) 	(56) 	(14) 	(14) 	12 	12 	12 	12
Expense assumption -10% 	3 	3 	6 	6 	6 	6 	56 	14 	14 	(12) 	(12) 	(12) 	(12)
Mortality and morbidity +10% 	25 	25 	43 	43 	43 	43 	(61) 	(9) 	(9) 	(157) 	(133) 	(154) 	(131)
Mortality and morbidity -10% 	(18) 	(18) 	(54) 	(54) 	(54) 	(54) 	64 	9 	9 	171 	146 	169 	143
Real curve -1% and inflation +1% 	– 	– 	(66) 	(66) 	(66) 	(66) 	118 	16 	16 	– 	– 	121 	108
Real curve +1% and inflation –1% 	– 	– 	55 	55 	55 	55 	(108) 	(14) 	(14) 	– 	– 	(125) 	(111)
Base: June 2024
assumptions
Lapse and surrender rates +10%
(e.g. from x% to 1.1x%) 	(1) 	(1) 	3 	3 	3 	3 	(338) 	(34) 	(34) 	– 	– 	(39) 	(33)
Lapse and surrender rates -10% (e.g.
from x% to 0.9x%) 	1 	1 	(3) 	(3) 	(3) 	(3) 	371 	31 	31 	– 	– 	51 	44
Investment return and inflation -1%
(e.g. from 5% to 4%) 	– 	– 	(504) 	(504) 	(504) 	(504) 	10 	(9) 	(9) 	(10) 	(10) 	(10) 	(10)
Investment return and inflation +1%
(from 5% to 6%) 	– 	– 	464 	464 	464 	464 	(8) 	7 	7 	10 	10 	10 	10
Expense assumption +10% 	(2) 	(2) 	(3) 	(3) 	(3) 	(3) 	(52) 	(11) 	(11) 	145 	121 	142 	119
Expense assumption -10% 	2 	2 	3 	3 	3 	3 	53 	10 	10 	(158) 	(132) 	(156) 	(130)
Mortality and morbidity +10% 	18 	18 	22 	22 	22 	22 	(57) 	(8) 	(8) 	– 	– 	(88) 	(80)
Mortality and morbidity -10% 	(18) 	(18) 	(23) 	(23) 	(23) 	(23) 	59 	8 	8 	– 	– 	99 	89
Real curve -1% and inflation +1% 	– 	– 	(44) 	(44) 	(44) 	(44) 	116 	12 	12 	– 	– 	– 	–
Real curve +1% and inflation –1% 	– 	– 	37 	37 	37 	37 	(106) 	(11) 	(11) 	– 	– 	– 	–
Changes in underwriting variables mainly affect the CSM, profit or loss and equity as follows.
CSM 	– Changes in fulfilment cash flows not relating to any loss components, other than those recognised as
insurance finance income or expenses.
Profit or loss 	– Changes in fulfilment cash flows relating to loss components.
– Changes in fulfilment cash flows that are recognised as insurance finance income or expenses in profit
or loss.
Equity
(includes OCI)
– Changes in fulfilment cash flows that are recognised as insurance finance income or expenses in OCI.
– The effect on profit or loss as noted.
The effects on profit or loss and equity are presented net of the related income tax.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
120 	121
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
121	120

-- 63 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.3 	Underwriting risk-sensitivity analysis continued
2.19.3.3 INSURANCE CONTRACTS MEASURED UNDER THE PAA APPROACH
Discovery estimates the ultimate cost of settling claims incurred but unpaid at the reporting date and the value of salvage
and other expected recoveries by reviewing individual claims reported and making allowances for claims incurred but not
yet reported. The ultimate cost of settling claims is estimated using a range of loss-reserving techniques. These techniques
assume that the Group’s own claims experience is indicative of future claims development patterns and, therefore, the
ultimate claims cost.
The sensitivity shown below considers a change in the assumption used in the reserving model for portfolios measured
under the PAA approach. The following sensitivity is provided under insurance risk:
■ Ultimate claims: The ultimate cost of settling claims is estimated separately for each geographic area and line of
business, except for large claims, which are assessed separately from other claims.
R million
(Decrease)/Increase
SA Life Group Risk and Other 	SA Insure and Other 	UK Health
Profit or loss 	Equity 	Profit or loss 	Equity 	Profit or loss 	Equity
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Gross of
reinsurance
Net of
reinsurance
Base: June 2025 assumptions
Ultimate claims cost +5% 	(52) 	(49) 	(52) 	(49) 	(24) 	(24) 	(20) 	(18) 	(45) 	(45) 	(45) 	(45)
Ultimate claims cost -5% 	52 	49 	52 	49 	24 	24 	20 	18 	45 	45 	45 	45
Base: June 2024 assumptions
Ultimate claims cost +5% 	(50) 	(48) 	(50) 	(48) 	(27) 	(23) 	(21) 	(18) 	(40) 	(40) 	(40) 	(40)
Ultimate claims cost -5% 	50 	48 	50 	48 	27 	23 	21 	18 	40 	40 	40 	40
The effects on profit or loss and equity are present net of the related income tax.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
122 	123
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
123	122

-- 64 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.5 	Market risk – Currency Risk
The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and
recognised assets and liabilities.
All the UK Life (Risk) portfolio’s insurance benefits and premiums are Pound Sterling, denominated as all business is sold in the
UK market, thereby exposing Discovery to currency risk. A significant part of operational expenses are Rand denominated as
systems and administration are based in South Africa. This creates a potential mismatch risk.
The Dollar Life Plan included in the SA Life (Risk) portfolio, provides a sum insured in US dollars. Premiums are paid in Rands but
linked to the Rand/USD exchange rate. Certain versions of the Dollar Life Plan provide guarantees on the Rand/USD exchange
rate for a specified period, thereby exposing Discovery Life to currency risk.
Other insurance business lines do not have significant currency risk.
The following table segregates the currency exposure by major currency:
R million
Assets/(Liabilities) 	Total 	USD
30 June 2025
Assets arising from insurance contracts issued
– SA Life (Risk) (GMM) 	829 	829
Total insurance and reinsurance assets 	829 	829
Liabilities arising from reinsurance contracts held
– SA Life (Risk) (GMM) 	(11) 	(11)
Total insurance and reinsurance liabilities 	(11) 	(11)
30 June 2024
Assets arising from insurance contracts issued
– SA Life (Risk) (GMM) 	578 	578
Total insurance and reinsurance assets 	578 	578
Liabilities arising from reinsurance contracts held
– SA Life (Risk) (GMM) 	(21) 	(21)
Total insurance and reinsurance liabilities 	(21) 	(21)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
125
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.4 	Market risk – Interest rate risk
SA LIFE AND INVEST (RISK) (GMM)
For Discovery Life, increased nominal or real interest rates would result in an adverse impact on the present value of future
profits. Cash flows on a material segment of the book are linked to inflation. While segment retains cash flows in real terms, this
segment is exposed to real interest rate movements. The balance of the book is exposed to changes in the nominal rates.
The outstanding claims and incurred but not reported claims are mostly short-term in nature and have consequently been
matched with cash. Reserves backing income contribution benefits in payment are backed by a combination of cash, money
market, gilts, and negative Rand reserves of appropriate duration.
The risk arising from the global linkage benefit is fully reinsured, and Discovery does not face any net direct market risk.
For Discovery Invest, guaranteed return plan liabilities are backed by a combination of negative Rand reserves and bonds of
appropriate duration. As maturity approaches, cash flows from negative reserves are invested in bonds, and therefore a
reinvestment risk exists. Furthermore, investment policy fee income is dependent on the underlying value of policyholders’
investments, which may be interest rate-sensitive.
UK LIFE (RISK) (GMM)
As a long-term insurance provider in the UK, VitalityLife has significant exposure to long-term interest rate risk, given the impact
on reserves of lower investment rate assumptions related to fixed future premium receipts to meet policy obligations.
Accordingly, lower long-term interest rates and yield assumptions may negatively impact on the valuation of future policy
obligations and result in a valuation loss.
2.19.4.1 SENSITIVITY ANALYSIS
An analysis of the sensitivity of the Group’s profit and loss and equity to a 1% increase or decrease in interest rates at the
reporting date, assuming that all other variables remain constant, is presented below.
R million
(Decrease)/Increase
Profit or loss 	Equity
Increase 	Decrease 	Increase 	Decrease
30 June 2025
Insurance contracts issued (net of reinsurance
contracts)
– SA Life (Risk) (GMM) 	(1) 	1 	(3 968) 	4 912
– SA Invest (Risk) (GMM) 	738 	(812) 	738 	(812)
– SA Invest (Participating) (VFA) 	6 	(6) 	6 	(6)
– UK Life (Risk) (GMM) 	3 	1 	(18) 	(281)
– SA Life Group Risk and Other (PAA) 	– 	– 	131 	(143)
– SA Insure and Other (PAA) 	(3) 	3 	(3) 	3
30 June 2024
Insurance contracts issued (net of reinsurance
contracts)
– SA Life (Risk) (GMM) 	(22) 	(26) 	(4 013) 	5 031
– SA Invest (Risk) (GMM) 	464 	(504) 	464 	(504)
– SA Invest (Participating) (VFA) 	7 	(9) 	7 	(9)
– UK Life (Risk) (GMM) 	– 	– 	23 	(337)
– SA Life Group Risk and Other (PAA) 	– 	– 	118 	(128)
Changes in underwriting variables mainly affect the profit or loss and equity as follows.
Profit or loss 	– Insurance finance income or expenses recognised in profit or loss for SA Life and Invest (Risk), UK Life
(Risk) and SA Life and Invest (Participating) as a result of discounting future cash flows at a revised
current rate.
Equity
(includes OCI)
– Insurance finance income and expenses recognised in OCI for life risk and life discretionary contracts
as a result of discounting future cash flows at a revised current rate
The effects on profit or loss and equity are presented net of the related income tax.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
124
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
125	124

-- 65 of 155 --

SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.6 	Regulatory adequacy requirements and protection against adverse experience
REGULATORY CAPITAL REQUIREMENTS
Discovery endeavours to manage its capital so that its regulated entities meet local regulatory capital requirements, in each
country in which Discovery operates, the local regulator specifies the minimum amount and type of capital that each of the
regulated entities must hold in addition to their liabilities. In addition to the minimum capital required to comply with the
solvency requirements, Discovery aims to hold an adequate buffer under local solvency requirements to ensure regulated
subsidiaries can absorb a level of volatility and meet local capital requirements.
2.19.6.1 REGULATORY REQUIREMENTS IN THE SOUTH AFRICAN MARKET
The South African entities are required to demonstrate solvency to the Prudential Authority (PA) in accordance with Insurance
Act 18 of 2017 (Insurance Act) requirements in respect of governance, risk management and internal controls for insurers and
align with international standards. The Insurance Act seeks to improve policyholder protection and contribute to financial
stability by aligning insurers’ regulatory capital requirements with underlying risks. It also strengthens the regulatory
requirements in respect of governance, risk management and internal controls for insurers and aligns with international
standards.
In accordance with the Prudential Standards, each insurance company must maintain sufficient shareholder assets (own funds),
over and above the assets required to meet policyholder liabilities (best-estimate liabilities plus a prescribed risk margin), to
support a multiple of the Solvency Capital Requirement (SCR). In practice, companies will hold a buffer above this minimum
requirement.
The SA insurance entities, Discovery Life and Discovery Insure, undertake an internal assessment of their risks and capital needs,
in addition to meeting the minimum capital requirements set by the PA. The SCR is calculated in accordance with the Prudential
Standards as issued by the PA. The SCR calculation is intended to approximate a risk-based capital measure and covers the
major areas of insurance risk.
Discovery Life and Discovery Insure regularly review the capital position and consider various new business scenarios. Typically,
a five-year new business projection horizon is allowed for, and the capital position is assessed at each valuation date during the
projection to ensure an acceptable capital cover is maintained.
Discovery Life has calculated its solvency position in accordance with the Insurance Act and related Prudential Standards since
30 June 2013. A consistent level of solvency cover, comfortably more than the statutory minimum, was observed at all valuation
dates. Discovery Insure has observed the solvency cover at all valuation dates.
2.19.6.2 REGULATORY REQUIREMENTS IN THE UNITED KINGDOM
In the UK market, the Prudential Regulation Authority (PRA) is a part of the Bank of England and responsible for the prudential
regulation and supervision of insurers. It sets standards and supervises financial institutions. The Prudential Sourcebook for
Insurers (INSPRU) contains standards for capital management.
SOLVENCY I
Under Solvency I, the capital requirements are calculated based on the concept of two pillars:
■ Pillar 1, which covers public solvency information that appears within the regulatory returns on the basis of prescriptive rules.
This includes the statutory valuation of liabilities together with a prescribed measure of additional capital, the Long-term
Insurance Capital Requirement (LTICR); and
■ Pillar 2, the Individual Capital Assessment (ICA), which covers a confidential company-specific assessment of solvency. This
assessment is done on a realistic basis with the aim of protecting against risks up to the 99.5 percentile over a one-year
period.
The amount of capital that ultimately needs to be held by a life insurance company in the UK is the larger of the Pillar 1 and Pillar
2 result. VitalityLife is required to provide capital to the PAC equal to one times the Pillar 1 capital requirement, increasing to one
and a half times from the Pillar 1 capital requirements from March 2024 onwards. The cover requirements were observed at all
valuation dates.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
127
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.5 	Market risk – Currency Risk continued
2.19.5.1 SENSITIVITY ANALYSIS
The Group determined that a 10% change is a reasonable expected strengthening or weakening of the US dollar and the UK
pound against the other functional currencies, most notably South African Rand, US Dollar and Pound Sterling.
The effect of translation differences which are recognised separately in other comprehensive income has also been excluded.
This analysis assumes that all other variables, in particular interest rates, remain constant and ignores any impact of forecast
sales and purchases. The impact on profit or loss and equity at 30 June is shown below. This analysis assumes that all other
variables remain constant.
R million
Increase/(Decrease)
Profit or loss 	Equity
Strengthening 	Weakening 	Strengthening 	Weakening
30 June 2025
USD 	– 	– 	73 	(72)
GBP 	– 	– 	96 	(96)
30 June 2024
USD 	2 	(2) 	74 	(66)
GBP 	– 	– 	69 	(69)
Profit or loss 	– Foreign currency gains and losses on insurance and reinsurance contracts that are recognised in profit or
loss, including those arising from the translation of the carrying amount of the CSM.
Equity
(includes OCI)
– Changes in fulfilment cash flows that are recognised as insurance finance income or expenses in OCI.
– The effect on profit or loss as noted above.
The effects on profit or loss and equity are presented net of the related income tax. Changes in foreign exchange rates mainly
affect the profit or loss and equity as follows.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
126
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
127	126

-- 66 of 155 --

SECTION 03
FINANCIAL
INSTRUMENTS AND
MANAGEMENT OF
FINANCIAL RISK
Introduction and overview
Financial instrument disclosures and
reconciliations (All financial assets,
financial liabilities, cash and cash
equivalents, finance costs)
Management of financial risk
129
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 2: INSURANCE AND REINSURANCE CONTRACTS AND MANAGEMENT
OF INSURANCE RISK continued
2.19 	MANAGEMENT OF INSURANCE RISK continued
2.19.6 	Regulatory adequacy requirements and protection against adverse experience
continued
2.19.6.2 REGULATORY REQUIREMENTS IN THE UNITED KINGDOM continued
SOLVENCY II
Capital requirements under Solvency II are calculated using the regulations and guidance originally published by the European
Insurance and Occupational Pensions Authority (EIOPA) and enforced by the PRA in the UK. A Solvency Cover ratio is calculated.
It has several components. The key ones are discussed below:
■ Best estimate liabilities (BEL): policyholder liabilities are calculated on a best estimate basis (excluding any margins) and
discounted at the latest swap curve published by Bank of England.
■ SCR: 1-in-200 stresses over one year to the key assumptions are applied to the BEL and the impacts aggregated using
specified correlation matrices.
■ Risk Margin (RM): 4% Cost of capital on a proportion of the SCR.
■ Technical Provisions (TP): the sum of the BEL and the RM.
■ Eligible Own Funds: the net assets of the company available to cover the SCR; negative TP can be included in the eligible
Own Funds; and
■ Solvency cover ratio: Eligible Own funds divided by SCR.
The Vitality Life business comprises business underwritten directly by VitalityLife (from 1 January 2016), and business
underwritten on behalf of VitalityLife on PAC’s life insurance licence (up to 31 December 2015).
Through a number of contractual and loan arrangements, Discovery retains 100% of the insurance risk associated with the
VitalityLife policies underwritten on the PAC life insurance licence. All policies are administered by VitalityLife, and they are
managed as a single portfolio. The arrangement with the PAC is accounted for under IFRS 17 as an in-substance reinsurance
contract which UK Group issued to the PAC.
Accordingly, all information for VitalityLife is presented on a combined basis, comprising both the business underwritten by
VitalityLife and underwritten on behalf of VitalityLife on the PAC life insurance licence.
The contractual cash flows between subsidiaries of the UK group and PAC for business that was underwritten on PAC life
insurance licence will, as per contractual agreement with PAC, still be measured under the Solvency I or old capital requirement
rules described below until such time it is transferred to the Vitality Life Limited (VLL) licence. If this business is transferred to VLL
then it would be recognised in VLL’s Solvency II reporting, and any such transfer would be subject to legal and regulatory
approval in the UK. During the financial period ended 30 June 2022, Discovery and PAC finalised a contractual agreement to a
long-term deferral of the transfer to the VLL licence (the Part VII transfer). The agreement is such that the Part VII transfer is now
deferred for the long term with options to extend further, and for all intents and purposes, should be viewed as an indefinite
deferral.
For business written on its own balance sheet, VLL is required to hold sufficient capital (measured in accordance with the PRA
Rulebook) to meet the PRA capital requirements. The capital requirements were met at all valuation dates.
Through the contractual mechanism with PAC, VitalityLife is required to provide capital to the PAC equal to one and a half times
the Pillar 1 capital requirement. The cover requirements were observed at all valuation dates.
VITALITYHEALTH
VitalityHealth is required to hold sufficient capital to meet the PRA capital requirements. The capital requirements were met at
all valuation dates.
VitalityHealth follows a standard formula with a premium risk undertaking-specific parameter (USP) derived from VitalityHealth
experience. The use of this parameter was approved by the PRA in the UK on 8 April 2024. Annually, the business publicly
discloses a Solvency and Financial Condition Report (SFCR) alongside private disclosures to the regulators on its Own Risk and
Solvency Assessment (ORSA). The standard formula approach is reviewed annually to determine its appropriateness for the
business. The use of this approach (now also incorporating the use of the USP from 8 April 2024) continues to be considered
appropriate for VitalityHealth.
The actual and projected capital position of VitalityHealth is monitored on a regular basis through a number of forums and
governance committees, including the Board of Directors as well as through VitalityHealth’s ORSA. In the event that sufficient
capital is not projected to be available, actions would be taken to obtain additional capital or to reduce the amount of risk
accepted and therefore reduce the capital requirement through, for example, reinsurance or an investment strategy.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
128
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
129	128

-- 67 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.3 	FINANCIAL ASSETS
For the accounting policies relevant to the recognition and measurement of financial assets, refer to Annexure B policies 8.1,
8.3, and 8.4.
R million 	Notes
Group
2025
Restated
Group
20243
The Group’s investment in financial assets are summarised by
measurement category in the table below:
Financial assets at fair value through profit or loss – mandatorily 	193 776 	165 671
– Equity portfolios 	99 936 	60 250
– Debt portfolios 	55 868 	47 099
– Money market portfolios 	12 948 	15 786
– Multi-asset portfolios 	25 024 	42 536
Financial assets at fair value through other comprehensive income 	14 	–
– Equity portfolios 	14 	–
Financial assets at amortised cost 	21 325 	17 128
Investments at amortised cost1 	12 812 	11 100
– Treasury Bills and Government Bonds 	10 115 	8 194
– Deposits 	2 697 	2 906
Loans and advances to customers at amortised cost2 	8 513 	6 028
Unsecured 	3.3.1.2 	6 828 	6 011
– Personal cards 	6 828 	6 011
Secured 	3.3.1.1 	1 685 	17
– Home loans 	1 685 	17
Total investments 	215 115 	182 799
– Listed3 	184 976 	151 768
– Unlisted3 	30 139 	31 031
Shareholder Investments: 	27 990 	21 784
– Investment at amortised cost 	21 325 	17 128
– Investments at fair value through profit or loss – mandatorily 	6 651 	4 656
– Investments at fair value through other comprehensive income 	14 	–
Policyholder Investments: 	187 125 	161 015
– Investments at fair value through profit or loss – mandatorily 	187 125 	161 015
Total Investments 	215 115 	182 799
1 The carrying value of instruments at amortised cost approximates the fair amount due to the relatively short term nature of the instrument.
2 The carrying value of unsecured loans and advances approximates the fair amount due to on demand repayment terms. The carrying value of the secured
loans and advances approximates the fair amount due to the market related variable interest rates and strong collateral position.
3 The comparative information has been restated for the presentation of certain government bonds (debt portfolios) from unlisted to listed. No impact on the
previously reported values.
3.3.1 	Loans and advances to customers at amortised cost
R million 	Notes
Group
2025
Group
2024
Total net secured loans and advances 	3.3.1.1 	1 685 	17
Total net unsecured loans and advances 	3.3.1.2 	6 828 	6 011
Total net loans and advances to customers at amortised cost 	8 513 	6 028
3.3.1.1 	SECURED LOANS AND ADVANCES AT AMORTISED COST
R million 	Notes
Group
2025
Group
2024
Secured
Home loans 	1 677 	17
Accrued interest 	13 	–
Total Gross advances 	1 690 	17
Less: IFRS 9 Expected credit losses (ECL) 	3.3.1.1.2 	(5) 	*
Total net secured loans and advances 	1 685 	17
* Amount less than R500 000.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
131
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
3.1 	INTRODUCTION AND OVERVIEW
This section provides information on financial instruments including the disclosure and reconciliation of all financial assets and
liabilities, cash and cash equivalents and interest expenses. This section also details how financial risk is managed.
3.2 	PRIMARY FINANCIAL STATEMENT AND INFORMATION ANALYSED IN THIS
SECTION
R million 	Notes
Group
2025
Group
2024
Statement of financial position
ASSETS
Financial assets
– Loans and advances to customers at amortised cost 	3.3.1 	8 513 	6 028
– Investments at amortised cost 	3.3 	12 812 	11 100
– Investments at fair value through other comprehensive income 	3.3 	14 	–
– Investments at fair value through profit or loss 	3.3 	193 776 	165 671
– Derivative financial instruments at fair value through profit or loss 	3.4 	63 	43
Contract receivables and other receivables (only financial assets) 	3.13 	5 667 	5 051
Cash and cash equivalents 	3.6 	21 968 	18 971
242 813 	206 864
LIABILITIES
Third-party interest in consolidated funds 	35 932 	31 456
Financial liabilities
– Borrowings at amortised cost 	3.7 	20 046 	21 662
– Other financial payables at amortised cost 	3.9 	9 148 	8 007
– Deposits from customers 	3.10 	23 326 	18 467
– Investment contracts at fair value through profit or loss 	3.8 	32 188 	25 710
– Derivative financial instruments at fair value through profit or loss 	3.4 	135 	31
120 775 	105 333
Income statement
– Net fair value gains on financial assets at fair value through profit or
loss 	3.11 	25 818 	16 245
– Interest expenses on borrowings and lease liabilities 	3.12 	2 087 	2 036
Additional information
Expected credit loss: Secured loans 	3.3.1.1.2
Expected credit loss: Unsecured loans 	3.3.1.2.2
Expected credit loss reconciliation on all other instruments at amortised
cost 	3.5
Management of financial risk 	3.13
Notes to the group annual financial statements continued
for the year ended 30 June 2025
130
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
131	130

-- 68 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.3 	FINANCIAL ASSETS continued
3.3.1 	Loans and advances to customers at amortised cost continued
3.3.1.2 	UNSECURED LOANS AND ADVANCES AT AMORTISED COST
R million 	Notes
Group
2025
Group
2024
Unsecured
Gross loans and advances 	7 414 	6 503
Accrued interest 	81 	76
Total Gross advances 	7 495 	6 579
Less: IFRS 9 Expected credit losses (ECL) 	3.3.1.2.2 	(667) 	(568)
Total net unsecured loans and advances 	6 828 	6 011
3.3.1.2.1 	UNSECURED LOANS AND ADVANCES PER CREDIT RISK RATING
R million 	DRG 1 – 4 	DRG 5 – 7 	DRG 8 – 10 	Not rated 	Total
As at 30 June 2025
Stage 1 	3 590 	2 218 	628 	5 	6 441
Stage 2: SICR1 	30 	46 	396 	– 	472
Stage 2: Arrears 	– 	4 	61 	– 	65
Stage 3 	2 	11 	423 	– 	436
Gross loans and advances 	3 622 	2 279 	1 508 	5 	7 414
As at 30 June 2024
Stage 1 	3 229 	1 928 	448 	– 	5 605
Stage 2: SICR1 	26 	34 	434 	– 	494
Stage 2: Arrears 	– 	3 	48 	– 	51
Stage 3 	2 	13 	336 	2 	353
Gross loans and advances 	3 257 	1 978 	1 266 	2 	6 503
1 Significant increase in credit risk.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
133
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.3 	FINANCIAL ASSETS continued
3.3.1 	Loans and advances to customers at amortised cost continued
3.3.1.1 	SECURED LOANS AND ADVANCES AT AMORTISED COST continued
3.3.1.1.1 	SECURED LOANS AND ADVANCES PER CREDIT RISK RATING
R million 	DRG 1 – 4 	DRG 5 – 7 	DRG 8 – 10 	Total
As at 30 June 2025
Stage 1 	148 	1 403 	100 	1 651
Stage 2: SICR1 	– 	– 	21 	21
Stage 2: Arrears 	– 	– 	5 	5
Secured loans 	148 	1 403 	126 	1 677
As at 30 June 2024
Stage 1 	1 	16 	– 	17
Secured loans 	1 	16 	– 	17
1 Significant increase in credit risk
Discovery risk grade (DRG), is an internal client rate allocated on the basis of risk profile. An adjusted DRG is allocated for the
purposes of calculating the expected credit losses.
3.3.1.1.2 	RECONCILIATION OF THE EXPECTED CREDIT LOSS (ECL)
R million
Stage 1 (12-
month
ECL)
Stage 2
(Lifetime ECL,
but no missed
payments)
Stage 2
(Lifetime ECL,
and missed
payments)
Stage 3
(Lifetime ECL,
and credit
impaired,
default) 	Total
30 June 2025
Balance at beginning of the year 	– 	– 	– 	– 	–
Total changes in ECL due to changes
in balances of advances 	4 	1 	– 	– 	5
New loans originated and acquired 	4 	1 	– 	– 	5
Balance at end of the year 	4 	1 	– 	– 	5
3.3.1.1.3 	COLLATERAL HELD AS SECURITY ON LOANS AND ADVANCES
R million
Gross
exposure
Impairment
allowance
Carrying
amount
Fair value of
collateral
held1
30 June 2025
Home Loans 	1 690 	(5) 	1 685 	2 826
1 690 	(5) 	1 685 	2 826
30 June 2024
Home Loans 	17 	* 	17 	34
17 	– 	17 	34
1 Fair value of collateral is determined by referencing the realisable value of security held before adjusting for expected recoveries.
* Amount less than R500 000.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
132
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
133	132

-- 69 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.4 	DERIVATIVE FINANCIAL INSTRUMENTS
For the accounting policies relevant to the recognition and measurement of derivatives, refer to Annexure B policy 9.
R million
Group 2025
Assets
Group 2025
Liabilities
Group 2024
Assets
Group 2024
Liabilities
Derivatives used as cash flow hedges:
Interest rate swaps1 	1 	(117) 	14 	(24)
Derivatives not designated as hedging instruments:
Equity price risk derivatives 	35 	– 	4 	(3)
Interest rate swaps 	27 	(18) 	25 	(4)
Total derivative financial instruments 	63 	(135) 	43 	(31)
Current 	52 	(15) 	18 	(7)
Non-current 	11 	(120) 	25 	(24)
Total derivative financial instruments 	63 	(135) 	43 	(31)
1 The interest rate derivative portfolio consists of both interest rate swaps and interest rate caps.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
135
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.3 	FINANCIAL ASSETS continued
3.3.1 	Loans and advances to customers at amortised cost continued
3.3.1.2 	UNSECURED LOANS AND ADVANCES AT AMORTISED COST continued
3.3.1.2.2 	RECONCILIATION OF THE EXPECTED CREDIT LOSS (ECL)
R million
Stage 1 (12-
month
ECL)
Stage 2
(Lifetime ECL,
but no missed
payments)
Stage 2
(Lifetime ECL,
and missed
payments)
Stage 3
(Lifetime ECL,
and credit
impaired,
default) 	Total
30 June 2025
Balance at beginning of the year 	157 	88 	30 	293 	568
Total changes in ECL due to changes
in balances of advances 	28 	7 	6 	(162) 	(121)
New loans originated and acquired1 	27 	9 	7 	23 	66
Repayments and other movements2 	5 	1 	– 	68 	74
Change in ECL due to derecognition
other than write-off 	(4) 	(3) 	(1) 	(4) 	(12)
Change in ECL due to write-off3 	– 	– 	– 	(249) 	(249)
Transfers between stages1 	(11) 	(3) 	5 	229 	220
Transfer (to)/from stage 1 	– 	12 	20 	127 	159
Transfer (to)/from stage 2: SICR 	(1) 	– 	6 	65 	70
Transfer (to)/from stage 2: Arrears 	(1) 	(1) 	– 	37 	35
Transfer (to)/from stage 3 	(9) 	(14) 	(21) 	– 	(44)
Balance at end of the year 	174 	92 	41 	360 	667
30 June 2024 Restated
Balance at beginning of the year 	156 	54 	46 	213 	469
Total changes in ECL due to changes
in balances of advances 	15 	19 	5 	(85) 	(46)
New loans originated and acquired1 	37 	17 	6 	16 	76
Repayments and other movements2 	(19) 	3 	– 	40 	24
Change in ECL due to derecognition
other than write-off 	(3) 	(1) 	(1) 	(6) 	(11)
Change in ECL due to write-off3 	– 	– 	– 	(135) 	(135)
Transfers between stages1 	(14) 	15 	(21) 	165 	145
Transfer (to)/from stage 1 	– 	18 	9 	93 	120
Transfer (to)/from stage 2: SICR 	(2) 	– 	(2) 	23 	19
Transfer (to)/from stage 2: Arrears 	– 	1 	– 	49 	50
Transfer (to)/from stage 3 	(12) 	(4) 	(28) 	– 	(44)
Balance at end of the year 	157 	88 	30 	293 	568
1 In the current year, the Group enhanced its disclosure on new loans and advances. New facilities granted are now reported at their closing balance and
credit stage at year-end (rather than the initial amount advanced), providing a more accurate representation of credit extended during the period. The
comparative disclosure has been updated accordingly to ensure consistency and comparability. Importantly, this change in presentation did not impact the
opening or closing balances, but only the movements between credit stages. Discovery Bank’s policy requires accounts to be transferred between stages
based on their Expected Credit Loss (ECL) classification at the reporting date. Accordingly, exposures may move directly from Stage 3 to Stage 1 if the curing
criteria have been satisfied during the period. Any change in stage classification is reflected in the corresponding transfer disclosures, as outlined above.
2 For the year ended 30 June 2025, the forecasted inflation and interest rates in the near term remains higher than the long run average and the Bank
therefore quantified a forward looking ECL adjustment of R9.2 million labelled as a macroeconomic overlay.
3 The contractual amount outstanding on financial assets that were written off during the year ended 30 June 2025 and that are still subject to enforcement
activity is R600 million (2024: R144 million).
Notes to the group annual financial statements continued
for the year ended 30 June 2025
134
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
135	134

-- 70 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.4 	DERIVATIVE FINANCIAL INSTRUMENTS continued
Year ended 30 June 2024
Carrying amount of the
hedging instrument 	Line item
in the Statement
of financial
position where
the hedging
instrument is
presented
Changes in fair
value of hedging
instrument used
for calculating
hedge ineffec-
tiveness
Group
R million
Interest rate
risk
Notional
amount of the
hedging
instrument 	Assets 	Liabilities
Ineffec-
tiveness
recognised in
profit or loss
Line item in
which hedge
ineffec-
tiveness is
presented in
profit or loss
Interest rate
risk 	5 018 	14 	(24) 	65 	–
Interest rate
swaps 	5 018 	14 	(24)
Financial Asset-
Derivative/
Financial
Liability-
Derivative 	65 	–
Net fair value
gains on
financial
assets at fair
value
through profit
or loss
Refer to note 3.13.4 for a detailed description of the derivative financial instruments listed above.
Year ended 30 June 2024
Changes in the
value of the
hedging
instrument
recognised in
other compre-
hensive income
Carrying amount of the
hedged item
Changes in fair
value of hedged
item used for
calculating
hedge ineffec-
tiveness
Group
R million
Interest rate
risk
Amount
reclassified
from the
cash flow
hedge reserve
to profit
or loss
Line item in
which the
reclassified
amount is
presented
in profit
or loss 	Assets 	Liabilities
Cash flow
hedge
reserve
Interest rate
risk 	(65) 	4 	– 	5 062 	(45) 	(20)
Interest rate
swaps 	(65) 	4
Interest
Expense On
Borrowings
And Lease
Liabilities 	– 	5 062 	(45) 	(20)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
137
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.4 	DERIVATIVE FINANCIAL INSTRUMENTS continued
Group
R million Interest
rate risk
Year ended 30 June 2025
Carrying amount of
the hedging
instrument 	Line item
in the
Statement of
financial
position
where the
hedging
instrument is
presented
Changes in
fair value
of hedging
instrument
used for
calculating
hedge ineffec-
tiveness
Notional
amount of
the hedging
instrument 	Assets 	Liabilities
Ineffec-
tiveness
recognised
in profit
or loss
Line item
in which
hedge
ineffec-
tiveness
is presented
in profit
or loss
Interest rate
risk 	6 768 	1 	(117) 	– 	106 	– 	–
Interest rate
swaps 	6 768 	1 	(117)
Financial
Asset-
Derivative/
Financial
Liability-
Derivative 	106 	–
Net fair
value gains
on financial
assets at fair
value
through
profit and
loss
Group
R million Interest
rate risk
Year ended 30 June 2025
Changes in
the value
of the
hedging
instrument
recognised
in other
compre-
hensive
income
Carrying amount of
the hedged item 	Changes in
fair value
of hedging
instrument
used for
calculating
hedge ineffec-
tiveness
Amount
reclassified
from the
cash flow
hedge
reserve to
profit or loss
Line item
in which the
reclassified
amount is
presented
in profit
or loss 	Assets 	Liabilities
Cash flow
hedge
reserve
Interest rate
risk 	(106) 	2 	– 	– 	6 820 	– 	(124)
Interest rate
swaps 	(106) 	2
Interest
Expense On
Borrowings And
Lease Liabilities 	– 	6 820 	– 	(124)
Refer to note 3.13.4 for a detailed description of the derivative financial instruments listed above.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
136
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
137	136

-- 71 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.7 	BORROWINGS AT AMORTISED COST
For the accounting policies relevant to the recognition and measurement of Borrowings, refer to Annexure B policies 14
and 21.1.
R million 	Notes
Group
2025
Group
2024
Borrowings from banks 	3.7.1 	16 103 	17 511
Lease liabilities 	3.7.2 	3 941 	4 145
Bank overdraft 	2 	6
Balance at end of the year 	20 046 	21 662
Current 	7 452 	2 988
Non-current 	12 594 	18 674
Balance at end of the year 	20 046 	21 662
3.7.1 	Borrowings from Banks
MOVEMENT ANALYSIS OF BORROWINGS
R million
Group
2025
Group
2024
Balance at beginning of the year 	17 511 	16 328
Loans raised1 	3 255 	3 400
Loans repaid1 	(4 836) 	(2 110)
Interest accrued 	1 546 	1 574
Interest paid 	(1 575) 	(1 545)
Raising fees capitalised 	9 	5
Translation differences 	193 	(141)
Balance at end of the year 	16 103 	17 511
1 During the prior financial year, the R1 400 million loan facility held in Discovery Central Services was restructured. In terms of IFRS 9 Financial Instruments,
the restructure was assessed as a substantial modification and therefore the original loan was extinguished and a new loan was recognised. Accordingly,
loans raised and loans repaid include R1 400 million without any impact on cash flows.
For variable rate loans the carrying amount approximates the fair value because the variable rate is set on market related terms.
For fixed rate loans, the fair value is R3 677 million (2024: R6 080 million) relative to the carrying value of R3 759 million
(2024: R6 189 million)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
139
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.5 	EXPECTED CREDIT LOSS RECONCILIATION
For breakdown of those contract receivables and other receivables for which allowance for expected credit loss was recognised,
refer to note 5.8 Contract receivables and other receivables. For the accounting policies relevant to the recognition and
measurement of expected credit losses refer to Annexure B policy 8.1.2.
General Model 	Simplified model
R million 	Notes
Stage 1 (12-
month
ECL)
Stage 2
(Lifetime
ECL)
Stage 3
(Lifetime
ECL/credit
impaired)
Not Credit
impaired
90 days
past due/
credit
impaired 	Total
Year ended
30 June 2025
Balance at beginning of the year 	7 	30 	351 	6 	30 	424
Increase in ECL 	– 	28 	20 	(4) 	42 	86
Amounts utilised during the
year 	(2) 	(2) 	– 	– 	(5) 	(9)
Balance end of the year 	5.8 	5 	56 	371 	2 	67 	501
Year ended
30 June 2024
Balance at beginning of the year 	49 	3 	257 	81 	39 	429
Acquisition/(disposal) of
business 	– 	25 	25 	– 	(50) 	–
Increase in ECL 	2 	2 	69 	3 	67 	143
Amounts utilised during the
year 	(44) 	– 	– 	(78) 	(26) 	(148)
Balance end of the year 	5.8 	7 	30 	351 	6 	30 	424
3.6 	CASH AND CASH EQUIVALENTS
For the accounting policies relevant to the recognition and measurement of Cash and cash equivalents, refer to Annexure B
policies 8.1.2 and 10.
R million
Group
2025
Group
2024
Cash at bank and in hand 	15 272 	13 609
Short-term deposits 	1 825 	2 264
Money market instruments 	4 322 	2 667
Cash and cash equivalents excluding mandatory reserve deposits with central banks 	21 419 	18 540
Mandatory reserve deposits with central bank1 	549 	431
Total cash and cash balances with central banks 	21 968 	18 971
1 Banks are required to deposit a minimum average balance, calculated monthly, with the central bank, which is available for use by the group subject to
certain restrictions and limitations determined by the central bank in South Africa. These deposits bear no interest.
The carrying value of cash and cash equivalents approximates the fair value due to the relatively short-term nature of the
instrument.
To meet the requirements for cash equivalents, as outlined in Annexure B, Policy 8.1.2 and 10 Cash and Cash Equivalents,
Discovery conducts assessments of its money market instruments. These instruments will only be classified as cash equivalents
if they meet the following criteria:
(1) The purpose of the investment is to fulfil short-term cash commitments
(2) The instrument demonstrates high credit quality within the relevant jurisdiction, as indicated by its credit rating
(3) The primary objective of the investment is to protect capital and provide liquidity
(4) The investment can be readily converted into known amounts of cash, similar to bank balances
(5) The fund is invested solely in interest-bearing instruments, similar to deposits, with institutions of high credit quality.
Additionally, the investment must not introduce speculative grade or equity-type risks and exposures. This can be demonstrated
by the yield returns relative to other deposit-type investments within the same jurisdiction.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
138
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
139	138

-- 72 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.7 	BORROWINGS AT AMORTISED COST continued
3.7.1 	Borrowings from Banks continued
3.7.1.1 	SA BORROWING FACILITIES continued
DISCOVERY CENTRAL SERVICES
Carrying value R million
Facility amount
R million 	Interest rate per annum 	Capital repayment and maturity date
Group
2025
Group
2024
1 400 9.97%1 	At maturity – 20 December 2028 	1 408 	1 407
650 11.56% 	At maturity – 29 October 2027 	300 	396
691 3-month JIBAR + 190bps1,3 	At maturity – 30 June 2027 	694 	695
1 500 3-month JIBAR + 145bps1,4 	At maturity – 08 June 2026 	– 	–
500 Prime rate less 145bps5 	At maturity – 364-day notice 	– 	–
Total Discovery Central Services Borrowings 	2 402 	2 498
1 Interest payable quarterly in arrears.
2 Instalments of interest and capital are monthly.
3 The interest rate exposure has been capped at 8.36% through a derivative instrument.
4 During the current period, the maturity date of this Revolving Credit Facility has been extended to 08 June 2026. This facility was not drawn down.
5 The Revolving Credit Facility is a committed 364-day notice facility granted in November 2023. A commitment fee of 0.60% per annum is paid monthly in
arrears on the undrawn portion. This facility was reduced from R750 million to R500 million during the period and was not drawn down.
3.7.1.2 	UK BORROWING FACILITIES
UK BORROWINGS
Carrying value
R million
Facility amount
GBP million 	Capital repayment and maturity date2
Group 2025 	Group 2024
Variable rate 	GBP 	R 	GBP 	R
25 SONIA + 275bps1 	At maturity – 23 December 2025 	25 	608 	25 	589
75 SONIA + 300bps1 	At maturity – 21 December 2025 	75 	1 828 	74 	1 714
55 SONIA + 285bps1 	At maturity – 12 December 2025 	52 	1 274 	54 	1 246
Total UK Borrowings 	152 	3 710 	153 	3 549
1 Interest payable quarterly in arrears.
2 In preparation for the upcoming debt maturities in the latter part of 2025, Discovery initiated a restructuring of its funding arrangements to optimise
financing costs. As part of this process, in August 2025 Discovery successfully secured a R2.1 billion revolving credit facility, priced at 3-month JIBAR plus
115 basis points.
3.7.2 	Leases
MOVEMENT ANALYSIS OF LEASES
R million
Group
2025
Group
2024
Balance at beginning of the year 	4 145 	4 225
New leases entered into 	107 	183
Interest accrued 	418 	433
Repayments 	(737) 	(675)
Modifications 	(4) 	(1)
Translation differences 	12 	(20)
Balance at end of the year 	3 941 	4 145
Total payments for leases for the year is R811 million (2024: R797 million).
During the 2018 financial year Discovery took occupation of a new head office building (1DP) under a lease. A lease liability and
related asset (refer to note 5.5) of R3 155 million was raised. At year end, R3 125 million (2024: R3 246 million) remained
outstanding. Finance charges of R345 million (2024: R356 million) have been recognised in profit or loss and repayments of
R466 million (2024: R436 million) have been made.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
141
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.7 	BORROWINGS AT AMORTISED COST continued
3.7.1 	Borrowings from Banks continued
3.7.1.1 	SA BORROWING FACILITIES
DISCOVERY LIMITED
Discovery had R2.2 billion in Domestic Medium Term Notes (DMTN) maturing in November 2024. As a risk mitigation measure, it
raised R1.5 billion notes in May 2024 and to complete the refinancing of the maturing November 2024 notes and avail itself of
continued favourable debt markets, the Company raised a further R1.75 billion in November 2024. To facilitate these issuances,
in advance of settling the maturing notes, Discovery increased the size of its notes programme registered in 2017 to R12.5 billion
from R10 billion on the same terms and conditions. The excess proceeds were used to settle R1.1 billion in notes maturing in
February 2025, with the remaining R1.4 billion maturity being extended to 21 May 2025. An additional R1.515 billion notes were
issued on 21 May 2025 to apply towards those notes maturing.
Carrying value
R million
Facility amount
R million 	Variable rate
Interest per
annum 	Capital repayment and maturity date
Group
2025
Group
2024
Listed DMTN
200 – 	10.46%1 	At maturity – 21 November 2024 	– 	202
800 3-month JIBAR + 191bps 	8.40%2,3 	At maturity – 21 November 2024 	– 	809
1200 3-month JIBAR + 191bps 	7.30%2,3 	At maturity – 21 November 2024 	– 	1 215
700 3-month JIBAR + 180bps 	8.49%2,3 	At maturity – 21 August 2026 	707 	707
300 3-month JIBAR + 180bps 	7.60%2,3 	At maturity – 21 August 2026 	303 	304
792 3-month JIBAR + 173bps 	7.98%2,3 	At maturity – 21 May 2027 	799 	800
226 3-month JIBAR + 180bps 	7.98%2,3 	At maturity – 21 May 2029 	228 	228
576 3-month JIBAR + 140bps 	7.50%2,3 	At maturity – 21 November 2027 	581 	582
924 3-month JIBAR + 159bps 	8.17%2,3 	At maturity – 21 November 2029 	932 	935
404 – 	7.90%1 	At maturity – 21 November 2025 	392 	–
750 3-month JIBAR + 140bps 	7.19%2,3 	At maturity – 21 November 2027 	758 	–
1 000 3-month JIBAR + 159bps 	8.17%2,3 	At maturity – 21 November 2029 	1 012 	–
1 111 3-month JIBAR + 95bps 	7.46% 3 	At maturity – 21 May 2026 	1 120 	–
Unlisted DMTN4
2 500 – 	9.62%3 	At maturity – 22 February 2025 	– 	2 525
1 650 – 	9.55%3 	At maturity – 10 March 2026 	1 659 	1 659
Other
1 000 3-month JIBAR + 190bps 	8.38%2,3 	At maturity – 2 March 2028 	1 000 	999
500 3-month JIBAR + 190bps 	7.51%2,3 	At maturity – 2 March 2028 	500 	499
Total Discovery Limited Borrowings 	9 991 	11 464
1 Interest is payable semi-annually in arrears.
2 The interest rate has been fixed through interest rate swaps.
3 Interest payable quarterly in arrears.
4 During the financial year ended 30 June 2020, Discovery Limited refinanced R3.6 billion bank syndicated loans through the issue of unlisted DMTN notes.
The notes, although underwritten by a bank until maturity, are structured to enable short-term issuances into the commercial paper market on an ongoing
basis.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
140
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
141	140

-- 73 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.11 	NET FAIR VALUE GAINS ON FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT
OR LOSS
R million
Group
2025
Group
2024
Total 	25 818 	16 245
3.12 	INTEREST EXPENSE ON BORROWINGS AND LEASE LIABILITIES
For the accounting policies relevant to the recognition and measurement of Borrowings, refer to Annexure B policies 14 and 23.
R million
Group
2025
Group
2024
Finance costs
Cash flow hedge recycled to other comprehensive income 	2 	4
Interest expense on:
– Borrowings measured at amortised cost using the effective interest method 	1 546 	1 573
– Lease liability (IFRS 16) 	418 	433
– Interest on other payables using the effective interest rate method 	1 	4
– Other 	120 	22
Total 	2 087 	2 036
Notes to the group annual financial statements continued
for the year ended 30 June 2025
143
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.8 	INVESTMENT CONTRACTS AT FAIR VALUE THROUGH PROFIT OR LOSS
R million
Group
2025
Group
2024
The movements during the year were as follows:
Balance at beginning of the year 	25 710 	28 903
Deposits received 	6 762 	6 888
Account balances paid on withdrawal and other terminations in the year 	(4 094) 	(12 054)
Fair value adjustment 	3 810 	2 142
Translation difference 	– 	(169)
Balance at end of the year 	32 188 	25 710
Current1 	32 188 	25 710
1 There is no maturity profile for these liabilities as this will depend on policyholder behaviour. Contractually, policyholders may disinvest on demand.
The benefits offered under the Group’s unit-linked investment contracts are based on the return on selected equities, debt
securities and money market securities. The Group communicates the actual performance of these contracts to its contract
holders.
Investment contracts at fair value through profit or loss are exactly matched with related assets and managed collectively as a
pool. Discovery’s credit risk is not reflected in the measurement of the assets or consequently the liability, which is measured
with reference to the underlying assets. Own credit risk has been assessed and determined to be immaterial.
3.9 	OTHER FINANCIAL PAYABLES AT AMORTISED COST
R million
Group
2025
Group
2024
Commissions payable 	370 	476
Consolidated unit trust payables 	627 	693
Expired hedge payables 	– 	3
Intermediary payables 	32 	38
Payables and accrued liabilities 	3 722 	3 188
Payroll creditors 	1 275 	1 068
Policyholder unallocated funds 	1 751 	1 214
Security deposits on derivatives 	53 	–
Unsettled trades 	87 	125
Other financial payables 	1 231 	1 202
Balance at end of the year 	9 148 	8 007
Current 	8 901 	7 880
Non-current 	247 	127
Total other payables 	9 148 	8 007
3.10 	DEPOSITS FROM CUSTOMERS
For the accounting policies relevant to the recognition and measurement of Deposits from customers, refer to Annexure B
policy 8.2.
R million
Group
2025
Group
2024
Term deposits from customers – fixed rates 	3 174 	3 219
Term deposits from customers – variable rates 	6 404 	4 608
On demand deposits from customers – non-rate sensitive 	653 	601
On demand deposits from customers – variable rate 	13 095 	10 039
Total customer deposits 	23 326 	18 467
The carrying amount of deposits due to customers approximates fair value, as the majority of instruments are either at variable
market-related rates or are short term in nature.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
142
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
143	142

-- 74 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
Discovery’s approach in monitoring credit risk continued
The Group’s Internal Rating Scale categories for disclosure purposes are defined below:
Group internal grading
for disclosures
Moody’s Investors Service
equivalent of internal rating
S&P Global Ratings equivalent of
internal rating
Discovery internal risk weighting
(RW) grading for internal credit
risk assessment1
Investment grade
Grade Aaa 	Aaa 	AAA 	RW1
Grades Aa1, Aa2, Aa3 	Aa1, Aa2, Aa3 	AA+, AA, AA- 	RW2-RW4
Grades A1, A2, A3 	A1, A2, A3 	A+,A,A- 	RW5-RW7
Grades Baa1, Baa2, Baa3 Baa, Baa1, Baa2, Baa3 	BBB+,BBB,BBB- 	RW8-RW10
Sub-investment grade
Grades Ba1, Ba2, Ba3 	Ba1, Ba2, Ba3 	BB+, BB, BB- 	RW11-RW14
Grades B1, B2, B3 	B1, B2, B3 	B+, B, B- 	RW15-RW19
Grades Caa1, Caa2, Caa3 Caa1, Caa2, Caa3 	CCC+, CCC, CCC- 	RW20-RW23
Grades Ca1, Ca2, Ca3 	Ca1, Ca2, Ca3 	CC 	RW24
Default
Grade C 	C 	RD 	RW25
1 Discovery utilises an internal risk weighting (RW) scale, calibrated to external rating agencies to develop internal credit ratings for financial guarantee
contracts and its internal borrowings amongst Discovery Group entities. It is a 25-point rating scale. The ratings are mapped to their probability of default,
which is then calibrated to a similar range of S&P Global Ratings and Moody’s Investors Service ratings.
Where a short-term rating is unavailable, for example, short-term cash deposits, Discovery includes, for the purpose of credit
risk disclosures the financial instrument as per the respective entity’s long-term credit rating. Discovery’s internal grading for
disclosures aligns with Moody’s Investors Service definitions of their respective ratings as follows:
Investment grade 	Aaa 	Obligations rated Aaa are judged to be of the highest quality, subject to the lowest level of
credit risk.
Aa 	Obligations rated Aa are judged to be of the highest quality, subject to the lowest level of
credit risk.
A 	Obligations rated A are judged to be upper-medium grade and are subject to low credit risk.
Baa 	Obligations rated Baa are judged to be medium-grade and subject to moderate credit risk
and as such may possess certain speculative characteristics.
Sub-investment grade Ba 	Obligations rated Ba are judged to be speculative and are subject to substantial credit risk.
B 	Obligations rated B are considered speculative, and are subject to high credit risk.
Caa 	Obligations rated Caa are judged to be speculative, of poor standing and are subject to very
high credit risk.
Ca 	Obligations rated Ca are highly speculative and are likely in, or very near, default, with some
prospect of recovery of principal and interest.
Default 	C 	Obligations rated C are the lowest rated and are typically in default, with little prospect for
recovery of principal or interest.
A numerical modifier may be added to each generic rating classification. Each modifier indicates the following:
■ The modifier 1 indicates that the obligation ranks at the higher end of its generic rating category
■ The modifier 2 indicates a mid-range ranking; and
■ The modifier 3 indicates a ranking in the lower end of that generic rating category.
POOLED FUNDS
The Group invests in funds through which it is also exposed to the credit risk of the underlying assets in which the funds are
invested. The Group’s exposure to risk is classified at fund level and not at the underlying asset level. Although funds are not
rated, fund managers are required to invest in credit assets within the defined parameters stipulated in the fund’s mandate.
These rules limit the extent to which fund managers can invest in unlisted and/or unrated credit assets and generally restrict
funds to the acquisition of local currency investment-grade assets.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
145
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK
Discovery’s activities expose it to a variety of financial risks. Financial risks include market risk, credit risk and liquidity risk.
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in
market prices and investment return. Market risk that could impact future cash flows and hence the value of a financial
instrument arises from:
■ Equity price risk: The impact of changes in equity prices and dividend income.
■ Interest rate risk: The impact of changes in market interest rates.
■ Currency risk: The impact of changes in foreign exchange rates.
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge
an obligation.
Liquidity risk is the risk that Discovery will encounter difficulty in meeting obligations associated with financial liabilities due to
insufficient cash or other financial assets being available to meet commitments as and when they become due.
Financial risks are managed by Discovery as follows:
■ Reputable external asset managers have been appointed to manage its investments.
■ The Actuarial Committee reviews the overall matching of shareholder and policyholder assets to their respective liabilities.
■ The Capital, Currency, and Investment Committee (CCIC) is a sub-committee of the Group Executive Committee and meets
quarterly to focus on shareholder and policyholder assets and the performance of asset managers responsible for managing
these assets. The CCIC also sets exposure limits for exposures to individual counterparties.
■ External consultants are periodically engaged to review past investment decisions.
■ The Investment Committee is a sub-committee of the CCIC and meets monthly to make operational decisions regarding
Discovery’s liquidity and foreign currency exposure.
Discovery’s approach in monitoring credit risk
Discovery’s credit risk rating systems and processes differentiate and quantify credit risk across counterparties and asset classes.
Discovery uses different credit rating approaches to monitor credit risk dependent on the financial assets. For financial assets
with externally rated ratings, for example, Moody’s, the external rating is always used. For non-Moody’s-rated instruments, the
following approaches will apply:
RATING SCALES FOR FUNDS
A credit rating, which is a ranking of creditworthiness, is allocated to the obligor. Where external ratings are unavailable, internal
rating assessments are conducted through analysis of the latest financial and other relevant information, in a consistent and
systematic manner. Where external ratings are available, the standard rating classifications used by the external rating agencies
have been applied and mapped to the internal categories per the Group’s internal rating scale. The internal rating scale is based
on internal definitions and influenced by definitions published by the external ratings agency, Moody’s.
Where applicable, internal ratings are mapped to equivalent external Moody’s rating scales.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
144
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
145	144

-- 75 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
Equity portfolios
The following have been defined as equity portfolios:
■ Portfolios that invest a minimum of circa 75% of the market value of the portfolio in equities and generally seek maximum
capital appreciation as their primary goal. These portfolios invest in selected shares across the range of large, mid, and
smaller-cap shares. While the managers of these portfolios may subscribe to different investment styles or approaches, their
intent is to produce a risk/return profile that is comparable with the risk/return profile of the overall equities market. The
portfolios in this category offer medium to long-term capital growth as their primary investment objective.
■ Investments or portfolios of equity-linked notes.
Debt (interest-bearing) portfolios
Interest-bearing portfolios are portfolios that invest exclusively in bonds, money market investments and other interest earning
securities. These portfolios may not include equity securities, real estate securities or cumulative preference shares.
In addition to the above, inflation-linked bonds have been defined as debt portfolios. Inflation-linked bonds are essentially loans
where the principal and interest payments are contractually linked to an inflation measure.
Money market portfolios
Money market portfolios are portfolios that seek to maximise interest income, preserve the portfolio’s capital, and provide
immediate liquidity. This is achieved by investing in money market instruments with a maturity of less than 13 months, while the
average duration of the underlying assets may not exceed 90 days and a weighted average legal maturity of 120 days. The
portfolios are typically characterised as short term, highly liquid vehicles.
Multi-asset portfolios
Multi-asset portfolios are portfolios that invest in a wide spread of investments in the equity, bond, money, and property
markets to maximise total returns, comprising capital and income growth over the long term. These portfolios do not fall within
the thresholds that have been determined for the equity portfolios or the debt portfolios.
The following tables reconcile the Group statement of financial position to the classes of risks and the categories listed on the
previous pages.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
147
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
Discovery’s approach in monitoring credit risk continued
DISCOVERY BANK
Loans and advances to customers are categorised according to Discovery Bank’s own internally developed credit models. The
Discovery Bank model uses a 10-point Discovery Risk Grade classification, with each point being in two decrements to further
distinguish risk. The following table summarises how Discovery Bank classifies its loans:
Discovery Risk Category 	Discovery Risk Grades 	Risk of default assessment
Exceptionally low risk 	DRG1 – DRG2 	Less than 0.4%
Low risk 	DRG3 – DRG5 	Less than 1.5%
Medium risk 	DRG5 – DRG8 	Less than 6%
High risk 	DRG8 – DRG9 	Less than 24%
Very high risk 	DRG10 	More than 24%
Categorisation of business in the analysis of financial risk
To assist in the analysis of the financial risks that Discovery and its policyholders are exposed to, the Statement of financial
position has been divided into five categories based on the nature of the products provided by Discovery and the nature of the
financial assets held to back the policyholder liabilities.
■ Unit-linked investment contracts: this category relates to contracts issued by Discovery where there is a direct relationship
between the returns earned on the underlying portfolio and the returns credited to the contract. Discovery holds the assets
on which the unit prices are based, and as a result, there is no mismatch. The market risk (including equity price, interest rate
and currency risk) as well as the credit risk for these contracts are therefore borne by the policyholder and not the Discovery
shareholders.
■ Unit-linked insurance contracts: this category relates to insurance contracts issued by Discovery that have a component
that is linked to the units of an underlying portfolio. For this component, Discovery holds the assets on which the unit prices
are based. However, the gross unit liabilities are reduced by the present value of future charges less the present value of
future expenses and risk claims. Under IFRS, the unit-linked component is not accounted for separately from the host
insurance contract. These contracts expose both Discovery shareholders and policyholders to financial risks.
■ Insurance contracts: this category relates to insurance contracts issued by Discovery which Discovery funds with a portfolio
of matching assets, exposing the Discovery shareholders to financial risk. The financial assets in this category include those
financial assets held within specific portfolios matched to specific liabilities, for example claims reserves and liabilities for
incurred claims.
■ Shareholder financial assets and liabilities: this category includes the financial assets and financial liabilities that expose
Discovery shareholders to financial risks, including financial assets and cash backing insurance reserves and statutory capital.
This category includes those financial assets that are not held in specific portfolios matched to insurance-related liabilities.
■ Shareholder non-financial assets and liabilities: No financial risk disclosures are required for these items.
The financial assets at fair value in each of these categories are sub-categorised into a second tier of classification, namely:
■ Equity portfolios
■ Debt portfolios
■ Money market portfolios
■ Multi-asset portfolios
In applying the definitions below, reliance is placed on the classifications made by asset managers.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
146
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
147	146

-- 76 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
Shareholder
Group
R million 	Total
Unit–
linked
investment
contracts1
Unit–
linked
insurance
contracts1
Insurance
contracts2
Financial
assets and
liabilities3
Other
assets and
liabilities
30 June 2024 Restated
Assets arising from insurance contracts issued 	37 339 	– 	– 	37 339 	– 	–
Assets arising from reinsurance contracts held 	837 	– 	– 	837 	– 	–
Loans and advances to customers at amortised
cost 	6 028 	– 	– 	– 	6 028 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 194 	– 	– 	– 	8 194 	–
– Fixed deposits 	2 906 	– 	– 	– 	2 906 	–
Financial instruments mandatorily at fair
value through profit or loss:
Listed:
– Equity portfolios 	59 546 	24 135 	34 977 	149 	285 	–
– Debt portfolios 	47 077 	13 059 	14 412 	17 833 	1 773 	–
– Money market portfolios 	2 609 	698 	695 	511 	705 	–
– Multi-asset portfolios 	42 536 	16 813 	25 373 	121 	229 	–
Unlisted:
– Equity portfolios 	704 	85 	547 	– 	72 	–
– Debt portfolios 	22 	– 	– 	22 	– 	–
– Money market portfolios 	13 177 	1 025 	1 650 	8 910 	1 592 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	– 	– 	– 	14 	–
– not designated as hedging instruments 	29 	– 	1 	1 	27 	–
Receivables:
– Contract receivables 	1 350 	– 	– 	– 	1 350 	–
– Other receivables 	5 379 	516 	663 	12 	2 510 	1 678
Cash and cash equivalents 	18 971 	1 616 	2 381 	820 	14 154 	–
Other non-financial assets 	32 916 	– 	– 	– 	– 	32 916
Total assets 	279 634 	57 947 	80 699 	66 555 	39 839 	34 594
Liabilities arising from insurance contracts
issued 	105 070 	– 	73 719 	31 351 	– 	–
Liabilities arising from reinsurance contracts
held 	5 396 	– 	– 	5 396 	– 	–
Borrowings at amortised cost 	21 662 	2 	4 	– 	21 656 	–
Deposits from customers 	18 467 	– 	– 	– 	18 467 	–
Other payables 	8 007 	777 	787 	476 	5 967 	–
Investment contracts at fair value through profit
or loss 	25 710 	25 710 	– 	– 	– 	–
Third-party interest in consolidated funds 	31 456 	31 456 	– 	– 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	24 	– 	– 	– 	24 	–
– not designated as hedging instruments 	7 	2 	2 	– 	3 	–
Other non-financial liabilities2 	9 384 	– 	– 	– 	– 	9 384
Total liabilities 	225 183 	57 947 	74 512 	37 223 	46 117 	9 384
1 The comparative information has been restated for the presentation of specified notes (equity portfolios) from unlisted to listed. No impact on the previously
reported values.
2 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
3 The comparative information has been restated for the presentation of certain government bonds (debt portfolios) from unlisted to listed. No impact on the
previously reported values.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
149
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
Group
R million
Shareholder
Total
Unit–
linked
investment
contracts
Unit–
linked
insurance
contracts
Insurance
contracts
Financial
assets and
liabilities
Other
assets and
liabilities
30 June 2025
Assets arising from insurance contracts issued 	48 047 	– 	– 	48 047 	– 	–
Assets arising from reinsurance contracts held 	962 	– 	– 	962 	– 	–
Loans and advances to customers at
amortised cost 	8 513 	– 	– 	– 	8 513 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 849 	– 	– 	– 	8 849 	–
– Fixed deposits 	2 697 	– 	– 	– 	2 697 	–
Listed:
Debt 	1 266 	– 	– 	– 	1 266 	–
Financial instruments mandatorily at fair
value through profit or loss:
Listed:
– Equity portfolios 	99 627 	41 583 	57 303 	254 	487 	–
– Debt portfolios 	55 612 	14 767 	16 616 	21 639 	2 590 	–
– Money market portfolios 	3 447 	481 	568 	519 	1 879 	–
– Multi-asset portfolios 	25 024 	8 898 	15 903 	59 	164 	–
Unlisted:
– Equity portfolios 	309 	28 	255 	– 	26 	–
– Debt portfolios 	256 	37 	50 	87 	82 	–
– Money market portfolios 	9 501 	993 	1 723 	5 362 	1 423 	–
Unlisted:
– Equity portfolios 	14 	– 	– 	– 	14 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	1 	– 	– 	– 	1 	–
– not designated as hedging
– instruments 	62 	5 	6 	– 	51 	–
Receivables:
– Contract receivables 	1 653 	– 	– 	– 	1 653 	–
– Other receivables 	5 715 	545 	711 	49 	2 709 	1 701
Cash and cash equivalents 	21 968 	1 646 	2 817 	289 	17 216 	–
Other non-financial assets 	33 927 	– 	– 	– 	– 	33 927
Total assets 	327 450 	68 983 	95 952 	77 267 	49 620 	35 628
Liabilities arising from insurance contracts
issued 	118 878 	– 	88 150 	30 728 	– 	–
Liabilities arising from reinsurance contracts
held 	9 121 	– 	– 	9 121 	– 	–
Borrowings at amortised cost 	20 046 	1 	1 	– 	20 044 	–
Deposits from customers 	23 326 	– 	– 	– 	23 326 	–
Other payables 	9 148 	688 	1 111 	774 	6 575 	–
Investment contracts at fair value through
profit or loss 	32 188 	32 188 	– 	– 	– 	–
Third-party interest in consolidated funds 	35 932 	35 932 	– 	– 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	117 	– 	– 	– 	117 	–
– not designated as hedging instruments 	18 	7 	8 	3 	– 	–
Other non-financial liabilities 	12 977 	– 	– 	– 	– 	12 977
Total liabilities 	261 751 	68 816 	89 270 	40 626 	50 062 	12 977
Notes to the group annual financial statements continued
for the year ended 30 June 2025
148
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
149	148

-- 77 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
The financial risks associated with each category are discussed below.
3.13.1 	Unit-linked investment contracts continued
3.13.1.2 CREDIT RISK
Credit risk is borne by the policyholder. For the majority of the unit-linked investments, Discovery has invested in mutual funds
in order to provide for obligations under unit-linked investment contract liabilities. Each mutual fund has its own legal
constitution and operates within a mandate that is delegated to the appointed fund manager. Credit risks assumed within the
assets held are controlled by various protection mechanisms within the mandate and in law. Each fund’s trustees or board
appoints administrators who are responsible for ensuring that the fund’s mandate and any internal and legislated control
procedures are adhered to. In the event of a breach, they are obligated to bring it immediately to the attention of the fund’s
trustees or board and the management of the administrators for remedial action.
3.13.1.3 LIQUIDITY RISK
Certain contracts can be surrendered before maturity for a cash surrender value specified in the contractual terms and
conditions. This surrender value is equal to or less than the carrying amount of the contract liabilities. If all the contracts with this
option were surrendered at the financial year-end, a loss of R1 237 million (2024: R1 135 million) would have been recorded in
profit or loss. This loss would result from an impairment to the asset raised for costs of obtaining contracts, but the impact is
reduced by the surrender penalties receivable. A maturity analysis based on the earliest contractual repayment date would
present 100% (2024: 100%) of the policyholder liabilities due within one year. The assets held to match these policyholder
liabilities are realisable in the short term.
3.13.2 	Unit-linked insurance contracts
A unit-linked insurance contract is an IFRS-defined insurance contract with a component that is linked to the units of an
underlying portfolio.
Investments held at risk of
policyholders
R million
Group
2025
Restated
Group
20241
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	57 303 	34 977
– Debt portfolios 	16 616 	14 412
– Money market portfolios 	568 	695
– Multi-asset portfolios 	15 903 	25 373
Unlisted:
– Equity portfolios 	255 	547
– Debt portfolios 	50 	–
– Money market portfolios 	1 723 	1 650
Derivative financial instruments at fair value:
– not designated as hedging instruments 	6 	1
Receivables:
– Other receivables 	711 	663
Cash and cash equivalents 	2 817 	2 381
Total assets 	95 952 	80 699
Liabilities arising from insurance contracts issued 	88 150 	73 719
Borrowings at amortised cost 	1 	4
Other payables 	1 111 	787
Derivative financial instruments at fair value:
– not designated as hedging instruments 	8 	2
Total liabilities 	89 270 	74 512
1 The comparative information has been restated for the presentation of specified notes (equity portfolios) from unlisted to listed. No impact on the previously
reported values.
3.13.2.1 CREDIT RISK
The credit risk for the unit-linked insurance contracts is similar to the credit risk for the unit-linked investment contracts. Refer to
section 3.13.1.2 for details on the exposure to the credit risk.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
151
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
The financial risks associated with each category are discussed below.
3.13.1 	Unit-linked investment contracts
Unit-linked investment contracts relate to contracts where there is a direct relationship between the returns earned on the
underlying portfolio and the returns credited to the contract.
Investments held at risk of
policyholders
R million
Group
2025
Restated
Group
20241
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	41 583 	24 135
– Debt portfolios 	14 767 	13 059
– Money market portfolios 	481 	698
– Multi-asset portfolios 	8 898 	16 813
Unlisted:
– Equity portfolios 	28 	85
– Debt portfolios 	37 	–
– Money market portfolios 	993 	1 025
Derivative financial instruments at fair value:
– not designated as hedging instruments 	5 	–
Receivables:
– Other receivables at amortised cost 	545 	516
Cash and cash equivalents 	1 646 	1 616
Total assets 	68 983 	57 947
Borrowings at amortised cost 	1 	2
Other payables 	688 	777
Investment contracts at fair value through profit or loss 	32 188 	25 710
Third-party interest in consolidated funds 	35 932 	31 456
Derivative financial instruments at fair value:
– not designated as hedging instruments 	7 	2
Total liabilities 	68 816 	57 947
1 The comparative information has been restated for the presentation of specified notes (equity portfolios) from unlisted to listed. No impact on the previously
reported values.
3.13.1.1 MARKET RISK
EQUITY AND INTEREST RATE RISK
Discovery’s primary exposure to market risk from these contracts is the volatility in asset management fees earned by Discovery,
due to the impact of interest rate, equity price and currency movements on the fair value of the assets held in the linked funds,
on which the investment management fees are based. An increase of 10% in the value of the assets would increase the asset
management fees by R89 million per annum before tax (2024: R77 million). A decrease of 10% in the value of the assets would
reduce the asset management fees by R89 million per annum before tax (2024: R78 million).
In respect of IFRS-defined investment management contracts, there may be an associated asset for the costs of obtaining
contracts. There is a risk that in the event of adverse market movements, future expected management fees may reduce, and
consequently, this asset may not be realised and therefore necessitate impairment. There were no impairments necessary in the
current or previous financial year.
CURRENCY RISK
The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and
recognised assets and liabilities. The currency risk is borne by the policyholder.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
150
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
151	150

-- 78 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.3 	Insurance contracts continued
3.13.3.2 CREDIT RISK
Discovery is exposed to credit risk through financial investments comprising money market portfolios and debt portfolios
entered into to match policyholders’ insurance contract liabilities. Discovery is exposed to the issuer’s credit standing on these
instruments, which is monitored by the CCIC by setting a minimum credit rating.
Group
R million 	Total
Aaa1
Aaa2
Aaa3
Aa1
Aa2
Aa3 	A1 A2 A3
Ba1 Ba2
Ba3
Baa1
Baa2
Baa3 	Govt1
Not
rated
30 June 2025
Assets arising from reinsurance
contracts held 	962 	– 	1 023 	– 	– 	– 	– 	(61)
Financial instruments
mandatorily at fair value through
profit or loss:
Listed:
– Debt portfolios 	21 639 	– 	60 	41 	439 	1 089 	20 010 	–
– Money market portfolios 	519 	– 	– 	3 	116 	310 	90 	–
Unlisted:
– Debt portfolios 	87 	– 	– 	– 	61 	26 	– 	–
– Money market portfolios 	5 362 	– 	2 408 	– 	24 	2 854 	76 	–
Cash and cash equivalents 	289 	– 	7 	1 	– 	281 	– 	–
Total 	28 858 	– 	3 498 	45 	640 	4 560 	20 176 	(61)
30 June 2024
Assets arising from reinsurance
contracts held 	837 	– 	964 	34 	– 	– 	– 	(161)
Financial instruments
mandatorily at fair value through
profit or loss:
Listed:
– Debt portfolios 	17 833 	6 	115 	2 	585 	491 	16 634 	–
– Money market portfolios 	511 	– 	41 	21 	444 	5 	– 	–
Unlisted:
– Debt portfolios 	22 	– 	2 	– 	18 	– 	2 	–
– Money market portfolios 	8 910 	– 	3 633 	130 	3 715 	1 238 	194 	–
Cash and cash equivalents 	820 	– 	3 	1 	496 	320 	– 	–
Total 	28 933 	6 	4 758 	188 	5 258 	2 054 	16 830 	(161)
1 These instruments are issued by the South African government.
3.13.3.3 LIQUIDITY RISK
The liquidity risk for assets and liabilities arising from insurance contracts is discussed in the insurance risks in Section 2.4.1
Management of Insurance Risk. The financial investments held at fair value through profit or loss are realisable in the short
term.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
153
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.2 	Unit-linked insurance contracts continued
3.13.2.2 LIQUIDITY RISK
All contracts can be surrendered before maturity for a cash surrender value specified in the contractual terms and conditions.
This surrender value is equal to or less than the carrying amount of the contract liabilities. If all the contracts with this option
were surrendered at the financial year-end, a loss of R3 158 million (2024: R4 305 million) would have been recorded in profit or
loss. This loss results from the impairment of assets arising from insurance contracts relating to these contracts, but the impact
is reduced by the surrender penalties receivable.
The assets held to match these policyholder liabilities are highly liquid and are realisable in the short term. A maturity analysis
based on the earliest contractual repayment date is as follows:
Group
R million 	Total
<1
Year
1 – 2
Years
3 – 5
Years
30 June 2025
Unit-linked insurance contracts 	95 144 	92 911 	478 	1 755
30 June 2024
Unit-linked insurance contracts 	79 952 	78 792 	409 	751
3.13.3 	Insurance contracts
For insurance contracts, Discovery funds the insurance liabilities with a portfolio of matching assets.
R million
Group
2025
Restated
Group
20241
Assets arising from insurance contracts issued 	48 047 	37 339
Assets arising from reinsurance contracts held 	962 	837
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	254 	149
– Debt portfolios 	21 639 	17 833
– Money market portfolios 	519 	511
– Multi-asset portfolios 	59 	121
Unlisted:
– Debt portfolios 	87 	22
– Money market portfolios 	5 362 	8 910
Derivative financial instruments at fair value:
– not designated as hedging instruments 	– 	1
Receivables:
– Other receivables 	49 	12
Cash and cash equivalents 	289 	820
Total assets 	77 267 	66 555
Liabilities arising from insurance contracts 	30 728 	31 351
Liabilities arising from reinsurance contracts 	9 121 	5 396
Derivative financial instruments at fair value:
– not designated as hedging instruments 	3 	–
Other payables 	774 	476
Total liabilities 	40 626 	37 223
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
3.13.3.1 MARKET RISK
When calculating the liabilities arising from insurance contracts, an increase or decrease in the investments would result in an
increase or decrease in the liability but it may not be an equal rand value movement, resulting in the difference being accrued to
the shareholders. Discovery aims to closely match liabilities with appropriate assets and maintains sufficient assets to protect
against residual mismatches between assets and liabilities at a 99.5% confidence interval over a one-year time horizon.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
152
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
153	152

-- 79 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK
3.13.4.1.1 EQUITY PRICE RISK
Investments
Discovery is exposed to equity price risk through its equity investments held that have been classified as investments at fair
value through profit or loss (FVTPL) and fair value through other comprehensive income (FVOCI) on the Group statement of
financial position. To manage its equity risk arising from investments in equity portfolios of R527 million (2024: R357 million), the
Group diversifies its portfolio and uses experienced asset managers.
For shareholder investments, a reasonable increase of 10% in the equity markets would result in a profit of R49 million before
tax (2024: R42 million). A reasonable decrease in the equity markets would result in a loss of R49 million before tax (2024:
R42 million). This impact would be recognised in profit or loss and equity. The sensitivity assumes that the equity markets had
increased or decreased by 10% with all other variables held constant.
Discovery is also exposed to equity price risk through its cash-settled share incentive schemes, namely the Phantom share
scheme and the Acquisition share scheme, the details of which are described in section 4.5. This liability has been included in
‘Other payables at amortised cost’ in the Statement of financial position. To manage this risk, Discovery has purchased total
return equity swaps (TRS) from Baa3 and Ba2 (2024: Baa3 and Ba2) South African banks to hedge a portion of its exposure to
changes in the Discovery share price.
With effect from 1 July 2022 the hedges became ineffective. Accordingly, Discovery discontinued hedge accounting under IFRS on
these TRSs. Previously accumulated balances in the hedge reserve had been reclassified to profit or loss in the prior financial
year.
3.13.4.1.2 INTEREST RATE RISK
Sensitivity to changes in interest rates is relevant to financial assets and financial liabilities bearing floating interest rates due to
the risk that future cash flows will fluctuate. However, sensitivity will also be relevant to fixed-rated financial assets and financial
liabilities that are re-measured to fair value. The table below details the specific interest rate risk that the Group is exposed to:
Group
R million
Carrying
amount 	Fixed 	Floating
Non-
interest
bearing
30 June 2025
Loans and advances to customers at amortised cost 	8 513 	– 	8 513 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 849 	6 865 	1 984 	–
– Fixed deposits 	2 697 	2 132 	565 	–
Listed:
– Debt 	1 266 	1 266 	– 	–
Financial instruments mandatorily at fair value through profit or
loss:
Listed:
– Debt portfolios 	2 590 	2 112 	478 	–
– Money market portfolios 	1 879 	42 	1 837 	–
– Multi-asset portfolios 	164 	– 	– 	164
Unlisted:
– Debt portfolios 	82 	3 	79 	–
– Money market portfolios 	1 423 	33 	1 390 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	1 	1 	– 	–
– not designated as hedging instruments 	51 	– 	– 	51
Receivables:
– Contract receivables 	1 653 	– 	– 	1 653
– Other receivables at amortised cost 	2 709 	138 	704 	1 867
Cash and cash equivalents 	17 216 	342 	16 764 	110
Total financial assets 	49 093 	12 934 	32 314 	3 845
Borrowings at amortised cost 	20 044 	7 697 	12 347 	–
Deposits from customers 	23 326 	3 174 	19 498 	654
Other payables at amortised cost 	6 575 	– 	16 	6 559
Derivative financial instruments at fair value:
– used as cash flow hedges 	117 	117 	– 	–
– not designated as hedging instruments 	– 	– 	– 	–
Total financial liabilities 	50 062 	10 988 	31 861 	7 213
Notes to the group annual financial statements continued
for the year ended 30 June 2025
155
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 	Shareholder financial assets and liabilities
The shareholders are exposed to financial risk through the following financial assets and liabilities:
Investments held at risk of
shareholders
R million
Group
2025
Restated
Group
20241
Loans and advances to customers at amortised cost 	8 513 	6 028
Investments at amortised cost:
Unlisted:
– Debt 	8 849 	8 194
– Fixed deposits 	2 697 	2 906
Listed:
– Debt 	1 266 	–
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	487 	285
– Debt portfolios 	2 590 	1 773
– Money market portfolios 	1 879 	705
– Multi-asset portfolios 	164 	229
Unlisted:
– Equity portfolios 	26 	72
– Debt portfolios 	82 	–
– Money market portfolios 	1 423 	1 592
Financial assets at fair value through other comprehensive income:
Unlisted:
– Equity portfolios 	14 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	1 	14
– not designated as hedging instruments 	51 	27
Receivables:
– Contract receivables 	1 653 	1 350
– Other receivables at amortised cost 	2 709 	2 510
Cash and cash equivalents 	17 216 	14 154
Total assets 	49 620 	39 839
Borrowings at amortised cost 	20 044 	21 656
Deposits from customers 	23 326 	18 467
Other payables 	6 575 	5 967
Derivative financial instruments at fair value:
– used as cash flow hedges 	117 	24
– not designated as hedging instruments 	– 	3
Total liabilities 	50 062 	46 117
1 The comparative information has been restated for the presentation of certain government bonds (debt portfolios) from unlisted to listed. No impact on the
previously reported values.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
154
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
155	154

-- 80 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK continued
3.13.4.1.2 INTEREST RATE RISK continued
INVESTMENTS
For shareholder investments with a floating rate at amortised cost, a 1% increase or decrease in the local interest rate would
result in an impact on profit or loss (investment income) and equity, before tax, of R18 million (2024: R8 million). The sensitivity
assumes that the interest rate had increased or decreased by 1% with all other variables held constant.
BORROWINGS AT AMORTISED COST AND RELATED HEDGES
For the floating interest rate borrowings at amortised cost, a 1% increase in the local interest rate would result in an impact on
profit or loss (finance costs) and equity, before tax, of R44 million (2024: R49 million). The sensitivity assumes that the interest
rate had increased or decreased by 1% with all other variables held constant.
Discovery is exposed to interest rate risk through long-term borrowings held with various financial institutions. Refer to note 3.7
Borrowings at amortised costs, for a breakdown of the borrowings, including details of fixed-rate and floating rate-facilities.
2025 	2024
Group
R million 	Ref
Carrying
value
Facility
value
Carrying
value
Facility
value
Interest rate risk from borrowings from banks
SA borrowings
Fixed interest rate loan facilities 	3 757 	4 104 	6 189 	6 400
Floating interest rate facilities with floating-to-fixed
interest rate swap 	i 	6 821 	6 768 	5 062 	5 018
Floating interest rate facilities 	1 815 	1 802 	2 711 	2 691
UK borrowings
Floating interest rate facilities 	3 710 	3 773 	3 549 	3 576
Total bank borrowings (refer to note 3.7) 	16 103 	16 447 	17 511 	17 685
i. 	During prior years and in the current financial year, Discovery entered into long-term borrowing facilities at floating interest
rates, which expose Discovery to cash flow interest rate risk. This risk has been managed by using floating-to-fixed interest
rate swaps. These interest rate swaps have the economic effect of converting the borrowings from floating to fixed rates.
Interest is payable quarterly in arrears, with capital repayable on maturity. The hedge ratio is 1:1.
The Group enters into interest rate swaps that have similar critical terms as the hedged item, such as reference rate, reset dates,
payment dates, maturities, and notional amount. As all critical terms matched during the year, there is an economic relationship.
Under the Group’s policy, the critical terms of the hedging instrument, such as the settlement dates, maturity dates and notional
amount, are matched with the interest rate risk of the hedged item.
Hedge ineffectiveness for interest rate swaps can arise from:
■ Day one fair value of the swap;
■ Events leading to mismatch in terms; and
■ The credit value/debit value adjustment on the interest rate swaps which is not matched by the loan.
The fair value movement of the notional cash flow interest rate hedge accumulated in equity is as follows:
Group
R million 	2025 	2024
Balance at beginning of the year 	20 	(41)
Unrealised gains accumulated in equity 	106 	65
Tax on unrealised gains 	– 	–
Recycled to profit or loss during the current year1 	(2) 	(4)
Tax on recycled losses 	– 	–
Balance at end of the year 	124 	20
The cash flow hedge will be recycled to profit or loss as follows:
Recycled to profit or loss within one year 	4 	(1)
Recycled to profit or loss within two to five years 	120 	21
Recycled to profit or loss within six to ten years 	– 	–
124 	20
1 Disclosed as interest on borrowings and lease liabilities in profit or loss.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
157
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK continued
3.13.4.1.2 INTEREST RATE RISK continued
Group
R million
Carrying
amount 	Fixed1 	Floating
Non-interest
bearing
30 June 2024 Restated
Loans and advances to customers at amortised cost 	6 028 	– 	6 028 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 194 	7 212 	982 	–
– Fixed deposits 	2 906 	2 906 	– 	–
Financial instruments mandatorily at fair value through
profit or loss:
Listed:
– Debt portfolios 	1 773 	1 745 	28 	–
– Money market portfolios 	705 	6 	699 	–
– Multi-asset portfolios 	229 	– 	– 	229
Unlisted:
– Money market portfolios 	1 592 	1 580 	12 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	14 	– 	–
– not designated as hedging instruments 	27 	– 	– 	27
Receivables:
– Contract receivables 	1 350 	– 	– 	1 350
– Other receivables at amortised cost 	2 510 	17 	500 	1 993
Cash and cash equivalents 	14 154 	535 	13 511 	108
Total financial assets 	39 482 	14 015 	21 760 	3 707
Borrowings at amortised cost 	21 656 	10 334 	11 322 	–
Deposits from customers 	18 467 	3 219 	14 647 	601
Other payables at amortised cost 	5 967 	– 	52 	5 915
Derivative financial instruments at fair value:
– used as cash flow hedges 	24 	24 	– 	–
– not designated as hedging instruments 	3 	– 	– 	3
Total financial liabilities 	46 117 	13 577 	26 021 	6 519
1 The comparative information has been restated for the presentation of certain government bonds (debt portfolios) from unlisted to listed. No impact on the
previously reported values.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
156
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
157	156

-- 81 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK continued
NON-HEDGE DERIVATIVE FINANCIAL INSTRUMENTS
Interest rate swap
VitalityLife has significant exposure to long-term interest rate risk, given the impact of rates on the long-term assumptions
applicable to the valuation of insurance contracts.
VitalityLife has an exposure to the FTSE Actuaries UK Conventional Gilts over 15 Year Index (“the index”) because of products
underwritten by The Prudential Assurance Company (PAC) on behalf of VitalityLife. To economically hedge the Vitality UK group’s
exposure to the index, a number of over-the-counter total return interest rate swap derivatives have been entered into, to
provide VitalityLife with the capital depreciation or appreciation and coupon payments on a basket of Gilts designed to closely
match that of the index in return for a payment of fixed interest to the counterparty. VitalityLife continues to hold certain
interest rate swaps and total returns swaps (“TRS”) to manage the interest rate risk on the legacy PAC book of business. These
instruments are contracted on the balance sheet of the PAC and, therefore, deemed integral to the underlying insurance
contracts entered into under IFRS17, and the valuation movements are treated accordingly.
Refer to note 2.19.4 for sensitivity on the interest rate exposures.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
159
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK continued
3.13.4.1.2 INTEREST RATE RISK continued
The interest rate swaps held by the Group at 30 June were:
Group
R million
2025 	2024
Nominal
value
Fair value
(liability)/
asset
Nominal
value
Fair value
(liability)/
asset
Maturity date:
21 November 2024 	– 	– 	800 	(1)
21 November 2024 	– 	– 	1 200 	6
21 August 2026 	300 	(2) 	300 	2
21 August 2026 	700 	(12) 	700 	(9)
21 August 2027 	509 	(9) 	509 	(1)
21 August 2027 	509 	1 	509 	6
22 November 2027 	576 	(6) 	– 	–
22 November 2027 	750 	(3) 	– 	–
02 March 2028 	1 000 	(34) 	1 000 	(13)
10 March 2028 	500 	(6) 	– 	–
21 November 2029 	924 	(34) 	– 	–
21 November 2029 	1 000 	(11) 	– 	–
6 768 	(116) 	5 018 	(10)
Deposits from customers
For the floating interest rate deposits measured at amortised cost a 1% increase or decrease in the local interest rate would
result in an impact on profit or loss and equity, before tax, of R209 million (2024: R162 million). The sensitivity assumes that the
interest rate had increased or decreased by 1% with all other variables held constant.
Group
R million
2025
Carrying
value
2024
Carrying
value
Term deposits from customers – fixed rate 	3 174 	3 219
Term deposits from customers – variable rate 	6 404 	4 608
On demand deposits from customers – non-rate sensitive 	653 	601
On demand deposits from customers – variable rate 	13 095 	10 039
Total customer deposits Discovery Bank 	23 326 	18 467
Notes to the group annual financial statements continued
for the year ended 30 June 2025
158
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
159	158

-- 82 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK continued
3.13.4.1.3 CURRENCY RISK continued
Group
R million 	Total 	Rand1
GBP in UK
subsidiary
GBP
other
USD in US
subsidiary
USD
other
Other
currencies
30 June 2024 Restated
Loans and advances to customers
at amortised cost 	6 028 	6 028 	– 	– 	– 	– 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 194 	8 194 	– 	– 	– 	– 	–
– Fixed deposits 	2 906 	1 607 	1 202 	– 	– 	97 	–
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Debt portfolios 	1 773 	682 	1 069 	– 	– 	22 	–
– Equity portfolios 	285 	259 	– 	1 	– 	24 	1
– Money market portfolios 	705 	704 	– 	– 	– 	1 	–
– Multi-asset portfolios 	229 	68 	– 	– 	– 	161 	–
Unlisted:
– Debt portfolios 	– 	– 	– 	– 	– 	– 	–
– Equity portfolios 	72 	72 	– 	– 	– 	– 	–
– Money market portfolios 	1 592 	1 592 	– 	– 	– 	– 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	14 	14 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	27 	27 	– 	– 	– 	– 	–
Receivables:
– Contract receivables 	1 350 	966 	– 	– 	372 	– 	12
– Other receivables 	2 510 	1 869 	371 	4 	159 	88 	19
Cash and cash equivalents 	14 154 	9 038 	2 513 	618 	427 	1 342 	216
Total financial assets 	39 839 	31 120 	5 155 	623 	958 	1 735 	248
Borrowings at amortised cost 	21 656 	17 545 	3 914 	– 	197 	– 	–
Deposits from customers 	18 467 	17 865 	– 	98 	– 	344 	160
Other payables 	5 967 	3 567 	2 054 	5 	221 	83 	37
Derivative financial instruments at
fair value:
– used as cash flow hedges 	24 	24 	– 	– 	– 	– 	–
– not designated as hedging
instrument 	3 	3 	– 	– 	– 	– 	–
Total financial liabilities 	46 117 	39 004 	5 968 	103 	418 	427 	197
1 The comparative information has been restated for the presentation of certain government bonds (debt portfolios) from unlisted to listed. No impact on the
previously reported values.
Financial assets and financial liabilities in respect of the Group’s US and UK subsidiaries are accounted for in their functional
currency. Foreign currency movements will be recognised in the foreign currency translation reserve.
The exchange rates at year-end are detailed in the table below (quoted as rand per foreign currency):
USD 	GBP
30 June 2025 	17.77 	24.34
30 June 2024 	18.26 	23.07
Notes to the group annual financial statements continued
for the year ended 30 June 2025
161
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK continued
3.13.4.1.3 CURRENCY RISK
The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and
recognised assets and liabilities. The following table segregates the currency exposure by major currency:
Group
R million 	Total 	Rand
GBP in UK
subsidiary
GBP
other
USD in US
subsidiary
USD
other
Other
currencies
30 June 2025
Loans and advances to
customers at amortised cost 	8 513 	8 513 	– 	– 	– 	– 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 849 	8 849 	– 	– 	– 	– 	–
– Fixed deposits 	2 697 	1 364 	1 333 	– 	– 	– 	–
Listed:
– Debt 	1 266 	1 266 	– 	– 	– 	– 	–
Financial instruments
mandatorily at fair value
through profit or loss:
Listed:
– Debt portfolios 	2 590 	1 369 	1 194 	– 	– 	26 	1
– Equity portfolios 	487 	375 	– 	1 	– 	110 	1
– Money market portfolios 	1 879 	1 874 	– 	– 	– 	5 	–
– Multi-asset portfolios 	164 	99 	– 	– 	– 	65 	–
Unlisted:
– Debt portfolios 	82 	81 	– 	– 	– 	1 	–
– Equity portfolios 	26 	26 	– 	– 	– 	– 	–
– Money market portfolios 	1 423 	1 423 	– 	– 	– 	– 	–
Unlisted:
– Equity portfolios 	14 	14 	– 	– 	– 	– 	–
Derivative financial instruments
at fair value:
– used as cash flow hedges 	1 	1 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	51 	51 	– 	– 	– 	– 	–
Receivables:
– Contract receivables 	1 653 	1 166 	– 	– 	444 	– 	43
– Other Receivables 	2 709 	2 001 	397 	15 	165 	91 	40
Cash and cash equivalents 	17 216 	9 364 	4 796 	483 	399 	1 941 	233
Total financial assets 	49 620 	37 836 	7 720 	499 	1 008 	2 239 	318
Borrowings at amortised cost 	20 044 	15 811 	4 051 	– 	182 	– 	–
Deposits from customers 	23 326 	22 672 	– 	97 	– 	386 	171
Other payables 	6 575 	3 570 	2 235 	90 	481 	165 	34
Derivative financial instruments
at fair value:
– used as cash flow hedges 	117 	117 	– 	– 	– 	– 	–
Total financial liabilities 	50 062 	42 170 	6 286 	187 	663 	551 	205
Notes to the group annual financial statements continued
for the year ended 30 June 2025
160
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
161	160

-- 83 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.2 CREDIT RISK
Key areas where Discovery is exposed to credit risk are:
■ Financial investments comprising money market and debt instruments entered into to invest surplus shareholder
funds: Discovery is exposed to the issuer’s credit standing on these instruments, which is monitored by the CCIC by setting a
minimum credit rating and maximum exposure per issuer. Discovery has appointed reputable asset managers to manage
these instruments. Information regarding the aggregated credit risk exposure for debt and money market instruments
categorised by credit ratings is provided below.
■ Cash and cash equivalents: This risk is managed by monitoring exposure to external financial institutions against approved
limits per institution. Credit ratings are provided below.
■ Certain accounts within the Statement of Financial Position category of contract receivables and other non-financial
receivables.
■ Reinsurance assets comprising receivables raised for expected recoveries on projected claims (Discovery’s liability as
primary insurer is not discharged) and amounts due from reinsurers in respect of claims already paid: This risk is
limited as risk premiums are paid monthly to reinsurers and claims can be offset against risk premiums. Further, it is expected
that there will be little build-up of actuarial liability on the reinsurers’ side. The risk thus mainly arises following a period of
higher-than-expected claims. Credit ratings of reinsurers are considered in reinsurance placement decisions. Credit exposure
to reinsurers is also limited using several reinsurers. Reinsurance is placed with reputable international companies directly or
through their national offices. The reinsurance companies used by Discovery are rated A or higher by A.M. Best, a rating
agency with an exclusive insurance industry focus. Refer to www.ambest.com for further detail.
■ Loans and advances to customers at amortised cost, which arises from credit extended to Discovery Bank customers.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
163
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.1 MARKET RISK continued
3.13.4.1.3 CURRENCY RISK continued
SENSITIVITY ANALYSIS
The Group determined that a 10% change is a reasonable expected strengthening or weakening of the US dollar and the UK
pound against all other currencies. The impact on profit or loss and equity before tax as at 30 June is shown below. For the
purpose of the analysis, the foreign exchange impact of intergroup balances which eliminate on consolidation has been
excluded. The effect of translation differences that are recognised separately in other comprehensive income has also been
excluded. This analysis assumes that all other variables, in particular interest rates, remain constant and ignores any impact of
forecast sales and purchases.
R million
Profit or loss 	Equity
Strengthening 	Weakening 	Strengthening 	Weakening
30 June 2025
USD 	169 	(169) 	169 	(169)
GBP 	31 	(31) 	31 	(31)
30 June 2024
USD 	166 	(166) 	166 	(166)
GBP 	44 	(44) 	44 	(44)
INVESTMENTS
Discovery has offshore assets in its investment portfolios. These offshore investments are made for the purpose of seeking
international diversification. There is a risk to future earnings that the value of these assets reduces due to a strengthening in
the rand. Performance of foreign currency assets is benchmarked against the MSCI World Index, an international index that
represents large and mid-capitalisation companies across 23 developed market countries. Refer to www.msci.com for further
details.
BORROWINGS
Discovery has long-term borrowings in the UK, which exposes the Group to currency risk. This risk is managed by aligning the
currency exposure to the underlying operational assets for which these borrowings have been raised. The currency risk is
mitigated as the cash flows emerging from the underlying assets are in the same currency (GBP) as the interest and capital
payments.
DEPOSITS FROM CUSTOMERS
Discovery Bank offers its customers the option to hold deposits in foreign currency of GBP, USD and EUR. These risks are
managed by aligning the currency exposure to the underlying assets. Discovery Bank does so by holding deposits in foreign
currency of GBP, USD and EUR. The currency risk is therefore matched in a 1:1 ratio to not transfer foreign currency risk to the
Group.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
162
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
163	162

-- 84 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.2 CREDIT RISK continued
CREDIT RISK RELATING TO RECEIVABLES
The table below summarises Discovery’s shareholder contract receivables and other receivables as at 30 June 2025. This table
reflects shareholder’s credit exposure for those financial receivables as disclosed in note 5.8.
R million 	Notes
Group
2025
Group
2024
Contract receivables: 	1 653 	1 350
– Closed scheme debtors 	(i) 	146 	130
– Discovery Health Medical Scheme 	(i) 	1 019 	818
– Other contract receivables 	490 	405
– Less allowance for expected credit losses 	3.5 	(2) 	(3)
Other loans and receivables: 	2 709 	2 510
– Agents and brokers 	(ii) 	721 	683
– Cash-in-transit debtors 	8 	69
– Consolidated unit trust debtors 	8 	6
– Loans to BEE initiatives 	(iii) 	497 	385
– Security deposit on derivatives1 	57 	10
– Vitality partner debtors 	200 	212
– Other financial receivables 	1 717 	1 566
– Less allowance for expected credit losses 	3.5 	(499) 	(421)
4 362 	3 860
1 Refer to note 3.13.7 for an explanation of the nature of the security deposit (cash collateral).
Credit risk relating to receivables is managed as follows:
i. 	The Discovery Health Medical Scheme (DHMS) has been rated AAA(za) by Global Credit Ratings. The closed schemes have
not been rated. Payments by DHMS and the other closed schemes are managed by Discovery and are paid by the seventh of
the following month.
ii. 	Agents and brokers are subject to a comprehensive relationship management programme, including credit assessment.
Agents and brokers are not rated by Discovery, as exposure to any single intermediary is insignificant. The widespread
nature of the individual amounts combined, with this close management relationship, reduces credit risk. Most commission
claw backs are offset against future payments and hence the risk of outstanding commission clawbacks is reduced.
iii. 	These loans are structured considering creditworthiness of the individual partners, and the purpose of the BEE relationship.
These loans are managed and monitored on an individual basis, and ECL is accordingly recognised on an individual basis
using management’s best estimate.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
165
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.2 CREDIT RISK continued
The following table details the aggregated credit risk exposure that the Group is exposed to, categorised by the rating scale
noted in note 3.13 in section 3 Discovery’s approach to monitoring credit risk.
Group
R million 	Total 	Aaa
Aa1
Aa2
Aa3
A1 A2
A3
Baa1
Baa2
Baa3
Ba1
Ba2
Ba3 	Govt1
Inter-
nally
rated
Pooled
funds
30 June 2025
Loans and advances to customers at
amortised cost 	8 513 	– 	– 	– 	– 	– 	– 	8 513 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 849 	– 	– 	– 	– 	– 	8 849 	– 	–
– Fixed deposits 	2 697 	– 	– 	1 376 	1 321 	– 	– 	– 	–
Listed:
– Debt 	1 266 	– 	– 	– 	– 	– 	1 266 	– 	–
Financial instruments mandatorily at fair
value through profit or loss:
Listed:
– Debt portfolios 	2 590 	18 	183 	713 	658 	172 	826 	– 	20
– Money market portfolios 	1 879 	– 	– 	1 	72 	25 	5 	– 	1 776
Unlisted:
– Debt portfolios 	82 	– 	– 	– 	71 	9 	– 	– 	2
– Money market portfolios 	1 423 	– 	– 	1 	1 385 	13 	24 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	1 	– 	– 	– 	1 	– 	– 	– 	–
– not designated as hedging instruments 	30 	– 	– 	– 	30 	– 	– 	– 	–
Cash and cash equivalents 	17 216 	3 457 	556 	2 584 	4 434 	533 	5 652 	– 	–
44 546 	3 475 	739 	4 675 	7 972 	752 16 622 	8 513 	1 798
30 June 2024 Restated
Loans and advances to customers at
amortised cost 	6 028 	– 	– 	– 	– 	– 	– 	6 028 	–
Investments at amortised cost:
Unlisted:
– Debt 	8 194 	– 	– 	– 	– 	– 	8 194 	– 	–
– Fixed deposits 	2 906 	– 	79 	1 299 	156 	1 372 	– 	– 	–
Financial instruments mandatorily at fair value
through profit or loss:
Listed:
– Debt portfolios2 	1 773 	61 	198 	525 	310 	38 	618 	– 	23
– Money market portfolios 	705 	– 	7 	– 	– 	1 	– 	– 	697
Unlisted:
– Debt portfolios 	– 	– 	– 	– 	– 	– 	– 	– 	–
– Money market portfolios 	1 592 	– 	106 	– 	7 	1 262 	217 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	– 	– 	– 	– 	14 	– 	– 	–
– not designated as hedging instruments 	27 	– 	– 	– 	3 	24 	– 	– 	–
Cash and cash equivalents 	14 154 	788 	1 630 	2 256 	2 239 	3 230 	4 011 	– 	–
35 393 	849 	2 020 	4 080 	2 715 	5 941 13 040 	6 028 	720
1 These instruments are issued by the South African government.
2 The comparative information has been restated for the presentation of certain government bonds (debt portfolios) from unlisted to listed. No impact on the
previously reported values.
Financial instruments included in cash and cash equivalents, fixed deposits and treasury bills have high credit quality based
on the rating of counterparties and/or have relatively short-term maturities. Impairment based on the expected credit loss
approach was assessed and considered immaterial. There are no amounts within these balances which are credit impaired
or where there has been a significant increase in credit risk since initial recognition.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
164
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
165	164

-- 85 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.3 LIQUIDITY RISK continued
The table below examines the Group’s financial assets and liabilities and net-settled interest rate swap derivative financial
liabilities into relevant maturity groupings based on the remaining period at the reporting date to the contractual maturity date.
The amounts are the undiscounted contractual payments and will therefore not agree to the Group statement of financial
position.
Group
R million 	Total 	<1 year
1 – 2
years
3 – 5
years
6 – 10
years
>10
years
30 June 2025
Loans and advances to customers at
amortised cost 	13 566 	4 335 	2 432 	3 315 	1 782 	1 702
Investments at amortised cost 	16 952 	7 334 	1 250 	3 134 	5 234 	–
Investments at fair value through profit or loss 	6 253 	4 521 	673 	879 	71 	109
Investments designated at fair value through
other comprehensive income 	14 	14 	– 	– 	– 	–
Derivative financial instruments at fair value:
– not designated as hedging instruments 	52 	41 	11 	– 	– 	–
Receivables 	4 363 	3 886 	60 	92 	67 	258
Cash and cash equivalents 	17 216 	17 216 	– 	– 	– 	–
Total financial assets 	58 416 	37 347 	4 426 	7 420 	7 154 	2 069
Deposits from customers 	23 766 	21 981 	625 	1 160 	– 	–
Borrowings net of interest rate swap
– Borrowings 	18 837 	8 220 	3 370 	7 247 	– 	–
– Interest rate swap 	116 	– 	22 	94
Finance leases 	5 725 	737 	729 	2 134 	2 079 	46
Other payables at amortised cost 	6 579 	6 330 	85 	163 	1 	–
Total financial liabilities 	55 023 	37 268 	4 831 	10 798 	2 080 	46
30 June 2024
Loans and advances to customers at
amortised cost 	8 785 	3 663 	1 974 	3 131 	17 	–
Investments at amortised cost 	13 171 	7 644 	1 132 	2 274 	2 121 	–
Investments at fair value through profit or loss 	4 318 	3 299 	195 	598 	129 	97
Derivative financial instruments at fair value:
– not designated as hedging instruments 	27 	11 	16 	– 	– 	–
Receivables 	3 860 	3 680 	42 	31 	59 	48
Cash and cash equivalents 	14 154 	14 063 	5 	21 	29 	36
Total financial assets 	44 315 	32 360 	3 364 	6 055 	2 355 	181
Deposits from customers 	18 984 	17 365 	473 	1 146 	– 	–
Borrowings net of interest rate swap
– Borrowings 	20 761 	6 055 	6 163 	7 573 	970 	–
– Interest rate swap 	10 	(5) 	– 	15 	– 	–
Finance leases 	6 127 	659 	676 	1 990 	2 738 	64
Other payables at amortised cost 	5 967 	5 833 	78 	55 	1 	–
Derivative financial instruments at fair value:
– not designated as hedging instruments 	3 	3 	* 	* 	– 	–
Total financial liabilities 	51 852 	29 910 	7 390 	10 779 	3 709 	64
* Amount less than R500 000.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
167
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.4 Shareholder financial assets and liabilities continued
3.13.4.2 CREDIT RISK continued
Discovery ages and pursues unpaid accounts on a monthly basis. The ageing of the components of receivables as at 30 June was:
Group
R million
Gross
2025
Impairment
2025
Gross
2024
Impairment
2024
Not past due (current) 	3 901 	(140) 	3 243 	(74)
30 days 	51 	(1) 	209 	(2)
60 days 	34 	(1) 	55 	(3)
90 days 	34 	(2) 	17 	(8)
120 days 	106 	(2) 	21 	(3)
150 days 	5 	(1) 	45 	(5)
>150 days 	732 	(354) 	694 	(329)
4 863 	(501) 	4 284 	(424)
Discovery establishes an allowance for expected credit losses that represents its estimate of expected losses with respect to
receivables that are financial assets. The allowance comprises of a specific loss component that relates to individually significant
exposures, and a collective loss component, established for groups of similar assets. The loss allowance is determined based on
historical data of payment statistics for similar financial assets, and where available without undue cost or effort, incorporates
forward-looking information.
For an analysis of the movement in the allowance for expected credit losses as well as provision for impairment, refer to note 3.5
Expected credit loss reconciliation as included in section 3.
3.13.4.3 LIQUIDITY RISK
Cash flow forecasting is performed in the operating entities of the Group and aggregated by Group Finance. Group Finance
monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to always meet operational needs
so that the Group does not breach borrowing limits or covenants (where applicable) on any of its borrowing facilities (refer to
note 3.7). Such forecasting takes into consideration the Group’s debt financing plans, covenant compliance and, if applicable,
external regulatory or legal requirements – such as capital requirements.
Cash held by the operating entities is managed by Group Treasury. Group Treasury invests this cash in interest-bearing
accounts, time deposits and money market deposits, choosing instruments with appropriate maturities or sufficient liquidity to
provide sufficient headroom as determined by the above-mentioned forecasts. For information on the liquidity risk
management of contracts with insurance risk, refer to note 2.19.1 Liquidity risk.
Discovery Bank manages its liquidity risk by comparing the credit utilisation and expected future utilisation of committed
facilities on its loans and advances against the deposits it holds. Discovery Bank performs normal stresses as well as additional
stresses to ensure that it can meet its obligations continuously.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
166
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
167	166

-- 86 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.5 Capital management continued
REGULATORY CAPITAL
For Group subsidiaries that operate in the insurance and financial services sectors, the relevant regulator specifies the minimum
amount and type of capital that must be held by each of the subsidiaries in addition to the capital held for their liabilities and
other regulatory financial obligations. The minimum required capital must be maintained at all times throughout the period.
Discovery Life and Discovery Insure are regulated under the Insurance Act 18 of 2017 and the related Prudential Standards,
while VitalityHealth and VitalityLife are regulated under the European Solvency II regulatory regime.
DEBT COVENANTS
The following are the key debt covenants and their proximity to minimum requirements as per the contractual financial
covenants.
Debt covenant and explanation 	Minimum requirement
Group
2025
Group
2024
Group Debt1 to EBITDA2 Ratio: 	Less than 2.5 times 	1.02 times 	1.4 times
Group financial indebtedness to embedded
value
– Group financial indebtedness is as per Group
Debt in the above calculation.
Less than 30% of Group Embedded
value
13.3 % 	16.7 %
Discovery Life Statutory Capital Requirement
(SCR) Cover
SCR cover must be more than 1.1 	1.9 times 	1.8 times
Group embedded value 	Greater than R30 billion 	R126 554 million 	R110 354 million
New business embedded value must not be
negative
Positive value of new business for 3
consecutive 6-month periods
June 2025:
R1 201 million
December 2024:
R953 million
June 2024:
R1 148 million
June 2024:
R1 148 million
December 2023:
R684 million
June 2023:
R500 million
1 Group debt is contractually defined and means the aggregate consolidated financial indebtedness of the Group and excludes items such as the 1DP lease
and includes guarantees issued to third parties.
2 EBITDA is contractually defined and specifically includes items such as dividends from associates, rental paid on 1DP and excludes items deemed
extraordinary and specified Financial Reinsurance (FinRe) arrangements.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
169
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.5 Capital management
The Group’s capital is defined as capital and reserves attributable to equity holders of the company as presented on the Group
statement of financial position. The Group’s objectives when managing capital are:
■ To comply with the statutory capital requirements required by the regulators of the insurance and banking markets where the
Group operates; refer to Capital section of the directors’ report for the statutory capital requirements;
■ To maintain a capital buffer more than the statutory capital requirements to reduce the risk of breaching the statutory
requirement in the event of deviations from the main assumptions affecting the Group’s insurance and banking businesses;
■ To ensure that sufficient capital is available to fund the Group’s working capital and strategic capital requirements;
■ To achieve an optimal and efficient capital funding profile; and
■ To consider capital management needs both in the short term and over a five-year planning horizon.
Discovery has a Finance and Capital Committee that ensures alignment in strategic financial management between the holding
company, the composites and their subsidiaries. The committee is the governance body for all capital allocation activities across
the Group.
A range of capital raising options are available to manage the capital structure of the Group, which includes the issue of new
shares, debt, reinsurance arrangements and other hybrid instruments.
FINANCIAL LEVERAGE RATIO
As part of the capital management process, the Group monitors its capital structure utilising various measures, one of which is
the Financial Leverage Ratio (FLR). This ratio is calculated as total debt1 divided by total debt plus total equity. The Group’s
strategy is to maintain a prudent FLR of 28.0% per the Group Risk Appetite statement. However, the 28.0% measure is merely a
risk appetite indicator and does not necessarily indicate any form of a breach in terms of regulatory or covenant restrictions.
The table below summarises the FLR position as at the end of the reporting period. With the adoption of IFRS 17, a significant
amount has been reallocated from equity to contractual service margin (CSM) and risk adjustment. In line with developing
market practice this CSM balance, representing the present value of margins to be released in future, is taken into account in the
calculation of the FLR. While some insurers recognise more than 50%, it appears that most ratings agencies apply the inclusion
of at least 50% of the CSM into the equity denominator. The current limit of 28.0% for the FLR remains conservative.
R million
Group
2025
Restated
Group
20241
– Borrowings at amortised cost (refer to note 3.7)2 	16 105 	17 517
Total debt2 	16 105 	17 517
Total equity 	65 699 	54 451
Total Contractual Service Margin (CSM)3 	28 047 	28 341
Financial leverage ratio % (50% CSM factored in) 	16.8% 	20.3%
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
2 Excluding all IFRS 16 lease liabilities of R3 941 million (2024: R4 145 million).
3 The CSM is net of reinsurance and net of tax..
The FLR at 30 June 2025 is in line with Discovery’s risk appetite.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
168
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
169	168

-- 87 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.6 	Fair value hierarchy continued
R million 	Level 1 	Level 2 	Level 3 	Total
30 June 2024
Financial assets
Financial instruments mandatorily at fair value through
profit or loss: 	97 618 	68 037 	16 	165 671
– Equity portfolios 	52 145 	8 089 	16 	60 250
– Debt portfolios 	45 473 	1 626 	– 	47 099
– Money market portfolios 	– 	15 786 	– 	15 786
– Multi-asset portfolios 	– 	42 536 	– 	42 536
Derivative financial instruments at fair value: 	– 	43 	– 	43
– used as cash flow hedges 	– 	14 	– 	14
– not designated as hedging instruments 	– 	29 	– 	29
Total financial assets 	97 618 	68 080 	16 	165 714
Non-financial assets
Non-current asset held for sale1 	– 	– 	136 	136
Total assets 	97 618 	68 080 	152 	165 850
Financial liabilities
Third-party interest in consolidated funds 	– 	31 456 	– 	31 456
Investment contracts at fair value through profit or loss 	– 	25 710 	– 	25 710
Derivative financial instruments at fair value: 	– 	31 	– 	31
– used as cash flow hedges 	– 	24 	– 	24
– not designated as hedging instruments 	– 	7 	– 	7
Total financial liabilities 	– 	57 197 	– 	57 197
1 The fair value was determined from an agreed sales price between unrelated parties, reflecting an arm’s length transaction under current market conditions.
Given the agreed sales price, no variability is expected in the fair value measurement, as the transaction price represents the best available estimate of fair
value. The measurement approach incorporates relevant observable market inputs where available.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
171
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.6 	Fair value hierarchy
The Group’s assets and liabilities measured at fair value are disclosed in accordance with the fair value hierarchy. The hierarchy
has three levels that reflect the significance of the inputs used in measuring fair value. These are as follows:
Level 1: includes those assets and liabilities that are measured using unadjusted, quoted prices in an active market for identical
assets and liabilities, generally financial instruments. Quoted prices are readily and regularly available from an exchange, dealer,
broker, industry group, pricing service or regulatory agency and those prices represent actual and regularly occurring market
transactions on an arm’s length basis.
Level 2: includes those assets and liabilities that are valued using techniques based significantly on observable market data.
Assets and liabilities in this category are valued using:
a. 	Quoted prices for similar or identical assets and liabilities, generally financial instruments, in markets which are not
considered to be active; or
b. Valuation techniques where all the inputs that have a significant effect on the valuation are directly or indirectly based on
observable market data.
Level 3: includes those assets and liabilities that are valued using valuation techniques that incorporate information other than
observable market data and where at least one input (which could have a significant effect on the instruments’ valuation) cannot
be based on observable market data.
R million 	Level 1 	Level 2 	Level 3 	Total
30 June 2025
Financial assets
Financial instruments mandatorily at fair value through
profit or loss: 	141 140 	52 636 	– 	193 776
– Equity portfolios 	87 458 	12 477 	– 	99 935
– Debt portfolios 	53 682 	2 186 	– 	55 868
– Money market portfolios 	– 	12 948 	– 	12 948
– Multi-asset portfolios 	– 	25 025 	– 	25 025
Financial instruments at fair value through other
comprehensive income: 	– 	– 	14 	14
– Equity portfolios 	– 	– 	14 	14
Derivative financial instruments at fair value: 	– 	41 	22 	63
– used as cash flow hedges 	– 	1 	– 	1
– not designated as hedging instruments 	– 	40 	22 	62
Total financial assets 	141 140 	52 677 	36 	193 853
Non-financial assets
Non-current asset held for sale 1 	– 	– 	62 	62
Total assets 	141 140 	52 677 	98 	193 915
Financial liabilities
Third-party interest in consolidated funds 	– 	35 932 	– 	35 932
Investment contracts at fair value through profit or loss 	– 	32 188 	– 	32 188
Derivative financial instruments at fair value: 	– 	135 	– 	135
– used as cash flow hedges 	– 	117 	– 	117
– not designated as hedging instruments 	– 	18 	– 	18
Total financial liabilities 	– 	68 255 	– 	68 255
1 The fair value was determined from an agreed sales price between unrelated parties, reflecting an arm’s length transaction under current market conditions.
Given the agreed sales price, no variability is expected in the fair value measurement, as the transaction price represents the best available estimate of fair
value. The measurement approach incorporates relevant observable market inputs where available. The Stockport non-current asset held for sale has been
sold in July 2025.
There were no transfers between hierarchy levels during the current financial period.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
170
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
171	170

-- 88 of 155 --

SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.7 	Offsetting financial assets and financial liabilities
FINANCIAL ASSETS
The following financial assets are subject to offsetting:
Group
R million
Gross
financial
assets
Gross offsetting
financial
liabilities
Net amount
presented
30 June 2025
Cash and cash equivalents 	22 126 	(158) 	21 968
30 June 2024
Cash and cash equivalents 	19 152 	(181) 	18 971
Offsetting of cash and cash equivalents takes place as a result of sweeping arrangements that Discovery has in force with
various financial institutions. No other amounts presented on the financial statements are subject to netting arrangements.
CASH COLLATERAL
To reduce the credit risk exposure from derivative instruments purchased (refer to note 3.4), Discovery has entered into
collateral agreements with the relevant financial institutions to post cash collateral periodically, equal to the fair value of the
derivatives. A total of R57 million (2024: R10 million) cash collateral was held by the various financial institutions and R53 million
(2024: Rnil million) was held by Discovery as at 30 June 2025.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
173
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL
RISK continued
3.13 	MANAGEMENT OF FINANCIAL RISK continued
3.13.6 	Fair value hierarchy continued
SPECIFIC VALUATION TECHNIQUES USED TO VALUE FINANCIAL INSTRUMENTS IN LEVEL 2
If a quoted market price is not available on a recognised stock exchange or from a broker for non-exchange traded financial
instruments, the fair value of the instrument is estimated by the asset managers, using valuation techniques including the use of
recent arm’s length market transactions, reference to the current fair value of another instrument that is substantially the same,
discounted cash flow techniques, option pricing models or other valuation techniques that provide a reliable estimate of prices
obtained in actual market transactions.
Valuation techniques used in determining the fair value of assets and liabilities.
Instruments 	Valuation technique
Main inputs and
assumptions for level 2
fair value hierarchy
Within equity
portfolios,
Equity-linked
notes
The calculation of the daily value of the equity linked investments is
made by the provider of the note. Discovery has procedures in place to
ensure that these prices are correct. Aside from the daily
reasonableness checks versus similar funds and movement since the
prior day’s price, the fund values are calculated with reference to a
specific formula or index, disclosed to the policyholders, which is
recalculated by Discovery to check if the price provided by the provider
is correct.
– discount rate
– spot prices of the
underlying
Debt portfolios
and Money
market
instruments
Money market instruments are valued by discounting the future cash
flows using a risk-adjusted discount rate.
– discount rate, credit
spread
Multi-assets 	The fair values of third-party financial liabilities arising on the
consolidation of mutual funds are determined using the quoted put
(exit) price provided by the fund manager and discounted for the
applicable notice period. The fair value of a financial liability with a
demand feature is not less than the amount payable on demand,
discounted from the first date on which the amount could be required
to be paid.
– discount rate
Investment
contracts at fair
value, including
third-party
interest in
consolidated
funds
Unit-linked policies: assets which are linked to the investment contract
liabilities are owned by the Group. The investment contract obliges the
Group to use these assets to settle these liabilities. Therefore, the fair
value of third-party interest in consolidated funds and investment
contract liabilities is determined with reference to the fair value of the
underlying assets (meaning, amount payable on surrender of the
policies).
Annuity certain: discounted cash flow models are used to determine
the fair value of the stream of future payments.
– discount rate
– spot price of underlying
Derivatives 	Standard derivative contracts are valued using market accepted
models and quoted parameter inputs. More complex derivative
contracts are modelled using more sophisticated modelling techniques
applicable to the instrument. Techniques include:
– Discounted cash flow model
– Black-Scholes model
– Combination technique models
– discount rate
– spot prices of the
underlying
– correlation factors
– volatilities
– earnings yield
– valuation multiples
Unlisted equity
instrument at
fair value
– For unlisted equity instruments, a discounted cash flow
methodology is used. The discounted cash flow methodology values
an asset by determining the present value of its expected future net
cash flows. This valuation considers both historic experience and
future projected budgets. The valuation is stress tested by
considering earnings multiples, e.g., price-earnings multiple (P/E
ratio).
– discount rate
– growth rate
– projected earnings
– valuation
– multiples, eg, P/E
– ratio
Notes to the group annual financial statements continued
for the year ended 30 June 2025
172
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
173	172

-- 89 of 155 --

SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED PARTIES
4.1 	INTRODUCTION AND OVERVIEW
This section provides information on the authorised and outstanding ordinary and preference share capital and share premium
of the Group, as well as changes thereto. The section further provides information on the share-based payment arrangements
of the Group as well as transactions and balances with related parties and major customers.
4.2 	PRIMARY FINANCIAL STATEMENT AND INFORMATION ANALYSED IN THIS
SECTION
R million 	Notes
Group
2025
Group
2024
Statement of financial
position 	Capital and reserves
Ordinary share capital and share premium 	4.3 	11 358 	10 667
Perpetual preference share capital 	4.4 	779 	779
12 137 	11 446
Additional
information
Information on share-based payment
arrangements and long-term incentives 	4.5
Information on related parties, major customers 	4.6
Notes to the group annual financial statements continued
for the year ended 30 June 2025
175
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 04
EQUITY, SHARE-BASED
PAYMENTS AND
RELATED PARTIES
Introduction and overview
Ordinary share capital and share premium
Perpetual preference share capital
Share-based payments and long-term
incentives
Related parties
174
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
175	174

-- 90 of 155 --

SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.4 	PERPETUAL PREFERENCE SHARE CAPITAL
For the accounting policies relevant to the recognition and measurement of Share capital and share premium, refer to Annexure
B Accounting policy 11.
R million
Group
2025
Group
2024
Authorised
40 000 000 A no par value preference shares 	– 	–
20 000 000 B preference shares of R100 each 	2 000 	2 000
20 000 000 C no par value preference shares 	– 	–
2 000 	2 000
Issued
8 000 000 B preference shares of R100 each 	800 	800
Share issue costs 	(21) 	(21)
At 30 June 	779 	779
The B preference shares are non-compulsory, non-cumulative, non-participating, non-convertible, voluntarily redeemable (at
option of Discovery) preference shares and were issued at a coupon rate of 85% of prime rate. With the introduction of dividend
withholding tax on 1 April 2012, the coupon rate on the preference shares was increased to 100% of the prime rate.
4.5 	SHARE-BASED PAYMENTS AND LONG-TERM INCENTIVES
For the accounting policies relevant to the recognition and measurement of Share-based payments refer to Annexure B
Accounting policy 16.3.
Incentive schemes
Discovery operates various share-based payment and long-term incentive arrangements. The details of these arrangements are
described below:
Share based-payment arrangements
1. BEE STAFF SHARE TRUST (EQUITY-SETTLED)
In 2005, 5 290 000 Discovery Limited shares were issued to the BEE staff share trust for current and future employees. These
shares had all been allocated during prior years. Additional shares have been purchased, for future allocation to employees.
The trusts consist of two components; the allocation scheme and the option scheme as described below.
ALLOCATION SCHEME
Shares have been allocated to senior black employees based on level of seniority and length of past service. The shares vest
to employees two, three, four and five years after allocation at a rate of 25% per annum. On each vesting date, the trustees
distribute to the employees the allocated shares to which the employees may be entitled.
OPTION SCHEME
Options granted to black employees may be exercised two, three, four and five years after the option is granted at a rate of
25% per annum. Any options not exercised by the end of the fifth year from the grant date shall lapse. On exercise of the
option, the employee pays cash to the trust for the full purchase price of the option.
2. DISCOVERY’S PHANTOM SCHEME (CASH-SETTLED)
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the Discovery Limited
share price. The bonus is earned if the participant is employed on each vesting date, with the vesting dates ranging between
one and five years after allocation of the bonus units. The bonus may not be carried forward.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
177
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.3 	ORDINARY SHARE CAPITAL AND SHARE PREMIUM
For the accounting policies relevant to the recognition and measurement of Share capital and share premium, refer to
Annexure B Accounting policy 11.
Issued 	Treasury shares
Group
R million
Share
capital
Share
premium
Subsidiaries of
Discovery
Limited
BEE Share
trust
Long-term
incentive
plan (LTIP)
Total
outstanding
At 1 July 2023 	1 	12 102 	(14) 	(44) 	(1 694) 	10 351
Share movements:
– new issue 	– 	432 	– 	– 	– 	432
– treasury shares delivered 	– 	– 	– 	2 	445 	447
– treasury shares purchased 	– 	– 	– 	(18) 	(545) 	(563)
At 30 June 2024 	1 	12 534 	(14) 	(60) 	(1 794) 	10 667
Share movements:
– new issue 	– 	626 	– 	– 	– 	626
– treasury shares delivered 	– 	– 	– 	2 	689 	691
– treasury shares purchased 	– 	– 	– 	– 	(626) 	(626)
At 30 June 2025 	1 	13 160 	(14) 	(58) 	(1 731) 	11 358
Treasury shares
Number of shares 	Company
Subsidiaries
of Discovery
Limited
BEE
Share trust 	LTIP
Total
outstanding
At 1 July 2023 	673 146 417 	(680 268) 	(589 143) 	(13 453 406) 	658 423 600
Share movements:
– new issue 	3 227 675 	– 	– 	– 	3 227 675
– treasury shares delivered 	– 	– 	46 991 	3 660 857 	3 707 848
– treasury shares purchased 	– 	– 	(150 000) 	(4 187 976) 	(4 337 976)
At 30 June 2024 	676 374 092 	(680 268) 	(692 152) 	(13 980 525) 	661 021 147
Share movements:
– new issue 	3 306 749 	– 	– 	– 	3 306 749
– treasury shares delivered 	– 	– 	33 841 	5 402 773 	5 436 614
– treasury shares purchased 	– 	– 	– 	(3 306 749) 	(3 306 749)
At 30 June 2025 	679 680 841 	(680 268) 	(658 311) 	(11 884 501) 	666 457 761
The total authorised number of ordinary shares is 1 billion (2024: 1 billion), with a par value of 0.1 cent per share.
Share movements during the 2025 financial reporting period
Discovery issued 3 306 749 shares for a cash consideration of R626 million (average share price R189.42). This was a specific
issuance, to the Discovery Long-Term Incentive Plan Trust.
Discovery delivered 5 436 614 shares that vested through the Discovery Long-Term Incentive Plan and BEE share Trust for a cash
consideration of R691 million.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
176
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
177	176

-- 91 of 155 --

SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.5 	DISCOVERY’S LONG-TERM INCENTIVE PLANS (EQUITY-SETTLED) continued
Summary of units granted under share-based payment arrangements
The following is a summary of the terms and conditions of the units granted:
Date granted
Share/
Option price
Final vesting
date
Shares
under
option at
beginning
of year
Share/
Options
granted
during
year
Share/
Options
vested
during
year
Share/
Options
cancelled or
adjusted
during year
Shares
under
option at
end of
year
1. BEE staff share trust
01/07/2019 - 30/06/2020 	R0.00 	30/09/2025 	3 444 	– 	(2 251) 	– 	1 193
01/07/2020 - 30/06/2021 	R0.00 	31/03/2026 	8 604 	– 	(5 054) 	– 	3 550
01/07/2021 - 30/06/2022 	R0.00 	30/09/2027 	44 183 	– 	(18 880) 	(2 555) 	22 748
01/07/2022 - 30/06/2023 	R0.00 	30/04/2028 	16 390 	– 	(3 156) 	(3 764) 	9 470
01/07/2023 - 30/06/2024 	R0.00 	30/04/2029 	53 703 	– 	(2 806) 	167 	51 064
01/07/2024 - 30/06/2025 	R0.00 	30/06/2029 	– 	13 111 	– 	– 	13 111
2. Discovery phantom scheme
01/07/2017 - 30/06/2018 	R0.00 	31/03/2023 	557 	– 	(557) 	– 	–
01/07/2018 - 30/06/2019 	R0.00 	31/03/2024 	949 	– 	(949) 	– 	–
01/07/2022 - 30/06/2023 	R0.00 	30/09/2027 	189 499 	– 	(81 287) 	– 	108 212
01/07/2023 - 30/06/2024 	R0.00 	30/09/2026 	125 411 	– 	(59 530) 	– 	65 881
3. Discovery LTIP and SIP
01/07/2019 - 30/06/2020 	R0.00 	30/09/2024 	714 156 	– 	(694 819) 	(19 337) 	–
01/07/2020 - 30/06/2021 	R0.00 	30/09/2025 	1 978 231 	– 	(987 929) 	(38 274) 	952 028
01/07/2021 - 30/06/2022 	R0.00 	30/09/2026 	3 022 285 	– (1 006 735) 	(80 655) 	1 934 895
01/07/2022 - 30/06/2023 	R0.00 	30/09/2027 	3 172 577 	– (1 321 243) 	(74 233) 	1 777 101
01/07/2023 - 30/06/2024 	R0.00 	30/04/2028 	3 985 777 	– (1 392 413) 	(137 151) 	2 456 213
01/07/2024 - 30/06/2025 	R0.00 	30/06/2029 	– 	3 177 330 	(75 825) 	(52 475) 	3 049 030
4. Acquisition schemes
01/07/2019- 30/06/2020 	R0.00 	30/06/2025 	35 036 	– 	(31 292) 	(1 056) 	2 688
01/07/2020- 30/06/2021 	R0.00 	30/06/2026 	90 565 	– 	(42 666) 	(6 808) 	41 091
01/07/2021- 30/06/2022 	R0.00 	30/06/2027 	639 700 	– 	(433 148) 	(110 334) 	96 218
01/07/2023- 30/06/2024 	R0.00 	30/06/2028 	857 017 	– 	(10 737) 	(29 116) 	817 164
01/07/2024- 30/06/2025 	R0.00 	30/06/2029 	– 	887 741 	– 	(34 674) 	853 067
Notes to the group annual financial statements continued
for the year ended 30 June 2025
179
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.5 	DISCOVERY’S LONG-TERM INCENTIVE PLANS (EQUITY-SETTLED) continued
3. DISCOVERY LONG-TERM INCENTIVE PLAN (LTIP)
The LTIP was introduced in the financial year ended 30 June 2020 and replaced (with limited exceptions) the cash-settled
Discovery Phantom scheme (see point 2 above) with an equity-settled scheme.
Participants will receive Discovery Limited shares subject to performance criteria and if the participant is employed on each
vesting date. For LTIP awards granted prior to the introduction of the Single Incentive Plan (SIP), the performance conditions
are aligned to the organic growth methodology of the Group and will vest from between the third and fifth anniversary of
these awards.
SINGLE INCENTIVE PLAN
During the financial year ended 30 June 2022, Discovery replaced its management short-term incentive scheme and
long-term incentive schemes with a single incentive scheme (SIP), consisting of a cash incentive (short-term incentive) and
deferred share awards (long-term incentive). The SIP is based on the annual award of a single total incentive relating to the
performance of the Group, business unit and the individual, and is assessed against financial and non-financial measures as
outlined by the Group scorecard as well as business unit and individual scorecards.
These performance measures are used to determine the value of the award granted. The vesting of the deferred share
awards is conditional on the participant still being employed on each vesting date, and not subject to any performance
conditions.
The first deferred share awards were granted in November 2022. These shares will vest between one and three years after
allocation of the shares for senior management and between three and five years for executive directors and prescribed
officers.
4. ACQUISITION SCHEMES (CASH AND EQUITY-SETTLED)
There are various schemes offered to franchise directors, agents and employees. Prior to the financial year ended
30 June 2024, participants were allocated share units which replicate the economics of a Discovery Limited share.
The share units are settled as a cash bonus on vesting. Awards granted in subsequent years, are equity-settled awards.
The vesting periods on the schemes vary from two to five years. The participants will earn the cash bonus (for cash-settled
awards) or receive Discovery Limited shares (for equity-settled awards) if the participant is employed by Discovery or
Discovery’s contracted affiliates on the vesting date.
5. DISCOVERY BANK SCHEME (EQUITY-SETTLED)
Participants will receive Discovery Limited shares subject to the ’Value Created’, which references the growth in the value
of Discovery Bank business after capital invested and interest. These awards vest from between the third and seventh
anniversary of the market launch date of Discovery Bank, and each vesting is settled in three equal instalments over three
years, if the participant is employed on each vesting date.
Other long-term incentive schemes
The following schemes are long-term staff incentives where the value is determined with reference to something other than
the Discovery Limited share price. These schemes are accounted for in terms of IAS 19: Employee benefits.
6. THE VITALITYHEALTH AND VITALITYLIFE PHANTOM SHARE SCHEME
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the Embedded Value
(EV) of VitalityLife and VitalityHealth respectively. The bonus is earned if the participant is employed on each vesting date.
For units issued, the vesting of the units is two, three and four years after allocation of the bonus units. The bonus may not
be carried forward.
7. ALL OTHER SEGMENT SCHEMES
Various other long-term incentive schemes exist within the Discovery Group in the All other segments. These schemes are
individually and in aggregate immaterial and as a result no further information is disclosed.
The schemes mentioned in bullets 2 and 4 have been classified as cash-settled schemes and a liability is raised in terms
of IFRS 2 Share-based Payment. The other long-term incentive schemes, have been accounted for in terms of IAS 19
Employee Benefits.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
178
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
179	178

-- 92 of 155 --

SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.6 	RELATED PARTIES continued
Transactions with related parties
Discovery Group had the following transactions and balances with the following equity-accounted investees:
Transactions (R'000) 	2025 	2024
PAHI
Other Income 	16 012 	14 643
CMT
Other expenses 	(30 621) 	(55 990)
Other
Other Income 	13 854 	85 473
Other expenses 	(31 703) 	(34 700)
Outstanding balances (R'000) 	2025 	2024
PAHI
Other receivables 	10 525 	13 720
CMT
Other payables 	(7 340) 	(29 442)
Other
Other receivables 	4 916 	4 350
Other payables 	– 	(1 585)
Key management personnel, families of key management (as defined in IAS 24) and
entities significantly influenced or controlled by key management
KEY MANAGEMENT PERSONNEL COMPENSATION
R'000 	2025 	2024
Salaries and other short-term benefits paid1 	249 628 	194 469
Long-term benefits 	30 539 	24 215
Share-based payments 	111 598 	81 442
391 766 	300 126
1 Other short-term benefits paid include defined contributions, paid leave, and short-term bonuses.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
181
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.5 	DISCOVERY’S LONG-TERM INCENTIVE PLANS (EQUITY-SETTLED) continued
Valuation of share-based payments and long-term incentives
The VitalityHealth and VitalityLife phantom share scheme is cash-settled and thus repriced at each reporting date. The value of
the shares and options allocated are dependent on the performance of VitalityLife and VitalityHealth, more specifically the EV of
each respective business.
The Discovery phantom scheme and certain Acquisition scheme awards are cash-settled and a liability is raised in terms of
IFRS 2 Share-based Payment (IFRS 2). The liability is repriced at each reporting date. The closing share price at 30 June 2025 was
R214.80.
Discovery determines the grant date fair value of its equity-settled schemes at the date of allocating the grant to the employee
using the following inputs. The grant date fair value is then recognised over the vesting period and a share-based payment
reserve is recognised in terms of IFRS 2.
Fair value Valuation methodology
Discovery LTIP and SIP
01/07/2020 – 30/06/2021 	110.56 - 136.74
Unconditional fair value is equal
to the underlying share price in
Discovery at grant dates.
01/07/2021 – 30/06/2022 	135.94 - 152.26
01/07/2022 – 30/06/2023 	127.58 - 149.05
01/07/2023 – 30/06/2024 	117.16 - 133.04
01/07/2024 – 30/06/2025 	153.00 - 217.40
BEE Staff share trust
01/07/2019 – 30/06/2020 	70.82
Unconditional fair value is equal
to the share price at the grant
date, less the present value of
estimated dividends paid prior
to the time of exercise.
01/07/2020 – 30/06/2021 	114.16 - 115.13
01/07/2021 – 30/06/2022 	118.85 - 175.38
01/07/2022 – 30/06/2023 	111.48 - 137.91
01/07/2023 – 30/06/2024 	109.75 - 141.87
01/07/2024 – 30/06/2025 	183.87 - 204.22
Acquisition Share Scheme
01/07/2023 – 30/06/2024 	146.46 Unconditional fair value is equal
to the underlying share price in
Discovery at grant dates.	01/07/2024 – 30/06/2025 	192.69
4.6 	RELATED PARTIES
List of related parties as defined
SUBSIDIARIES
Details of subsidiaries directly owned by Discovery Limited are contained in Company note 3.3. In addition, Annexure A sets out
all subsidiary and other investments held within Discovery Group.
ASSOCIATES AND JOINT VENTURES
Details of Discovery’s material associates and joint ventures are contained in note 5.7.
KEY MANAGEMENT PERSONNEL
Key management personnel have been defined as directors of Discovery Limited, Discovery Health Proprietary Limited and
Discovery Life Limited, as these businesses constitute the majority of the Discovery Group.
A list of the directors and prescribed officers of Discovery Limited can be found in the Directors’ report. Also refer to Annexure C
for Directorate remuneration.
To the extent that specific transactions have occurred between Discovery and key management personnel, including close family
members of key management, (as defined in IAS 24 Related Party Disclosures) the details are included within the aggregate
disclosure contained below under key management personnel and where significant, full details of all relationships and terms of
the transactions are provided.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
180
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
181	180

-- 93 of 155 --

SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.6 	RELATED PARTIES continued
Major customers and other Discovery entities not part of Discovery Group continued
CLOSED SCHEMES
Discovery Health administers the following restricted membership medical schemes:
– Anglo Medical Scheme 	– Multichoice Medical Aid Scheme
– Anglovaal Group Medical Scheme 	– Netcare Medical Scheme
– Bankmed Medical Scheme 	– Remedi Medical Scheme
– BMW Employees Medical Aid Society 	– Retail Medical Scheme
– Engen Medical Benefit Fund 	– Sasolmed
– Glencore Medical Scheme 	– TFG Medical Scheme
– LA Health Medical Scheme 	– Tsogo Sun Group Medical Scheme
– LibCare Medical Scheme 	– UKZN Medical Scheme
– Lonmin Medical Scheme (Terminated 30 June 2025)
– Malcor Medical Scheme
– MediPos Medical Scheme (Effective 1 April 2025)
Discovery Health charges these schemes administration fees which are determined on an annual basis and approved by the
trustees of the respective closed schemes. The fees totalled R1 621 million (2024: R1 425 million). Discovery Health and its
subsidiaries also provide wellness services to these schemes. The fees received for these services totalled R8.5 million
(2024: R9.2 million). Amounts due to Discovery Health at year-end totalled R143 million (2024: R126 million). DTPRS provides a
service to some of the closed schemes to recover all claims that are due from the Compensation for Occupational Injuries and
Diseases. DTPRS received R2.2 million (2024: R1.1 million) for this service.
Discovery Vitality receives monthly contributions from the closed scheme members that have activated the Vitality Wellness
programme through various product integrations. The membership fees totalled R130 million (2024: R112 million).
DISCOVERY FRANCHISES
Discovery has established a network of 29 (2024: 28) franchises in order to establish a national footprint for its products.
Discovery has paid R268 million (2024: R301 million) in fees to the franchises.
The franchises participate in the Acquisition Scheme (refer to note 4.5 for further details). During the year, R32 million (2024: R13
million) was accrued for in terms of this scheme.
THE DISCOVERY FOUNDATION
The Discovery Foundation’s principal aim is to invest in the education and training of medical specialists and the development of
academic and research centres. It is an independent shareholder of Discovery. During the year, the Discovery Foundation
received a management fee of R3.4 million (2024: R3 million).
THE DISCOVERY FUND
The Discovery Fund is a fund for sustainable non-governmental healthcare projects, especially in primary healthcare. These
projects complement the delivery of primary and preventative care in the public sector and help to relieve the burden on state
facilities.
The Discovery Fund received contributions from Discovery of R25 million during the year (2024: R23 million). Discovery also paid
a management fee of R2.6 million (2024: R2.5 million).
DISCOVERY RETIREMENT FUNDS
The Discovery Life Pension Umbrella Fund and the Discovery Life Provident Umbrella Fund (“the Funds”) are underwritten and
administered by Discovery Life and are the retirement funds used by all the Discovery Staff employed by the Group in
South Africa.
Contributions to the Funds by Discovery Staff during the year amounted to R684 million (2024: R634 million). The Funds have
R6 836 million (2024: R5 751 million) of assets under administration on behalf of Discovery Staff, R6 538 million is invested in unit
linked insurance policies issued by Discovery Life (2024: R5 510 million). R4 650 million (2024: R4 882 million) of the unit linked
insurance policies are in turn linked to unit trusts managed by Discovery Life Collective Investments.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
183
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 4: EQUITY, SHARE-BASED PAYMENTS AND RELATED
PARTIES continued
4.6 	RELATED PARTIES continued
Key management personnel, families of key management (as defined in IAS 24) and
entities significantly influenced or controlled by key management continued
INSURANCE CONTRACTS
Aggregated insured
cover 	Premiums received 	Claims paid
R’000 	2025 	2024 	2025 	2024 	2025 	2024
Life insurance 	1 561 516 1 310 246 	12 719 	10 819 	– 	–
Short-term insurance 	750 049 	642 978 	3 273 	2 726 	1 139 	1 104
Short-term health insurance 	– 	– 	309 	18 	166 	37
INVESTMENT CONTRACTS
Investment values 	Premiums received 	Withdrawal benefits 	Investment returns
R’000 	2025 	2024 	2025 	2024 	2025 	2024 	2025 	2024
Investment contracts 	75 000 	64 256 	10 917 	2 301 	3 464 	1 465 	8 133 	4 440
VITALITY PROGRAMME
Premiums received 	Amounts paid
R’000 	2025 	2024 	2025 	2024
Vitality benefits 	214 	187 	1 914 	1 676
DISCOVERY BANK
Loans 	Savings 	Fees
R’000 	2025 	2024 	2025 	2024 	2025 	2024
Discovery Bank 	1 856 	1 898 	75 104 	43 213 	373 	322
Key management personnel, their families (as defined in IAS 24) and entities significantly influenced or controlled by key
management accrued 484 952 Discovery miles as part of the Vitality Reward Programme for the year ended 30 June 2025 (2024:
403 037).
Major customers and other Discovery entities not part of Discovery Group
DISCOVERY HEALTH MEDICAL SCHEME
Discovery Health administers DHMS and provides managed care services for which it charges an administration fee and a
managed healthcare fee respectively. These fees are determined on an annual basis and approved by the trustees of DHMS. The
fees totalled R8 386 million (2024: R7 940 million). DHMS owes Discovery Health R989 million (2024: R779 million) at year-end.
Discovery offers the members of DHMS access to the Vitality programme. Southern Rx and Discovery HealthCare provide
wellness services to DHMS for which it received fees totalling R94 million (2024: R88 million). Discovery Vitality also receives
monthly contributions from DHMS members that have activated the Vitality Wellness programme through various product
integrations. The membership fees totalled R2 331 million for the year ended 30 June 2025 (2024: R2 115 million).
Discovery Third Party Recovery Services (DTPRS) paid R21.1 million in the prior year to acquire all the risks and rewards of
ownership relating to claims due from the Road Accident Fund up to 19 February 2024. No additional claim portfolios were
purchased in the current year. DTPRS also provides a service to DHMS to recover all claims that are due from the Compensation
for Occupational Injuries and Diseases. DTPRS received R29.7 million (2024: R21.3 million) for this service. DHMS owes DTPRS
R2.2 million (2024: R2.3 million owed by DHMS to DTRPS) at year-end.
Discovery Central Services receives monthly rent from DHMS for office space at 1 Discovery Place which totalled R7.5 million for
the year ended 30 June 2025, (2024: R7.3 million).
Notes to the group annual financial statements continued
for the year ended 30 June 2025
182
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
183	182

-- 94 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE
5.1 	INTRODUCTION AND OVERVIEW
This section provides information on the remainder of the assets, liabilities, income and expense in the Annual Financial
Statements.
5.2 	PRIMARY FINANCIAL STATEMENTS AND INFORMATION ANALYSED IN THIS
SECTION
R million 	Notes
Group
2025
Restated Group
20241
Statement of financial
position
Assets
Goodwill 	5.3 	5 429 	5 292
Intangible assets 	5.4 	7 542 	7 239
Property and equipment 	5.5 	3 266 	3 581
Deferred tax asset 	5.9.1 	4 886 	5 631
Assets arising from contracts with customers 	5.6 	3 722 	2 598
Investment in equity-accounted investees 	5.7 	8 989 	8 189
Contract receivables and other receivables 	5.8 	7 368 	6 729
Non-current assets held for sale 	5.5.1 	62 	136
41 264 	39 395
Liabilities
Deferred tax liability 	5.9.1 	8 755 	6 975
Contract liabilities to customers 	5.6 	1 516 	512
Provisions 	5.10 	– 	449
Other payables 	5.10 	2 333 	1 216
12 604 	9 152
Income statement 	Fee income from administration businesses 	5.6.1 	14 326 	13 596
Vitality income 	5.6.1 	5 322 	4 655
Net banking fee and commission income 	1 695 	1 398
Insurance service expenses 	5.11.1 	(49 028) 	(46 117)
Marketing and administration expenses 	5.11.3 	(21 765) 	(19 644)
Foreign exchange (losses)/gains 	5.12 	(36) 	(87)
Income tax expense 	5.9.2 	(4 089) 	(2 715)
(53 575) 	(48 914)
Additional Information Non-current assets held for sale 	5.5.1
Acquisition of businesses and subsidiaries 	5.13
1 The comparative information has been restated due to correction of a period error. Refer to note 7.5 for more detail.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
185
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 05
OTHER ASSETS,
LIABILITIES, EQUITY-
ACCOUNTED
INVESTMENTS AND
ITEMS OF INCOME AND
EXPENSE
Introduction and overview
Other investments, assets and liabilities
Goodwill
Intangible assets
Property and equipment
Assets and liabilities arising from contracts with
customers
Investment in equity-accounted investees
Contract receivables and other receivables
Income tax
Other payables and provisions
Acquisition of businesses and subsidiaries
Revenue, income and expense
Revenue
Marketing and administration expenses
Foreign exchange gains or losses
Income tax expense
184
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
185	184

-- 95 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.3 	GOODWILL continued
Annual assessment of goodwill impairment
DISCOVERY BANK
The Discovery Bank CGU comprises the various assets that collectively produce independent cash flows for Discovery Bank.
Discovery Bank’s income streams comprise interest earned on loans to customers, interest on excess cash invested, and fees
(e.g., banking fees, interchange fees and transaction fees) from banking. For the financial years ended 30 June 2025 and
30 June 2024, the recoverable amount of the Discovery Bank cash-generating unit (CGU) was determined based on fair value
less costs to sell. Estimation uncertainty is inherent in determining fair value less costs to sell. The recoverable amount is the fair
value less costs to sell using the income approach.
In determining the assets to attribute to the Discovery Bank CGU, Discovery considered the assets required to perform banking
operations, including the banking license costs, the internally developed software in use, and the goodwill associated with the
DiscoveryCard business acquisition and related assets and liabilities. Therefore, the valuation also supports the recoverability of
goodwill, intangible assets and deferred tax.
Management has reviewed its business forecast, which comprises:
– A detailed 10-year business plan. The 10-year plan considers regulatory capital requirements, macro-economic forecasts
and customer behaviour assumptions when forecasting a statement of financial position, income statement and resultant
equity cash flows to/from shareholders. The 10-year period used to assess impairment is longer than the standard 5-year
forecast model generally applied in Discovery’s impairment testing. The business is still in the start-up phase, resulting in a
5-year forecast that does not adequately reflect the business plan.
Management can project beyond the 5 years due to the insights from the Discovery Card business it acquired and the 6 years of
operating since the launch of Discovery Bank.
– The terminal value was calculated using an extended cash flow forecasting method until earnings growth stabilised in year
17 (2024: 18). The final value was considered perpetual terminal growth, and this terminal value was discounted to year 10.
– As a reasonability check, Discovery Bank translates the value of the business at year 10 into a Price-Earnings (PE) multiple,
which it benchmarks against Discovery’s PE ratio and other emerging banks within the South African environment. The ratio
was determined to be in range.
The key assumptions used by Discovery in the estimation are as follows:
– Conservative customer growth, targeting an achievable level of customers in year 10. After that, the customer base is
treated as stable. From the point of stability in year 17, the projected growth in profits is estimated at a conservative 5.3%
(2024: 5.4%), considering long-term inflation and long-term nominal GDP estimations. The increase in growth projections is
based on the growth over the past financial year.
– System-build costs and intangible assets acquired in the business combination have been amortised over 10 years (2024:
10 years). The useful lives of these assets are determined as 10 years (2024: 10 years).
The discount rate applied to the cashflows comprises the following:
Group
2025
Group
2024
Risk-free rate based on 10-year SA bond curve 	10.03% 	11.20%
Beta factor: The beta factor is a weighted average of large SA banks and Discovery 	0.83 	0.76
Discount rate applied 	16.11% 	16.90%
For the year ended 30 June 2025, management has engaged independent external valuation experts to benchmark the key
assumptions and ratios within the South African market. This exercise determined that the assumptions were within acceptable
ranges.
Management has further performed stress tests by increasing the discount rate to 18.5% (2024: 20%) while simultaneously
decreasing the terminal growth rate to 4.4% (2024: 4.5%). Again, no impairment was triggered with these stressed scenarios.
Based on management’s assessment, Discovery did not identify any impairments in respect of the Discovery Bank CGU.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
187
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.3 	GOODWILL
For the accounting policies relevant to the recognition and measurement of Goodwill, refer to Annexure B policies 2.1, 2.4.1, 3.3,
6 and 7.
Goodwill is not amortised but tested annually for impairment. Any impairment is recognised immediately in profit or loss and is
not subsequently reversed.
The table below sets out the reconciliation of the carrying amount of goodwill allocated to the respective cash-generating units
(CGUs), which are expected to benefit from the combination’s synergies. Impairment of goodwill is assessed at this CGU level.
R million
Vitality
Health1, 2, 5 Vitality Life1, 5
Discovery
Bank3 	Other4 	Total
Year ended 30 June 2025
Cost 	2 315 	540 	2 417 	29 	5 301
Accumulated impairment 	– 	– 	– 	(9) 	(9)
Opening carrying amount 	2 315 	540 	2 417 	20 	5 292
Movements
Impairment 	– 	– 	– 	(20) 	(20)
Translation differences 	127 	30 	– 	– 	157
Closing carrying amount 	2 442 	570 	2 417 	– 	5 429
Cost 	2 442 	570 	2 417 	29 	5 458
Accumulated impairment 	– 	– 	– 	(29) 	(29)
Year ended 30 June 2024
Cost 	2 407 	562 	2 417 	29 	5 415
Accumulated impairments 	– 	– 	– 	(9) 	(9)
Opening carrying amount 	2 407 	562 	2 417 	20 	5 406
Movements
Translation differences 	(92) 	(22) 	– 	– 	(114)
Closing carrying amount 	2 315 	540 	2 417 	20 	5 292
Cost 	2 315 	540 	2 417 	29 	5 301
Accumulated impairments 	– 	– 	– 	(9) 	(9)
1 GBP96.7 million and GBP23.4 million of the goodwill was allocated to VitalityHealth and VitalityLife respectively as at 31 July 2010. The goodwill arose from
the acquisition of Standard Life Healthcare and related capital restructure of the PAC joint venture.
2 GBP2.5 million goodwill from the acquisition of Insure Your Health (25 March 2013) and GBP1.1 million of goodwill from the acquisition of KYS Paid Limited
(30 April 2014) were allocated to the VitalityHealth CGU.
3 R2 417 million goodwill from the acquisition of the DiscoveryCard business on 1 March 2019 was allocated to the Discovery Bank CGU.
4 In October 2020, Discovery acquired Liberty Health Administration, a wholly owned subsidiary, which performs medical aid administration for specified
medical aids. Liberty Health Administration has been renamed to Discovery Administration Services Proprietary Limited as of 11 August 2021. At the
beginning of July 2022 Discovery acquired a controlling stake in Nanolabs Health Solutions Proprietary Limited (Nanolabs) with Point of Care Testing
technology. Subsequent to the acquisition the goodwill was fully impaired.
5 Based on the work performed for the financial years ended 30 June 2025 and 30 June 2024, management considered a very low risk of material adjustment
to the carrying amount of goodwill allocated to VitalityHealth and VitalityLife within the next financial year. Accordingly, no further information is included
within this note, as this no longer meets the requirement of significant estimation uncertainty under IAS 1 Presentation of Financial Statements. As part of the
annual assessment of impairment, Discovery has done significant stresses on the goodwill of VitalityHealth and VitalityLIfe. The value-in-use considers the
value of in-force business as well as new business. The value-in-use is calculated as the present value of the best-estimate pre-tax cash flows of the CGU for
the in-force policies at the valuation date and 10 years of new business. The outcome of the working indicated that the recoverable amount significantly
exceeds the carrying amount of the CGUs, with little risk of impairment.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
186
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
187	186

-- 96 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.5 	PROPERTY AND EQUIPMENT
For the accounting policies relevant to the recognition and measurement of Property and equipment, refer to Annexure B,
policies 4 and 7 and for the accounting policies relevant to the recognition and measurement of Leases, refer to Annexure B,
policies 14 and 21.
Group
R million
Land and
buildings
Furniture,
fittings
and
equip-
ment
Computer
equip-
ment and
operating
systems
Lease-
hold
improve-
ments
Motor
Vehicles
Tele-
matic
devices1 	Total
Year ended 30 June 2025
Cost – owned 	– 	166 	914 	900 	64 	279 	2 323
Accumulated depreciation – owned 	– 	(101) 	(474) 	(431) 	(51) 	(181) 	(1 238)
Opening carrying amount – owned 	– 	65 	440 	469 	13 	98 	1 085
Cost – leased 	3 884 	– 	262 	300 	7 	– 	4 453
Accumulated depreciation – leased 	(1 592) 	– 	(230) 	(134) 	(1) 	– 	(1 957)
Opening carrying amount – leased 	2 292 	– 	32 	166 	6 	– 	2 496
Opening carrying amount – total 	2 292 	65 	472 	635 	19 	98 	3 581
Movements
Additions 	93 	25 	228 	– 	9 	45 	400
Owned: cost 	– 	24 	217 	– 	7 	45 	293
Leased: cost 	93 	1 	11 	– 	2 	– 	107
Disposals 	– 	– 	– 	– 	– 	(1) 	(1)
Owned: cost 	– 	– 	(1) 	– 	(5) 	(24) 	(30)
Owned: accumulated depreciation 	– 	– 	1 	– 	5 	23 	29
Derecognition 	– 	– 	– 	– 	– 	(11) 	(11)
Owned: cost 	– 	(27) 	(179) 	(59) 	– 	(48) 	(313)
Owned: accumulated depreciation 	– 	27 	179 	59 	– 	37 	302
Leased: cost 	(53) 	– 	(26) 	– 	– 	– 	(79)
Leased: accumulated depreciation 	53 	– 	26 	– 	– 	– 	79
Depreciation charge 	(328) 	(23) 	(227) 	(98) 	(9) 	(39) 	(724)
Owned 	– 	(23) 	(191) 	(77) 	(6) 	(39) 	(336)
Leased 	(328) 	– 	(36) 	(21) 	(3) 	– 	(388)
Leased: Changes or modifications in
estimated ROUA cost 	(4) 	– 	– 	– 	– 	– 	(4)
Translation differences 	14 	1 	1 	5 	2 	2 	25
Owned 	– 	1 	1 	5 	2 	2 	11
Leased 	14 	– 	– 	– 	– 	– 	14
Closing carrying amount – owned 	– 	67 	467 	397 	16 	94 	1 041
Cost – owned 	– 	166 	963 	847 	65 	255 	2 296
Accumulated depreciation – owned 	– 	(99) 	(496) 	(450) 	(49) 	(161) 	(1 255)
Closing carrying amount – leased 	2 067 	1 	7 	145 	5 	– 	2 225
Cost – leased 	3 937 	1 	246 	300 	9 	– 	4 493
Accumulated depreciation – leased 	(1 870) 	– 	(239) 	(155) 	(4) 	– 	(2 268)
Closing carrying amount – total 	2 067 	68 	474 	542 	21 	94 	3 266
1 In Discovery Insure, when policies relating to motor vehicle insurance lapse, the telematic devices installed in those vehicles are not always recovered. The
value of these unrecovered units are derecognised.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
189
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.4 	INTANGIBLE ASSETS
For the accounting policies relevant to the recognition and measurement of Intangible assets, refer to Annexure B, policies 5 and 7.
Group
R million
Software
development
Acquisition of
businesses and
subsidiaries:
Identifiable
intangible assets Banking license 	Total
Year ended 30 June 2025
Cost 	12 503 	2 456 	29 	14 988
Accumulated amortisation and impairment 	(5 598) 	(2 151) 	– 	(7 749)
Opening carrying amount 	6 905 	305 	29 	7 239
Movements
Additions: Owned: cost1 	1 682 	310 	– 	1 992
Impairment: Owned: accumulated amortisation 	(65) 	– 	– 	(65)
Derecognition: Owned 	(131) 	– 	– 	(131)
– Cost 	(1 368) 	– 	– 	(1 368)
– Accumulated amortisation 	1 237 	– 	– 	1 237
Amortisation charge: Owned 	(1 450) 	(71) 	– 	(1 521)
Translation differences 	21 	7 	– 	28
Closing carrying amount 	6 962 	551 	29 	7 542
Cost 	12 886 	2 887 	29 	15 802
Accumulated amortisation 	(5 924) 	(2 336) 	– 	(8 260)
Year ended 30 June 2024
Cost 	11 256 	2 548 	29 	13 833
Accumulated amortisation and impairment 	(4 592) 	(2 177) 	– 	(6 769)
Opening carrying amount 	6 664 	371 	29 	7 064
Movements
Additions: Owned: cost 	1 789 	– 	– 	1 789
Impairment: Owned: accumulated amortisation 	(8) 	– 	– 	(8)
Derecognition: Owned 	(45) 	– 	– 	(45)
– Cost 	(371) 	– 	– 	(371)
– Accumulated amortisation 	326 	– 	– 	326
Amortisation charge: Owned 	(1 411) 	(56) 	– 	(1 467)
Translation differences 	(84) 	(10) 	– 	(94)
Closing carrying amount 	6 905 	305 	29 	7 239
Cost 	12 503 	2 456 	29 	14 988
Accumulated amortisation 	(5 598) 	(2 151) 	– 	(7 749)
1 Refer to note 5.13 for details on acquisition of businesses and subsidiaries.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
188
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
189	188

-- 97 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.5 	PROPERTY AND EQUIPMENT continued
5.5.1 	Classification of land and buildings as non-current asset held for sale
As at 30 June 2025, the Group continues to classify the property owned by Vitality in the United Kingdom in accordance with
IFRS 5 Non-current Assets Held for Sale and Discontinued Operations. The property was initially classified as held for sale on 30 June
2024, following management’s commitment to a plan to dispose of the asset.
At year end, the sale had not yet been completed due to ongoing negotiations. However, management remains committed to
the disposal plan, and the property continues to be actively marketed at a price considered reasonable in relation to its current
fair value. The property was remeasured to fair value less costs to sell, resulting in an impairment loss of R14 million for the
financial year ended 30 June 2024. At 30 June 2025, the building was stated at a fair value less costs to sell of £2.54 million (R62
million) (June 2024: £5.9 million (R136 million)). The sale was concluded in July 2025.
The non-recurring fair value measurement related to the property was categorised as Level 3, as the binding offer was subject to
significant unobservable inputs. Discovery used the binding offer without adjustment as the fair value, and therefore no
quantitative unobservable inputs were developed when measuring the fair value.
5.6 	ASSETS AND LIABILITIES ARISING FROM CONTRACTS WITH CUSTOMERS
For the accounting policies relevant to the recognition and measurement of Revenue, refer to Annexure B policy 19.
Where either party to a contract has performed, Discovery presents either a contract asset or contract liability, depending on the
relationship between Discovery’s performance and the customer’s payment. Where Discovery has performed and has
unconditional rights to consideration a IFRS 9 receivable asset is presented separately.
Group
R million
Assets arising
from contracts
with customers1
Costs of
obtaining
contracts1
Contract
liabilities
Contract
receivables2
Year ended 30 June 2025
Balance at beginning of the year 	697 	1 901 	(512) 	1 350
Contract receivables recognised in the current year 	– 	– 	– 	5
Accrued income recognised during the year3 	1 319 	– 	– 	–
Payments received 	(287) 	– 	– 	(14 484)
Costs of obtaining new contracts 	– 	534 	– 	–
Amortised during the year 	– 	(475) 	– 	–
Contract liabilities recognised in the current year 	– 	– 	(1 231) 	–
Revenue recognised in the year 	– 	– 	224 	14 799
Foreign exchange revaluations 	76 	– 	– 	(6)
Translation differences 	(43) 	– 	3 	(11)
Balance at end of the year 	1 762 	1 960 	(1 516) 	1 653
Year ended 30 June 2024
Balance at beginning of the year 	542 	1 679 	(656) 	1 268
Accrued income recognised during the year 	434 	– 	– 	–
Payments received 	(206) 	– 	– 	(14 796)
Costs of obtaining new contracts 	– 	715 	– 	–
Amortised during the year 	– 	(492) 	– 	–
Contract liabilities recognised in the current year 	– 	– 	(855) 	–
Revenue recognised in the year 	– 	– 	998 	14 894
Foreign exchange revaluations 	(51) 	– 	– 	(4)
Translation differences 	(22) 	(1) 	1 	(12)
Balance at end of the year 	697 	1 901 	(512) 	1 350
1 Presented as Assets arising from contracts with customers.
2 Presented as part of Contract receivables and other receivables. Also see note 5.8.
3 This includes a modification of a contract during the year within the Vitality Network, resulting in a net increase in assets arising from contracts with
customers and a corresponding increase in revenue amounting to R 354 million (US $ 19 million).
The contract liability comprises:
■ Advance consideration received from customers for initial adviser fees, with revenue recognised over the expected term of
the arrangement.
■ Discovery Miles provision under the Vitality Programme, presented as part of contract liabilities as it is closely associated with
the income earned from the programme.
■ Rebates, discounts and boosts on investment-based products, which are dependent on client behaviour.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
191
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.5 	PROPERTY AND EQUIPMENT continued
Group
R million
Land and
buildings
Furniture,
fittings
and
equip-
ment
Computer
equip-
ment and
operating
systems
Lease-
hold
improve-
ments
Motor
Vehicles
Tele-
matics
devices1 	Total
Year ended 30 June 2024
Cost – owned 	235 	154 	919 	812 	67 	260 	2 447
Accumulated depreciation – owned 	(75) 	(92) 	(449) 	(376) 	(56) 	(177) 	(1 225)
Opening carrying amount – owned 	160 	62 	470 	436 	11 	83 	1 222
Cost – leased 	3 841 	– 	272 	300 	2 	– 	4 415
Accumulated depreciation – leased 	(1 386) 	– 	(227) 	(113) 	(1) 	– 	(1 727)
Opening carrying amount – leased 	2 455 	– 	45 	187 	1 	– 	2 688
Opening carrying amount – total 	2 615 	62 	515 	623 	12 	83 	3 910
Movements
Additions 	145 	27 	193 	151 	15 	68 	599
Owned: cost 	– 	27 	160 	151 	8 	68 	414
Leased: cost 	145 	– 	33 	– 	7 	– 	185
Disposals 	(2) 	– 	– 	(27) 	– 	(1) 	(30)
Owned: cost 	– 	(4) 	(128) 	(28) 	(11) 	(2) 	(173)
Owned: accumulated depreciation 	– 	4 	128 	1 	11 	1 	145
Leased: cost 	(74) 	– 	– 	– 	(2) 	– 	(76)
Leased: accumulated depreciation 	72 	– 	– 	– 	2 	– 	74
Classified as held for sale2 	(139) 	– 	– 	– 	– 	– 	(139)
Owned: cost 	(231) 	– 	– 	– 	– 	– 	(231)
Owned: accumulated depreciation 	92 	– 	– 	– 	– 	– 	92
Impairment: Owned: accumulated
depreciation 	(14) 	– 	– 	– 	– 	– 	(14)
Derecognition 	– 	– 	– 	– 	– 	(10) 	(10)
Owned: cost 	– 	(8) 	(25) 	(26) 	– 	(47) 	(106)
Owned: accumulated depreciation 	– 	8 	25 	26 	– 	37 	96
Leased: cost 	(12) 	– 	(43) 	– 	– 	– 	(55)
Leased: accumulated depreciation 	12 	– 	43 	– 	– 	– 	55
Depreciation charge 	(298) 	(23) 	(233) 	(105) 	(8) 	(42) 	(709)
Owned 	(5) 	(23) 	(187) 	(84) 	(6) 	(42) 	(347)
Leased 	(293) 	– 	(46) 	(21) 	(2) 	– 	(362)
Translation differences 	(15) 	(1) 	(3) 	(7) 	– 	– 	(26)
Owned 	(2) 	(1) 	(3) 	(7) 	– 	– 	(13)
Leased 	(13) 	– 	– 	– 	– 	– 	(13)
Closing carrying amount – owned 	– 	65 	440 	469 	13 	98 	1 085
Cost – owned 	– 	166 	914 	900 	64 	279 	2 323
Accumulated depreciation – owned 	– 	(101) 	(474) 	(431) 	(51) 	(181) 	(1 238)
Closing carrying amount – leased 	2 292 	– 	32 	166 	6 	– 	2 496
Cost – leased 	3 884 	– 	262 	300 	7 	– 	4 453
Accumulated depreciation – leased 	(1 592) 	– 	(230) 	(134) 	(1) 	– 	(1 957)
Closing carrying amount – total 	2 292 	65 	472 	635 	19 	98 	3 581
1 In Discovery Insure, when policies relating to motor vehicle insurance lapse, the telematics devices installed in those vehicles are not always recovered.
The value of these unrecovered units are derecognised.
2 Refer to note 5.5.1 for more information on non-current assets held for sale.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
190
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
191	190

-- 98 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.7 	INVESTMENTS IN EQUITY-ACCOUNTED INVESTEES continued
5.7.1 	Material interests in associates and joint ventures
The table below provides summarised financial information for the Group’s material joint ventures and associates. The
information disclosed reflects the amounts presented in the financial statements of the relevant associates and joint ventures
and not Discovery’s share of those amounts.
PING AN HEALTH INSURANCE COMPANY OF CHINA, LIMITED (PAHI)
PAHI offers policyholders in China cover for a range of private healthcare-related claims. PAHI is a strategic partnership for the
Group, providing access to new clients and markets in China.
CAMBRIDGE MOBILE TELEMATICS INC. (CMT)
A United States of America based leading telematics technology provider. This partnership provides the Group with expertise in
the telematics environment that Discovery Insure harnesses to manage its insurance risk.
PAHI 	CMT
Ownership structure 	Equity-accounted associate 	Equity-accounted associate
Nature 	Insurance 	Telematics technology
Place of business 	China 	USA
R million
Group
2025
Group
2024
Group
2025
Group
2024
% of ownership interest at end of the year 	24.99% 	24.99% 	8.70% 	8.72%
Summarised statement of comprehensive income
Revenue 	45 928 	39 669 	5 870 	4 287
Net profit/(loss) for the year 	5 223 	4 791 	321 	(18)
Other comprehensive income 	156 	249 	– 	–
Total comprehensive income/(loss) 	5 379 	5 040 	321 	(18)
Summarised statement of financial position
Current assets 	16 582 	12 540 	5 028 	4 665
Non-current assets 	65 824 	59 559 	11 392 	12 448
Current liabilities 	(49 524) 	(41 898) 	(1 183) 	(1 395)
Non-current liabilities 	(4 726) 	(5 292) 	(287) 	(390)
Net assets 	28 156 	24 909 	14 950 	15 328
Reconciliation to carrying amounts
Opening net assets 	24 909 	21 802 	15 328 	15 529
Net profit/(loss) for the year 	5 223 	4 791 	321 	(18)
Other comprehensive income 	156 	249 	– 	–
Movement in share capital and share premium 	– 	– 	(283) 	319
Dividends paid to ordinary shareholders 	(1 771) 	(1 021) 	– 	–
Translation differences 	(361) 	(912) 	(416) 	(502)
Closing net assets 	28 156 	24 909 	14 950 	15 328
Group's share of net assets 	7 036 	6 225 	1 301 	1 337
Goodwill 	295 	298 	37 	38
Carrying value 30 June 	7 331 	6 523 	1 338 	1 375
5.7.2 	Individually immaterial associates and joint ventures
5.7.2.1 	SUMMARY OF FINANCIAL INFORMATION
Associates 	Joint ventures
Group
R million
Group
2025
Group
2024
Group
2025
Group
2024
Aggregate amount of the Group’s share of (loss)/profit 	(151) 	(236) 	30 	16
Aggregate amount of the Group’s share of other comprehensive
(loss)/income 	(4) 	5 	(3) 	(6)
Aggregate amount of the Group’s share of total
comprehensive (loss)/income 	(155) 	(231) 	27 	10
Notes to the group annual financial statements continued
for the year ended 30 June 2025
193
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.6 	ASSETS AND LIABILITIES ARISING FROM CONTRACTS WITH CUSTOMERS continued
Discovery has unsatisfied performance obligations relating to providing intellectual property services for the VitalityOne System.
The transaction price relating to unsatisfied performance obligations is expected to be recognised as revenue as follows:
R million
Group
2025
Group
2024
Provision of stand-ready Intellectual Property services
– <1 year 	489 	537
– 2 – 3 years 	338 	831
– 4 – 5 years 	886 	525
– >5 years 	1 575 	807
Total contract amount for future services 	3 288 	2 700
Where performance obligations are discharged within 12 months or where contracts are cancellable giving 12 months or less
notice, without the payment of a significant penalty, a practical expedient has been applied. Discovery has excluded these
contracts from the disclosures above. Contracts that include variable considerations have also not been included in the
table above.
5.6.1 	Revenue from non-insurance activities
Also refer to accounting policy 19 Revenue recognition. Discovery Group’s Revenue includes ‘Fee income from administration
businesses’, ‘Vitality income’ and ‘Banking fee and commission income’.
The split of revenue per geographical region and reportable segment can be viewed in Note 1.1, Segment information.
The split of revenue according to the timing of satisfaction of performance obligations, i.e. ‘over time’ or a ‘point-in-time’ is as
follows:
R million
Group
2025
Restated
Group
20241
Fee income from administration businesses 	14 326 	13 596
– Over time 	13 769 	13 573
– Point-in-time 	557 	23
Vitality income 	5 322 	4 655
– Over time 	3 671 	3 178
– Point-in-time 	1 651 	1 477
Banking fee and commission income 	2 238 	1 872
– Over time 	1 455 	836
– Point-in-time 	783 	1 036
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
For specified contracts earning fee income from administration business through the Vitality Network, the Group exercised its
judgement in concluding that the minimum enforceable amount to which it is entitled in all scenarios forms part of the
transaction price as variable consideration. The variable consideration was estimated using the expected value method, based
on the present value of future expected fees from new business written by the customer. In determining the financing
component, a discount rate of between 1% – 2% was applied, reflecting the counterparty’s incremental borrowing rate.
5.7 	INVESTMENTS IN EQUITY-ACCOUNTED INVESTEES
For the accounting policies relevant to the recognition and measurement of investment in equity-accounted investees, refer to
Annexure B, policies 2.4.1 and 7.
R million
Group
2025
Group
2024
Carrying value of material interests in associates and joint ventures – PAHI 	7 331 	6 523
Carrying value of material interests in associates and joint ventures – CMT 	1 338 	1 375
Carrying value of individually immaterial interests in associates 	265 	221
Carrying value of individually immaterial interests in joint ventures 	55 	70
Investment in equity-accounted investees 	8 989 	8 189
Notes to the group annual financial statements continued
for the year ended 30 June 2025
192
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
193	192

-- 99 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.9 	INCOME TAX
5.9.1 	Deferred tax assets and liabilities
For the accounting policies relevant to the recognition and measurement of deferred tax, refer to Annexure B policy 15.2.
R million
Group
2025
Restated Group
20241
Deferred tax asset – non-current 	4 886 	5 631
Deferred tax liability – non-current 	(8 755) 	(6 975)
Total deferred tax 	(3 869) 	(1 344)
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Group
R million
Charge for the year
Balance at
beginning of
the year
Recognised
in profit or
loss
Recognised
in other
compre-
hensive
income
Recognised
in equity
Translation
differences
Balance at
end of the
year
Year ended 30 June 2025
Assessed loss in Company
Policyholders’ Fund 	96 	(5) 	– 	– 	– 	91
Assessed loss in Individual
Policyholders’ Fund 	620 	(319) 	– 	– 	– 	301
Assessed loss in subsidiaries 	3 171 	(138) 	– 	– 	45 	3 078
Financial Instruments and
share-based payments 	(45) 	(19) 	– 	13 	– 	(51)
Deferred acquisition costs 	(217) 	1 	– 	– 	(1) 	(217)
Contract liability 	243 	(66) 	– 	– 	(7) 	170
Difference between wear and
tear and depreciation/
amortisation and leases 	(340) 	83 	– 	– 	4 	(253)
Intangible asset recognised on
acquisition of business 	(66) 	13 	– 	– 	(3) 	(56)
Prepayments 	(17) 	5 	– 	– 	– 	(12)
Provisions 	582 	(25) 	– 	– 	2 	559
Difference between accounting
and tax balances arising from
insurance contracts 	(5 209) 	(1 383) 	(675) 	– 	(2) 	(7 269)
Unrealised gains on revaluation
of investments 	(68) 	(47) 	– 	– 	– 	(115)
Other 	(94) 	(2) 	– 	– 	1 	(95)
Total 	(1 344) 	(1 902) 	(675) 	13 	39 	(3 869)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
195
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.8 	CONTRACT RECEIVABLES AND OTHER RECEIVABLES
For the accounting policies relevant to the recognition and measurement of Contract receivables and other receivables, refer to
Annexure B policy 8.1 and 19.
R million 	Notes
Group
2025
Group
2024
Contract receivables: 	5.6 	1 653 	1 350
– Discovery Health: Closed scheme debtors 	146 	130
– Discovery Health: Discovery Health Medical Scheme debtors 	1 019 	818
– Other contract receivables 	490 	405
– Less allowance for expected credit losses of contract receivables 	3.5 	(2) 	(3)
Other financial receivables: 	4 014 	3 701
– Agents and brokers 	721 	683
– Cash-in-transit debtors 	174 	69
– Consolidated unit trust debtors 	1 214 	1 184
– Loans to BEE initiatives 	497 	385
– Security deposit on derivatives2 	57 	10
– Vitality partner debtors 	200 	212
– Other financial debtors 	1 650 	1 579
– Less allowance for expected credit losses 	3.5 	(499) 	(421)
Other non-financial receivables1 	1 701 	1 678
– Prepayments 	1 530 	1 426
– Indirect taxes 	112 	155
– Other debtors 	59 	97
Total contract receivables and other receivables 	7 368 	6 729
Current 	6 665 	6 129
Non-current 	703 	600
7 368 	6 729
1 These non-financial assets have been excluded from the risk disclosures presented in note 3.13.4.2.
2 To reduce the credit risk exposure from the hedge derivative instruments purchased, Discovery has entered into collateral agreements with the relevant
financial institutions to post cash collateral periodically, equal to the fair value of the derivatives. The posting of the collateral does not result in legal
settlement of the outstanding derivative balance. The collateral will only be used to settle the derivative upon default or bankruptcy of either party.
The carrying value of short-term receivables approximates the fair value. Long-term receivables are interest bearing at market
rates and fully secured, and therefore, the carrying value approximates the fair value.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
194
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
195	194

-- 100 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.9 	INCOME TAX continued
5.9.2 	Income tax expense
For the accounting policies relevant to the recognition and measurement of taxation, refer to Annexure B, Policies 15.
R million
Group
2025
Restated
Group
20241
Charge for the year:
Current taxation 	2 187 	1 380
Normal taxation
– prior year over provision 	29 	(114)
– current year charge 	2 073 	1 470
Capital gains taxation 	85 	24
Deferred taxation 	1 902 	1 335
Total income tax expense recognised in profit or loss 	4 089 	2 715
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail
%
Group
2025
Group
2024
Taxation rate reconciliation
Statutory rate 	27.0 	27.0
Non-taxable income: Equity-accounted profit or loss and dividend income 	(2.4) 	(2.9)
Non-taxable income: Other individually immaterial 	(0.1) 	(0.1)
Non-deductible expenditure: Including items of a capital nature and non-deductible
provisions 	0.3 	*
Non-deductible expenditure: Other individually immaterial 	1.6 	0.6
Subsidiary current period losses for which no deferred tax asset was recognised,
net of deferred tax assets on losses recognised for prior period losses 	1.3 	2.6
Insurance policyholder funds I-E taxes and related DTA recognitions 	2.6 	(0.8)
Accounting gains and losses taxable at CGT rates 	(0.1) 	(0.1)
CFC imputations and WHT not recovered 	0.2 	0.7
Additional tax allowances 	(0.1) 	*
Prior year (under)/over provision 	(0.1) 	0.2
Tax rate changes 	– 	(0.3)
Tax rate differences 	(0.3) 	(0.3)
Effective taxation rate 	29.9 	26.5
* Amount is less than 0.1%.
The current tax rate for South African entities in a tax paying position is 27%. Discovery, a holding company listed on the JSE,
uses the South African tax rate for its tax rate reconciliation since it is based in South Africa and the most significant operations
are in South Africa. The South African life insurance operations tax rate is determined based on the rates and basis applicable to
section 29A of the Income Tax Act 58 of 1962 at the reporting date.
Vitality Group International Inc, a subsidiary of Discovery Limited in the US, is subject to taxation under section 11(b) of the
Internal Revenue Code 1986. The applicable current tax rate for all of Vitality Group International Inc’s taxable profit is 21%.
Discovery Group Europe Limited, incorporated and operating in the UK, is governed by the Corporation Tax Act 2010 Chapter 2,
which sets the main corporation tax rate on taxable profit at 25%.
Discovery Group is subject to taxation in a number of jurisdictions. There may be transactions and calculations during the
ordinary course of business for which the final tax determination has an element of uncertainty due to interpretation of
legislation. Where this occurs, the group recognises liabilities based on objective estimates of the amount of taxes that may be
due in accordance with IAS 12 Income Taxes and IFRIC 23 Uncertainty over Income Tax Treatments.
Where the final tax determination is different from amounts that were initially recorded, such differences will impact the income
tax and deferred tax provisions in the period in which such determination is made.
Discovery Group is a multinational enterprise with a turnover of more than €750 million. Therefore, it is subject to the
Organisation for Economic Cooperation and Development (OECD) Pillar Two Model Rules, which aim to ensure that the effective
tax rate of affected entities is at least 15%.
In South Africa where the Group is ultimately parented, the Global Minimum Tax Act, 46 of 2024 and the Global Minimum Tax
Administration Act, 47 of 2024 has been enacted and is effective for the June 2025 financial year. Therefore, Discovery Limited as the
Ultimate Parent Entity (UPE) is required to compute the Global Minimum Tax exposure of all relevant tax jurisdictions where it operates.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
197
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.9 	INCOME TAX continued
5.9.1 	Deferred tax assets and liabilities continued
Charge for the year
Group
R million
Balance at
beginning of
the year
Recognised
in profit or
loss
Recognised
in other
compre-
hensive
income
Recognised
in equity
Translation
differences
Balance
at end of
the year
Year ended 30 June 2024
Restated1
Assessed loss in Company
Policyholders’ Fund 	155 	(59) 	– 	– 	– 	96
Assessed loss in Individual
Policyholders’ Fund 	979 	(359) 	– 	– 	– 	620
Assessed loss in subsidiaries 	2 899 	322 	– 	– 	(50) 	3 171
Financial Instruments and share-
based payments 	(28) 	– 	– 	(16) 	(1) 	(45)
Deferred acquisition costs 	(207) 	(9) 	– 	– 	(1) 	(217)
Contract liability 	275 	(1) 	– 	– 	(31) 	243
Difference between wear and
tear and depreciation/
amortisation and leases 	(235) 	(113) 	– 	– 	8 	(340)
Intangible asset recognised on
acquisition of business 	(10) 	(58) 	– 	– 	2 	(66)
Prepayments 	(9) 	(8) 	– 	– 	– 	(17)
Provisions 	484 	100 	– 	– 	(2) 	582
Difference between accounting
and tax balances arising from
insurance contracts1 	(3 240) 	(1 446) 	(495) 	– 	(28) 	(5 209)
Unrealised gains on revaluation
of investments 	(301) 	233 	– 	– 	– 	(68)
Other 	(180) 	63 	– 	– 	23 	(94)
Total 	582 	(1 335) 	(495) 	(16) 	(80) 	(1 344)
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
196
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
197	196

-- 101 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.10 	OTHER PAYABLES AND PROVISIONS
For the accounting policies relevant to the recognition and measurement of Other payables and provisions, refer to Annexure B
policies 17.
R million 	Notes
Group
2025
Group
2024
Non-financial payables 	2 333 	1 216
Provisions 	– 	449
Balance at end of the year 	2 333 	1 665
Current 	2 287 	1 168
Non-current 	46 	497
Non-financial payables
R million
Group
2025
Group
2024
Indirect taxes 	1 956 	867
Employee leave pay benefit 	377 	349
Balance at end of the year 	2 333 	1 216
Current 	2 287 	1 165
Non-current 	46 	51
Total 	2 333 	1 216
5.11 	EXPENSES
For the accounting policies relevant to the recognition and measurement of Marketing and administration expenses, refer to
Annexure B policy 22.
5.11.1 	Insurance service expenses
R million 	Notes
Group
2025
Restated Group
20241
Insurance service expenses
Claims and benefits 	5.11.4 	30 231 	29 462
– Incurred claims and benefits 	30 273 	29 349
– Adjustment to liabilities for incurred claims (LIC) 	(42) 	113
Directly attributable service expenses, excluding insurance acquisition cash flows 	5.11.3 	8 883 	8 323
Losses and reversal of losses on onerous contracts 	529 	(185)
GMM/VFA: Insurance acquisition cash flows including amortisation 	6 209 	5 510
PAA: Insurance acquisition cash flows including amortisation 	3 176 	3 007
49 028 	46 117
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
5.11.2 	Commissions insurance contracts
R million 	Notes
Group
2025
Restated Group
20241
Commission paid to obtain insurance contracts 	9 041 	7 060
1 The comparative period total commission paid and insurance acquisition cash flows were understated, because not all of the associated cost and
corresponding allocation were disclosed. The correction does not affect the reported amounts in the Group income statement or Segment information.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
199
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.9 	INCOME TAX continued
5.9.2 	Income tax expense continued
In terms of Discovery’s other operating jurisdictions, Global Minimum Tax legislation is also effective in the United Kingdom and
Australia for the year ended 30 June 2025, while Singapore, Guernsey, Hong Kong and Isle of Man and Mauritius are set to take effect in
the 2026 Financial year. The Group continues to monitor the status of any pending legislation in its other remaining operating
jurisdictions.
Discovery has no related current tax exposure for the year ended 30 June 2025 and in terms of a temporary mandatory relief
from deferred tax accounting for the impacts of Global Minimum Tax no deferred tax will be raised in respect of temporary
differences that may arise, as provided in the amendments to IAS 12 issued in May 2023.
Due to the complexities in applying the Pillar Two Rules and calculating the Top-up Tax payable, the Group will continue to work
with its advisors to monitor any exposure to Pillar Two Top-up Taxes as the legislation and associated guidance evolve.
5.9.3 	Assessed losses
Discovery did not recognise deferred tax assets in respect of the following assessed losses:
R million
Group
2025
Group
2024
Better Health Insurance Advice Limited 	40 	39
Cogence Proprietary Limited 	109 	74
Discovery Central Services Proprietary Limited 	5 213 	4 932
Discovery Group Europe Limited 	9 	9
Discovery Life Limited – Individual Policyholders’ Fund 	731 	1 960
Discovery Vitality Australia Proprietary Limited 	280 	285
Grove Nursing Services Proprietary Limited 	41 	45
Medical Services Organisation International Proprietary Limited 	36 	26
Southern Rx Proprietary Limited 	– 	33
Discovery Green Proprietary Limited 	82 	33
Nanolabs Health Services Proprietary Limited 	11 	13
6 552 	7 448
The Group recognises deferred tax assets on carried forward losses to the extent that there are sufficient estimated future
taxable profits and/or taxable temporary differences against which the tax losses can be utilised.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
198
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
199	198

-- 102 of 155 --

SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.11 	EXPENSES continued
5.11.4 	Claims and benefits
R million
(Income)/expenses 	Note
Group
2025
Group
2024
SA Life (Risk) and UK Life (Risk) insurance claims 	8 334 	7 357
Death 	5 808 	4 935
Disability 	4 366 	4 483
Payback benefits 	2 500 	2 356
Less: Reinsurance recoveries 	(4 340) 	(4 417)
SA Invest (Risk) and SA Invest (Participating) investment benefits 	608 	462
Death 	48 	42
Annuity payments 	560 	420
SA Life, Group Life and Other insurance claims 	2 097 	2 268
Death 	1 215 	1 109
Disability 	1 136 	1 401
Payback benefits 	29 	18
Less: Reinsurance recoveries 	(283) 	(260)
SA Discovery Insure and Other insurance claims 	3 222 	4 428
Gross claims 	3 270 	5 136
Less: Reinsurance recoveries 	(48) 	(708)
UK Health insurance claims 	11 297 	9 561
Gross claims 	11 299 	9 562
Less: Reinsurance recoveries 	(2) 	(1)
25 558 	24 076
Claims and policyholders’ benefits 	5.11.1 	30 231 	29 462
Insurance claims recovered from reinsurers 	(4 673) 	(5 386)
Net claims and policyholder benefits 	25 558 	24 076
5.11.5 	Auditors remuneration
Group
R million 	Deloitte 	KPMG 	Other 	Total
Year ended 30 June 2025
ISA 700 audit fees 	124 	91 	10 	225
Current year 	87 	83 	7 	177
Prior year 	37 	8 	3 	48
Other assurance and related services performed under IAASB
standard and regulatory related services 	10 	7 	– 	17
Subtotal: Auditor services 	134 	98 	10 	242
Non-audit services 	– 	– 	7 	7
Total 	134 	98 	17 	249
% Non-audit services compared to auditor services 	0% 	0%
Year ended 30 June 2024
ISA 700 audit fees 	130 	74 	4 	208
Current year 	130 	74 	4 	208
Prior year 	– 	– 	– 	–
Other assurance and related services performed under IAASB
standard and regulatory related services 	7 	8 	– 	15
Subtotal: Auditor services 	137 	82 	4 	223
Non-audit services 	1 	– 	– 	1
Total 	138 	82 	4 	224
% Non-audit services compared to auditor services 	<1% 	0%
Notes to the group annual financial statements continued
for the year ended 30 June 2025
201
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.11 	EXPENSES continued
5.11.3 	Marketing and administration expenses
R million 	Notes
Group
2025
Restated
Group
2024
Auditors remuneration 	5.11.5 	249 	224
Lease charges
Short-term leases 	6 	6
Low-value item leases 	87 	116
93 	122
Staff costs including executive directors1
Salaries, wages and allowances 	11 235 	10 438
Medical aid fund contributions 	551 	600
Defined contribution provident fund contributions 	534 	499
Social security levies 	484 	425
Share-based payment expenses
– equity-settled 	715 	717
– cash-settled 	23 	24
Staff training 	86 	90
Recruitment fees 	54 	63
Temporary staff 	661 	569
Provision for leave pay 	18 	16
Other 	474 	282
14 835 	13 723
Other operating costs
Amortisation of software 	5.4 	1 450 	1 411
Amortisation of intangibles acquired in a business combination 	5.4 	71 	56
Building related and office costs 	648 	689
Depreciation of property and equipment 	5.5 	724 	709
Loss on derecognition of property and equipment and intangible assets 	142 	55
Gain on disposal of property and equipment 	(1) 	(1)
Impairment of property and equipment and intangible assets 	65 	22
NCAHFS impairment 	79 	–
Allowance for expected credit losses on financial receivables and contract
receivables 	86 	3
Insurance 	91 	83
IT systems and consumables 	3 221 	3 124
Marketing and distribution costs 	2 136 	2 300
Non-executive directors fees 	61 	63
Professional fees 	966 	1 326
Vitality benefit expenses 	6 092 	5 354
Other operating expenses 	4 266 	3 443
Subtotal of other operating costs 	20 097 	18 637
Total expenses2 	44 315 	39 766
Represented by:
Insurance service expense 	5.11.1 	8 883 	8 323
Other: Experience adjustment on CSM 	17 	(86)
Insurance acquisition cash flows3 	13 650 	11 885
Marketing and administration expenses 	21 765 	19 644
Total expenses 	44 315 	39 766
1 Executive directors’ and prescribed officers’ remuneration is included in employee costs. Refer to Annexure C – Directorate for detailed disclosure.
2 Total expenses include commission paid to obtain insurance contracts. Refer to note 5.11.2
3 The comparative period total commission paid and insurance acquisition cash flows were understated, because not all of the associated cost and
corresponding allocation were disclosed. The correction does not affect the reported amounts in the Group income statement or Segment information.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
200
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
201	200

-- 103 of 155 --

SECTION 06
CASH FLOW
INFORMATION
Introduction and overview
Cash flow information
Cash generated from operations
Taxation paid
Movement in borrowings
Interest paid
Dividends received
203
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 5: OTHER ASSETS, LIABILITIES, EQUITY-ACCOUNTED INVESTMENTS
AND ITEMS OF INCOME AND EXPENSE continued
5.12 	FOREIGN EXCHANGE LOSSES
For the accounting policies relevant to the recognition and measurement of foreign exchange gains/ (losses), refer to
Annexure B, policy 3.
R million
Group
2025
Group
2024
Net foreign exchange losses 	(36) 	(87)
The net foreign exchange gains and losses arise primarily from foreign denominated loans, some of which are internal.
The total amount of foreign exchange gains/(losses) recognised in profit or loss is a profit of R42 million (2024: R53 million loss)
presented in the Income Statement within various lines associated with the underlying transaction.
5.13 	ACQUISITION OF BUSINESSES AND SUBSIDIARIES
In November 2024, The Vitality Group acquired 100% of the shares in WellSpark Health Inc. (‘WellSpark’), a United States-based
company specialising in customised wellbeing, coaching, and disease prevention services. This acquisition enables The Vitality
Group to leverage WellSpark’s specialised wellness product suite and established customer base.
Vitality Group concluded that substantially all of the value of the acquisition is concentrated in a single identifiable asset, namely
the intangible asset – customer relationships. In line with the Group’s accounting policy outlined in section 2.1 Business
Combinations (Annexure B), Discovery has elected to apply the optional concentration test. Based on the outcome of this
assessment, the transaction has been accounted for as an asset acquisition under IFRS 3 with no resultant goodwill.
The table below summarises the recognised assets acquired, and liabilities assumed at the acquisition date:
R million
Group
2025
Recognised assets, comprising of cash, cash equivalents, prepayments and accounts receivable 	6
Recognised liabilities, comprising of taxes payable and accrued expenses 	(*)
New identified asset acquired: Intangible asset, Customer relationships1 	310
Total identifiable net assets acquired/Purchase consideration 	316
* Amount less than R500 000.
1 The multi-period excess earnings model was used to measure the fair value of the customer relationship intangible asset. This model considers the present
value of net cash flows expected to be generated by the customer relationships, by excluding any cash flows related to contributory assets.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
202
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
203	202

-- 104 of 155 --

SECTION 6: CASH FLOW INFORMATION continued
6.2 	CASH FLOW INFORMATION continued
6.2.1 	Cash generated/(utilised) from operations continued
6.2.1.2 	INCREASE IN OPERATING LIABILITIES
R million
Group
2025
Restated
Group
20241
– Deposits from customers 	4 801 	4 134
– Other payables at amortised cost 	1 695 	617
– Investment contract liabilities 	2 668 	(5 166)
– Third-party interest liabilities 	82 	237
– Contract liabilities to customers 	1 007 	(443)
– Other payables and provisions 	(97) 	(687)
– Assets and liabilities arising from insurance contracts issued, adjusted for changes
recognised in OCI 	7 257 	4 870
– Assets and liabilities arising from reinsurance contracts held, adjusted for changes
recognised in OCI 	2 814 	243
20 227 	3 805
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
6.2.2 	Taxation paid
R million
Group
2025
Restated
Group
20241
Balance at beginning of year 	18 	(124)
Taxation charged for the year in the income statement 	(4 089) 	(2 715)
Adjustment for movement in deferred taxation 	1 902 	1 335
Reallocation to separately disclosable items 	(45) 	4
Translation difference 	5 	(4)
Balance at end of year 	342 	(18)
Taxation paid 	(1 867) 	(1 522)
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
6.2.3 	Movement in borrowings
R million
Group
2025
Group
2024
Balance at beginning of year excluding bank overdraft 	21 657 	20 553
Leased assets acquired 	107 	183
Increase in borrowings 	3 255 	2 000
Raising fees capitalised 	9 	5
Interest accrued on borrowings 	1 964 	2 007
Interest paid on borrowings 	(1 575) 	(1 545)
Repayment of borrowings 	(5 573) 	(1 385)
Modification to lease assets 	(4) 	(1)
Translation difference 	204 	(160)
Balance at end of year 	20 044 	21 657
Notes to the group annual financial statements continued
for the year ended 30 June 2025
205
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 6: CASH FLOW INFORMATION
6.1 	INTRODUCTION AND OVERVIEW
This section provides more information on the Group statement of cash flows
6.2 	CASH FLOW INFORMATION
6.2.1 	Cash generated from operations
R million
Group
2025
Restated
Group
20241
Profit before income tax 	13 647 	10 264
Adjusted for items presented separately in Statement of cash flows:
– Interest received 	(3 201) 	(2 700)
– Interest paid 	3 324 	3 097
Adjusted for non-cash items:
– Gains on financial assets at fair value through profit or loss 	(23 080) 	(14 109)
– (Gains)/losses from derivative financial instruments 	(80) 	36
– Fair value adjustment to liabilities under investment contracts 	3 810 	2 142
– Third-party interest: fair value adjustment to liabilities under investment contracts 	4 394 	2 873
– Cash flow hedge losses/(gains) from derivative financial instruments 	2 	4
– Other gains on financial instruments 	9 	(5)
– Marketing and administration expenses 	3 354 	2 996
– Share-based payment expenses – cash settled 	23 	24
– Share-based payment expenses – equity settled 	715 	717
– Amortisation of software 	1 450 	1 411
– Amortisation of intangibles acquired in a business combination 	71 	56
– Depreciation of property and equipment 	336 	347
– Depreciation of right of use assets 	388 	362
– Loss on derecognition of property and equipment 	11 	10
– Loss on derecognition of intangible assets 	131 	45
– (Gain)/loss on disposal of property and equipment 	(1) 	(1)
– Impairment of property and equipment 	– 	14
– Impairment of intangible assets (excluding goodwill) 	65 	8
– Impairment of non-current assets held for sale 	79 	–
– Allowance for expected credit losses on financial receivables and contract receivables 	86 	3
– Allowance for expected credit losses on loans and advances to customers 	279 	235
– Impairment of goodwill 	20 	–
– Loss/(gain) on dilution of equity-accounted investment 	32 	(22)
– Share of profits from equity-accounted investments 	(1 215) 	(975)
– Foreign exchange losses/(gains) 	(6) 	140
Cash generated from operations 	1 289 	3 976
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
6.2.1.1 	INCREASE IN OPERATING ASSETS
R million
Group
2025
Restated
Group
20241
– Investments held to back policyholder liabilities 	(3 494) 	(5 190)
– Loans and advances to customers 	(2 670) 	(1 484)
– Contract receivables and other receivables 	(694) 	(1 119)
– Trading assets and derivative instruments 	(105) 	(553)
– Financial investments 	(2 827) 	5 573
– Assets arising from contracts with customers 	(1 270) 	(451)
(11 060) 	(3 224)
1 The comparative information has been restated due to correction of a prior period error. Refer to note 7.5 for more detail.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
204
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
205	204

-- 105 of 155 --

SECTION 07
OTHER
DISCLOSURES
Introduction and overview
Capital commitments
Events after reporting period
Restatements
207
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 6: CASH FLOW INFORMATION continued
6.2 	CASH FLOW INFORMATION continued
6.2.4 	Interest paid
R million
Group
2025
Group
2024
Interest expenses on borrowings, lease liabilities and bank interest and similar expense per
the income statement 	(3 324) 	(3 097)
Bank interest and similar expense using effective interest rate method 	(1 237) 	(1 061)
Interest expenses on borrowings and lease liabilities 	(2 087) 	(2 036)
Adjusted for:
– Bank borrowings interest accruals 	(29) 	29
– Lease liabilities interest accrual not paid 	418 	433
– Other payables or interest accrual 	58 	8
Interest paid 	(2 877) 	(2 627)
6.2.5 	Dividends received
R million
Group
2025
Group
2024
Dividends from equity-accounted investments 	490 	305
Total dividends received 	490 	305
Notes to the group annual financial statements continued
for the year ended 30 June 2025
206
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
207	206

-- 106 of 155 --

SECTION 7: OTHER DISCLOSURES continued
7.4 	EVENTS AFTER THE REPORTING PERIOD CONTINUED
The following non-adjusting events occurred between the end of the reporting period and the date when the financial
statements were authorised for issue.
7.4.1 	Dividend declared continued
7.4.1.2 	ORDINARY SHARES
7.4.1.2.1 	ORDINARY SHARE CASH DIVIDEND DECLARATION
On Wednesday, 10 September 2025, the Board of Directors declared a final gross cash dividend of 201.00000cents (160.80000
cents net of dividend withholding tax) per ordinary share, out of the income reserves of the Company. A dividend withholding
tax of 20% will be applicable to all shareholders who are not exempt.
The number of ordinary shares in issue at the date of declaration is 679 680 841.
The salient dates for the dividend will be as follows:
Last day of trade to receive a dividend 	Tuesday, 14 October 2025
Shares commence trading “ex” dividend 	Wednesday, 15 October 2025
Record date 	Friday, 17 October 2025
Payment date 	Monday, 20 October 2025
Ordinary share certificates may not be dematerialised or rematerialised between Wednesday, 15 October 2025 and Friday,
17 October 2025, both days inclusive.
7.4.1.2.2 	ORDINARY SHARE CASH DIVIDEND DECLARATION HISTORY
Payment date 	Nature and financial period 	Dividend declared per share
31 March 2025 	Interim dividend, financial year 2025 	87.00000 cents
(69.60000 cents net of dividend withholding tax)
21 October 2024 	Final dividend, financial year 2024 	152.00000 cents
(121.60000 cents net of dividend withholding tax)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
209
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 7: OTHER DISCLOSURES
7.1 	INTRODUCTION AND OVERVIEW
This section provides information on other disclosures that are non-recurring. Disclosures include restatements, capital
commitments, any contingent liabilities and assets, as well as events after reporting date including dividend declarations.
7.2 	PRIMARY FINANCIAL STATEMENTS AND INFORMATION ANALYSED IN THIS
SECTION
Additional information 	Notes
Capital commitments 	7.3
Events after the reporting period 	7.4
Restatements 	7.5
7.3 	CAPITAL COMMITMENTS
R million
Group
2025
Group
2024
Capital expenditure approved but not contracted for at the reporting date as follows:
– Property and equipment 	252 	32
– Intangible assets 	84 	170
– Developments costs for Discovery Bank 	280 	280
616 	482
7.4 	EVENTS AFTER THE REPORTING PERIOD
The following non-adjusting events occurred between the end of the reporting period and the date when the financial
statements were authorised for issue.
7.4.1 	Dividend declared
7.4.1.1 	B PREFERENCE SHARES
7.4.1.1.1 	B PREFERENCE SHARE CASH DIVIDEND DECLARATION
On Thursday, 4 September 2025, the Board of directors declared a final gross cash dividend of 545.47945 cents (436.38356 cents
net of dividend withholding tax) per B preference share for the period 1 January 2025 to 30 June 2025, payable from the income
reserves of the Company.
A dividend withholding tax of 20% will be applicable to all shareholders who are not exempt.
The issued preference share capital at the declaration date is 8 million B preference shares.
The salient dates for the dividend will be as follows:
Last day of trade to receive a dividend 	Monday, 22 September 2025
Shares commence trading “ex” dividend 	Tuesday, 23 September 2025
Record date 	Friday, 26 September 2025
Payment date 	Monday, 29 September 2025
B preference share certificates may not be dematerialised or rematerialised between Tuesday, 23 September 2025 and Friday,
26 September 2025, both days inclusive.
7.4.1.1.2 	B PREFERENCE SHARE CASH DIVIDEND HISTORY
Payment date 	Nature and financial period 	Dividend declared per share
17 March 2025 	Interim dividend, financial year 2025 	582.67123 cents
(466.13699 cents net of dividend withholding tax)
23 September 2024 	Final dividend, financial year 2024 	585.89041cents
(468.71233 cents net of dividend withholding tax)
25 March 2024 	Interim dividend, financial year 2024 	592.32877 cents
(473.86302 cents net of dividend withholding tax)
26 September 2023 	Final dividend, financial year 2023 	548.49315 cents
(438.79452 cents net of dividend withholding tax)
Notes to the group annual financial statements continued
for the year ended 30 June 2025
208
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
209	208

-- 107 of 155 --

SECTION 7: OTHER DISCLOSURES continued
7.5 	RESTATEMENT continued
7.5.1 	Restatement as a result of prior period error continued
RECONCILIATION OF THE RESTATED GROUP STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2024
R million
Group
30 June 2024
(previously
reported)
Item 1
Correction
Increase/
(Decrease)
Group
30 June 2024
Restated
Assets
Assets arising from insurance contracts issued 	41 816 	(4 477) 	37 339
– Estimates of PVFCF 	85 318 	– 	85 318
– RA for non-financial Risk 	(10 050) 	– 	(10 050)
– Contractual service margin 	(37 676) 	(4 477) 	(42 153)
– Portfolios applying the PAA approach 	4 224 	– 	4 224
Total of assets unaffected by restatement 	242 295 	– 	242 295
TOTAL ASSETS 	284 111 	(4 477) 	279 634
Equity
Other reserves 	6 275 	(4 099) 	2 176
Retained earnings 	39 998 	831 	40 829
Total of equity unaffected by restatement 	11 446 	– 	11 446
TOTAL EQUITY 	57 719 	(3 268) 	54 451
Liabilities
Deferred liability 	8 184 	(1 209) 	6 975
Total of liabilities unaffected by restatement 	218 208 	– 	218 208
TOTAL LIABILITIES 	226 392 	(1 209) 	225 183
TOTAL EQUITY AND LIABILITIES 	284 111 	(4 477) 	279 634
RECONCILIATION OF GROUP INCOME STATEMENT FOR THE YEAR ENDED 30 JUNE 20241
R million
Group
30 June 2024
(previously
reported)
Item 1
Correction
Increase/
(Decrease)
Group
30 June 2024
Restated
Insurance revenue 	51 857 	273 	52 130
Insurance service expenses 	(46 145) 	28 	(46 117)
Net income/(expenses) from reinsurance contracts 	(915) 	– 	(915)
Insurance service result 	4 797 	301 	5 098
Net financial result from insurance finance income and expense 	(7 245) 	(48) 	(7 293)
– Net finance expense from insurance contracts 	(6 902) 	(48) 	(6 950)
– Net finance expense from reinsurance contracts 	(343) 	– 	(343)
Net insurance and investment results 	9 647 	253 	9 900
Net income 	31 952 	253 	32 205
Operating profit 	11 137 	253 	11 390
Profit before financing and income tax 	12 134 	253 	12 387
Profit before income tax 	10 011 	253 	10 264
Income tax expense 	(2 647) 	(68) 	(2 715)
Profit for the year 	7 364 	185 	7 549
Earnings per share for profit attributable to ordinary shareholders of
the company during the year (cents):
– Basic 	1 082.7 	27.6 	1 110.3
– Diluted 	1 076.3 	27.4 	1 103.7
1 Only the financial statement line items impacted by the adjustments have been included in this note; therefore, the note does not reproduce all line items
from the Group income statement.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
211
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 7: OTHER DISCLOSURES continued
7.5 	RESTATEMENTS
7.5.1 	Restatement as a result of prior period error
This section provides summary information of the impact as a result of the correction of prior period errors. The corrections
impacted the Group statement of financial position as at 1 July 2023 and 30 June 2024, the Group income statement and Group
statement of other comprehensive income for the year ended 30 June 2024 as well as the Group statement of cash flows for the
year ended 30 June 2024. The information is set out to reconcile the previously published information to the final restated
financial positions and performance.
ITEM 1: CORRECTION OF SA LIFE AND SA INVEST INSURANCE RESULTS
In the previous financial year ended 30 June 2024, Discovery adopted IFRS 17 Insurance Contracts for the first time, with full
retrospective effect. The impacts of adoption of IFRS 17 were fully disclosed in the prior year’s financial statements.
During the current year under review, Discovery identified the need to correct a coding error that impacted the quantification of
the transitional impact of IFRS 17. This error affected the way in which the SA Life and SA Invest businesses accounted for
changes in estimates. The correction resulted in a reallocation from the Insurance Finance Reserve, a component of equity, with
a resultant increase in the Contractual Service Margin (CSM).
As explained during transition to IFRS 17, the positive increase in CSM represents a “store of value” that is expected to release to
the income statement, and ultimately to equity as retained earnings, over time. The CSM releases to the income statement as
services are provided based on the coverage units of the underlying groups of insurance contracts.
Notably, the strengthening of the CSM resulted in a decrease in the number of groups classified as onerous. The decrease in the
onerous contract groups resulted in an increase in retained earnings as well as an increase in earnings of the prior year.
The other measurement components of insurance contract balances, namely the present value of fulfilment cash flows and the
risk adjustment, were unaffected by this correction. Importantly, the correction had a cumulative impact on the later years of the
fully retrospective transition.
Discovery corrected the error in the earliest period presented (1 July 2023) and in the comparative period ended 30 June 2024.
The restatement has had no effect on operating, investing, or financing cash flows. While there was no overall impact on cash
flows from operating activities, the correction resulted in an increase of R253 million in cash generated from operations, with an
equal and opposite adjustment to operating liabilities. Consistent with the impacts explained upon transition, the restatement
does not affect regulatory solvency positions or embedded value.
RECONCILIATION OF THE RESTATED GROUP STATEMENT OF FINANCIAL POSITION AS AT 1 JULY 2023
R million
Group
30 June 2023
(previously
reported)
Item 1
Correction
Increase/
(Decrease)
Group
1 July 2023
Restated
Assets
Assets arising from insurance contracts issued 	33 624 	(3 400) 	30 224
– Estimates of PVFCF 	80 340 	– 	80 340
– RA for non-financial Risk 	(8 981) 	– 	(8 981)
– Contractual service margin 	(41 244) 	(3 400) 	(44 644)
– Portfolios applying the PAA approach 	3 509 	– 	3 509
Total of assets unaffected by restatement 	225 115 	– 	225 115
TOTAL ASSETS 	258 739 	(3 400) 	255 339
Equity
Other reserves 	4 690 	(3 128) 	1 562
Retained earnings 	33 900 	646 	34 546
Total of equity unaffected by restatement 	11 134 	– 	11 134
TOTAL EQUITY 	49 724 	(2 482) 	47 242
Liabilities
Deferred tax liability 	6 706 	(918) 	5 788
Total of liabilities unaffected by restatement 	202 309 	– 	202 309
TOTAL LIABILITIES 	209 015 	(918) 	208 097
TOTAL EQUITY AND LIABILITIES 	258 739 	(3 400) 	255 339
Notes to the group annual financial statements continued
for the year ended 30 June 2025
210
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
211	210

-- 108 of 155 --

RECONCILIATION OF GROUP STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 30 JUNE 20241
R million
Group
30 June 2024
As previously
published,
including
correction of
item 1 as set
out above
Item 3
Correction
Increase/
(Decrease)
Group
30 June 2024
Restated
Cash flow from operating activities 	2 733 	– 	2 733
Cash generated by operations 	3 250 	726 	3 976
Net movement in operating assets and liabilities 	1 307 	(726) 	581
– Increase in operating assets 	(7 513) 	4 289 	(3 224)
– Increase in operating liabilities 	8 820 	(5 015) 	3 805
1 Only the financial statement line items impacted by the adjustments have been included in this note; therefore, the note does not reproduce all line items from
the Group statement. of cash flows
Notes to the group annual financial statements continued
for the year ended 30 June 2025
213
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 7: OTHER DISCLOSURES continued
7.5 	RESTATEMENT continued
7.5.1 	Restatement as a result of prior period error continued
RECONCILIATION OF GROUP STATEMENT OF OTHER COMPREHENSIVE INCOME FOR THE YEAR ENDED 30 JUNE 20241
R million
Group
30 June 2024
(previously
reported)
Item 1
Correction
Increase/
(Decrease)
Group
30 June 2024
Restated
Profit for the year 	7 364 	185 	7 549
Net finance income/(expense) from insurance contracts issued 	2 672 	(971) 	1 701
– Unrealised income/(expense) 	3 595 	(1 330) 	2 265
– Tax on unrealised (income)/expense 	(923) 	359 	(564)
Total income and expenses that will be reclassified to profit or loss
when specific conditions are met 	1 331 	(971) 	360
Other comprehensive income for the year, net of tax 	1 348 	(971) 	377
Total comprehensive income for the year 	8 712 	(786) 	7 926
1 Only the financial statement line items impacted by the adjustments have been included in this note; therefore, the note does not reproduce all line items
from the Group statement of other comprehensive income.
ITEM 2: CORRECTION OF THE NON-INSURANCE ACQUISITION COSTS FOR DISCOVERY INVEST
During the year ended 30 June 2025, Discovery identified that it had not eliminated intragroup transactions for the
reimbursement of the acquisition costs incurred within the SA Invest segment. This incorrect treatment resulted in an
overstatement of both the fee income from administration business and non-insurance acquisition costs in the period
ended 30 June 2024.
The correction does not impact the Group income statement’s total profit, basic earnings per share, or diluted earnings per
share. The restatement has had no impact on operating, investing, or financing cash flows.
RECONCILIATION OF GROUP INCOME STATEMENT FOR THE YEAR ENDED 30 JUNE 20241
R million
Group
30 June
2024
(post item 1
correction)
Item 2
Correction
Increase/
(Decrease)
Group
30 June 2024
Restated
Fee income from administration business 	14 093 	(497) 	13 596
Non-insurance revenue and income 	22 305 	(497) 	21 808
Net income 	32 205 	(497) 	31 708
Non-insurance acquisition costs 	(988) 	497 	(491)
Operating profit 	11 390 	– 	11 390
Profit before financing and income tax 	12 387 	– 	12 387
Profit before income tax 	10 264 	– 	10 264
Income tax expense 	(2 715) 	– 	(2 715)
Profit for the year 	7 549 	– 	7 549
1 Only the financial statement line items impacted by the adjustments have been included in this note; therefore, the note does not reproduce all line items
from the Group income statement.
ITEM 3: GROUP STATEMENT OF CASH FLOWS
Discovery regularly reviews its presentation and disclosures in line with evolving market practices, IFRS Accounting Standards,
and changes in its business to enhance clarity and understanding. The Group has accordingly updated its statement of cash
flows, applying the changes to the year ended 30 June 2025 and restating the prior year for comparability, with a reconciliation
provided between the originally published 2024 figures and the restated balances.
Previously, changes in ‘Fair value adjustments to liabilities under investment contracts’ and ‘Third-party interest: fair value
adjustment to liabilities under investment contracts’ were recorded as cash outflows in Cash generated from operations with a
corresponding entry within changes in operating liabilities. These fair value adjustments are now appropriately recognised as
non-cash movements, with an equal and opposite change to the operating liabilities. In addition, the method for determining
realised gains and losses on investments has been revised, and the prior year corrected accordingly.
Importantly, the restatements have no impact on total ‘Cash flows from operating activities’, as reflected below.
Notes to the group annual financial statements continued
for the year ended 30 June 2025
212
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
213	212

-- 109 of 155 --

R million 	Notes
Company
2025
Company
2024
Assets
Deferred tax asset 	3.5 	– 	3
Investments in subsidiaries 	3.3 	36 579 	35 115
Investment in associate 	3.4 	2 584 	2 584
Financial assets
– Loans to subsidiaries at amortised cost 	1.3 	9 690 	8 260
– Loans to BEE partners 	1.4 	363 	271
– Derivative financial instruments at fair value through profit or loss 	1.5 	1 	14
Other receivables 	3.6 	57 	–
Current tax asset 	– 	12
Cash and cash equivalents 	4.2.5 	613 	1 992
Total assets 	49 887 	48 251
Equity
Capital and reserves
Ordinary share capital and share premium 	2.3 	11 474 	10 783
Perpetual preference share capital 	2.4 	779 	779
Other reserves 	1 765 	1 824
Retained earnings 	17 693 	12 804
Total equity 	31 711 	26 190
Liabilities
Financial liabilities
– Borrowings at amortised cost 	1.6 	9 991 	11 464
– Loans from subsidiaries at amortised cost 	1.7 	7 937 	10 546
– Financial guarantee contracts 	1.8 	8 	11
– Other financial payables at amortised cost 	1.9 	69 	16
– Derivative financial instruments at fair value through profit or loss 	1.5 	117 	24
Current tax liability 	54 	–
Total liabilities 	18 176 	22 061
Total equity and liabilities 	49 887 	48 251
Company statement of financial position
as at 30 June 2025
215
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
Company annual
financial statements
for the year ended 30 June 2025
214
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Company annual
financial statements
for the year ended 30 June 2025
214
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
215	214

-- 110 of 155 --

R million 	Notes
Company
2025
Restated1
Company
2024
Cash flows from operating activities 	(1 947) 	1 865
Cash (utilised)/generated by operations 	4.2.1 	(78) 	3
Interest received 	4.2.7 	459 	265
Interest paid 	4.2.8 	(1 052) 	(966)
Taxation paid 	4.2.2 	(10) 	(74)
Net movement in operating assets and liabilities 	(1 266) 	2 637
– Decrease in operating assets 	(172) 	(54)
– (Decrease)/Increase in operating liabilities 	(1 094) 	2 691
Cash flows from investing activities 	(623) 	(668)
Dividends received 	4.2.6 	1 431 	1 379
Increase in investments in subsidiaries 	4.2.3 	(1 375) 	(4 358)
Increase in loans granted to subsidiaries 	(3 210) 	(3 472)
Proceeds from settlement of subsidiary loans 	2 531 	5 783
Cash flows from financing activities 	1 187 	529
Repurchase of treasury shares 	– 	(131)
Proceeds from issuance of ordinary shares 	626 	432
Proceeds from long-term borrowings 	4.2.4 	3 255 	2 000
Repayment of long-term borrowings 	4.2.4 	(4 703) 	(504)
Premium refunded/(paid) on interest rate swap 	1 	2
Increase in loans from subsidiaries 	3 772 	–
Refunds of collateral in terms of CSA Margin 	105 	–
Payment of collateral in terms of CSA Margin 	(160) 	–
Dividends paid to ordinary shareholders 	(1 616) 	(1 179)
Dividends paid to preference shareholders 	(93) 	(91)
Net (decrease)/increase in cash and cash equivalents 	(1 383) 	1 726
Cash and cash equivalents at beginning of the year 	1 992 	282
Effects of exchange rate changes on cash and cash equivalents 	4 	(16)
Cash and cash equivalents at end of the year 	4.2.5 	613 	1 992
1 Restated, refer to section 5 for more details on the restatement.
Company statement of cash flows
for the year ended 30 June 2025
217
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
R million 	Notes
Company
2025
Company
2024
Investment income 	3.8 	7 679 	3 882
– At amortised cost interest income, using the effective interest rate 	1 014 	1 079
– Dividends received from subsidiaries 	6 665 	2 803
Other income 	3.9 	21 	24
Marketing and administration expenses 	3.10 	(83) 	(18)
Movement in allowance for expected credit losses 	3.11 	– 	(3)
Profit before financing and income tax 	7 617 	3 885
Interest expenses on borrowings 	(1 030) 	(993)
Foreign exchange gains/ (losses) 	111 	(100)
Profit before income tax 	6 698 	2 792
Income tax expense 	3.7 	(79) 	(19)
Profit for the year 	6 619 	2 773
Attributable to:
– Ordinary shareholders 	6 526 	2 682
– Preference shareholders 	93 	91
6 619 	2 773
Company statement of other comprehensive income
for the year ended 30 June 2025
R million
Company
2025
Company
2024
Profit for the year 	6 619 	2 773
Income and expenses that will be reclassified to profit or loss when specific conditions are met:
Cash flow hedges 	(104) 	(62)
– unrealised losses 	(106) 	(66)
– losses reclassified to profit or loss 	2 	4
Other comprehensive (loss)/income for the year, net of tax 	(104) 	(62)
Total comprehensive income for the year 	6 515 	2 711
Attributable to:
– Ordinary shareholders 	6 422 	2 620
– Preference shareholders 	93 	91
Total comprehensive income for the year 	6 515 	2 711
Company income statement
for the year ended 30 June 2025
216
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
217	216

-- 111 of 155 --

Notes to the company annual financial
statements
for the year ended 30 June 2025
The principal accounting policies applied in the preparation of these separate financial statements are consistent with those
set out in Annexure B.
SECTION 01
Financial instruments and
management of financial risk
Introduction and overview
Financial instruments
■ Loans to BEE partners
■ Loans to subsidiaries
■ Derivative financial instruments at fair value through
profit or loss
■ Borrowings at amortised cost
■ Loans from subsidiaries
■ Financial guarantee contracts
■ Other financial payables at amortised cost
Management of financial risk
■ Interest rate risk
■ Currency risk
■ Credit risk
■ Liquidity risk
■ Fair value hierarchy
SECTION 02
Equity
Introduction and overview
Ordinary share capital and share premium
Perpetual preference share capital
SECTION 03
Other assets, liabilities and items
of income and expense
Introduction and overview
Other investments, assets and liabilities
■ Investments in subsidiaries
■ Investment in associate
■ Deferred tax asset
■ Other receivables
Items of income and expense
■ Investment income
■ Income tax expense
■ Other income
■ Marketing and administration expenses
■ Movement in allowance for expected credit losses
SECTION 04
Cash flow information
Cash flow information
■ Cash generated by operations
■ Taxation paid
■ Increase in investments in subsidiaries
■ Long-term borrowings
■ Cash and cash equivalents
■ Dividends received
■ Interest received
■ Interest paid
SECTION 05
Other disclosures
Introduction and overview
Events after reporting date
219
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
Company
R million
Share capital
and share
premium
Perpetual
Preference
share capital
Share-based
payment
reserve
Hedging
reserve
Retained
earnings 	Total
Year ended 30 June 2025
At beginning of the year 	10 783 	779 	1 845 	(21) 	12 804 	26 190
Total comprehensive income for the year 	– 	93 	– 	(104) 	6 526 	6 515
Profit for the year 	– 	93 	– 	– 	6 526 	6 619
Other comprehensive income 	– 	– 	– 	(104) 	– 	(104)
Transactions with owners 	691 	(93) 	45 	– 	(1 637) 	(994)
Issue of shares 	626 	– 	– 	– 	– 	626
Increase in treasury shares 	(626) 	– 	– 	– 	– 	(626)
Delivery of treasury shares 	691 	– 	(691) 	– 	– 	–
Employee share option schemes:
– Value of employee services net of tax 	– 	– 	715 	– 	– 	715
Transfer of vested shares 	– 	– 	21 	– 	(21) 	–
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	(1 616) 	(1 616)
Dividends paid to preference shareholders 	– 	(93) 	– 	– 	– 	(93)
Balance at 30 June 2025 	11 474 	779 	1 890 	(125) 	17 693 	31 711
Year ended 30 June 2024
At beginning of the year 	10 467 	779 	1 560 	41 	11 315 	24 162
Total comprehensive income for the year 	– 	91 	– 	(62) 	2 682 	2 711
Profit for the year 	– 	91 	– 	– 	2 682 	2 773
Other comprehensive income 	– 	– 	– 	(62) 	– 	(62)
Transactions with owners 	316 	(91) 	285 	– 	(1 193) 	(683)
Issue of shares 	433 	– 	– 	– 	– 	433
Increase in treasury shares 	(564) 	– 	– 	– 	– 	(564)
Delivery of treasury shares 	447 	– 	(447) 	– 	– 	–
Employee share option schemes: 	–
– Value of employee services net of tax 	– 	– 	718 	– 	– 	718
Transfer of vested shares 	– 	– 	14 	– 	(14) 	–
Dividends paid to ordinary shareholders 	(1 179) 	(1 179)
Dividends paid to preference shareholders 	– 	(91) 	– 	– 	– 	(91)
Balance at 30 June 2024 	10 783 	779 	1 845 	(21) 	12 804 	26 190
Company statement of changes in equity
for the year ended 30 June 2025
218
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
219	218

-- 112 of 155 --

SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.3 	LOANS TO SUBSIDIARIES continued
Terms for interest-bearing loans
GBP DENOMINATED
Discovery Limited has granted GBP denominated loans to Discovery Group Europe Limited. The terms are as follows:
Carrying value
Original
loan value
GBP million
Capital repayment and
maturity date
Company
2025 	Company 2024
Variable rate 	R million 	GBP million 	R million 	GBP million
25
Bank of England base
rate + 600bps 	At maturity - 1 April 2027 	600 	25 	569 	25
6
Bank of England base
rate + 600bps 	At maturity - 1 November 2027 	146 	6 	138 	6
11
Bank of England base
rate + 600bps 	At maturity - 1 June 2028 	256 	10 	242 	11
9
Bank of England base
rate + 600bps 	At maturity - 21 August 2028 	219 	9 	208 	9
7
Bank of England base
rate + 600bps 	At maturity - 24 November 2028 	158 	7 	150 	6
12
Bank of England base
rate + 400bps 	At maturity - 31 December 2028 	499 	20 	433 	19
3
Bank of England base
rate + 615bps 	At maturity - 1 March 2029 	68 	3 	64 	3
7
Bank of England base
rate + 615bps 	At maturity - 1 June 2029 	173 	7 	164 	7
7
Bank of England base
rate + 615bps 	At maturity - 1 August 2029 	158 	7 	150 	7
2 277 	94 	2 118 	92
ZAR DENOMINATED
Discovery Limited has granted ZAR denominated loans to subsidiaries. The terms are as follows:
Carrying value
Rand million
Subsidiary the loan was granted to
Original
loan value
R million Variable rate
Capital repayment and
maturity date
Company
2025
Company
2024
Discovery Group Europe Limited 	268
3-month JIBAR +
200bps 	At maturity – 31 July 2030 	520 	507
Discovery Health
Proprietary Limited1 	727
3-month JIBAR +
240bps 	At maturity – 30 June 2026 	1 607 	1 451
Discovery Health
Proprietary Limited1,2 	93
At maturity – 30 September
2027 	227 	205
Discovery Health
Proprietary Limited1,2 	282
At maturity – 30 September
2027 	688 	622
Discovery Health
Proprietary Limited1,2 	235
At maturity – 15 December
2027 	562 	507
Discovery Health
Proprietary Limited1,2 	173 	At maturity – 28 March 2027 	402 	363
Discovery Health
Proprietary Limited1,2 	288 	At maturity – 30 June 2027 	651 	588
Discovery Health
Proprietary Limited1,2 	212 	At maturity – 3 July 2027 	479 	433
Discovery Central Services
Proprietary Limited 	2 932
3-month JIBAR +
115bps 	On demand 	1 966 	1 241
7 102 	5 917
1 Interest payable quarterly in arrears, with the option available for Discovery Health to capitalise the interest to the value of the loan.
2 Interest accrues at a fixed rate of 10.2% per annum.
For the loans to Discovery Group Europe Limited, interest of R277 million was earned in respect of these loans in the
current financial year (2024: R284 million) and R118 million foreign exchange gain was recognised in profit and loss
(2024: R83 million loss).
Notes to the company annual financial statements continued
for the year ended 30 June 2025
221
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
1.1 	INTRODUCTION AND OVERVIEW
This section provides information on financial instruments including the disclosure and reconciliation of all financial assets and
liabilities and cash and cash equivalents. This section also details how the financial risk is managed.
1.2 	PRIMARY FINANCIAL STATEMENT AND INFORMATION ANALYSED IN THIS
SECTION
R million 	Notes
Company
2025
Company
2024
Statement of financial position
ASSETS
Financial assets
– Loans to subsidiaries at amortised cost 	1.3 	9 690 	8 260
– Loans to BEE partners 	1.4 	363 	271
– Derivative financial instruments at fair value through profit or loss 	1.5 	1 	14
Cash and cash equivalents 	4.2.5 	613 	1 992
10 667 	10 537
LIABILITIES
Financial liabilities
– Borrowings at amortised cost 	1.6 	9 991 	11 464
– Loans from subsidiaries at amortised cost 	1.7 	7 937 	10 546
– Financial guarantee contracts 	1.8 	8 	11
– Other financial payables at amortised cost 	1.9 	69 	16
– Derivative financial instruments at fair value through profit or loss 	1.5 	117 	24
18 122 	22 061
1.3 	LOANS TO SUBSIDIARIES1
R million
Company
2025
Company
2024
Interest bearing loans 	9 379 	8 035
Discovery Group Europe Limited 	2 797 	2 625
Discovery Health Proprietary Limited 	4 616 	4 169
Discovery Central Services Proprietary Limited 	1 966 	1 241
Non-interest bearing loans2 	322 	236
Discovery Connect Distribution Services Proprietary Limited 	– 	2
Discovery Green Proprietary Limited 	1 	1
Discovery Group Europe Limited 	2 	2
Discovery Holdings Europe Limited 	2 	2
Discovery Insure Limited 	– 	–
Discovery Life Investment Services Proprietary Limited 	3 	93
Discovery Telematic Services Proprietary Limited 	* 	16
Discovery Vitality Proprietary Limited 	108 	108
Vitality Corporate Services Limited 	14 	12
Vitality Group International Incorporated 	192 	–
Total gross loans 	9 701 	8 271
Less: IFRS 9 Expected credit losses (ECL) 	(11) 	(11)
Total net loans 	9 690 	8 260
Current 	3 895 	1 478
Non-current 	5 795 	6 782
9 690 	8 260
Balance at beginning of the year 	8 260 	9 840
Additional loan granted 	3 554 	3 999
Repayment of loans
– capital portion 	(2 784) 	(6 299)
– interest portion 	(354) 	(214)
Interest receivable 	900 	1 020
Movement in allowance for expected credit losses 	– 	(2)
Exchange differences 	114 	(84)
Balance at end of the year 	9 690 	8 260
1 All loans to subsidiaries are measured at amortised cost, which approximates to fair value, as the loans bear interest at market related terms. For those that
are non-interest bearing and repayable on demand, the amortised cost approximates fair value.
2 Non-interest bearing loans are repayble on demand.
* Amount is less than R500 000.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
220
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
221	220

-- 113 of 155 --

SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.6 	BORROWINGS AT AMORTISED COST continued
Credit rating
In November 2024, Moody’s Investors Service (“Moody’s”) reaffirmed Discovery Limited’s global-scale long-term issuer rating of
Ba3 and upgraded the national-scale long-term issuer rating to Aa3.za from A1.za. The outlook remained unchanged as stable,
aligned to the outlook of the country.
Domestic Medium Term Notes (DMTN) and other
Carrying value
R million
Facility amount
R million Variable rate
Interest per
annum
Capital repayment and
maturity date
Company
2025
Company
2024
Listed DMTN
200 – 	10.46%2 	At maturity - 21 November 2024 	– 	202
800 3-month JIBAR + 191bps 	8.4%1, 3 	At maturity - 21 November 2024 	– 	809
1 200 3-month JIBAR + 191bps 	7.30%1, 3 	At maturity - 21 November 2024 	– 	1 215
404 – 	7.90% 	At maturity - 21 November 2025 	392 	–
1 111 3-month JIBAR + 95bps 	7.46%3 	At maturity - 21 May 2026 	1 120 	–
700 3-month JIBAR + 180bps 	8.49%1, 3 	At maturity - 21 August 2026 	707 	707
300 3-month JIBAR + 180bps 	7.60%1, 3 	At maturity - 21 August 2026 	303 	304
792 3-month JIBAR + 173bps 	7.98%1, 3 	At maturity - 21 May 2027 	799 	800
576 3-month JIBAR + 140bps 	7.50%1, 3 	At maturity - 21 November 2027 	581 	582
750 3-month JIBAR + 140bps 	7.19%1, 3 	At maturity - 21 November 2027 	758 	–
226 3-month JIBAR + 180bps 	7.98%1, 3 	At maturity - 21 May 2029 	228 	228
924 3-month JIBAR + 159bps 	8.17%1, 3 	At maturity - 21 November 2029 	932 	935
1 000 3-month JIBAR + 159bps 	8.17%1, 3 	At maturity - 21 November 2029 	1 012 	–
Unlisted DMTN4
2 500 – 	9.62%3 	At maturity – 22 February 2025 	– 	2 525
1 650 – 	9.55%3 	At maturity – 10 March 2026 	1 659 	1 659
Other
1 000 3-month JIBAR + 190bps 	8.38%1,3 	At maturity – 02 March 2028 	1 000 	999
500 3-month JIBAR + 190bps 	7.51%1,3 	At maturity – 02 March 2028 	500 	499
Total Discovery Limited Borrowings 	9 991 	11 464
1 The interest rate has been fixed through interest rate swaps.
2 Interest is payable semi-annually in arrears.
3 Interest is payable quarterly in arrears.
4 During the financial year ended 30 June 2020, Discovery Limited refinanced R3.6 billion bank syndicated loans through the issue of unlisted DMTN notes.
The notes, although underwritten by a bank until maturity, are structured to enable short-term issuances into the commercial paper market on an
ongoing basis.
The borrowings are unsecured senior debt and are not callable or convertible. Interest is payable quarterly in arrears other than
footnote 2 in the table above. Refer to company note 4.2.4 for movement analysis and Group Note 3.7.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
223
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.4 	LOANS TO BEE PARTNERS1
R million
Company
2025
Company
2024
Balance at beginning of the year 	271 	219
Interest receivable 	23 	18
Additional loan granted 	84 	58
Repayment of loans 	(15) 	(24)
– Capital 	– 	(14)
– Interest 	(15) 	(10)
Balance at end of the year 	363 	271
Current 	363 	271
1 All loans to BEE partners are measured at amortised cost, which approximates to fair value.
These loans are due from Mohau Equity Partners. R318 million (2024: R219 million) is a bridge loan that accrues interest at prime
rate less 2%. R45 million (2024: R52 million) is an interest-free loan to provide empowerment financing towards a newly formed
brokerage. There are no repayment terms for these loans.
1.5 	DERIVATIVE FINANCIAL INSTRUMENTS AT FAIR VALUE THROUGH PROFIT OR
LOSS
R million
Company
2025
Assets
Company
2025
Liabilities
Company
2024
Assets
Company
2024
Liabilities
Interest rate derivatives – used as cash flow hedges1 	1 	117 	14 	24
Total 	1 	117 	14 	24
Current 	– 	– 	6 	1
Non-current 	1 	117 	8 	23
Total 	1 	117 	14 	24
1 For further information, refer to Group note 3.4 in section 3 which sets out information on the ‘Interest Rate Swaps’ which equally apply to the Company.
1.6 	BORROWINGS AT AMORTISED COST
R million
Company
2025
Company
2024
Borrowings from banks1 	9 991 	11 464
Current 	3 224 	2 304
Non-current 	6 767 	9 160
9 991 	11 464
1 Collateral in the form of financial guarantees by Discovery Health Proprietary Limited and Discovery Vitality Proprietary Limited has been given to secure
these borrowings.
The borrowings were acquired for general corporate purposes in order to fund the various growth initiatives within the Group.
For variable rate loans the carrying amount approximates the fair value because the variable rate is set on market related terms.
For fixed rate loans, the fair value is R1 989 million (2024: R4 351 million) relative to the carrying value of R2 050 million (2024:
R4 387 million).
Notes to the company annual financial statements continued
for the year ended 30 June 2025
222
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
223	222

-- 114 of 155 --

SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.8 	FINANCIAL GUARANTEE CONTRACTS
Company
2025
Company
2024
Discovery Limited has accrued for financial guarantees issued for the
following subsidiary:
Discovery Central Services Proprietary Limited 	i 	8 	11
Total 	8 	11
Balance at the beginning of the year 	11 	12
New guarantee contracts 	– 	1
Fee income released 	(3) 	(3)
Expected credit losses 	– 	1
Balance at end of year 	8 	11
i. 	Discovery Limited has guaranteed the following borrowing facilities of Discovery Central Services Proprietary Limited:
– R650 million facility to fund the systems build of Discovery Bank. The full amount has been drawn down and the balance
outstanding at 30 June 2025 is R300 million (2024: R396 million).
– a 5 year borrowing facility for an amount of R1.4 billion. These funds were acquired for general corporate purposes and
the full amount has been drawn down and the balance outstanding at 30 June 2025 is R1 408 million
(2024: R1 408 million).
– A R1.5 billion financial credit facility was in place during the year and remains undrawn. The outstanding balance of
R154 million was fully settled on 7 June 2024 upon the facility’s expiry, resulting in no balance outstanding at 30 June 2025
(2024: Rnil). The facility was renewed at the end of June 2024 for a further two years, to June 2026.
– a R691 million facility, drawn down in full. The balance outstanding at 30 June 2025 is R694 million (2024: R695 million).
– a R500 million facility, undrawn at 30 June 2025. This facility is a committed 364-day notice facility granted in
November 2023.
ii. 	In December 2022, Discovery Finance Company Europe Limited entered into borrowing facilities for an amount of
GBP 56 million. The facility has been guaranteed by Discovery Limited. Discovery Limited charges a financial guarantee fee
on an arms length basis. For more information refer to company note 3.9. As at 30 June 2025, Discovery Finance Company
Europe Limited owed GBP 52 million (2024: GBP 54 million) in respect of these borrowings.
iii. During 2020, Discovery Holdings Europe Limited entered into borrowing facilities for an amount of GBP 100 million to fund
its operations. The loan was reduced to GBP 25 million in December 2022. This facility has been guaranteed by Discovery
Limited. Discovery Limited charges a financial guarantee fee on an arms length basis. For more information refer to
company note 3.9.
1.9 	OTHER FINANCIAL PAYABLES AT AMORTISED COST
R million
Company
2025
Company
2024
Accrued expenditure 	54 	6
Dividends due to shareholders 	15 	10
69 	16
The amortised cost of the financial payables approximate the fair value due to the short-term nature of these payables.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
225
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.7 	LOANS FROM SUBSIDIARIES1
R million
Company
2025
Company
2024
Discovery Bank Limited 	4 	3
Discovery Health Proprietary Limited 	3 247 	5 744
Discovery Insure Limited 	– 	19
Discovery Life Limited 	4 686 	4 780
Total loans 	7 937 	10 546
Current 	7 937 	10 546
7 937 	10 546
Balance at beginning of the year 	10 546 	9 384
Additional loan granted 	4 223 	5 928
Repayment of loans 	(6 832) 	(4 766)
Balance at end of the year 	7 937 	10 546
1 All loans from subsidiaries are measured at amortised cost, which approximates fair value, either due to their repayable on demand terms or because they
bear interest at market related rates.
Discovery Limited receives funds from its subsidiaries, through intercompany accounts, to assist with operational requirements.
These loans are interest free and are settled as and when sufficient cash becomes available.
For the purposes of determining which cash flows the Company presents as ‘cash flows from operating activities’ and ‘cash flows
from financing activities,’ the Company considers the nature of the liabilities. Cash flows related to long-term borrowings and the
financing of the Company are presented as part of ‘cash flows from financing activities.’ In contrast, cash flows associated with
the Company’s revenue activities, such as investment income or working capital requirements, are presented as ‘cash flows from
operating activities.’ Working capital includes current receivables and payables with no stated repayment terms and that are
revolving in nature.
Loans from subsidiaries, as noted above, amounting to approximately R7.9 billion (2024: R9.3 billion), are considered part of
financing. Therefore, cash flows used to repay these loans are classified as ‘cash flows from financing activities.’ Cash flows
exceeding this base amount are regarded as part of working capital and included in ‘cash flows from operating activities.’
The loans considered part of financing will be reviewed at specified intervals to ensure they reflect the Company’s long-term
funding. Where applicable, the base amount and the associated classification of cash flows as ‘financing’ will be adjusted
accordingly.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
224
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
225	224

-- 115 of 155 --

SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.10 	MANAGEMENT OF FINANCIAL RISK continued
1.10.2 	Currency risk
The Company operates internationally and is exposed to foreign exchange risk arising from various currency exposures,
primarily with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and
recognised assets and liabilities
The following table segregates the currency exposure by major currency:
Company
R million 	Total 	Rand 	GBP 	USD
At 30 June 2025
Derivative financial instruments at fair value:
– used as cash flow hedges 	1 	1 	– 	–
Loans to subsidiaries 	9 690 	7 224 	2 274 	192
Loans to BEE partners 	363 	363 	– 	–
Other receivables 	57 	57 	– 	–
Cash and cash equivalents 	613 	289 	291 	33
Total financial assets 	10 724 	7 934 	2 565 	225
Borrowings at amortised cost 	9 991 	9 991 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	117 	117 	– 	–
Loans from subsidiaries at amortised cost 	7 937 	7 937 	– 	–
Financial guarantee contracts 	8 	8 	– 	–
Other payables 	69 	69 	– 	–
Total financial liabilities 	18 122 	18 122 	– 	–
At 30 June 2024
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	14 	– 	–
Loans to subsidiaries 	8 260 	6 144 	2 116 	–
Loans to BEE partners 	271 	271 	– 	–
Cash and cash equivalents 	1 992 	1 563 	429 	*
Total financial assets 	10 537 	7 992 	2 545 	*
Borrowings at amortised cost 	11 464 	11 464 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	24 	24 	– 	–
Loans from subsidiaries at amortised cost 	10 546 	10 546 	– 	–
Financial guarantee contracts 	11 	11 	– 	–
Other payables 	16 	16 	– 	–
Total financial liabilities 	22 061 	22 061 	– 	–
* Amount is less than R500 000.
A 10% increase on respective foreign exchange rates of GBP: ZAR would result in additional gains of R267 million (2024:
R235 million), or in the case of decrease, a loss of R267 million (2024: R235 million), recognised in profit or loss and equity
(before tax).
Notes to the company annual financial statements continued
for the year ended 30 June 2025
227
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.10 	MANAGEMENT OF FINANCIAL RISK
The Company’s activities expose it to a variety of financial risks. Financial risks include market risk, credit risk and liquidity risk.
Refer to the Group note 3.13 Management of financial risk for a detailed explanation of financial risks and how they are
managed.
1.10.1 	Interest rate risk
Sensitivity to changes in interest rates is relevant to financial assets or liabilities bearing floating interest rates due to the risk
that future cash flows fluctuate. However, sensitivity will also be relevant to fixed-rated financial assets and financial liabilities
that are re-measured to fair value.
The table below details the specific interest rate risk that the Company is exposed to:
Company
R million
Carrying
amount 	Fixed 	Floating
Non-interest
bearing
At 30 June 2025
Derivative financial instruments at fair value:
– used as cash flow hedges1 	1 	1 	– 	–
Loans to subsidiaries at amortised cost 	9 690 	3 010 	6 358 	322
Loans to BEE partners 	363 	– 	318 	45
Other receivables 	57 	– 	57 	–
Cash and cash equivalents 	613 	237 	376 	–
Total financial assets 	10 724 	3 248 	7 109 	367
Borrowings at amortised cost 	9 991 	2 050 	7 941 	–
Derivative financial instruments at fair value:
– used as cash flow hedges1 	117 	117 	– 	–
Loans from subsidiaries at amortised cost 	7 937 	– 	– 	7 937
Financial guarantee contracts 	8 	– 	– 	8
Trade and other payables 	69 	– 	– 	69
Total financial liabilities 	18 122 	2 168 	7 941 	8 014
At 30 June 2024
Derivative financial instruments at fair value:
– used as cash flow hedge1 	14 	14 	– 	–
Loans to subsidiaries at amortised cost 	8 260 	2 715 	5 309 	236
Loans to BEE partners 	271 	– 	219 	52
Cash and cash equivalents 	1 992 	231 	1 761 	–
Total financial assets 	10 537 	2 960 	7 289 	288
Borrowings at amortised cost 	11 464 	4 385 	7 079 	–
Derivative financial instruments at fair value: 	–
– used as cash flow hedges1 	24 	24 	– 	–
Loans from subsidiaries at amortised cost 	10 546 	– 	– 	10 546
Financial guarantee contracts 	11 	– 	– 	11
Trade and other payables 	16 	– 	– 	16
Total financial liabilities 	22 061 	4 409 	7 079 	10 573
1 For further information on the use of interest rate swaps to manage the interest rate risk of Discovery Limited, refer to the following note in the Group
financials, which equally applies to Discovery Limited:
– Note 3.13.4.1 Shareholder financial assets and liabilities, “Borrowings at amortised cost and related hedges”.
For those financial assets at amortised cost, a 1% increase or decrease in the interest rate would result in an increase/decrease
in profit or loss (interest income) and equity, before tax, of R77 million (2024: R84 million). The sensitivity is based on the
assumption that the interest rate has increased/decreased by 1% with all other variables held constant.
Borrowings at amortised cost include facilities at floating interest rates, which expose Discovery Limited to cash flow interest
rate risk. This risk has been managed by using floating-to-fixed interest rate swaps. These interest rate swaps have the economic
effect of converting the borrowings from floating to fixed rates. Interest is payable quarterly in arrears, with capital repayable on
maturity. The hedge ratio is 1:1. For borrowings at floating interest rates that have not been hedged, a change of 1% in the
interest rate would result in an increase of R1 million (2024: R6 million) in finance costs. The sensitivity is based on the
assumption that the interest rate has increased/decreased by 1% with all other variables held constant.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
226
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
227	226

-- 116 of 155 --

SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.10 	MANAGEMENT OF FINANCIAL RISK continued
1.10.4 	Liquidity risk
Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities due to
insufficient cash available to meet commitments as and when due.
Liquidity is managed through the Group Treasury Management function, which considers the liquidity position at the respective
Company level as well as the overall Group position. As part of this assessment, the liquidity position in each entity is optimised
and takes account of available credit facilities to the Group within the Board approved maximum financial leverage ratio. The
Company is in the process of refinancing short term borrowings as part of its ongoing debt capital management activities. The
group structure is conducive for the Company to receive dividends and other forms of funding from underlying subsidiaries to
enable it to meet its obligations.
Cash flow forecasting is performed by the Company and liquidity requirements are monitored to ensure it has sufficient cash to
meet operational needs. Such forecasting takes into consideration the Company’s debt financing plans and covenant
compliance.
Cash held by the Company is invested in interest-bearing accounts, term deposits and money-market deposits with appropriate
maturities or sufficient liquidity to provide headroom as determined by the above-mentioned forecasts. At the reporting date,
the Company had money market funds and cash and cash equivalents of R613 million (2024: R1 992 million).
The table below analyses Discovery Limited’s financial liabilities into relevant maturity groupings based on the remaining period
at the reporting date to the contractual maturity date. These amounts do not agree to the Statement of financial position as
these are the undiscounted contractual payments.
Company
R million 	Total 	<1 year
1 – 2
years
3 – 5
years
6 – 10
years
At 30 June 2025
Borrowings 	11 946 	3 993 	2 339 	5 614 	–
Derivative financial instruments:
– used as cash flow hedges 	117 	– 	23 	94 	–
Loans from subsidiaries at
amortised cost 	7 937 	7 937 	– 	– 	–
Trade and other payables 	69 	69 	– 	– 	–
20 069 	11 999 	2 362 	5 708 	–
Financial guarantees 	3 268 	3 268 	– 	– 	–
23 337 	15 267 	2 362 	5 708 	–
At 30 June 2024
Borrowings 	13 800 	5 662 	2 274 	4 894 	970
Derivative financial instruments: 	–
– used as cash flow hedges 	14 	6 	– 	8 	–
Loans from subsidiaries at
amortised cost 	10 546 	10 546 	– 	– 	–
Trade and other payables 	16 	16 	– 	– 	–
24 376 	16 230 	2 274 	4 902 	970
Financial guarantees 	5 729 	5 729 	– 	– 	–
30 105 	21 959 	2 274 	4 902 	970
Notes to the company annual financial statements continued
for the year ended 30 June 2025
229
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.10 	MANAGEMENT OF FINANCIAL RISK continued
1.10.3 	Credit risk
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge
an obligation. The credit risk associated with Cash and cash equivalents is managed by monitoring exposure to external financial
institutions against limits set by the CCIC.
CREDIT EXPOSURE FOR DEBT INSTRUMENTS, MONEY MARKET INSTRUMENTS AND CASH AND CASH
EQUIVALENTS
The following table provides information regarding the credit risk exposure categorised by Moody’s credit ratings. These assets
are all in stage 1 for purposes of determining expected credit losses.
Company
R million 	Total 	Aa1-3 	A1-3 	Baa1-3 	Ba1-3 	B1-3
Internally
rated/
assessed
At 30 June 2025
Derivative financial instruments at fair
value:
– used as cash flow hedges 	1 	– 	– 	1 	– 	– 	–
Loans to subsidiaries 	9 690 	– 	2 	2 807 	6 876 	5 	–
Loans to BEE partners 	363 	– 	– 	– 	– 	– 	363
Other receivables 	57 	– 	– 	57 	– 	– 	–
Cash and cash equivalents 	613 	23 	– 	582 	8 	– 	–
Total financial assets 	10 724 	23 	2 	3 447 	6 884 	5 	363
Financial guarantee contracts 	8 	– 	– 	– 	8 	– 	–
At 30 June 2024
Derivative financial instruments at
fair value:
– used as cash flow hedges 	14 	– 	– 	– 	14 	– 	–
Loans to subsidiaries 	8 260 	– 	2 	2 634 	5 513 	111 	–
Loans to BEE partners 	271 	– 	– 	– 	– 	– 	271
Cash and cash equivalents 	1 992 	481 	– 	564 	947 	– 	–
Total financial assets 	10 537 	481 	2 	3 198 	6 474 	111 	271
Financial guarantee contracts 	11 	– 	– 	– 	11 	– 	–
Long-term credit ratings were used on the credit risk analysis above. Refer to Group Note 3.13 Management of financial risk in
section 3, ‘Discovery’s approach in monitoring credit risk’ for a summary of how credit ratings are aligned to external credit
ratings.
Loans to BEE partners are not assigned formal credit ratings externally or internally. These loans are structured considering
creditworthiness of the individual partners, and the purpose of the BEE relationship. These loans are managed and monitored
on an individual basis, and ECL is accordingly recognised on an individual basis using management’s best estimate.
Discovery Limited has issued financial guarantees as security for loans incurred by subsidiaries in the group. The maximum
credit risk that Discovery Limited is exposed to on these contracts is the carrying amount, which amounted to R3 268 million
(2024: R5 729 million). For majority of the issued financial guarantees, Discovery Limited is co-guarantor with Discovery Health
(Pty) Ltd and Discovery Vitality (Pty) Ltd.
Loans to subsidiaries and financial guarantee contracts do not have external credit ratings. Credit ratings are internally assigned
using the RW rating scale.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
228
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
229	228

-- 117 of 155 --

SECTION 2: EQUITY
2.1 	INTRODUCTION AND OVERVIEW
This section provides information on the approved, outstanding and changes in the Company’s ordinary and preference share
capital and share premium.
2.2 	PRIMARY FINANCIAL STATEMENTS AND INFORMATION ANALYSED IN THIS
SECTION
R million 	Notes
Company
2025
Company
2024
Statement of financial position
Capital and reserves
Ordinary share capital and share premium 	2.3 	11 474 	10 783
Perpetual preference share capital 	2.4 	779 	779
12 253 	11 562
Notes to the company annual financial statements continued
for the year ended 30 June 2025
231
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 1: FINANCIAL INSTRUMENTS AND MANAGEMENT OF FINANCIAL RISK
continued
1.10 	MANAGEMENT OF FINANCIAL RISK continued
1.10.5 	Fair value hierarchy
Discovery Limited’s financial instruments measured at fair value have been disclosed using a fair value hierarchy. The hierarchy
has three levels that reflect the significance of the inputs used in measuring fair value. Refer to Group Note 3.13.6 Fair value
hierarchy for more details on the valuation techniques.
These are as follows:
Level 1: includes financial instruments that are measured using unadjusted, quoted prices in an active market for identical
financial instruments. An active market in which transactions for the asset or liability take place with sufficient frequency and
volume to provide information on an ongoing basis. Quoted prices are readily and regularly available from an exchange, dealer,
broker, industry group, pricing service or regulatory agency and those prices represent actual and regularly occurring market
transactions on an arm’s length basis.
Level 2: includes financial instruments that are valued using techniques based significantly on observable market data.
Instruments in this category are valued using:
(a) Quoted prices for similar instruments or identical instruments in markets which are not considered to be active; or
(b) Valuation techniques where all the inputs that have a significant effect on the valuation are directly or indirectly based on
observable market data.
Level 3: includes financial instruments that are valued using valuation techniques that incorporate information other than
observable market data and where at least one input (which could have a significant effect on instruments’ valuation) cannot be
based on observable market data.
Company
R million 	Total 	Level 1 	Level 2 	Level 3
At 30 June 2025
Derivative financial instruments at fair value:
– Used as cash flow hedges 	1 	– 	1 	–
Total financial assets 	1 	– 	1 	–
Derivative financial instruments at fair value:
– Used as cash flow hedges 	117 	– 	117 	–
Total financial liabilities 	117 	– 	117 	–
At 30 June 2024
Derivative financial instruments at fair value:
– Used as cash flow hedges 	14 	– 	14 	–
Total financial assets 	14 	– 	14 	0
Derivative financial instruments at fair value:
– Used as cash flow hedges 	24 	– 	24 	–
Total financial liabilities 	24 	– 	24 	–
Notes to the company annual financial statements continued
for the year ended 30 June 2025
230
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
231	230

-- 118 of 155 --

SECTION 3: OTHER ASSETS, LIABILITIES AND ITEMS OF INCOME AND EXPENSE
3.1 	INTRODUCTION AND OVERVIEW
This section provides information on the remainder of the assets, liabilities, income and expense in the rest of the annual
financial statements.
3.2 	PRIMARY FINANCIAL STATEMENTS AND INFORMATION ANALYSED IN THIS
SECTION
R million 	Notes
Company
2025
Company
2024
Statement of financial position
Assets
Deferred tax asset 	3.5 	– 	3
Investment in subsidiaries 	3.3 	36 579 	35 115
Investment in associate 	3.4 	2 584 	2 584
Other receivables 	3.6 	57 	–
39 220 	37 702
Income statement
Investment income 	3.8 	7 679 	3 882
Other income 	3.9 	21 	24
Marketing and administration expenses 	3.10 	(83) 	(18)
Movement in allowance for expected credit losses 	3.11 	– 	(3)
Income tax expense 	3.7 	(79) 	(19)
7 538 	3 866
Notes to the company annual financial statements continued
for the year ended 30 June 2025
233
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 2: EQUITY continued
2.3 	ORDINARY SHARE CAPITAL AND SHARE PREMIUM
Issued 	Treasury Shares
R million 	Share capital
Share
premium
BEE
Share Trust 	LTIP
Total
Outstanding
Issued
At 1 July 2023 	1 	12 202 	(44) 	(1 692) 	10 467
Share movements:
– shares issued 	* 	433 	– 	– 	433
– treasury shares delivered 	– 	– 	2 	445 	447
– treasury shares purchased 	– 	– 	(18) 	(546) 	(564)
At 30 June 2024 	1 	12 635 	(60) 	(1 793) 	10 783
Share movements: 	–
– shares issued 	* 	626 	– 	– 	626
– treasury shares delivered 	– 	– 	2 	689 	691
– treasury shares purchased 	– 	– 	– 	(626) 	(626)
At 30 June 2025 	1 	13 261 	(58) (1 730) 	11 474
* Amount is less than R500 000.
The total authorised number of ordinary shares is 1 billion (2024: 1 billion), with a par value of 0.1 cent per share.
Treasury Shares
Number of shares 	Company
BEE
Share Trust
Long-term
incentive plan
Total
Outstanding
Issued
At 1 July 2023 	673 146 417 	(589 143) 	(13 453 406) 	659 103 868
Share movements:
– shares issued 	3 227 675 	– 	– 	3 227 675
– treasury shares delivered 	– 	46 991 	3 660 857 	3 707 848
– treasury shares purchased 	– 	(150 000) 	(4 187 976) 	(4 337 976)
At 30 June 2024 	676 374 092 	(692 152) 	(13 980 525) 	661 701 415
Share movements:
– shares issued 	3 306 749 	– 	– 	3 306 749
– treasury shares delivered 	– 	33 841 	5 402 773 	5 436 614
– treasury shares purchased 	– 	– 	(3 306 749) 	(3 306 749)
At 30 June 2025 	679 680 841 	(658 311) 	(11 884 501) 	667 138 029
2.4 	PERPETUAL PREFERENCE SHARE CAPITAL
R million
Company
2025
Company
2024
Authorised
40 000 000 A no par value preference shares 	– 	–
20 000 000 B preference shares of R100 each 	2 000 	2 000
20 000 000 C no par value preference shares 	– 	–
2 000 	2 000
Issued
8 000 000 B preference shares of R100 each 	800 	800
Share issue costs 	(21) 	(21)
779 	779
The B preference shares are non-compulsory, non-cumulative, non-participating, non-convertible, voluntary redeemable (at the
option of Discovery Limited) preference shares and were issued at a coupon rate of 85% prime rate. With the introduction of
dividend withholding tax on 1 April 2012, the coupon rate on the preference shares was increased to 100% of the prime rate.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
232
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
233	232

-- 119 of 155 --

SECTION 3: OTHER ASSETS, LIABILITIES AND ITEMS OF INCOME AND EXPENSE
continued
3.4 	INVESTMENT IN ASSOCIATE
% ownership interest
R million
Company
2025
Company
2024
Company
2025
Company
2024
Investment at cost:
– Ping An Health Insurance Company of China, Limited 	24.99 % 	24.99 % 	2 584 	2 584
Refer to Group note 5.7 for disclosure of the investment in associate.
3.5 	DEFERRED TAX ASSET
R million
Company
2025
Company
2024
Deferred tax asset – non-current 	– 	3
Movement summary:
Balance at beginning of the year 	3 	5
Income statement charge 	(3) 	(2)
Balance at end of the year 	– 	3
Deferred taxation comprises:
Section 6 quat credits 	– 	–
Capital loss 	– 	3
– 	3
3.6 	OTHER RECEIVABLES
R million
Company
2025
Company
2024
Margin call 	57 	–
Balance at end of the year 	57 	–
Notes to the company annual financial statements continued
for the year ended 30 June 2025
235
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: OTHER ASSETS, LIABILITIES AND ITEMS OF INCOME AND EXPENSE
continued
3.3 	INVESTMENTS IN SUBSIDIARIES
Issued
ordinary capital
R million
Effective
percentage
holding %
Investment in
subsidiaries3
R million
Company
2025
Company
2024
Company
2025
Company
2024
Company
2025
Company
2024
Cogence Proprietary Limited 	37 	37 	100 	100 	37 	37
Discovery Bank Holdings Limited 	11 512 	10 715 	100 	100 	11 887 	11 040
Discovery Connect Distribution Services
Proprietary Limited 	555 	555 	100 	100 	546 	543
Discovery Central Services Proprietary
Limited 	3 000 	3 000 	100 	100 	3 064 	3 073
Discovery Finance Company Europe
Limited1 	393 	393 	100 	100 	394 	394
Discovery Group Europe Limited1 	14 172 	14 172 	100 	100 	14 147 	14 153
Discovery Health Proprietary Limited 	271 	271 	100 	100 	298 	277
Discovery Insure Limited 	2 552 	2 552 	100 	100 	1 600 	1 601
Discovery Life Limited 	1 416 	1 416 	100 	100 	1 587 	1 567
Discovery Life Collective Investments
Proprietary Limited 	15 	15 	100 	100 	15 	15
Discovery Life Investment Services
Proprietary Limited 	203 	203 	100 	100 	223 	211
Discovery Mauritius Asset Management 	1 	1 	100 	100 	1 	1
Discovery Vitality Proprietary Limited 	* 	* 	100 	100 	12 	8
Discovery Partner Markets Asia Private
Limited2 	211 	211 	100 	100 	113 	113
Vitality Group International Incorporated4 	4 527 	3 948 	100 	100 	2 653 	2 082
Discovery Green Proprietary Limited 	* 	* 	100 	100 	* 	*
Discovery Telematic Services Proprietary
Limited5 	– 	– 	– 	– 	1 	–
Vitality Corporate Services Limited5 	– 	– 	– 	– 	1 	–
Balance at the end of the year 	36 579 	35 115
* Amount is less than R500 000.
1 Incorporated in England and Wales.
2 Incorporated in Singapore.
3 Investments in subsidiaries include cost less impairments plus the value of share options issued to subsidiary staff.
4 Incorporated in the United States of America.
5 These subsidiaries are indirect subsidiaries. The investment cost arose as a result of the Group-wide equity-settled long term incentive scheme.
Refer to company note 4.2.3 in section 4 for a detailed movement analysis.
Refer to Group note 4.6 for additional details on related parties.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
234
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
235	234

-- 120 of 155 --

SECTION 3: OTHER ASSETS, LIABILITIES AND ITEMS OF INCOME AND EXPENSE
continued
3.8 	INVESTMENT INCOME1
R million
Company
2025
Company
2024
At amortised cost interest income, using the effective interest rate 	1 014 	1 079
– cash and cash equivalents 	91 	41
– BEE partners 	23 	18
– subsidiaries 	900 	1 020
Dividends received from subsidiaries and associate 	6 665 	2 803
7 679 	3 882
Interest income was received from the following subsidiaries:
– Discovery Central Services Proprietary Limited 	175 	325
– Discovery Group Europe Limited 	277 	284
– Discovery Health Proprietary Limited 	447 	411
900 	1 020
Dividends were received from the following subsidiaries and associate:
– Discovery Central Services Proprietary Limited 	– 	–
– Discovery Finance Company Europe Limited 	– 	24
– Discovery Green Proprietary Limited 	– 	1
– Discovery Health Proprietary Limited2 	5 234 	1 420
– Discovery Life Collective Investments Proprietary Limited 	90 	–
– Discovery Life Limited 	830 	1 100
– Discovery Mauritius Asset Management 	68 	–
– Discovery Telematic Services Proprietary Limited 	– 	2
– PingAn Health Insurance Company of China Limited 	443 	255
– Vitality Corporate Services Limited 	– 	1
6 665 	2 803
1 Investment Income for Discovery Limited is seen as Revenue.
2 The dividends received settled a portion of the loan due to Discovery Health Proprietary Limited and was not received in cash.
3.9 	OTHER INCOME
R million
Company
2025
Company
2024
Guarantee fees 	i 	18 	21
Amortisation of financial guarantee contracts 	ii 	3 	3
21 	24
i. 	Discovery Limited issued guarantees in respect of Discovery Finance Company Europe Limited and Discovery Holdings
Europe Limited obligations. A guarantee fee is charged by Discovery Limited to Discovery Finance Company Europe Limited
of R12 million (2024: R13 million) and Discovery Holdings Europe Limited of R6 million (2024: R8 million).
ii. 	Amortisation of initial financial guarantee contracts over the term of the loan. Refer to company note 1.8 in section 1 for a
list of guarantees that Discovery Limited has issued.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
237
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: OTHER ASSETS, LIABILITIES AND ITEMS OF INCOME AND EXPENSE
continued
3.7 	INCOME TAX EXPENSE
R million
Company
2025
Company
2024
Charge for the year:
Current taxation 	76 	17
Normal taxation
– prior year (over)/under provision 	(1) 	1
– current year charge 	57 	16
Capital gains tax 	20 	–
Deferred taxation 	3 	2
– prior year under provision 	– 	3
– current year charge 	3 	(1)
Total income tax expense recognised in profit or loss 	79 	19
% 	%
Taxation rate reconciliation
Effective taxation rate 	1.2 	0.7
Non-taxable income: Dividend income 	26.9 	27.1
Exempt income 	* 	*
Non-deductible expenditure including items of a capital nature 	(0.4) 	(0.1)
Prior year over/(under) provision 	* 	(0.2)
Accounting gains and losses taxable at CGT rates 	(0.4) 	*
Controlled foreign imputations and foreign tax credits 	(0.3) 	(0.5)
Tax rate differences 	* 	*
Standard rate of taxation 	27.0 	27.0
* Amount is less than R500 000.
Tax has been provided at 27% (2024: 27%). The company uses the South African tax rate in respect of its tax rate reconciliation
as Discovery Limited (holding company listed on the JSE) is domiciled in South Africa and the most significant operations are in
South Africa.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
236
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
237	236

-- 121 of 155 --

SECTION 4: CASH FLOW INFORMATION
4.1 	INTRODUCTION AND OVERVIEW
This section provides more information on the Company statement of cash flows.
4.2 	CASH FLOW INFORMATION
4.2.1 	Cash generated/(utilised) from operations:
R million
Company
2025
Restated
Company
2024
Profit before income tax 	6 698 	2 792
Adjusted for items presented separately in statement of cash flows:
– Interest received 	(1 014) 	(1 079)
– Dividends received 	(6 665) 	(2 803)
– Interest expenses on borrowings 	1 030 	993
Adjusted for non-cash items:
– Movement in expected credit losses 	– 	3
– Amortisation of financial guarantee contracts 	(3) 	(3)
– Unrealised foreign exchange (losses)/gains 	(124) 	100
Cash (utilised)/generated from operations 	(78) 	3
4.2.1.1 	INCREASE IN OPERATING ASSETS
R million
Company
2025
Company
2024
– Loans to BEE Partners 	(84) 	(44)
– Loans and advances to subsidiaries 	(88) 	(10)
(172) 	(54)
4.2.1.2 	INCREASE IN OPERATING LIABILITIES
R million
Company
2025
Company
2024
– Other payables at amortised cost 	53 	76
– Loans from subsidiaries 	(1 147) 	2 615
(1 094) 	2 691
4.2.2 	Taxation paid
R million
Company
2025
Company
2024
Balance at beginning of the year 	12 	(45)
Current taxation charged for the year in the income statement 	(76) 	(17)
Balance at end of the year 	54 	(12)
(10) 	(74)
Notes to the company annual financial statements continued
for the year ended 30 June 2025
239
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 3: OTHER ASSETS, LIABILITIES AND ITEMS OF INCOME AND EXPENSE
continued
3.10 	MARKETING AND ADMINISTRATION EXPENSES
R million
Company
2025
Company
2024
Marketing and administration expenses comprise:
– Audit fees 	8 	7
ISA 700 audit fees 	5 	5
Other assurance and related services performed under IAASB standard and regulatory
related services 	3 	2
– Professional fees 	50 	8
– Other 	25 	3
83 	18
3.11 	MOVEMENT IN ALLOWANCE FOR EXPECTED CREDIT LOSSES1
R million
Company
2025
Company
2024
Financial guarantee contracts:
– Discovery Central Services Proprietary Limited 	* 	1
Loans to subsidiaries:
– Discovery Central Services Proprietary Limited 	* 	(2)
– Discovery Group Europe Limited 	(1) 	1
– Discovery Health Proprietary Limited 	1 	4
– Discovery Life Collective Investments Proprietary Limited 	– 	(1)
– 	3
1 In determining the expected credit loss, credit ratings are internally assigned using the RW rating scale. Refer to company note 1.10.3 Credit risk in section 1,
for more information.
* Amount is less than R500 000.
R million
12 month
credit losses 	Total
30 June 2025
Balance at beginning of the year 	(11) 	(11)
Increase in allowance 	(1) 	(1)
Decrease in allowance 	1 	1
Balance at end of the year 	(11) 	(11)
30 June 2024
Balance at beginning of the year 	(8) 	(8)
Increase in allowance 	(6) 	(6)
Decrease in allowance 	3 	3
Balance at end of the year 	(11) 	(11)
Notes to the company annual financial statements continued
for the year ended 30 June 2025
238
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
239	238

-- 122 of 155 --

SECTION 4: CASH FLOW INFORMATION continued
4.2 	CASH FLOW INFORMATION continued
4.2.6 	Dividends received
R million
Company
2025
Company
2024
Dividends received per income statement 	6 665 	2 803
Dividends used to settle subsidiary loan (note 3.8) 	(5 234) 	(1 420)
Deemed dividends allocated to investments in subsidiaries (note 4.2.3) 	– 	(4)
1 431 	1 379
4.2.7 	Interest received
R million
Company
2025
Company
2024
At amortised cost interest income, using the effective interest rate 	1 014 	1 079
Interest received from Loans to subsidiaries (note 1.3) 	(547) 	(806)
– accrued 	(900) 	(1 020)
– received 	353 	214
Interest received from Loans to BEE partners (note 1.4) 	(8) 	(8)
– accrued 	(23) 	(18)
– received 	15 	10
459 	265
4.2.8 	Interest paid
R million
Company
2025
Company
2024
Interest expense on borrowings 	1 030 	993
Interest on long-term borrowings 	26 	(20)
– accrued 	(1 024) 	(998)
– paid 	1 050 	978
IFRS9 cost of hedging transferred from hedging reserve 	(4) 	(4)
Amortisation of contract fees transferred from prepayments 	– 	(3)
1 052 	966
Notes to the company annual financial statements continued
for the year ended 30 June 2025
241
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
SECTION 4: CASH FLOW INFORMATION continued
4.2 	CASH FLOW INFORMATION continued
4.2.3 	Increase in investments in subsidiaries
R million
Company
2025
Company
2024
Balance at beginning of the year 	35 115 	30 579
Value of share options issued to subsidiary staff 	715 	718
Financial guarantee contracts raised 	– 	1
Deemed dividends 	– 	4
Long-term incentive plan share recharges 	(626) 	(545)
Balance at end of the year 	(36 579) 	(35 115)
Increase in investment in subsidiary 	(1 375) 	(4 358)
4.2.4 	Long-term borrowings
R million
Company
2025
Company
2024
Balance at beginning of the year 	11 464 	9 948
Interest accrued 	1 024 	998
Interest paid 	(1 050) 	(978)
Increase in borrowings 	3 255 	2 000
Raising fees capitalised 	(5) 	(6)
Raising fees amortised 	6 	6
Repayment of borrowings 	(4 703) 	(504)
Balance at end of the year 	9 991 	11 464
4.2.5 	Cash and cash equivalents
R million
Company
2025
Company
2024
Cash at bank and in hand 	102 	235
Short-term deposits 	487 	796
Money market instruments1 	24 	961
613 	1 992
The carrying value of cash and cash equivalents approximates the fair value due to the relatively short-term nature of the
instrument.
1 	To meet the requirements for cash equivalents, as outlined in Annexure B, Policy 10 Cash and Cash Equivalents, Discovery conducts assessments of its
money market instruments. These instruments will only be classified as cash equivalents if they meet the following criteria
(1) The purpose of the investment is to fulfil short-term cash commitments
(2) The instrument demonstrates high credit quality within the relevant jurisdiction, as indicated by its credit rating
(3) The primary objective of the investment is to protect capital and provide liquidity
(4) The investment can be readily converted into known amounts of cash, similar to bank balances
(5) The fund is invested solely in interest-bearing instruments, similar to deposits, with institutions of high credit quality.
Additionally, the investment must not introduce speculative grade or equity-type risks and exposures. This can be demonstrated by the yield returns relative
to other deposit-type investments within the same jurisdiction.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
240
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
241	240

-- 123 of 155 --

SECTION 5: OTHER DISCLOSURES
5.1 	INTRODUCTION AND OVERVIEW
This section provides information on other disclosures that are non-recurring, restatements and events after reporting date.
5.2 	RESTATEMENTS FOR CHANGES IN PRESENTATION OF SPECIFIED ITEMS IN THE
STATEMENT OF CASH FLOWS AND ASSOCIATED RESTATEMENTS
Discovery continuously evaluates its presentation and disclosures to developing market practices, changes in IFRS Accounting
Standards and changes in its business composition that may indicate a need for change in presentation or disclosures in order
to enhance the relevance and understanding gained by users of the financial statements.
CHANGES IN PRESENTATION OF GROUP STATEMENT OF CASH FLOWS
Discovery had implemented changes to its Group statement of cash flows for the year ended 30 June 2024 to enhance the
understandability and to align with best practices in the market. These changes have now been applied to the Company
statement of cash flows. As such, these changes have been applied retrospectively to the comparative year ended 30 June 2024
and are detailed below.
Other operating assets and liabilities: Discovery has reclassified certain items that are working capital in nature, previously
recognised under cash generated from operations as non-cash adjustments to profit before tax, to now be presented as
changes in working capital. This includes movements in loans to/from subsidiaries, assets arising from contracts with customers,
liabilities related to customers, as well as trading and derivative assets and liabilities.
Dividends received: Discovery has reclassified dividends received from operating activities to investing activities, in accordance
with IAS 7 Statement of Cash Flows and in line with Discovery Group’s accounting policy. This classification better reflects the
nature of dividends as returns on investments rather than operating inflows, and ensures that all dividends received are
presented on a consistent basis.
Company statement of cash flows
for the year ended 30 June 2024
Company
As previously
reported
Working
capital
changes
Change in
presentation
of dividend
received
Company
Restated
R million 	Notes 	2024 	2024
Cash flow from operating activities 	3 244 	– 	(1 379) 	1 865
Cash generated by operations 	2 640 	(2 637) 	3
Dividends received 	1 379 	– 	(1 379) 	–
Interest received 	265 	– 	– 	265
Interest paid 	(966) 	– 	– 	(966)
Taxation paid 	(74) 	– 	– 	(74)
Net movement in operating assets and liabilities 	– 	2 637 	– 	2 637
– Decrease in operating assets 	(54) 	– 	(54)
– Increase in operating liabilities 	– 	2 691 	– 	2 691
Cashflow from investing activities 	(2 047) 	– 	1 379 	(668)
Dividend received 	– 	– 	1 379 	1 379
Cashflow from financing activities 	529 	– 	– 	529
Net increase in cash and cash equivalents 	1 726 	– 	– 	1 726
Cash and cash equivalents at beginning of the year 	282 	– 	– 	282
Effects of exchange rate changes on cash and
cash equivalents 	(16) 	– 	– 	(16)
Cash and cash equivalents at end of the year 	1 992 	– 	– 	1 992
5.3 	EVENTS AFTER REPORTING DATE
Refer to Group note 7.4 in section 7 for a list of the events after the reporting date.
Notes to the company annual financial statements continued
for the year ended 30 June 2025
242
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Annexures
for the year ended 30 June 2025
243
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
242 	243

-- 124 of 155 --

Discovery is directly and indirectly the holding company of:
Annexure A – Group structure
for the year ended 30 June 2025
244 	245
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
245	244

-- 125 of 155 --

In addition to the above subsidiaries, Discovery consolidates unit trusts which are deemed to be under the Group’s control in terms of IFRS
10 Consolidated Financial Statements. The consolidated unit trusts include:
■ Cogence Discovery Balanced Dynamic Asset Optimiser Fund
of Funds
■ Discovery Balanced Fund
■ Discovery Cautious Balanced Fund
■ Cogence Discovery Cautious Dynamic Asset Optimiser Fund
of Funds
■ Discovery Diversified Income Fund
■ Discovery Equity Fund
■ Discovery Flexible Property Fund
■ Discovery Global Equity Feeder Fund
■ Discovery Global Real Estate Securities Feeder Fund
■ Discovery Global Value Equity Feeder Fund
■ Discovery Moderate Balanced Fund
■ Cogence Discovery Moderate Dynamic Asset Optimiser Fund
of Funds
■ Discovery Money Market Fund
■ Discovery Target Retirement 2015 Fund
■ Discovery Target Retirement 2020 Fund
■ Discovery Target Retirement 2025 Fund
■ Discovery Target Retirement 2030 Fund
■ Discovery Target Retirement 2035 Fund
■ Discovery Target Retirement 2040 Fund
■ Discovery Target Retirement 2045 Fund
■ Discovery Target Retirement 2050 Fund
■ Discovery Target Retirement 2055 Fund
■ Discovery Target Retirement 2060 Fund
■ Discovery Global Multi Asset Fund (previously named
Discovery Worldwide Best Ideas Fund)
■ Discovery Strategic Bond Fund
■ Cogence Global Cautious Portfolio (Mauritius)
■ Cogence Global Balanced Portfolio (Mauritius)
■ Cogence Global Growth Portfolio Fund (Mauritius)
Annexure A – Group structure continued
for the year ended 30 June 2025
246
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES
1. 	BASIS OF PRESENTATION
The consolidated and separate Annual Financial Statements have been prepared in accordance with JSE Limited (JSE) Listings
Requirements, IFRS® Accounting Standards as issued by the International Accounting Standards Board (IFRS Accounting
Standards), the South African Institute of Chartered Accountants (SAICA) Financial Reporting Guides as issued by the Accounting
Practices Committee, Financial Pronouncements as issued by the Financial Reporting Standards Council (FRSC), and the
requirements of the South African Companies Act. The Group Annual Financial Statements have been prepared in accordance
with the going concern principle using the historical cost basis, except where otherwise stated in the accounting policies below.
The preparation of the Group Annual Financial Statements, in conformity with the IFRS Accounting Standards, requires the use
of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying The
Group’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and
estimates are material to the consolidated financial statements, are outlined in the following notes to the Annual Financial
Statements:
Notes 	Topic
2.3.18 	Insurance and reinsurance contracts and management of insurance risk
5.3 	Goodwill
5.9.1 	Deferred tax assets and liabilities
1.1 	New standards and amendments that became effective during the financial year
The Group has not early adopted any IFRS Accounting Standards, amendments, or interpretations that have been issued but
have yet to be effective.
The Group does not expect other new IFRS Accounting standards, amendments, or interpretations that became effective during
the financial year to have a material impact on recognised or disclosed amounts.
1.2 	New standards and amendments to published standards not yet effective
■ The Group does not expect the IFRS Accounting Standards, amendments, or annual improvements it has not listed below to
have a material impact on recognised or disclosed amounts
■ The Group expects the following IFRS Accounting Standards, amendments, and annual improvements that were issued during
the financial year but are not yet effective to have a material effect on recognised and disclosed accounts:
IFRS 18 Presentation and
Disclosure in Financial
Statements
IFRS 18 supersedes IAS 1 Presentation of Financial Statements and provides additional
requirements for the presentation and disclosure of information in the primary financial
statements and the notes to improve transparency and comparability of information.
IFRS 18 is effective for annual reporting periods beginning on or after 1 January 2027. For
the Group it will be effective from 1 July 2027.
IFRS 18 will impact The Group’s Income statement and related note disclosures. The Group
will assess additional disclosure requirements required.
INTEREST RATE BENCHMARK REFORMS (IBOR)
In recent years, major interest rate benchmarks have been reformed globally, including the replacement of certain interbank
offered rates (IBORs) with alternative nearly risk-free rates (referred to as “IBOR reform”). Discovery has financial instruments
that have been or will be affected by these market-wide changes, most notably the transition from LIBOR to Sterling Overnight
Index Average (SONIA) in the UK and the upcoming replacement of Johannesburg Interbank Average Rate (JIBAR) with South
African Rand Overnight Index Average Rate (ZARONIA).
JIBAR will be replaced by the ZARONIA. Following an observation period from 1 November 2022 to 31 October 2023, ZARONIA
was identified and endorsed as JIBAR’s successor. The South African Reserve Bank (SARB) has indicated that JIBAR is expected to
be discontinued by the end of 2026, with the official cessation date to be confirmed in December 2025. Several key milestones
leading up to the cessation are outlined in the industry timeline published by the SARB, including:
■ November 2024 – ZARONIA-first for derivatives
■ June 2025 – ZARONIA-first for the cash market
■ March 2026 – No new JIBAR
Discovery has the following current JIBAR-linked exposures as at 30 June 2025:
■ SA Bank borrowings, with associated interest rate derivatives, as detailed in Note 3.7.1
■ Investments of c. R7.8 billion
■ Home loans provided to customers of c. R1.7 billion
Annexure B – Group accounting policies
for the year ended 30 June 2025
247
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
247	246

-- 126 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
1.2 	New standards and amendments to published standards not yet effective continued
INTEREST RATE BENCHMARK REFORMS (IBOR) continued
Discovery will apply the same transition relief under IFRS Accounting Standards as it did when transitioning from LIBOR to
SONIA.
IBOR reforms generally result in changes to the basis for determining the contractual cash flows of financial assets and liabilities,
including derivatives.
For financial assets and liabilities measured at amortised cost, the entity will update the effective interest rate without
recognising a gain or loss, provided that:
■ The change is a direct consequence of IBOR reform, and
■ The new basis for determining contractual cash flows is economically equivalent to the previous basis.
For cash flow hedges, when assessing whether a forecast transaction remains highly probable, an entity will assume that the
interest rate benchmark on which the hedged cash flows are based remains unchanged as a result of IBOR reform.
2. 	CONSOLIDATION
The consolidated financial statements include the assets, liabilities, and results of operations of the Group and its subsidiaries,
joint ventures, and associates.
2.1 	Business combinations
The Group uses the acquisition method of accounting to account for its business combinations. The consideration transferred
for the acquisition of a business is the fair value of the assets transferred, the liabilities incurred, and the equity interests issued
by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent
consideration arrangement. The Group expenses acquisition-related costs as incurred.
The Group has an option to apply a ‘concentration test’ that permits a simplified assessment of whether an acquired set of
activities and assets is not a business. The optional concentration test is met if substantively all of the fair value of the gross
assets acquired is concentrated in a single identifiable asset or group of similar assets. The Group evaluates whether the
optional concentration test is appropriate on a transaction-by-transaction basis.
The Group measures identifiable assets acquired and liabilities and contingent liabilities it assumes in a business combination
initially at their fair values at the acquisition date. On an acquisition-by-acquisition basis, the Group recognises any non-
controlling interest in the acquiree either at fair value or at the non-controlling interest’s proportionate share of the acquiree’s
net assets. The excess of the consideration transferred, being the amount of any non-controlling interest in the acquiree and the
acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the identifiable net assets
acquired, the Group records as goodwill. If this is less than the fair value of the net assets of the subsidiary acquired in the case
of a bargain purchase, the Group recognises the difference directly in profit or loss as “gain on bargain purchase”.
COMPANY ACCOUNTING POLICY:
The company is, directly and indirectly, the holding company of subsidiaries, equity-accounted associates and joint
ventures as set out in Annexure A.
Investments in subsidiaries and associates are accounted for at cost less impairment. Cost includes the fair value of any
asset or liability resulting from a contingent consideration arrangement on initial recognition.
The Company assesses whether there is objective evidence that the investment in subsidiaries, equity-accounted
associates and joint ventures is impaired at each reporting date. If such evidence of impairment exists, the Company
calculates the amount of impairment as the difference between the recoverable amount of the investment and its
carrying value.
Common control transactions refer to business combinations in which all the combining entities or businesses are
ultimately controlled by the same party (or parties) before and after the combination. This includes businesses that are
associates and joint ventures.
The Company applies book value accounting to account for common control transactions. The company will dispose of
its investment at the carrying amount. Any difference between the consideration received and the carrying amount of the
investment disposed of is recognised as an equity transaction with shareholders in equity. No gain or loss is recognised
in profit or loss on disposal.
2.2 	Consolidation of entities in which the Group holds less than 50%
The Group analysed its relationships with Discovery Unit Trusts and has determined that it has power to direct the relevant
activities of the funds, has sufficient exposure to the variable returns of the funds and has the ability to use its power over the
investee to affect its returns. This analysis concluded that the Group has control of the Discovery Unit Trusts even if the
economic interest is less than 50% and is therefore required to consolidate these funds.
The Group controls these unit trusts as it has the right to the variable returns in the form of fund management fees it receives
from its involvement with the funds. Furthermore, the Group exercises control over these unit trusts through the setting of the
mandates and the appointment of the independent trustees. Within the regulatory framework, the Group can also amend the
mandates and change the independent trustees.
Of the 25 (2024: 25) Discovery Unit Trusts and 3 (2024: 3) Discovery International Collective Investment Unit Trusts consolidated
at 30 June 2025, the Group holds less than a 50% economic interest in none (2024: None) of these funds. Refer to Annexure A of
the Annual Financial Statements for a list of consolidated unit trusts.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
248
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
2. 	CONSOLIDATION continued
2.3 	Subsidiaries
Subsidiaries are all entities (including structured entities) over which the Group has control. The Group consolidates subsidiaries
from the date on which the Group obtains control. The Group discontinues consolidation from the date on which control ceases.
Intra-group transactions, balances, and unrealised gains or losses on intra-group transactions are eliminated. Subsidiaries’
accounting policies have been changed where necessary to ensure consistency with the policies adopted by the Group. The
Group does not eliminate intra-group foreign exchange gains and losses arising from intra-group balances.
COMPANY ACCOUNTING POLICY: FINANCIAL GUARANTEE CONTRACTS ISSUED OVER THE DEBT OF SUBSIDIARIES
The Company accounts for financial guarantee contracts (FGCs) in accordance with IFRS 9 Financial Instruments. The
Company issues FGCs to assist in securing funding for its subsidiaries.
FGCs are contracts which require the Company, as the issuer of the contract, to make specified payments to reimburse
the holder for a loss that the holder incurs because the specified debtor fails to make payment when it is due under the
original or modified terms of the debt instrument.
The Company measures the FGC:
■ Initially at fair value and
■ Subsequently, at the higher of:
– The amount of expected credit losses determined under IFRS 9 (calculation 1), and
– The amount initially recognised less, when appropriate, the cumulative amount of income recognised under the
principles of IFRS 15 Revenue from Contracts with Customers (calculation 2)
Where the Company issues FGCs for the debt of a related entity in the Group, the Company determines the fair value.
These FGCs are seen as transactions in a capacity as the shareholder and are treated as capital contributions.
In instances where the Company issues FGCs for the debt of its parent, Discovery Limited, or another related entity within
the Group where the issuer of the FGC does not have a direct parent or subsidiary relationship, the Company shows this
as a capital distribution to its parent company, Discovery Limited.
In some instances, the Group entity can also pay a premium to the issuer of the FGCs. The Company then determines if
the premium paid represents the fair value, or whether there is an additional cost that exceeds the fair value, incurred in
the issuance of the FGC that the Company should recognise.
In the instance where the Company does not receive all the premiums upfront, it recognises the FGC using a net
approach. The net approach requires that the Company presents the financial guarantee as its fair value less all future
premiums.
The Company subsequently recognises financial guarantee fee income as follows:
■ Amortises the fair value recognised on initial recognition over the period that the FGC is outstanding, generally the
period of the underlying debt
■ Recognises any premiums received for issuing the FGC as financial guarantee fee income and
■ Where the Company has applied the net approach, the Company adjusts for the premiums subsequently received to
ensure it takes into account all premiums in using calculation 2
The Company calculates the 12 month expected credit losses for purposes of calculation 1.
Where the outcome is that calculation 1 is more than calculation 2, differences are recognised and presented as part of
expected credit losses.
Where the outcome is such that calculation 2 is more than calculation 1, no adjustments are required. Any previously
recognised expected credit losses can be reversed but limited to the total value previously recognised.
The Company derecognises FGCs when the FGC is extinguished, expires, or the underlying debt is extinguished. At the
date of derecognition:
■ Where the FGC is extinguished in exchange for a new FGC to the same holder and in respect of the same guaranteed
entity, the FGC derecognised is seen as compensation for the new FGC, or
■ In all other instances, the FGC is derecognised with an associated gain or loss in profit or loss
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
249
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
249	248

-- 127 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
2. 	CONSOLIDATION continued
2.4 	Associates and joint arrangements
2.4.1 	ASSOCIATES AND JOINT VENTURES
Associates are entities over which the Group has the ability to exercise significant influence but not control over the financial and
operational policies. Significant influence is primarily based on the percentage of voting rights, generally between 20% and 50%,
together with other factors such as board participation and participation in the policy-making process. In certain instances, the
Group holds less than 20% equity interests but holds rights that still give it significant influence (activities that allow for
significant influence, such as board participation).
A joint venture is a joint arrangement in which the parties have joint control and rights to the net assets.
The Group recognises its interest in an associate or a joint venture as an investment and accounts for that investment using the
equity method. Under the equity method, on initial recognition, the investment in an associate or a joint venture is recognised at
cost. The carrying amount is adjusted to recognise the Group’s share of the post-acquisition profit or loss of the investee and is
recognised in profit or loss. Distributions received from an investee reduce the carrying amount of the investment. Dividends
received from the investee are presented as part of investing activities in the Statement of cash flows.
Adjustments to the carrying amount may also be necessary for changes in the Group’s proportionate interest in the investee
arising from changes in the investee’s other comprehensive income. Such changes include those arising from foreign exchange
translation differences. The Group recognises its share of those changes in other comprehensive income.
The Group discontinues equity accounting when the carrying amount of the investment in an associate or a joint venture
reaches zero unless it has incurred obligations, guaranteed obligations or made payments on behalf of the associate or the joint
venture. The Group resumes equity accounting only after its share of the profits equals the share of losses not recognised.
The Group will discontinue the use of the equity method from the date when its investment ceases to be an associate or a joint
venture.
CHANGES IN OWNERSHIP
An investor may reduce its ownership interest in an associate or joint venture by selling a portion of its share or through an
investee transaction such as a dilution. When an investor disposes of a portion of an investment, the investor will need to
determine the applicable gain or loss on the disposal. The gain or loss on the dilution of an equity-accounted investee is
calculated as the difference between:
■ The entity’s ownership interest in the new assets received by the investee for the subscription of the new shares (eg. the cash
paid by the other party), and
■ The reduction in ownership interest in the previous carrying amount.
The Group’s investment in an associate or a joint venture includes goodwill identified on acquisition. Discovery assesses whether
there is objective evidence that an associate or a joint venture is impaired at each reporting date. If such evidence of impairment
exists, the Group calculates the amount of impairment as the difference between the recoverable amount of the investment and
its carrying value. For impairment, please refer to accounting policy note 7.
■ Unrealised gains or losses on transactions between the Group and its associates or joint ventures are eliminated to the extent
of the Group’s interest in these entities unless the transaction provides evidence of an impairment of the asset transferred.
The accounting policies of associates and joint ventures have been changed where necessary to ensure consistency with the
policies adopted by the Group.
2.4.2 	FINANCIAL GUARANTEE CONTRACTS (FGC) ISSUED OVER THE DEBT OF AN EQUITY-ACCOUNTED INVESTMENT
The Group accounts for financial guarantee contracts (FGCs) under IFRS 9 Financial Instruments (IFRS 9) when it becomes a party
to the irrevocable commitment of the FGC.
FGCs are contracts that require the entity, as the issuer of the contract, to make specified payments to reimburse the holder for
a loss that the holder incurs because the specified debtor fails to make payment when it is due under the original or modified
terms of the debt instrument or the equity-accounted investment. The Group may issue FGCs over the debt of an equity-
accounted investment.
The Group measures the FGC:
■ Initially at fair value and
■ Subsequently, at the higher of:
– The amount of expected credit losses determined under IFRS 9 (calculation 1), and
– The amount initially recognised less, when appropriate, the cumulative amount of income recognised under the principles
of IFRS 15 Revenue from Contracts with Customers (calculation 2)
In instances where the Group issues FGCs over the debt of a related entity that is equity accounted in accordance with the
provisions of IAS 28 Investments in Associates and Joint Ventures, it determines the fair value of the FGCs. These FGCs issued over
the debt of an associate entity are seen as transactions in the capacity as shareholders and are treated as capital contributions.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
250
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
2. 	CONSOLIDATION continued
2.4 	Associates and joint arrangements continued
2.4.2 	FINANCIAL GUARANTEE CONTRACTS (FGC) ISSUED OVER THE DEBT OF AN EQUITY-ACCOUNTED INVESTMENT
In the instance the Group does not receive all the premiums upfront, it recognises the FGC using a net approach. The net
approach requires that the Group presents the financial guarantee as its fair value less all future premiums.
The Group subsequently recognises financial guarantee fee income as follows:
■ Amortises the fair value recognised on initial recognition over the period that the FGC is outstanding, generally the period of
the underlying debt
■ Recognises any premiums received for issuing the FGC as financial guarantee fee income and
■ Where the Group has applied the net approach, the Group adjusts for the premiums subsequently received to ensure it takes
into account all premiums in using calculation 2
The Group calculates the lifetime expected credit losses for purposes of calculation 1. Where the outcome is that calculation 1 is
more than calculation 2, differences are recognised and presented as part of expected credit losses.
Where the outcome is such that calculation 2 is more than calculation 1, no adjustments are required. Any previously recognised
expected credit losses can be reversed but limited to the total value previously recognised. The Group derecognises FGCs when
the FGC is extinguished, expires, or the underlying debt is extinguished.
At the date of derecognition:
■ Where the FGC is extinguished in exchange for a new FGC to the same holder and in respect of the same guaranteed entity,
the FGC derecognised is seen as compensation for the new FGC, or
■ In all other instances, the FGC is derecognised with an associated gain or loss in profit or loss
2.4.3 	JOINT OPERATIONS
A joint operation is a joint arrangement in which the parties have joint control of an arrangement and rights to the assets and
obligations for the liabilities relating to the arrangement.
The Group recognises its share of those assets, liabilities, revenues and expenses the operators incur jointly.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
251
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
251	250

-- 128 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
3. 	FOREIGN CURRENCY TRANSLATION
3.1 	Functional and presentation currency
The Consolidated financial statements are presented in Rand, the Group’s presentation currency.
3.2 	Transactions and balances
The Group translates foreign currency transactions into the functional currency using the exchange rates prevailing at the dates
of the transactions. The Group includes foreign exchange gains and losses as follows:
■ The settlement of trading transactions in profit or loss
■ The settlement of financing transactions and the translation at year-end exchange rates of assets and liabilities denominated
in foreign currencies in profit or loss as foreign exchange gains and losses, and
■ Qualifying cash flow hedges are deferred in the Statement of other comprehensive income. Subsequently, the Group
reclassifies these foreign exchange gains and losses to profit or loss in the periods in which the hedged item affects profit or
loss
3.3 	Group companies
The Group translates results and financial position of all Group entities (none of which has the currency of a hyperinflationary
economy) that have a functional currency different from the presentation currency into the presentation currency as follows:
■ For each Statement of financial position presented, the assets and liabilities are translated, applying the closing rate at the
date of that Statement of financial position.
■ For each Income statement presented, the income and expenses are translated applying the average exchange rates
applicable for the period (unless this average is not a reasonable approximation of the cumulative effect of the rates
prevailing on the transaction dates, in which case income and expenses are translated at rates at the date of the transactions),
and
■ The Group recognises the resulting exchange differences as a separate component of equity, namely the foreign currency
translation reserve (FCTR)
On consolidation, exchange differences including their tax effects, arising from the translation of the net investment in foreign
entities are recognised in FCTR in the Statement of other comprehensive income. When a foreign operation is disposed of or
sold, such exchange differences, together with their tax effects, are reclassified to profit or loss as part of the gain or loss on sale.
Goodwill and fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the
foreign entity and translated at the closing rate.
4. 	PROPERTY AND EQUIPMENT
The Group measures property and equipment at cost, which includes capitalised borrowing costs, less accumulated
depreciation, and any accumulated impairment losses.
The Group includes subsequent costs in the asset’s carrying amount or recognises costs as a separate asset, as appropriate, only
when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be
measured reliably. The Group recognises all other repairs and maintenance in profit or loss during the financial period in which
they are incurred.
If significant parts of an item of property and equipment have different useful lives, then the Group accounts for the
components as separate items (major components) of property and equipment.
The Group depreciates property and equipment when the assets are available for use, applying the straight-line method over
their estimated useful lives, as follows:
Owner occupied property 	40 years
Leasehold improvements 	Shorter of estimated life or period of lease
Leased asset 	3 – 15 years
Computer equipment 	3 – 7 years
Furniture, fittings and building fit-out 	5 – 15 years
Motor vehicles 	4 years
Telematics devices 	2 – 5 years
The Group reviews assets’ residual values and useful lives at least at each financial year-end and adjusts if appropriate. For the
treatment of impairment of items of property and equipment, refer to accounting policy 7.
Property and equipment shall be derecognised:
■ On disposal, or
■ When no future economic benefits are expected from their use or disposal
The Group determines gains/losses on derecognition by comparing the proceeds with the carrying amount. The Group records
these gains/losses in profit or loss.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
252
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
5. 	INTANGIBLE ASSETS
5.1 	Software development costs
The Group measures items of software development costs at cost, less accumulated amortisation and any accumulated
impairment losses. The Group does not capitalise internally generated intangibles, excluding capitalised development costs, and
it reflects the related expenditure in profit or loss in the period in which the expenditure is incurred.
The Group recognises development costs that are directly attributable to the design and testing of identifiable software products
which the Group controls as intangible assets when the following criteria are met:
■ It is technically feasible to complete the software product so that it will be available for use
■ Management intends to complete the software product and use or sell it
■ There is an ability to use or sell the software product
■ The Group can demonstrate the software product will generate probable future economic benefits
■ Adequate technical, financial, and other resources to complete the development and to use or sell the software product are
available, and
■ The Group can reliably measure expenditure attributable to the software product during its development
Directly attributable costs that are capitalised as part of the software product include the software development employee costs
and an appropriate portion of directly attributable overheads. For cloud computing arrangements, implementation costs that do
not meet the requirements to be capitalised as an asset are expensed as incurred.
The Group expenses the following items as incurred:
■ Costs associated with maintaining computer software programmes
■ Other development expenditures that do not meet the criteria noted above
The Group does not recognise development costs previously recognised as expenses, as assets in a subsequent period. The
Group recognises computer software development costs as assets from the point where the recognition criteria above are
satisfied and the Group amortises the asset when it is available for use, over its useful life. The Group presents amortisation as
part of marketing and administration expenses in profit or loss.
If significant parts of computer software development costs have different useful lives, the Group accounts for the components
as separate items (major components) of computer software development costs. Computer software development costs
recognised as assets are amortised over their useful lives.
Software applications 	3 – 7 years
Core Systems 	12 – 16 years
5.2 	Other intangible assets
The Group does not recognise costs incurred for internally developed trademarks, patents and similar rights and assets,
including franchises and management contracts. The Group recognises these costs in profit or loss in the period they are
incurred.
The Group measures intangible assets at cost plus any directly attributable cost of preparing the asset for its intended use, less
accumulated amortisation and any accumulated impairment losses. The Group amortises these intangible assets over their
useful lives.
The Group capitalises intangible assets acquired as part of business combinations at their fair value. These fair values are
represented by the estimated net present value of future cash flows relating to the existing business or at a value as determined
by an independent valuer. The Group amortises these intangible assets over their useful lives, and the Group tests for
impairment if an indication of impairment arises.
The Group reviews intangible assets’ residual values and useful lives at least at each financial year-end and adjusts if
appropriate. For the treatment of impairment of intangible assets, refer to accounting policy 7.
The Group derecognises intangible assets
■ On disposal, or
■ When no future economic benefits are expected from their use or disposal
The Group determines gains/ losses arising from the derecognition of an intangible asset as the difference between the net
disposal proceeds, if any, and the carrying amount of the asset. The Group recognises such gains/ losses in profit or loss when
the asset is derecognised.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
253
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
253	252

-- 129 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
6. 	GOODWILL
Goodwill arises on the acquisition of businesses and represents the excess of the consideration transferred, being the amount
of any non-controlling interest in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree
over the fair value of the identifiable net assets acquired.
For the purpose of impairment testing, the Group allocates goodwill acquired in a business combination to each of the cash-
generating units (CGUs) or groups of CGUs that are expected to benefit from the synergies of the combination. Each unit or
group of units to which the goodwill is allocated represents the lowest level within the entity at which the goodwill management
monitors for internal management purposes. The Group monitors goodwill at the operating segment level.
The carrying value of the CGU containing the goodwill is compared to the recoverable amount, which is the higher of value-in-
use and the fair value less costs to sell. The Group recognises any impairment immediately as an expense and this impairment is
not subsequently reversed.
7. 	IMPAIRMENT OF NON-FINANCIAL ASSETS
The Group tests goodwill annually for impairment or more frequently if events or changes in circumstances indicate that
goodwill may be impaired.
The Group reviews assets, including equity-accounted investments and intangible assets for impairment whenever events or
changes in circumstances indicate that the carrying amount may not be recoverable. Such indicators include continued losses
and changes in technology, market, economic, legal, and operating environments.
The Group recognises an impairment loss for the amount by which the asset’s carrying value exceeds its recoverable amount.
The Group measures the recoverable amount using the higher of the value-in-use and the fair value less costs to sell. The Group
immediately recognises these costs in profit or loss in the period they are incurred.
The Group reviews other assets, other than goodwill, that suffered an impairment for possible reversal of the impairment at the
end of each reporting period.
8. 	FINANCIAL INSTRUMENTS
The Group initially recognises financial instruments when it becomes party to the contract.
The Group measures financial instruments at initial recognition at the fair value net of directly attributable transaction costs
unless the financial instrument is classified as fair value through profit or loss. For instruments the Group classifies at fair value
through profit or loss, attributable transaction costs are immediately expensed.
8.1 	Financial assets
8.1.1 	RECOGNITION, CLASSIFICATION, MEASUREMENT AND DERECOGNITION
At initial recognition, the Group considers the appropriate classification of financial assets as at Amortised cost (AC), Fair value
through profit or loss (FVTPL), Fair value through other comprehensive income (FVOCI) for debt instruments, or Fair value
through other comprehensive income (FVOCI) for equity instruments. The Group considers:
■ Whether the contractual cash flows of the financial asset are solely payments of principal and interest (SPPI). Such contractual
cash flows are consistent with a basic lending arrangement and compensate the Group for the elements of the time value of
money, credit risk and other basic lending risks and a profit margin. Examples of such instruments include Treasury Bills,
Government Bonds, cash and cash equivalents, and fixed-term deposits. It excludes instruments such as equity-linked
financial assets or puttable investments in unit trusts, and
■ Whether the business model of the Group is to hold to collect contractual cash flows or a business model that results in
collecting contractual cash flows and selling the financial assets
Based on the criteria above, the Group will classify a debt instrument as:
■ Amortised cost, if the financial asset meets the SPPI criterion and is held for the purpose to collect the contractual cash flows.
Examples of this include loans and advances to customers (eg credit card advances and home loans) and fixed-term deposits
■ Fair value with changes in other comprehensive income (debt instruments) if the financial asset meets the SPPI criterion and is
held either to collect contractual cash flows or for sale. The Group currently does not hold financial assets in this category.
However, specified equity-accounted associates have certain debt instruments in the category
■ Fair value through profit or loss for all other financial assets that do not meet the criteria above are mandatorily classified as
financial instruments at fair value through profit and loss. In addition, the Group can irrevocably designate financial assets
into this category if this will reduce measurement inconsistencies (ie ‘accounting mismatch’). The Group’s business includes,
amongst others, providing unit-linked insurance, unit-linked investment and non-linked insurance products to customers.
Financial assets and liabilities in these portfolios are managed to achieve the objectives of the portfolio and to ensure that
liabilities are appropriately matched with assets. Additionally, Discovery Bank uses specified fixed-rate debt instruments to
manage interest rate risk, and these may also be designated at FVTPL if such designation helps eliminate an accounting
mismatch. In considering whether the objective of a portfolio is to collect contractual cash flows or to trade in financial
instruments, the Group considers the purpose for which instruments are held, the methods of risk management in a portfolio,
the manner of performance reporting on a portfolio and the basis for determining compensation to managers for asset
performance. For those financial assets backing insurance contracts, the Group measures these financial assets at fair value
through profit or loss. Financial assets held within the portfolio of unit-linked investment contracts are also mandatorily
classified at fair value through profit or loss
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
254
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
8. 	FINANCIAL INSTRUMENTS continued
8.1 	Financial assets continued
8.1.1 	RECOGNITION, CLASSIFICATION, MEASUREMENT AND DERECOGNITION continued
For equity instruments, the Group is permitted to make the irrevocable election to present changes in fair value in other
comprehensive income. However cumulative gains or losses recognised cannot be reclassified to profit or loss on disposal. This
election is available on an instrument-by-instrument basis. The Group has made this election in the accounting records of
specified associates. All other equity instruments are measured at FVTPL.
Subsequent measurement
Amortised cost (AC) 	The Group measures these instruments at amortised cost using the effective interest
method. Movements in the balance of the instrument relate to expected credit losses,
interest income and foreign exchange gains and losses which are recognised in profit
or loss.
The Group measures interest revenue using the effective interest rate (EIR) on the
gross carrying amount for those financial assets categorised in Stage 1.
Fair value through profit or loss
(FVTPL)
The Group measures these instruments at fair value with gains and losses recognised
in profit or loss. Movements in this balance are due to fair value gains or losses,
interest or dividends, and foreign exchange gains or losses.
The Group has elected to present the entire fair value gains and losses on a net basis
as a single amount.
Fair value through other
comprehensive income (FVOCI)
– equity
The Group measures these instruments at fair value with gains and losses recognised
in other comprehensive income. On derecognition, gains and losses accumulated in
other comprehensive income are not reclassified to profit or loss. Dividends are
recognised in profit or loss.
Fair value through other
comprehensive income (FVOCI)
– debt
The Group measures these instruments at fair value with changes in fair value
recognised in other comprehensive income. Movements in the balance relate to
expected credit losses, interest income and translation differences are recognised in
profit or loss. The Group measures interest revenue using the effective interest rate
on the gross carrying amount for those financial assets categorised in Stage 1. Refer
to accounting policy 8.1.2.
On derecognition, gains and losses accumulated in other comprehensive income are
reclassified to profit or loss.
The Group has not designated financial assets at fair value through profit or loss.
The Group expects the business model for managing a group of financial instruments to remain stable. In rare instances where
the business model changes, there can be a reclassification of the business model. Any reclassifications are applied
prospectively from the first day of the first reporting period after the change in business model, with no restatement of any
previously recognised gains, losses or interest. The Group has not had any changes in business models in the current reporting
period, and consequently, there have been no reclassifications.
The Group derecognises financial assets when the rights to receive cash flows from them expire or when they have been
transferred and the Group has also transferred substantially all the risks and rewards of ownership with no retention of control
of financial assets.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
255
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
255	254

-- 130 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
8. 	FINANCIAL INSTRUMENTS continued
8.1 	Financial assets continued
8.1.2 	EXPECTED CREDIT LOSSES
The Group measures expected credit losses on the following items:
■ Debt instruments at amortised cost or fair value with changes in other comprehensive income, which include treasury bills,
banking loans and advances and fixed deposits. This also includes loan commitments for undrawn credit facilities
■ Lease receivables
■ Financial guarantee contracts
■ Other receivables which are financial assets at amortised cost
■ Contract receivables and contracts assets with non-insurance customers and cash and cash equivalents
The Group has a multitude of different debtors and loans included in other receivables, which are financial assets which do not
represent a homogeneous group of assets. The approach to determining expected credit losses varies according to the asset
type, past bad debt experience and the potential to incorporate forward-looking information. In certain instances, the Group
aggregates financial assets based on shared characteristics (ie debt payment pattern similarities, financial instruments with
collateral, debtor type), and the Group determines expected credit losses on a collective basis.
In calculating the expected credit losses, the general expected credit loss approach requires that the Group assess the credit risk
of the instrument and determine whether there has been a significant increase in credit risk since initial recognition.
The Group measures the loss allowance using the following approach:
■ The Group refers to financial assets that have not had a significant increase in credit risk since initial recognition as Stage 1
financial assets. The Group/Company measures loss allowances on Stage 1 financial assets at an amount equal to the 12-
month expected credit losses
■ The Group/Company refers to financial assets that have had a significant increase in credit risk since initial recognition as
Stage 2 and 3 financial assets. If the financial assets have had a significant increase in credit risk since initial recognition and
are credit impaired or in default, the Group/Company refers to these as Stage 3 financial assets. The Group/Company
recognises lifetime expected credit losses in measuring the loss allowance for Stage 2 and 3 financial assets
The Group measures expected credit losses on:
■ Financial assets that are not credit-impaired at the reporting date as the present value of all cash shortfalls (ie the difference
between the cash flows due to the entity in accordance with the contract and the cash flows that Discovery expects to receive)
■ Financial assets that are credit-impaired at the reporting date: as the difference between the gross carrying amount and the
present value of estimated future cash flows, and
■ Undrawn loan commitments: as the present value of the difference between the contractual cash flows that are due to the
Group if the commitment is drawn down and the cash flows that the Group expects to receive (adjusted using a credit
conversion factor)
The Group measures assets that are trade receivables, contract assets, and lease receivables using the simplified approach,
should there be no significant financing component. The simplified approach does not require the Group to track changes
in credit risk but instead requires the entity to recognise a loss allowance based on lifetime expected credit loss at each
reporting date.
The Group does not recognise expected credit losses on Treasury Bills, Government Bonds issued by the South African Reserve
Bank, or cash and cash equivalents receivable on demand, following an assessment that these items are immaterial.
SIGNIFICANT INCREASE IN CREDIT RISK (SICR)
At each reporting date, the Group assesses whether the credit risk on a financial asset has increased significantly since initial
recognition. When making the assessment, the Group uses the change in the risk of a default occurring over the expected life of
the financial instrument instead of the change in the amount of expected credit losses.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
256
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
8. 	FINANCIAL INSTRUMENTS continued
8.1 	Financial assets continued
8.1.2 	EXPECTED CREDIT LOSSES continued
UNSECURED
The Group considers the following factors:
Qualitative 	Quantitative
■ When contractual payments are in arrears, i.e. when
the contractual payments are more than 30 days
past due, Discovery applies the presumption that
there was a significant increase in credit risk, in
conjunction with Discovery Risk Grade (DRG)
■ Bureau population segment data which falls into
one of the following categories
– Bureau debt review
– Bureau deceased
– Bureau notices
– Bureau under administration
– Bureau judgements
– Bureau judgements
– Bureau low score
■ Clients that have been under debt review for 6
months and have kept to the revised payments
schedule (ie. are in an up-to-date state) will be
moved out of Stage 3 into Stage 2: SICR
■ The quantitative definition of SICR is based on a comparison of
the Discovery Risk Decrements (DRD) at origination and the DRD
at the reporting date. Origination is defined as the account
origination date or a limit increase or limit decrease event,
whichever is most recent relative to the reporting date. The
following table summarises the quantitative triggers:
Origination DRD 	Reporting DRD 	Trigger SICR
Missing/Invalid 	Valid DRD 	Trigger if Reporting
DRD >= 17
Valid DRD 	Missing/Invalid 	Trigger SICR
Missing/Invalid 	Missing/Invalid 	Trigger SICR
DRD 1- 16 	>= DRD 17 	Trigger SICR
DRD 17 	>= DRD 18 	Trigger SICR
DRD 18 	>= DRD 19 	Trigger SICR
DRD 19 	>= DRD 20 	Trigger SICR
DRD 20 	>= DRD 20 	Trigger SICR
SECURED
The Group considers the following factors:
Qualitative 	Quantitative
■ Loans are more than 1 month in arrears
■ Loans in debt counselling
■ Deceased estate unsecured
■ Rescheduled loans above their committed balance
■ The loan had deteriorated below a predetermined risk
rating.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
257
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
257	256

-- 131 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
8. 	FINANCIAL INSTRUMENTS continued
8.1 	Financial assets continued
8.1.2 	EXPECTED CREDIT LOSSES continued
CREDIT IMPAIRED AND DEFAULT
The Group considers a financial instrument to be credit-impaired when current circumstances and economic conditions indicate
that the expected future cash flows from a financial instrument may not be recoverable. These circumstances include but are
not limited to evidence of financial or operational challenges for the debtor and missed contractual payments.
‘Default’ is defined on a facility level and considers both quantitative and qualitative factors, as provided in the Basel capital
framework. The qualitative criterion requires banks to identify credit deterioration before the exposure becomes delinquent, or
“unlikeliness to pay” events, while the quantitative criterion requires banks to look at the material delinquency status.
The Group considers the following factors as to what constitutes a default from a qualitative and quantitative perspective, which
is in line with the South African Reserve Bank definition.
Qualitative 	Quantitative
■ The borrower is placed in debt counselling/debt review
■ The borrower is deceased
■ The facility has undergone a distressed restructure/special
arrangement
■ The facility has been transferred to charge-off/legal status
■ The client is insolvent
■ The facility is written off
■ It is considered unlikely that the borrower will pay its
credit obligations to Discovery Bank in full, without
recourse by Discovery Bank to actions such as realising
security (if held)
■ The borrower is more than 90 days past due on any
material credit obligation to Discovery Bank. Overdrafts
will be considered as being past due once the customer
has breached an advised limit or been advised of a limit
smaller than current outstanding
As mentioned, the Group regards default events as confirmed debt review and debt counselling cases. The exposure will remain
in Default (Stage 3) for a minimum probation period of 6 months. The Group will cure the exposure to Stage 2: SICR if the
exposure is in an up-to-date state (performing) after 6 months.
WRITE-OFF
The Group will reduce the gross carrying amount of a financial asset when it has no reasonable expectation of recovering a
financial asset in its entirety or a portion thereof. Currently, Discovery Bank bases the write-off point at 15 payments in arrears
and at least 12 months in default. This point of write-off is appropriate as the average recovery rate after 15 months is 0.7% of
the balance at default. To ensure the appropriateness of the write-off point, Discovery Bank assesses the proposed write-off
point on an annual basis. Discovery Bank considers both time in default and recency of repayments for the write-off point.
Discovery Bank categorises collections into early-stage collections and late-stage collections. Early-stage collections are identified
as accounts in arrears that are less than 90 days past due, whereas late-stage collections are identified as debts with an arrears
status greater than 90 days past due. Early-stage collections are subject to internal enforcement activities. Once the debt has
reached 120 days in arrears, Discovery Bank appoints an external debt collection agency to collect outstanding payments on its
behalf.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
258
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
8. 	FINANCIAL INSTRUMENTS continued
8.2 	Financial liabilities
At initial recognition, the Group considers the appropriate classification as at Amortised cost (AC) or Fair value through profit or
loss (FVTPL).
Financial liabilities are measured at FVTPL if:
■ They are held for trading
■ The financial liabilities are part of a group of financial assets and financial liabilities which are managed and performance
evaluated on a fair value basis. These include financial liabilities held within the portfolios of unit-linked insurance and unit-
linked investments
The Group measures all other financial liabilities that are within the scope of IFRS 9 at amortised cost.
Subsequent measurement
Amortised cost (AC) 	The Group measures these instruments at amortised cost using the effective interest
method. Interest income and foreign exchange gains and losses are recognised in
profit or loss.
Fair value through profit or loss
(FVTPL)
The Group measures these instruments at fair value with gains and losses and any
interest recognised in profit or loss.
The Group has investment contracts which have financial risk and are consequently recognised and measured in terms of IFRS 9
rather than IFRS 17. These contracts are classified at fair value through profit or loss. The Group links the investment contracts
policies to the return on underlying financial assets as these are directly matched. The movement on the Group’s own credit risk
is considered immaterial. The Group measures the remaining financial liabilities at amortised cost.
The Group derecognises financial liabilities when the obligation is extinguished.
8.3 	Offset
The Group offsets the financial assets and liabilities and it reports the net amount in the Statement of financial position when
there is a legally enforceable right to set off the recognised amounts, and there is an intention to settle on a net basis or to
realise the asset and settle the liability simultaneously. The legally enforceable right must not be contingent on future events and
must be enforceable in the normal course of business and in the event of default, insolvency or bankruptcy of the reporting
entity or the counterparty.
8.4 	Modifications
Where an existing financial asset or liability is replaced by another with the same counterparty on substantially different terms
or the terms of an existing financial asset or liability are substantially modified, the Group treats an exchange or modification as
a derecognition of the original asset or liability and the recognition of a new asset or liability at fair value, including calculating a
new effective interest rate, with the difference in the respective carrying amounts being recognised in other gains and losses on
financial instruments within non-interest revenue. The Group consequently considers the date of recognition of a new asset to
be the date of initial recognition for impairment calculation purposes.
If the terms are not substantially different for financial assets or financial liabilities, the Group recalculates the new gross
carrying amount by discounting the modified cash flows of the financial asset or financial liability using the original effective
interest rate. The difference between the new gross carrying amount and the original gross carrying amount is recognised as a
modification gain or loss within credit impairments (for distressed financial asset modifications) or in other gains and losses on
financial instruments (for all other modifications).
In assessing whether a financial asset was substantially modified, the Group performs a qualitative assessment to determine if
the terms were substantially modified. In assessing whether a financial liability has been substantially modified, the Group
performs both a qualitative and quantitative (10% threshold) assessment to determine if the terms were substantially modified.
8.4.1 	MODIFICATION OF DISTRESSED RESTRUCTURES
Debt restructuring involves adjusting the terms of an account, such as lowering the interest rate, payment holidays etc, based on
legal requirements. These revised terms are not the same as those offered commercially for a new product to a customer with a
similar risk profile.
When the Group changes the terms of a contract due to the borrower’s financial difficulties, the asset is not derecognised unless
the contract undergoes substantial changes (eg, such as the introduction of equity participation or a significant change in the
counterparty). If the asset is not substantially modified, the financial asset’s carrying amount is recalculated based on the
present value of the modified cash flows, discounted using the original EIR. Any resulting modification gain or loss is recognised
in profit or loss as part of the total expected credit losses.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
259
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
259	258

-- 132 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
8. 	FINANCIAL INSTRUMENTS continued
8.5 	Interbank offered rates (IBOR) reforms
A fundamental reform of major interest rate benchmarks is being undertaken globally, including the replacement of some IBORs
with alternative, nearly risk-free rates (referred to as ’IBOR reform’). The Group has exposures to IBORs on its financial
instruments, such as Libor and JIBAR, that have been or will be replaced or reformed as part of these market-wide initiatives.
The United Kingdom has seen a change from the GBP Libor to the Reformed Sterling Overnight Index Average (SONIA) and the
South African Rand Overnight Index Average (ZARONIA) has been designated as the preferred alternative near risk-free rate to
succeed JIBAR. On 3 November 2023, the South African Reserve Bank (SARB) announced that ZARONIA may henceforth be used
in financial contracts.
The IBOR reforms will result in changes in the basis for determining the contractual cash flows of financial assets and financial
liabilities, including derivatives.
■ For financial assets and liabilities measured at amortised cost, the Group will update the effective interest rate without
recognising a gain or loss if:
– The change is a direct consequence of reform, and
– The new basis for determining the contractual cash flows is economically equivalent to the previous basis.
8.6 	REVERSE REPURCHASE AGREEMENTS
Reverse repurchase agreements are a form of secured lending whereby the Group provides a loan to a counterparty in
exchange for the transfer of collateral, generally in the form of marketable securities subject to an agreement to transfer the
securities back to the counterparty at a fixed higher price in the future (This arrangement functions as short-term financial asset
for the Group, with the securities serving as collateral to secure the loan).
The Group purchases securities (under a reverse repurchase agreement) subject to a commitment to resell or return them. The
securities are not included on the statement of financial position as the Group does not acquire the risks and rewards of
ownership.
Consideration paid by the Group (or cash collateral provided) in a reverse repo is recognised as a loan asset. The difference
between the original purchase price and pre-arranged buyback price is accounted for as interest income using the effective
interest rate method.
9. 	DERIVATIVE FINANCIAL INSTRUMENTS
The Group classifies derivative financial instruments as held for trading unless they are designated as effective hedging
instruments.
The Group initially recognises derivative financial instruments in the Statement of financial position at fair value on the date on
which a derivative contract is entered into (the best evidence of fair value on day one is the transaction price). The Group
subsequently remeasures these instruments to fair value. The method of recognising the resulting fair value gain or loss
depends on whether the derivative is designated as a hedging instrument and, if so, the nature of the item being hedged. Fair
values are obtained from quoted prices in active markets, including recent market transactions, and valuation techniques,
including discounted cash flow models and options pricing models, as appropriate. The Group presents all derivatives as assets
when the fair value is positive and as liabilities when the fair value is negative.
Under general hedge accounting, the Group has assessed that derivatives that qualify for cash flow hedge accounting are those
derivatives designated as hedges of highly probable future cash flows attributable to a recognised asset or liability, or a forecast
transaction. The Group applies hedge accounting when the hedging relationship meets the following requirements:
■ There is an economic relationship between the hedged item and the hedging instrument
■ The effect of credit risk does not dominate the value changes that result from that economic relationship, and
■ The hedge ratio of the hedging relationship is the same as that resulting from the quantity of the hedged item that the entity
actually hedges and the quantity of the hedging instrument that the entity actually uses to hedge that quantity of hedged item
The Group documents, at the inception of the transaction, the relationship between hedged items and hedging instruments, as
well as its risk management objective and strategy for undertaking various hedging relationships. The Group also documents its
assessment, both at the inception of the hedge and on an ongoing basis, of whether the derivatives that are used in hedging
transactions are expected to be and have been highly effective in offsetting changes in fair values or cash flows of hedged items.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
260
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
9. 	DERIVATIVE FINANCIAL INSTRUMENTS
9.1 	Cash flow hedge
The Group recognises the effective portion of fair value changes of derivatives that are designated as cash flow hedges in OCI,
and accumulated in the cash flow hedging reserve in the Statement of other comprehensive income. The Group recognises the
gain or loss relating to the ineffective portion immediately in profit or loss, within net fair value gains on financial assets at fair
value through profit or loss.
Amounts accumulated in the Statement of other comprehensive income are reclassified to profit or loss in the period in which
the hedged item will affect profit or loss. Where the forecast transaction or a foreign currency firm commitment results in the
recognition of a non-financial asset or liability, the gains and losses previously deferred are transferred from the Statement of
other comprehensive income and included in the initial measurement of the cost of the non-financial asset or liability. Where the
forecast transaction subsequently results in the recognition of a financial asset or liability, the Group transfers gains or losses
deferred in equity from the Statement of other comprehensive income to the Income statement when the financial asset or
liability is sold or impaired.
When a hedging instrument expires or is sold, or when a hedge no longer meets the criteria for hedge accounting, any
cumulative gain or loss existing in equity at that time remains in equity and is recognised when the forecast transaction is
ultimately recognised in profit or loss. When a forecast transaction is no longer expected to occur, the cumulative gain or loss
that was reported in equity is immediately transferred to profit or loss.
9.2 	Derivatives that do not qualify for hedge accounting
Certain derivative instruments do not qualify for hedge accounting. The Group recognises changes in the fair value of all such
derivative instruments immediately in profit or loss, within net fair value gains on financial assets at fair value through profit or
loss.
9.3 	Hedging reserve
The hedging reserve includes the cash flow hedge reserve. The cash flow hedge reserve is used to recognise the effective portion
of gains or losses on derivatives that are designated and qualify as cash flow hedges. Amounts are subsequently reclassified to
profit or loss as follows:
■ For the effective portion reclassified for hedges relating to share-based payments as part of marketing and administration
expenses (staff costs)
■ For the effective portion recycled for hedges relating to interest rate risk, as part of finance costs
For the purpose of cash flow hedges (see accounting policy 9.1), in determining whether a forecast transaction is highly
probable, an entity will assume that the interest rate benchmark on which the hedged cash flows are based is not altered as a
result of IBOR reforms. The Group anticipates that ZARONIA will impact some of its JIBAR risk management and hedge
accounting relationships in the longer term.
10. 	CASH AND CASH EQUIVALENTS
Cash and cash equivalents comprise:
■ Cash in hand
■ Balances with banks, including bank overdrafts repayable on demand and that form an integral part of the cash management
process
■ Deposits held at call and short notice, including short-term highly liquid investments that are readily convertible into known
amounts of cash and subject to insignificant risk of changes in value, e.g. certain money market investments
Cash and cash equivalents only include items held for the purpose of meeting short-term cash commitments rather than for
investing or other purposes. Cash and cash equivalents have a maturity of less than three months from the date of acquisition.
Cash and cash equivalents are carried at amortised cost (or, in specified instances, at fair value through profit or loss), which,
due to their short-term nature, approximates fair value.
Due to the Group’s sweeping arrangements with various financial institutions, positive and negative cash balances are presented
on a net basis to represent cash and cash equivalents in the Statement of cash flows.
11. 	SHARE CAPITAL
The Group classifies shares as equity when there is no contractual obligation to transfer cash or other financial assets to the
holder. Incremental costs directly related to the issue of new shares or options are shown in equity as a deduction from the
proceeds, net of tax.
Where any company within the Group purchases Discovery Limited equity share capital (treasury shares), the consideration
paid, including any directly attributable incremental costs (net of income taxes), is deducted from equity attributable to
Discovery Limited equity holders. Where such shares are subsequently sold, reissued or otherwise disposed of, any
consideration received is included in equity attributable to Discovery Limited equity holders, net of any directly attributable
incremental transaction costs and the related income tax effects.
The Group holds treasury shares through the Discovery Unit Trusts that the Group controls and consolidates. The Group elected,
irrevocably to continue to account for the shares as outstanding equity and to account for the reacquired share as if the
instrument was a financial asset measured at fair value through profit or loss under IFRS 9.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
261
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
261	260

-- 133 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS
12.1 	Insurance contracts scope and grouping
12.1.1 	DEFINITION AND CLASSIFICATION
Insurance contracts are contracts under which the Group accepts significant insurance risk from a policyholder by agreeing to
compensate the policyholder should a specified uncertain future event adversely affect the policyholder. Reinsurance contracts
are contracts under which the reinsurer accepts significant insurance risk from the Group. Even in situations where the contract
does not expose the reinsurer to the possibility of a significant loss, the contract will still be deemed to be a reinsurance contract
transferring significant risk if it transfers substantially all of the insurance risk resulting from the reinsured portions of the
underlying reinsurance contracts.
The Group determines whether it has assumed significant insurance risk by comparing benefits payable after an insured event
with benefits payable if the insured event had not occurred. Insurance and reinsurance contracts can also expose the Group to
financial risk, which is not taken into account in the determination of significant insurance risk.
12.1.2 	SEPARATING COMPONENTS WITHIN INSURANCE CONTRACTS
IFRS 17 requires an analysis of whether the contract contains components that should be separated from the insurance contract
and accounted for under different IFRS Accounting Standards. IFRS 17 requires that cash flows relating to embedded derivatives,
cash flows relating to distinct investment components and promises to transfer distinct goods or distinct services, other than
insurance contract services, be accounted for separately.
The Group presently has no contracts requiring further separation or a combination of insurance contracts.
12.1.3 	UNIT OF ACCOUNT, AGGREGATION AND RECOGNITION OF INSURANCE AND REINSURANCE CONTRACTS
Under IFRS 17, the unit of account is defined as a group of insurance contracts. The way insurance contracts are grouped affects
the timing of profit recognition for insurance services but does not affect the measurement of the estimated cash flows to fulfil
the insurance contracts. In terms of IFRS 17, the unit of account is determined by first establishing a portfolio of insurance
contracts and then creating separate cohorts within the portfolio based on the date of origination. Each such cohort is further
grouped into three groupings based on estimated profitability.
IFRS 17 Illustration of principles 1: Unit of account
At initial recognition, the Group recognises groups of insurance contracts issued from the earliest of the following:
■ The beginning of the coverage period
■ The date when the policyholder’s first payment is due or received if there is no due date
■ When the Group determines that a group of insurance contracts become onerous
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
262
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Insurance contracts that are subject to similar risks and managed together
E.g., whole-of-life insurance, guarantee endowments, household insurance
Only contracts issued within a given 12-month period (cohort) can be included in the same group.
Annual cohorts are further grouped into one of the following:
Onerous at initial Recognition
(Onerous)
At initial recognition, no
significant possibility of
becoming onerous
(Profitable)
Other
(Profitable at risk)
Portfolio
Cohort
Groups
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.1 	Insurance contracts scope and grouping continued
12.1.4 	MEASUREMENT MODELS
IFRS 17 provides three possible measurement models
1. The default model is the General Measurement Model (GMM). The GMM is typically used for measuring long-term insurance
risk and annuity contracts.
2. The GMM is supplemented by the Variable Fee Approach (VFA) for contracts where policyholders have purchased
investment-linked insurance contracts integrated with insurance coverage (meaning insurance contracts with direct
participating features)
3. The Premium Allocation Approach (PAA) is a simplified approach of the GMM for short-duration contracts such as group risk,
personal lines and private medical insurance.
Direct participating contracts are contracts for which, at inception:
■ The contractual terms specify that the policyholder participates in a share of a clearly identified pool of underlying items
■ The Group expects to pay to the policyholder an amount equal to a substantial share of the fair value returns on the
underlying items, the Group considers that a substantial share is a majority of returns, and
■ The Group expects a substantial proportion of any change in the amounts to be paid to the policyholder to vary with the
change in fair value of the underlying items. The Group considers that a substantial proportion is a majority proportion of
change on a present value probability-weighted average of all scenarios.
Within the Group, the unit-linked products and Discovery Optimiser products offered by Discovery Life are examples of
insurance contracts with DPFs.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
263
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
263	262

-- 134 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.2 	Overview of the Group portfolios, measurement models and accounting policy
elections
The table below summarises the material insurance contracts the Group issues and reinsurance contracts it holds. It sets out the
measurement model applied and key assumptions and elections.
Measurement
Model
Risk adjustment
confidence level1 	Elections on IFIE
PAA only – election for
treatment of initial
acquisition cash flows
(IACF)
Insurance contract issued and business lines
Individual life insurance
contracts:
Discovery Life and VitalityLife
GMM
90%
Elected to present
changes in IFIE in OCI
and profit or loss
n/a
Insurance-linked investment
contracts:
General endowments in
Discovery Invest 	Elected to present
changes in IFIE in
profit or loss	Unit-linked insurance
contracts:
Unit-linked and DRO in
Discovery Invest
VFA
Group life insurance
contracts:
Discovery Life
PAA
90%
Elected to present
changes in IFIE in OCI
and profit or loss for
long-tail claims.
Elected not to reflect
the interest for cash
flows less than 12
months
Elected to immediately
expense IACF
Car, household and business
insurance:
Discovery Insure
75%
Elected not to reflect
interest for cash
flows less than 12
months
Elected to immediately
expense IACF
Health insurance:
VitalityHealth
Consistent with default
IFRS 17 requirement,
defer IACF and
amortise over the initial
and renewal periods
Reinsurance contracts held
Individual life:
Quota share reinsurance for
Discovery Individual Life and
VitalityLife 	GMM 	90%
Elected to present
changes in IFIE in OCI
and profit or loss
n/a
Individual life:
Excess of loss reinsurance
Group life insurance
contracts:
Catastrophe, group
continuation and mass lapse
treaties
PAA
90%
Elected not to reflect
interest for cash
flows less than 12
months
Elected to immediately
expense IACF
Car, household and business
insurance:
Quota share reinsurance and
excess of loss insurance 	75%
Health insurance:
Quota share reinsurance
1 Risk adjustment was determined using the confidence level technique unless otherwise stated.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
264
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.3 	Contracts measured under the GMM and VFA
Under IFRS 17, any company that issues insurance contracts must report those contracts on the Statement of financial position
as the total of:
■ The expected fulfilment cash flows (EFCF): the current estimates of amounts that the company expects to collect from
premiums net of the payout for claims, benefits, and expenses, including an adjustment for the timing and risk of those
amounts, and
■ The CSM: the expected profit for providing insurance coverage recognised in profit or loss over the period of insurance
coverage.
Under IFRS 17, Insurance Contracts are measured as the sum of:
the expected fulfilment cash flows (EFCF), representing the present
value of current estimates of amounts that the insurer expects to
collect from premiums net of the pay out for claims, benefits and
expenses, including an adjustment for the risk of those cash flows.
Those cash flows for future services are known as “liability
for remaining coverage” (LRC) and those cash flows for services already
incurred constitute liability for insurance claims (LIC)
À
the contractual service margin (CSM), represents the remaining
inherent value of the cohort and is similar to unearned profit for
providing future insurance coverage. On initial recognition, for a
profitable contract, the CSM is the equal and opposite amount of the
net cash inflow, resulting in no income or expense arising on initial
recognition.
IFRS 17 Illustration of principles 2: General Measurement Model (GMM)
12.3.1 	EXPECTED FULFILMENT CASH FLOWS (EFCF)
The measurement of a group of insurance contracts includes all future cash flows expected to arise within the contract
boundary of each contract in the group. Cash flows are within the contract boundary if they arise from substantive rights and
obligations that exist during the reporting period in which the Group can compel the policyholder to pay premiums or has a
substantive obligation to provide services (including insurance coverage and any investment services).
EFCF include payments to (or on behalf of) policyholders, insurance acquisition cash flows and other costs incurred in fulfilling
contracts. Other costs incurred to fulfil a group of contracts include direct costs and an allocation of fixed and variable
overheads directly attributable to fulfilling the group of insurance contracts.
The estimates of these future cash flows are based on probability-weighted expected future cash flows. The Group estimates
which cash flows are expected and the probability that they will occur as at the measurement date. When estimating, the Group
uses information about past events, current conditions and forecasts of future conditions.
Insurance acquisition cash flows arise from activities of selling, underwriting and commencing a group of contracts that are
directly attributable to the portfolio of contracts to which the group belongs.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
265
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
EFCF –
Inflow
EFCF –
Outflow
EFCF –
discounting
EFCF –
Risk adj
CSM
265	264

-- 135 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.3 	Contracts measured under the GMM and VFA continued
12.3.2 	REFLECTING THE TIME VALUE OF MONEY AND DISCOUNT RATES
Discounting adjusts the estimates of expected cash flows to reflect the time value of money and the financial risks associated
with those cash flows to the extent that the financial risks are not already included in the cash flow estimates.
The following table shows which discount rate to apply throughout measuring a group of insurance contracts and the general
objective of determining that discount rate.
Element of measurement model
Fulfilment cash flows 	Current discount rates
CSM interest accretion for contracts without direct
participation features (i.e. portfolios under GMM).
Discount rates are determined on initial recognition of the group,
i.e. locked-in at inception.
Adjustments to the CSM for changes in the fulfilment
cash flows for contracts without direct participation
features (i.e. portfolios under GMM).
Discount rates are determined on initial recognition of the group,
i.e. locked-in at inception.
Adjustments to the CSM for changes in the fulfilment
cash flows for DPF contracts that do not vary based on
the returns on underlying items (i.e. portfolios under
VFA), excluding the change in the effect of the time value
of money and financial risks.
Current discount rates.
The bottom-up approach is used to derive the discount rate for the cash flows. Under this approach, the Group determines the
discount rate as the risk-free yield, adjusted for differences in liquidity characteristics of the insurance contracts sold. For
portfolios of contracts where the insurance contract liability is materially matched with assets, a top-down approach is used to
derive the discount rate for the cash flows.
For the Group, the risk-free yield curve will be ‘current’ and reflect the risk-free yield curve derived on the last day of the
reporting period. The nominal risk-free yield curve is used to discount nominal cash flows, while real cash flows are discounted
using the real risk-free yield curve.
12.3.3 	RISK ADJUSTMENT
The risk adjustment for non-financial risk for a group of insurance contracts, determined separately from the other estimates, is
the compensation required for bearing uncertainty about the amount and timing of the cash flows that arise from nonfinancial
risk as the Group fulfils insurance contracts. It measures the compensation that the entity would require to make it indifferent
between:
■ Fulfilling a liability that has a range of possible outcomes arising from non-financial risk and
■ Fulfilling a liability that will generate fixed cash flows with the same expected present value as the insurance contract
A lower risk adjustment would be observed for those insurance contracts with shorter durations, high frequency and low
severity type products and narrow probability of distribution. A higher risk adjustment would be observed for insurance
contracts that are longer in duration, have a low frequency and high severity and have a wide probability of distribution.
IFRS 17 does not prescribe methods for determining the risk adjustment for non-financial risk. Therefore, management’s
judgement is necessary to determine an appropriate risk adjustment technique.
When applying a confidence level technique, the first step in the process is to calculate the best estimate reserve, where there is
an equal chance that the actual amount needed to pay future claims will be higher or lower than the calculated best estimate.
The risk adjustment is then calculated such that there is a specified percentage probability that the reserves will be sufficient to
cover future claims. For the specified percentages applied, refer to section 12.2.
ACCOUNTING POLICY ELECTION: PRESENTATION OF RISK ADJUSTMENT BETWEEN INSURANCE SERVICE RESULT
AND IFIE
Discovery disaggregates changes in risk adjustment for non-financial risk between the insurance service result and
insurance finance income and expenses.
■ Insurance Service Result: the portion of the risk adjustment related to current and past insurance service expenses is
recognised as part of the insurance service result
■ IFIE: The financial effects of changes in the risk adjustment due to the time value of money and financial risk are
included in IFIE.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
266
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.3 	Contracts measured under the GMM and VFA continued
12.3.4 	CONTRACTUAL SERVICE MARGIN (CSM)
The CSM represents the future unearned profit. On initial recognition of a group of insurance contracts, if the total of the
fulfilment cash flows, including insurance acquisition cash flows:
■ Is a net inflow, then the group is profitable. In this case, the Group measures CSM as the equal and opposite amount of the
net inflow, which results in no income or expenses arising on initial recognition
■ Is a net outflow, then the group is onerous. In this case, the Group recognises the net outflow immediately as a loss in profit or
loss. The Group creates a loss component to depict the amount of the net cash outflow, which determines the amounts that are
subsequently presented in profit or loss as reversals of losses on onerous contracts and are excluded from insurance revenue
12.3.5 	SUBSEQUENT MEASUREMENT
The carrying amount of a group of insurance contracts at each reporting date is the sum of the liability for remaining coverage
(LRC) and the liability for incurred claims (LIC).
■ The LRC comprises the fulfilment cash flows related to services that will be provided under the contracts in future periods and
any remaining CSM at that date
■ The LIC includes the fulfilment cash flows for incurred claims and expenses that have not yet been paid, including claims that
have been incurred but not yet reported
IFRS 17 requires a company to update the EFCF at each reporting date, using current estimates of the amount, timing, and
uncertainty of cash flows and discount rates. The Group:
■ accounts for changes to estimates of future cash flows from one reporting date to another, either as an amount in profit or
loss or as an adjustment to the expected profit for providing insurance coverage, depending on the type of change and the
reason for it, and
■ chooses where to present IFIE either:
– All in profit or loss, or
– Include IFIE in profit or loss using systematic allocation. The remainder of IFIE is recognised in OCI. The treatment can be
summarised as follows:
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
267
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
IFRS 17 Illustration of principles 3: Subsequent measurement
Fulfilment
cash
inflows
CSM
Financial risk assumptions (e.g., interest rates and inflation index)
Past and current service
Future service
Either
Or Reclassify
P/L
OCI
CSM allocation
267	266

-- 136 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.3 	Contracts measured under the GMM and VFA continued
12.3.6 	CHANGES IN EFCF
Changes in expected fulfilment cash flows from the estimates at the previous reporting date or inception of the contracts are
recognised as follows:
Nature of change 	Treatment
Changes relating to current or past services 	Recognised in the insurance service result in profit or loss.
Changes relating to future services 	Adjusted against the CSM (or recognised in the insurance
service result in profit or loss if the group is onerous).
Effects of the time value of money, financial risk and changes
therein on estimated future cash flows
Recognised as insurance finance income or expenses.
Changes in the obligation to pay policyholders an amount
equal to the fair value of the underlying items for a group of
direct participating contracts (VFA)
Recognised in the insurance service result in profit or loss.
Accounting policy election: Presentation of IFIE
The Group has elected to disaggregate IFIE for the period in OCI and present in profit or loss IFIE using a systematic
allocation on its long-term life insurance business lines in Discovery Life, VitalityLife and associated reinsurance contracts
and a long-tail claims in its Group Risk business. In disaggregating the IFIE using systematic allocation, the Group applies
the guidance of a group of insurance contracts where the financial risk has a substantial effect on the amount paid to
policyholders, most notably changes in assumptions of inflation. The systematic rate allocates the remainder of the
revised IFIE over the remaining duration of the group of contracts, ie effective yield approach. For the remainder of
business lines, the IFIE and changes therein relating to insurance contracts are presented in profit or loss, offset by the
changes in the value of assets backing the insurance contracts.
CHANGES IN CSM
As noted in 12.2.3.4, the CSM represents the future unearned profit. The movement in the CSM during a financial reporting
period can be summarised as follows:
Movement in CSM during reporting period
CSM at the end of
previous reporting
period
1. New business
written during the
period
2. Interest accretion
at locked-in rate
3. Changes in
fulfillment cash
flows for future
services (Non IFIE)
4. Effect of currency
exchange
differences on CSM
5. VFA only – change
in the amount of
the entity’s share of
the fair value of the
underlying items
6. Amounts in CSM
recognised in profit
or loss for any
insurance service
for the period
(coverage units)
CSM at the end of
current reporting
period
IFRS 17 Illustration of principles 4: Subsequent changes in CSM
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
268
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.3 	Contracts measured under the GMM and VFA continued
12.3.6 	CHANGES IN EFCF continued
The carrying amount of the CSM at each reporting date is the carrying amount at the start of the financial year, adjusted for:
1. The CSM of any new contracts added to the group in the year
2. Interest accreted on the carrying amount of the CSM during the year. As noted in 12.2.3.2, discount rates are determined on
initial recognition of the group, meaning locked-in at inception. As noted in 12.2.3.2., the CSM for group of insurance
contracts in VFA is not locked in
3. Changes in fulfilment cash flows that relate to future services, except to the extent that:
a. 	Any increases in the fulfilment cash outflows exceeding the carrying amount of the CSM, in which case the excess is
recognised immediately in profit or loss
b. Any decreases in the fulfilment cash outflows are allocated to the loss component, reversing losses previously
recognised in profit or loss
4. Reflects changes in exchange rates for those contracts denominated in different currency than the functional currency of the
insurer that issued the policy
5. For contracts measured using the VFA, the change in the amount of the insurer’s share of the fair value of the underlying
item
6. The amount recognised as insurance revenue because of the services provided in the year, meaning release of CSM using
coverage units. In determining the coverage units, Discovery has elected to reflect the time value of money in the coverage
units using a real rate of return for insurance contracts measured using the GMM. For insurance contracts measured using
the VFA, Discovery has elected to reflect the time value of money in the coverage units using a nominal rate of return.
12.4 	Contracts measured under the PAA
As permitted in IFRS 17, the Group has elected to apply the premium allocation approach (PAA) to measure a group of insurance
contracts issued or reinsurance contracts held if, at the inception of the group:
■ The coverage period of each contract in the group of insurance contracts is one year or less, or
■ The Group reasonably expects that the PAA would produce a measurement of the LRC for a group of insurance contracts that
would not differ materially from the measurement achieved by applying the GMM.
The PAA simplifies the general measurement model. At initial recognition, the insurance contract is measured as:
■ The premiums, if any, received at initial recognition
■ Minus any insurance acquisition cash flows (applicable only if the group has elected to defer the insurance acquisition cash
flows), and
■ Plus/minus non-acquisition assets or liabilities previously recognised for cash flows related to the group of insurance
contracts.
Where insurance acquisition cash flows are directly attributable to a group of contracts, the Group allocates costs to that group
and the groups that will include renewals of those contracts. The Group expects to recover part of the related insurance
acquisition cash flows through renewals of these contracts. The allocation to renewals is based on how the Group expects to
recover those cash flows.
At each reporting date, the Group revises the amounts allocated to groups to reflect any changes in assumptions that determine
the inputs to the allocation method used. The Group does not revise amounts allocated to a group once all contracts have been
added to the group.
At each reporting date, if facts and circumstances indicate that an asset for insurance acquisition cash flows may be impaired,
the Group:
■ Recognises an impairment loss in profit or loss so that the carrying amount of the asset does not exceed the expected net
cash inflow for the related group, and
■ If the asset relates to future renewals, the Group recognises an impairment loss in profit or loss to the extent that it expects
those insurance acquisition cash flows to exceed the net cash inflow for the expected renewals, and this excess has not
already been recognised as an impairment loss.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
269
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
269	268

-- 137 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.4 	Contracts measured under the PAA continued
The Group reverses any impairment losses in profit or loss and increases the asset’s carrying amount to the extent that the
impairment conditions have improved.
IFRS 17 permits an accounting policy election on a group-by-group basis:
■ Not to adjust the components of the insurance contracts and onerous contracts for the time value of money (i.e. no
discounting)
■ An entity may elect to immediately expense insurance acquisition cash flows when incurred.
Accounting policy elections
For those contracts that apply the PAA, the Group has elected not to reflect the time value of money in the measurement
of the LRC and the LIC when:
■ LRC: On initial recognition of the contract, the time between the insurance service and the related premium is less
than a year
■ LIC: The cash flows are expected to be paid or received in less than one year from the date the claim is incurred.
In some instances, claims might be disputed. If the claim is expected to be disputed and settlement deferred beyond
12 months, the exception would not apply
The Group has elected to immediately expense insurance acquisition cash flows for the following material portfolios:
■ Group Life
■ Discovery Insure – Discovery Insure has the following portfolios: Personal lines for motor and household, Business
insurance, Medical gap, trauma cover and travel insurance
■ AfricaHealth portfolios
12.4.1 	RISK ADJUSTMENT
Refer to section 12.3.3 for the detailed accounting policy on risk adjustment. For the specified percentages applied, refer to
section 12.2.
12.5 	Reinsurance contracts
Each reinsurance contract is allocated to the applicable group of reinsurance contracts when that contract is initially recognised
in line with the requirements of IFRS17. The Group concludes that the reinsurance contract’s legal form as a single contract
reflects the substance of the Group’s contractual rights and obligations.
A group of reinsurance contracts is recognised, as required under IFRS 17, on the following dates.
■ Reinsurance contracts initiated by the Group that provide proportionate coverage: The date on which any underlying
insurance contract is initially recognised. This applies to the Group’s quota share reinsurance contracts
■ Other reinsurance contracts initiated by the Group: The beginning of the coverage period of the group of reinsurance
contracts. Where the Group recognises an onerous group of underlying insurance contracts on an earlier date, and the
related reinsurance contract was entered into before that earlier date, in that case, the group of reinsurance contracts is
recognised on that earlier date. This applies to the Group’s excess of loss and stop-loss reinsurance contracts
■ Reinsurance contracts acquired: The date of acquisition
The Group applies the same accounting policies to measure a group of reinsurance contracts, adapted where necessary to
reflect features that differ from those of the underlying insurance contracts. When a loss-recovery component is created for a
group of reinsurance contracts measured under the PAA, the Group will adjust the asset’s carrying amount for remaining
coverage instead of adjusting the CSM.
12.6 	Derecognition and modifications
The Group derecognises a contract when it is extinguished, meaning when the specified obligations in the contract expire or are
discharged, the contract is cancelled.
The Group also derecognises a contract if its terms are modified in a way that would have changed the accounting for the
contract significantly had the new terms always existed, in which case a new contract based on the modified terms is recognised.
If a contract modification does not result in derecognition, the Group treats the changes in cash flows caused by the
modification as changes in estimates of fulfilment cash flows.
On derecognition of a contract from within a group of contracts not measured under the PAA:
■ The fulfilment cash flows allocated to the group are adjusted to eliminate those that relate to the rights and obligations
derecognised
■ The CSM of the group is adjusted for the change in the fulfilment cash flows, except where such changes are allocated to a
loss component
■ The number of coverage units for the expected remaining services is adjusted to reflect the coverage units derecognised from
the group
If a contract is derecognised because it is transferred to a third party, then the Group adjusts the CSM for the premium charged
by the third party unless the group is onerous.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
270
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
12. 	INSURANCE CONTRACTS continued
12.7 	Exceptions Where The Modified Retrospective Approach Was Applied
12.7.1 	DISCOVERY INDIVIDUAL LIFE PORTFOLIO
The Group’s/ Company’s applied the modified retrospective approach for the Discovery Individual Life portfolio by aggregating
pre-June 2003 contracts into a single group. Applying the full retrospective approach was impracticable due to the absence of
historical models and sufficiently detailed data, particularly for business sold before the June 2002 financial year. These early
cohorts are immaterial, as Discovery Life only commenced operations in 2000.
12.7.2 	DISCOVERY INVEST PORTFOLIOS
For the Discovery Invest portfolios, the modified retrospective approach was applied by grouping:
■ Contracts issued before June 2016 for the discretionary participation features (DRO) portfolio, and
■ Contracts issued before June 2012 for the general endowments and unit-linked portfolios
The application of the full retrospective approach on transition was assessed as impracticable for Discovery Invest, due to the
unavailability of sufficiently granular data for policies sold prior to June 2012. Discovery Invest began operations in 2007, and
detailed data collection practices were still being established during the early years.
13. 	INVESTMENT CONTRACTS
Investment contracts transfer financial risk without significant insurance risk. Financial risk refers to the risk of a possible future
change in the value of an asset or financial instrument due to a change in interest rate, commodity price, index of prices (e.g.
consumer price index and retail price index), foreign exchange rate, or other measurable variables.
The Group issues investment contracts without fixed benefits (e.g. unit-linked investment contracts and structured products)
and investment contracts with fixed and guaranteed benefits (e.g. term certain annuity)
Valuation of policyholder liabilities
Investment contracts without fixed benefits are financial liabilities whose fair value is dependent on the fair value of the
underlying financial assets and derivatives (unit-linked investment contracts), which are classified at fair value through profit or
loss. The Group designates these investment contracts to be measured at fair value through profit or loss because the Group
manages and evaluates the performance of the group of financial instruments on a fair value basis. See Accounting Policy 8.1.1
for the financial assets backing these liabilities.
The Group’s main valuation techniques incorporate all factors that market participants would consider and are based on
observable market data. The fair value of a unit-linked investment contract financial liability is determined using the current unit
price that reflects the fair values of the financial assets contained within the Group’s unitised investment funds linked to the
financial liability.
The Group determines the fair value of the financial liabilities by multiplying the number of units attributed to each policyholder
at the reporting date by the unit price for the same date.
For investment contracts with fixed and guaranteed terms, valuation techniques are used to establish the fair value at inception
and at each reporting date. Valuation techniques include discounted cash flow analysis using current market rates of interest
and reference to other instruments that are substantially the same.
Premium revenue
All premiums received under investment contracts are recorded as deposits to investment contract liabilities, and claims
incurred on investment contracts are recorded as deductions from investment contract liabilities.
Fees on investment contracts
■ The Group recognises service fee income on investment management contracts over time as and when the related
performance obligation is satisfied. For service fee income, please refer to accounting policy note 19. Fees on investment
contracts are included in fee income from administrative business.
The Group charges regular fees to the customer monthly either directly or by making a deduction from invested funds.
Costs of obtaining contracts
The costs of obtaining contracts represent the contractual customer relationship and the right to receive future investment
management fees. Incremental costs directly attributable to securing rights to receive policy fees for services sold with
investment contracts are recognised as an asset where they can be identified separately and measured reliably, and it is
probable that they will be recovered. An incremental cost is one that would not have been incurred if the Group had not secured
the investment contract.
The asset represents the Group’s contractual right to benefit from providing asset management services and is amortised over
the expected life of the contract as the entity recognises the related revenue.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
271
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
271	270

-- 138 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
14. 	BORROWINGS
The Group recognises borrowings initially at fair value, net of transaction costs incurred.
Subsequently, the Group measures borrowings at amortised cost. Any difference between the proceeds and the redemption
value is recognised in profit or loss over the period of the borrowings using the effective interest method.
Fees paid on the establishment of loan facilities are recognised as transaction costs against the loan to the extent that it is
probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. To the
extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalised as a
prepayment and amortised over the period of the facility to which it relates.
Preference shares, which are mandatorily redeemable on a specific date, are classified as liabilities. The dividends on these
preference shares are recognised in profit or loss as finance costs using the effective interest method.
15. 	INCOME TAXES, DIRECT AND INDIRECT TAXES
15.1 	Current tax
The Group calculates and measures current tax at the amount expected to be paid to or recovered from the taxation authorities.
The Group uses the tax rates and tax laws that have been enacted or substantively enacted by the end of the reporting period.
15.2 	Deferred tax
The Group calculates deferred tax on all temporary differences using the Statement of financial position approach. The Group
calculates deferred tax liabilities or assets by applying corporate tax rates that have been substantively enacted to the temporary
differences between the tax values of assets and liabilities and their carrying amount, where such temporary differences are
expected to result in taxable or deductible amounts in determining taxable income for future periods when the carrying amount
of the assets or liabilities are recovered or settled.
The Group recognises deferred tax assets if its directors consider it probable that future taxable income will be available against
which the tax losses can be utilised.
Temporary differences arise primarily from the difference between accounting and tax balances arising from:
■ Insurance contracts
■ Property and equipment
■ The effect of accounting for lease liabilities and right-of-use assets
■ The revaluation of financial assets and liabilities at fair value through profit or loss
■ Provisions for leave pay
■ Liabilities for share-based payments, and
■ Tax losses carried forward
Deferred tax is not accounted for if it arises from the initial recognition of an asset or liability in a transaction other than a
business combination that, at the time of the transaction, affects neither accounting nor taxable income. Deferred tax related to
cash flow hedges, which are charged or credited directly to the statement of other comprehensive income, is also credited or
charged directly to the Statement of other comprehensive income and is subsequently recognised in profit or loss when the gain
or loss is realised.
The Group offsets deferred tax assets and liabilities when:
■ There is a legally enforceable right to offset current tax assets against current tax liabilities, and
■ When the deferred tax assets and liabilities relate to income taxes levied by the same taxation authority on either the taxable
entity or different taxable entities where there is an intention to settle the balances on a net basis
If offsetting does not apply, the Group separately discloses the deferred tax asset and deferred tax liability.
The Group reviews the carrying amount of the deferred tax asset at each reporting date and it is reduced to the extent that it is
no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilised. The
Group reassesses unrecognised deferred tax assets at each reporting date and recognises them to the extent that it has become
probable that future taxable profits will allow the deferred tax asset to be recovered.
15.3 	Direct and indirect taxes
Direct taxes include South African and foreign jurisdiction corporate tax payable and are disclosed as taxation in profit or loss.
Indirect taxes include various other taxes paid to central and local governments, including value-added tax and skills
development levies. The Group includes those indirect taxes which it cannot reclaim directly as part of marketing and
administration expenses in profit or loss. Alternatively, if the indirect taxes qualify to be capitalised, they are included as part of
the cost of property, equipment, or intangible assets.
15.4 	Interest arising from taxes
The Group recognises interest arising from tax disputes and indirect taxes such as value-added tax as finance costs in the
income statement.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
272
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
16. 	EMPLOYEE BENEFITS
16.1 	Short-term employee benefits
Short-term employee benefits are expensed as the related service is provided. A liability is recognised for the amount expected
to be paid if the Group has a present legal or constructive obligation to pay this amount as a result of past service provided by
the employee and the obligation can be estimated reliably.
16.2 	Post-employment benefits
The Group operates defined contribution schemes, the assets of which are held in separate private trustee-administered funds.
The Group pays contributions to these funds on a mandatory basis. These funds are registered in terms of the Pension Funds
Act of 1956, and membership is compulsory for all Discovery employees. Qualified actuaries perform annual valuations. The
Group has no further payment obligations once the contributions have been paid. The contributions are recognised as an
employee benefit expense when they are due.
16.3 	Share-based compensation
The Group operates equity-settled and cash-settled share-based compensation plans.
EQUITY-SETTLED SHARE-BASED COMPENSATION PLANS
The Group expenses the fair value of the employee services received in exchange for the grant of the options, over the vesting
period of the awards, as employee costs, with a corresponding credit to a share-based payment reserve in the Statement of
changes in equity. The total value of the services received is calculated with reference to the fair value of the options on the
grant date.
The fair value of the options are determined, excluding non-market vesting conditions. The non-market vesting conditions are
included in the assumptions of the number of options expected to vest. At each reporting date, the Group revises its estimate of
the number of options expected to vest. Any changes to the estimated number of options are recognised in profit or loss
immediately.
CASH-SETTLED SHARE-BASED COMPENSATION PLANS
The Group recognises employee services received in exchange for cash-settled share-based payments at the fair value of the
liability incurred and expenses these services over the vesting period of the benefits, as employee costs.
The Group remeasures the liability at each reporting period to its fair value and recognises all changes immediately in profit
or loss.
COMPANY ACCOUNTING POLICY:
Two of the schemes that the Group operates, namely the BEE Staff Share Trust and Discovery Long-Term Incentive Plan
(LTIP), are both equity-settled share-based payment arrangements in accordance with the requirements of IFRS 2 Share-
based Payments. In these schemes, Discovery Limited grants the awards to the employees within the Discovery Group.
The Company classifies the share-based payment transaction according to whether the entity has the obligation to settle.
As Discovery Limited’s shares are being awarded to employees, the Company classifies the transaction as equity-settled.
Under the IFRS Accounting Standards, the Group does not consider any repayment or recharge arrangements in
determining the classification of these group share-based payments. Any recharge payments the Group receives from its
subsidiaries are treated as a return on capital from the subsidiary. When the recharge made exceeds the charge
recognised in accordance with IFRS 2, the excess is accounted for as dividend income.
Discovery Limited manages the two share trusts. Discovery Limited treats the share trusts set up to facilitate the share-
based payment arrangements as an agent, i.e. an extension of Discovery Limited. In other words, shares held by the
Trust are treated as treasury shares of Discovery Limited.
■ BEE Staff Share Trust: Shares and options to acquire shares have been allocated to senior black employees based on
their level of seniority and length of past service. The trust will hold shares until the date of vesting of the shares to the
employee or the exercise date of the option
■ Discovery LTIP Trust: Participants will receive Discovery Limited shares subject to performance criteria and if the
participant is employed on each vesting date. The trust will hold shares until the date of vesting of the shares to the
employee. Per the LTIP Trust deed, the LTIP Trust recharges the costs of the shares acquired for the employees to the
relevant subsidiary whose employees are awarded the shares
The Company capitalises to the investment in subsidiary the fair value of employee services received in exchange for the
grant of the options, over the vesting period, with a corresponding credit to a share-based payment reserve in the
Statement of changes in equity. the subsidiary recognises the related share-based payment expennse. The total value of
the services received is calculated with reference to the fair value of the options on grant date.
The fair values of the options are determined excluding non-market vesting conditions. These vesting conditions are
included in the assumptions of the number of options expected to vest.
At each reporting date, the Company revises its estimate of the number of options expected to vest. Any changes to the
estimated number of options are recognised in profit or loss immediately.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
273
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
273	272

-- 139 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
16. 	EMPLOYEE BENEFITS
16.4 	Profit share and bonus plan
The Group operates several other profit-sharing and bonus compensation arrangements and recognises these when a
constructive obligation has been created by past practice. These are calculated with reference to predetermined formulae.
The Group has other deferred compensation schemes in place where employees are incentivised based on a variable other than
the share price of Discovery Limited, such as embedded value, value of in-force and earnings multiples. The Group recognises a
liability and the related expense is included in employee costs in profit or loss.
17. 	OTHER PAYABLES AND PROVISIONS
17.1 	Other payables
Other payables consist of VAT payables, premiums and fees received in advance. These are not financial liabilities and are,
accordingly, not measured at amortised cost.
The Group measures as management’s best estimate of the amount required to settle VAT obligations and the present value of
the cash consideration received in advance on premiums and fees.
17.2 	Provisions
The Group recognises provisions when it has a present legal or constructive obligation of uncertain timing or amount, as a result
of past events and it is probable that a transfer of economic benefits will be required to settle the obligation, and a reliable
estimate of the amount of the obligation can be made.
The Group measures provisions as the present value of management’s best estimate of the amount required to settle the
obligation at the reporting date. The pre-tax discount rate used to determine the present value reflects current market
assessments of the time value of money and the risks specific to the obligation. The increase in the provision due to the passage
of time is recognised as finance costs.
18. 	CONTINGENT LIABILITIES
A contingent liability is a possible obligation that arises from past events and whose existence will be confirmed only by the
occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity, or a present
obligation that arises from past events but is not recognised because it is not probable that an outflow of resources embodying
economic benefits will be required to settle the obligation or the amount of the obligation cannot be measured with sufficient
reliability.
The Group does not recognise contingent liabilities, but it discloses a contingent liability when:
■ It has a possible obligation arising from past events, the existence of which will be confirmed only by the occurrence or non-
occurrence of one or more uncertain future events not wholly within the control of the entity, or
■ It has a present obligation that arises from past events but is not recognised because:
– It is not probable that an outflow of resources will be required to settle an obligation, or
– The amount of the obligation cannot be measured with sufficient reliability
19. 	REVENUE RECOGNITION
A primary source of revenue for the Group arises from the sale of insurance contracts, which are accounted for under IFRS 17
and are excluded from the scope of IFRS 15 Revenue from Contracts with Customers which is applicable to the Group’s revenue
from administration business, Vitality income and banking fee and commission income.
IFRS 15 requires that once the Group identifies contracts, it identifies the performance obligations in the contract. The Group
determines this on the basis of whether the customer can benefit from the promised good or service individually or together
with other readily available resources and whether the performance obligation is distinct in the context of the contract. For the
Group, most contracts contained a single performance obligation.
The timing of revenue recognition is dependent on whether the Group transfers control over the good or service over time or at
a point in time. In determining the appropriate timing for revenue recognition, the Group considers whether the customer
benefits as the entity performs. For most revenue types, the Group provides stand-ready services to customers, where
customers benefit as the entity’s services are consumed. In limited instances where revenue is not recognised over time, the
Group recognises revenue at a point in time when control transfers. For revenue the Group recognises over time, the stand-
ready service is recognised in a straight line over the term of the contract.
In determining the amount of revenue to recognise, the Group considers any uncertainty created through variable consideration
contained in the contract and constrains the recognition of revenue in order to recognise revenue only to the extent that it is
highly probably that a significant reversal in the amount of cumulative revenue recognised will not occur when the associated
uncertainty is resolved. The Group also considers the impact of the timing of receiving payments for revenue transactions and
determines whether a significant financing component should be taken into account in the measurement of the transaction
price. As the Group’s contracts routinely include single performance obligations, there is limited complexity in allocating
transaction prices to performance obligations. Payment terms vary across the different revenue types earned by the Group.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
274
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
19. 	REVENUE RECOGNITION continued
Where contracts with customers involve a third party, the Group considers whether it is acting as the principal or the agent in
the delivery of the promised goods or services to the customer. This assessment is based on whether the Group controls the
goods or services before it is transferred to the customer.
For certain contracts with customers, the Group receives income in advance of discharging the related performance obligation.
In these instances, the amount is recognised as a contract liability incurred in the acquisition or fulfilment of a contract. The
Group considers whether there are costs incurred for the acquisition or fulfilment of a contract. The Group recognises these
costs as an asset and amortises the costs over the expected period over which performance obligations under the contract are
satisfied. The Group expenses contract costs it incurs which are considered to be of a general and administrative nature and that
are not explicitly recovered from the customer, as it incurs the cost.
Where the transaction price included in a contract is payable less than 12 months from the date of satisfying the related
performance obligation, the practical expedient is applied in that a significant financing component is not recognised. Similarly,
where the costs of obtaining a contract would be amortised over 1 year or less, the costs are not recognised as a separate asset.
For contracts that contain a significant financing component, the discount rate applied reflects a market rate of interest at
inception of the contract, consistent with a separate financing transaction between the parties. The rate is determined at
contract inception and not reassessed subsequently. Interest income recognised on the financing component is presented as
investment income in profit or loss.
Fee income from administration business 	Vitality Income
Banking fee and
commission income
Nature of
performance
obligations
The Group recognises fee income on health
administration and managed care services it
renders. Fee income is also generated on asset
administration and fees earned on the use of
intellectual property (such as software-as-a-
service). For Discovery Telematic Services fee
income is generated from the Vitality Drive
device activation. In the respective businesses,
the Group considers these as revenue, and
most are seen as single performance
obligations in the respective legal entities.
These revenues are separated by the
underlying reported entity in the segment
information shown in Section 1.
Fees earned on the use of intellectual property
(such as software-as-a-service) also include
fees earned through the Vitality Network where
the Group/ Company identified separate
performance obligations relating to services to
obtain new business and services to create
ongoing value for certain contracts.
Vitality income includes
the fee income that
Vitality members pay to
access the Vitality
benefit and various
activation fees for
activating additional
benefits. The
performance obligation
relates to access to the
Vitality rewards
programme and partner
benefits the Group
provides to its members.
Banking fee and
commission income
include banking service
fees for banking services.
The performance
obligation relates to
access to banking and
banking services
rendered.
Commission income
relates to the interchange
fees Discovery Bank earns
on transactions using
debit or credit cards. The
performance obligation
relates to the settlement
of transactions via the
card network.
When does
control pass
– Point in time
(PIT) vs over
time
Performance obligations to provide
administration services are considered stand-
ready services, the customer obtains control over
the service as the entity makes its services
available on an “as and when” basis. As a result,
the Group recognises revenue over time, as the
respective entity makes the services available,
based on the passage of time.
For fees earned on certain contracts through the
Vitality Network, services to obtain new business
are recognised at the point in time as this is when
the performance condition is satisfied. Revenue
relating to services to create ongoing value are
recognised over time as improvements in lapse,
mortality and morbidity are observed and
measured.
Performance obligations
to provide access to
benefits are considered
stand-ready services as
the customers obtain
benefits over the
duration of the contract
and when required by
the customers. As a
result, the Group
recognises revenue over
time based on the
passage of time.
The performance
obligation associated with
the banking fee and
commission income is
satisfied over time
because the client obtains
substantially all of the
remaining benefits from
the service over the
period of the month for
which the banking fee was
charged.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
275
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
275	274

-- 140 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
19. 	REVENUE RECOGNITION continued
For contracts that contain a significant financing component, the discount rate applied reflects a market rate of interest at
inception of the contract, consistent with a separate financing transaction between the parties. The rate is determined at
contract inception and not reassessed subsequently. Interest income recognised on the financing component is presented as
investment income in profit or loss.
Fee income from administration business 	Vitality Income
Banking fee and
commission income
When are
amounts
payable?
Amounts are billed for health administration and
managed care business at the end of the respective
month, with amounts paid within 30 days. For fees
on asset administration business, the Group
disinvests amounts for the units held at the end of
the related month. Certain fees, such as advisor fees,
are received upfront but are deferred as a contract
liability over the expected term of the entity’s
performance.
The Group bills the
amounts either
monthly, payable
within 30 days, or
billed on activation
of the benefit,
payable
immediately.
Banking fees are
charged monthly, and
payment is immediate.
Interchange income is
charged at the point of
payment and settled
daily in batch format.
Variable
consideration
and estimates
There is no potential for amounts of revenue to vary
relating to discounts or rebates on the health
administration business.
For the asset administration business, fees are
determined based on assets under management at a
point in time. There are no benchmark performance-
based fees. The nature of the integrated products
that the Group sells related to the investment
business allows for fee discounts and rebates to be
determined based on client behaviour.
For fees earned on certain contracts through the
Vitality Network, the transaction price includes fixed
and variable components.
Revenue is estimated and recognised in line with the
constraint on variable consideration, only to the
extent that it is highly probable that there will not be
a significant reversal of revenue already recognised
once the uncertainty is resolved. The fee discounts
and rebates are determined according to a fixed
methodology incorporating policyholder specific
information including Vitality status. The Group has
experience in estimating these amounts, which are
based on a limited number of outcomes.
There are no
adjustments to the
transaction price as
a result of any
variable
consideration. There
is no significant
financing
component.
There are no
adjustments to the
transaction price as a
result of any variable
consideration. There is
no significant financing
component.
Costs to
capitalise
Where costs are incurred directly to secure a new
health administration customer, and the contract is
expected to exceed 12 months, the Group capitalises
and amortises costs over the expected term of
contract. Costs are routinely incurred on the asset
administration business related to commission and
other incremental costs of entering into the contract.
The Group capitalises and recognises these over the
expected duration of the customer relationship. The
Group tests these assets for impairment to the
extent that the carrying amount of the asset exceeds
the expected remaining net cash inflows from the
customer contract.
In respect of the
Apple Watch benefit,
the Group incurs
costs
upfront to purchase
the device and
provide it to the
customer. These
costs are deferred
and recognised over
the two-year term of
the benefit.
Discovery Bank incurs
direct costs attributable
to card production,
delivery costs, and
commission fees. The
incremental costs of
obtaining the contracts
and cost to fulfil
contracts are capitalised.
Discovery Bank
amortises these costs
over the expected life of
the contract.
The Group presents any unconditional rights to consideration separately as a receivable. The Group assesses a contract asset for
impairment in accordance with IFRS 9. An impairment of a contract asset is measured, presented and disclosed on the same
basis as a financial asset that is within the scope of IFRS 9. Any impairment losses the Group recognises on any receivables or
contract assets arising from its contracts with customers are disclosed separately from impairment losses from other contracts.
Costs of obtaining contracts
The Group defers and recognises as an asset arising from its contracts with customers in the Statement of financial position the
incremental costs of acquiring new contracts, which are expected to be recovered out of future revenue margins as an expense
over the period in which the related performance obligations are satisfied.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
276
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
20. 	OTHER NON-REVENUE INCOME
20.1 	Investment income
Investment income comprises dividends as well as the interest the Group receives from assets held at amortised cost and cash
and cash equivalents.
The Group recognises dividends when its right-to-receive payment is established. This is on the “last day to trade” for listed
shares and on the “date of declaration” for unlisted shares. Dividend income includes scrip dividends, irrespective of whether
there is an option to receive cash instead of shares.
The Group has elected to classify the cash flows arising from dividends received as investing activities as the dividends received
are returns on investments.
Interest is accounted for on an accrual basis using the effective interest method.
20.2 	Net fair value gains/(losses) on financial assets at fair value through profit or loss
Net fair value gains/(losses) on financial assets at fair value through profit or loss include gains and losses arising from interest,
dividends and net realised and unrealised gains or losses on financial assets held at fair value through profit or loss.
The Group has elected to present the entire fair value gains and losses; interest, dividends and the net realised and unrealised
gains or losses on a net basis as a single amount.
Identification of a lease
At the inception of a contract, the Group assesses whether a contract is, or contains a lease. A contract is, or contains, a lease if
the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. To
assess whether a contract conveys the right to control the use of an identified asset, the Group uses the definition of a lease in
IFRS 16 Leases.
Contracts where the service provider has a substantive right to substitute the asset for an alternative asset during the lease term
is not regarded as a lease, but instead a service contract. Accordingly, the Group does not account for these contracts under IFRS
16. For the Group, such contracts include items such as vending machines.
21.1 	As a lessee
At commencement or on modification of a contract that contains a lease component, the Group allocates the consideration in
the contract to each component on the basis of its relative stand-alone prices. However, for property leases, the Group has
elected not to separate non-lease components and accounts for the lease and non-lease components as a single lease
component.
The Group recognises a right-of-use asset and a lease liability at the lease commencement date. The Group presents right-of-
use assets in ‘Property and equipment’ and lease liabilities in ‘Borrowings at amortised cost’ in the Statement of financial
position.
The Group leases the following assets with a range of lease terms:
Qualitative 	Subsequent measurement
Large offices 	5 – 15 years
Small offices/Franchise offices (SA only) 	1 – 3 years
Computer equipment (e.g. servers) (SA only) 	3 – 4 years
Motor vehicles (UK only) 	3 years
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
277
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
277	276

-- 141 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
21. 	LEASES continued
21.1 	As a lessee continued
MEASUREMENT
LEASE LIABILITY
The Group measures the lease liability at the present value of the lease payments that are not paid at the commencement date,
discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the lessee’s incremental
borrowing rate. Generally, the Group uses its incremental borrowing rate as the discount rate.
The Group determines its incremental borrowing rate by obtaining interest rates from various external financing sources and
makes certain adjustments to reflect the terms of the lease and type of the asset leased. The incremental borrowing rates were
calculated for each legal entity within the Group that entered into lease arrangements. The incremental borrowing rate
considers a base interest rate reflective of the jurisdiction in which the legal entity operates (South Africa, United Kingdom and
United States of America), the term of the lease arrangement and the nature of the assets.
Lease payments the Group includes in the measurement of the lease liability comprise the following:
■ Fixed payments, including in-substance fixed payments
■ Variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the
commencement date
■ Amounts expected to be payable under a residual value guarantee, and
■ The exercise price under a purchase option that Discovery is reasonably certain to exercise, lease payments in an optional
renewal period if Discovery is reasonably certain to exercise an extension option, and penalties for early termination of a
lease unless Discovery is reasonably certain not to terminate early
Variable lease payments that do not depend on an index or a rate are not included in the measurement of the lease liability or
right-of-use (ROU) asset at initial recognition. The Group recognises these variable lease expenses as an expense in profit or loss
in the period in which the event or condition that triggers the payment occurs.
Extension or termination options are included in a number of the building leases across Discovery. These terms are used to
maximise operational flexibility in terms of managing contracts. In determining the lease term, management considers all facts
and circumstances that create an economic incentive to exercise an extension option, or not exercise a termination option. The
Group considers extension options (for periods after termination options) in the lease term when there is reasonable certainty
that those options will be exercised.
The Group measures the lease liability at amortised cost using the effective interest method. The Group remeasures the liability
when there is a change in future lease payments arising from a change in an index or rate, if there is a change in its estimate of
the amount expected to be payable under a residual value guarantee, if the Group changes its assessment of whether it will
exercise a purchase, extension or termination option or if there is a revised in-substance fixed lease payment. When the Group
remeasures the lease liability in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset
or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.
RIGHT-OF-USE ASSET
The Group initially measures the right-of-use asset at cost, which comprises the initial amount of the lease liability adjusted for
any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to
dismantle and remove the underlying asset or to restore the underlying asset, less any lease incentives received. The Group
receives incentives such as reimbursements for installations or rent-free periods.
The Group subsequently depreciates the right-of-use asset using the straight-line method from the commencement date to the
end of the lease term, unless the lease transfers ownership of the underlying asset to the Group by the end of the lease term or
the cost of the right-of-use asset reflects that the Group will exercise a purchase option.
In that case, the Group depreciates the right-of-use asset over the useful life of the underlying asset, which is determined on the
same basis as those of property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses,
if any, and adjusted for certain remeasurements of the lease liability.
SHORT-TERM LEASES AND LOW VALUE ITEMS
The Group has elected not to recognise right-of-use assets and lease liabilities for leases of low-value assets and short-term
leases. The Group recognises the lease payments associated with these leases as an expense on a straight-line basis over the
lease term.
Leases of low-value assets relate to those categories of assets which, at the inception of the lease, typically have a value, if
bought new, of no more than approximately R70 000. For the Group, these categories include computer equipment such as
desktops, laptops, monitors and related IT peripherals.
Short-term leases are those leases with a lease term of less than 12 months.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
278
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
21. 	LEASES continued
21.2 	As a lessor
At inception or on modification of a contract that contains a lease component, the Group allocates the consideration in the
contract to each component on the basis of their relative standalone prices.
CLASSIFICATION
To classify the lease, the Group makes an overall assessment of whether the lease transfers substantially all of the risks and
rewards incidental to ownership of the underlying asset. If this is the case, then the lease is a finance lease; if not, then it is an
operating lease. As part of this assessment, the Group considers indicators such as whether the lease is for a major part of the
economic life of the asset, the specialised nature of the asset and the present value of lease payments.
The Group leases out portions of its leased property in the form of subleases. The Group has classified these leases as operating
leases.
MEASUREMENT
As the Group is an intermediate lessor, it accounts for its interests in the head lease and the sub-lease separately. It assesses the
lease classification of a sublease with reference to the right-of-use asset arising from the head lease, not with reference to the
underlying leased asset.
If an arrangement contains lease and non-lease components, the Group applies IFRS 15 to allocate the consideration in the
contract.
The Group recognises lease payments received under operating leases as income on a straight-line basis over the lease term as
part of ‘Other income’.
22. 	MARKETING AND ADMINISTRATION EXPENSES
Marketing and administration expenses include marketing and development expenditures, all other non-acquisition-related
expenditures, and benefits paid under the Vitality programme. These costs are expensed in profit or loss as incurred.
23. 	INTEREST EXPENSE ON BORROWINGS AND LEASE LIABILITIES
Interest expenses (net of investment income earned on the temporary investment of specific borrowings pending their
expenditure on qualifying assets) directly attributable to the acquisition, construction or production of assets that necessarily
take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time
as the assets are substantially ready for their intended use or sale. The Group recognises all other interest as an expense in
profit or loss on an accrual basis using the effective interest method.
In addition, interest expense includes any reclassified gains or losses from other comprehensive income arising from cash flow
hedges of interest rates, amortisation of financing-related fees such as loan commitment fees and letter of credit fees, and
modification gains and losses on borrowings.
24. 	DIVIDEND DISTRIBUTION
Dividend distribution to the Group’s shareholders is recognised as a liability in the financial statements in the period in which the
dividends are approved.
25. 	NORMALISED HEADLINE EARNINGS
The Group assesses its performance using normalised headline earnings, an alternative profit measure not under the IFRS
Accounting Standards, alongside its IFRS Accounting Standards profit measures. Management considers that Normalised
Headline Earnings Per Share (NHEPS) is an appropriate alternative performance measure to enhance the comparability and
understanding of the financial performance of the Group.
Measures not in terms of IFRS Accounting Standards are not uniformly defined or used by all entities and may not be
comparable with similarly labelled measures and disclosures provided by other entities.
The Group calculates headline earnings in accordance with the latest SAICA circular ’Headline Earnings’. NHEPS is calculated by
starting with headline earnings and adjusted to exclude material items that are not considered to be part of the Group’s normal
operations as follows:
■ Once-off transactions – eg, restructuring costs, transaction costs related to interest rate derivatives and initial deferred tax
assets raised on previously unrecognised assessed losses
■ Unusual items – the Group considers items to be unusual when they have limited predictive value, or it is reasonable that
items of a similar nature would not necessarily arise for several future reporting periods
■ Income or expenses not considered to be part of the Group’s normal operations – for example, amortisation of intangibles
from business combinations and fair value gains or losses on foreign exchange contracts not designated as hedges
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
279
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
279	278

-- 142 of 155 --

SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
25. 	NORMALISED HEADLINE EARNINGS
Management is responsible for the calculation of NHEPS and determining the inclusions and exclusions in accordance with the
policy. The Discovery Limited Audit Committee reviews the normalised headline earnings for transparency and consistency.
The following adjustments may be made in the determination of NHEPS:
Adjustment 	Explanation
Fair value (gains)/losses on foreign
exchange contracts not designated as a
hedge
The adjustment reflects fair value gains or losses on foreign exchange
contracts entered in anticipation of future capital injections in foreign
operations. These derivative instruments are not designated as a hedge and as
a result, the fair value adjustments are recognised in profit or loss.
The fair value adjustments of these derivative instruments can result in
volatility in profit or loss and is therefore excluded in assessing the normal
business operations of the Group as it relates specifically to a future once-off
transaction.
Amortisation of intangibles from business
combinations
The adjustment reflects the amortisation of intangible assets which arose from
the purchase of various subsidiaries and associates within the Group and were
recognised in accordance with IFRS 3 Business Combinations.
Intangible assets recognised from business combinations provide little
predictive value of the earnings from the business, as these assets will not be
reacquired, renewed, or replaced once depleted. Discovery also infrequently
acquires businesses. The amortisation of these assets is therefore excluded in
assessing the normal business operations of the Group.
Deferred tax assets raised on assessed
losses
The adjustment reflects the initial recognition of deferred tax assets in respect
of assessed losses in prior financial periods, after evaluating that there is
future taxable income that will arise in the respective business.
The initial recognition of this deferred tax asset results in a once-off income
recognised in profit or loss. It provides no predictive value in assessing the
normal business operations of the Group.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
280
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
SUMMARY OF MATERIAL ACCOUNTING POLICIES continued
25. 	NORMALISED HEADLINE EARNINGS continued
Adjustment 	Explanation
Changes in tax balances as a result of use
of different tax rates
The adjustments reflect the changes in current and deferred tax balances
resulting from the use of different tax rates that related to items that were
excluded from normalised headline earnings in the current or prior periods.
Restructuring Costs 	The adjustment reflects restructuring costs which are once-off costs incurred
to restructure specified business areas.
These transaction costs are infrequent and therefore excluded in assessing the
normal business operations of the Group.
Gain on disposal of intangible assets –
Vitality Group International
The adjustments include those gains on disposal of intangible assets, eg in the
AmplifyHealth deal, where Vitality Group International monetised a specified
regional right to an initial component of its intellectual property rights via sale
as opposed to a licensing arrangement.
These gains are not considered part of normal operations for assessing the
normal business operations of the Group.
26. 	NON-CURRENT ASSETS HELD FOR SALE
Non-current assets, or disposal groups comprising assets and liabilities, are classified as held-for-sale if it is highly probable that
they will be recovered primarily through sale rather than through continuing use. Such assets, or disposal groups, are generally
measured at the lower of their carrying amount and fair value less costs to sell.
Any impairment loss on a disposal group is allocated first to goodwill, and then to the remaining assets and liabilities on a pro-
rata basis, except that no loss is allocated to inventories, financial assets, deferred tax assets, employee benefit assets,
investment property, which continue to be measured in accordance with the Group’s other accounting policies. Impairment
losses on initial classification as held-for-sale or held-for-distribution and subsequent gains and losses on remeasurement are
recognised in profit or loss.
Once the Group classifies a non-current asset as held-for-sale, intangible assets, property, and equipment are no longer
amortised or depreciated, and any equity-accounted investee is no longer equity-accounted. Interest and other expenses
attributable to the liabilities of a disposal group classified as held for sale continue to be recognised. Non-current assets and
liabilities classified as held for sale are presented separately from the other assets and liabilities in the balance sheet.
Annexure B – Group accounting policies continued
for the year ended 30 June 2025
281
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
281	280

-- 143 of 155 --

REMUNERATION AND FEES
Payment to directors and prescribed officers for the year ended 30 June 2025 for services rendered are set out in the table below. It should
be noted that these payments reflect cash payments made to directors and prescribed officers during the financial year and therefore all
variable pay components are reflective of performance measurements relating to previous periods. The variable pay components relating
to the current year under review are physically paid in the following financial year and are analysed in detail in the Group’s annual
remuneration report and are more reflective of the performance of the period under review.
Payments to directors and prescribed officers for the year ended 30 June 2025 for services rendered are as follows:
R’000
Services
as directors Basic salary
Perfor-
mance
bonus 	LTIP1
Provident
fund contri-
butions
Other
benefits2 	Total
Executive
A Gore 	– 	9 346 	10 623 	10 984 	922 	422 	32 297
B Swartzberg 	– 	6 770 	8 529 	10 379 	701 	416 	26 795
DM Viljoen 	– 	7 154 	8 757 	7 046 	1 132 	395 	24 484
Prescribed officer
HD Kallner 	– 	8 914 	24 294 	16 525 	434 	233 	50 400
NS Koopowitz3 	– 	27 201 	21 472 	39 673 	235 	631 	89 212
Sub-total 	– 	59 385 	73 675 	84 607 	3 424 	2 097 	223 188
Non-executive
ME Tucker4 	8 655 	– 	– 	– 	– 	52 	8 707
R Farber5 	4 045 	– 	– 	– 	– 	4 178 	8 223
LM Chiume 	1 453 	– 	– 	– 	– 	– 	1 453
MW Hlahla 	1 729 	– 	– 	– 	– 	– 	1 729
FN Khanyile 	2 511 	– 	– 	– 	– 	– 	2 511
D Macready 	2 570 	– 	– 	– 	– 	– 	2 570
TT Mboweni6 	495 	– 	– 	– 	– 	– 	495
KC Ramon 	1 666 	– 	– 	– 	– 	– 	1 666
M Schreuder 	2 775 	– 	– 	– 	– 	– 	2 775
B van Kralingen7 	2 324 	– 	– 	– 	– 	103 	2 427
Sub-total 	28 223 	– 	– 	– 	– 	4 333 	32 556
Total 	28 223 	59 385 	73 675 	84 607 	3 424 	6 430 	255 744
Less: paid by subsidiaries 	(28 223) 	(59 385) 	(73 675) 	(84 607) 	(3 424) 	(6 430) 	(255 744)
Paid by holding company 	– 	– 	– 	– 	– 	– 	–
1 “LTIP” comprises cash-settled and equity-settled incentives.
2 “Other benefits” comprise medical aid contributions, travel, other allowances and fees from group subsidiaries.
3 Salary and incentive are paid in GBP.
4 Director’s fees for services rendered are paid in GBP.
5 Director’s fees for services and fees for other consulting services rendered by R Farber were paid in AUD. Director’s fees for consulting services are included as part of other
benefits.
6 Mr TT Mboweni passed away on 12 October 2024.
7 Director’s fees for services rendered are paid in USD.
Annexure C – Directorate
282
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
REMUNERATION AND FEES continued
Payment to directors and prescribed officers for the year ended 30 June 2024 for services rendered are set out in the table below. It should
be noted that these payments reflect cash payments made to directors and prescribed officers during the financial year and therefore all
variable pay components are reflective of performance measurements relating to previous periods. The variable pay components relating
to the current year under review are physically paid in the following financial year and are analysed in detail in the Group’s annual
remuneration report and are more reflective of the performance of the period under review.
Payments to directors and prescribed officers for the year ended 30 June 2024 for services rendered are as follows
R’000
Services
as directors 	Basic salary
Perfor-
mance
bonus 	LTIP1
Provident
fund contri-
butions
Other
benefits2 	Total
Executive
A Gore 	– 	8 436 	9 151 	11 363 	1 264 	489 	30 703
B Swartzberg 	– 	5 860 	12 151 	3 503 	621 	347 	22 482
DM Viljoen 	– 	6 838 	7 103 	7 950 	1 078 	352 	23 321
Prescribed officer
HD Kallner3 	– 	8 197 	22 743 	18 399 	410 	298 	50 047
NS Koopowitz4 	– 	24 202 	47 989 	5 633 	236 	620 	78 680
Sub-total 	– 	53 533 	99 137 	46 848 	3 609 	2 106 	205 233
Non-executive
ME Tucker5 	8 350 	– 	– 	– 	– 	53 	8 403
R Farber6 	3 791 	– 	– 	– 	– 	4 268 	8 059
LM Chiume9 	912 	– 	– 	– 	– 	– 	912
MW Hlahla 	1 647 	– 	– 	– 	– 	– 	1 647
FN Khanyile 	2 131 	– 	– 	– 	– 	– 	2 131
D Macready 	2 441 	– 	– 	– 	– 	– 	2 441
Dr TV Maphai7 	635 	– 	– 	– 	– 	– 	635
TT Mboweni 	1 724 	– 	– 	– 	– 	– 	1 724
KC Ramon 9 	1 165 	– 	– 	– 	– 	– 	1 165
M Schreuder 	2 618 	– 	– 	– 	– 	– 	2 618
B van Kralingen8 	2 354 	– 	– 	– 	– 	108 	2 462
SV Zilwa7 	1 821 	– 	– 	– 	– 	– 	1 821
Sub-total 	29 589 	– 	– 	– 	– 	4 429 	34 018
Total 	29 589 	53 533 	99 137 	46 848 	3 609 	6 535 	239 251
Less: paid by subsidiaries 	(29 589) 	(53 533) 	(99 137) 	(46 848) 	(3 609) 	(6 535) 	(239 251)
Paid by holding company 	– 	– 	– 	– 	– 	– 	–
1 “LTIP” comprises cash-settled and equity-settled incentives.
2 “Other benefits” comprise medical aid contributions, travel, other allowances and fees from group subsidiaries.
3 Transitioned from Group Executive Director to Prescribed Officer with effect from 1 March 2023. The remuneration presented above is for the full financial year.
4 Salary and incentive are paid in GBP. Transitioned from Group Executive Director to Prescribed Officer with effect from 1 March 2023.
5 Director’s fees for services rendered are paid in GBP.
6 Director’s fees for services and fees for other consulting services rendered by R Farber were paid in AUD. Director’s fees for consulting services are included as part of other
benefits.
7 Retired as Non-executive Directors effective 16 November 2023.
8 Director’s fees for services rendered are paid in USD.
9 Appointed as Non-executive Directors effective 18 September 2023.
Annexure C – Directorate continued
283
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
283	282

-- 144 of 155 --

DIRECTORS’ PARTICIPATION IN LONG-TERM INCENTIVE SCHEMES
Discovery’s directors and prescribed officers participate in the various long-term incentive schemes offered by the Group and their
participation is disclosed below. Refer to Group section 4.5 for a detailed description of the various schemes offered.
DISCOVERY LIMITED PHANTOM SHARE SCHEME
Directors and prescribed officers participation as at 30 June 2025:
Directors and prescribed officers
Outstanding
shares 	Date granted
Final vesting
date
Value at
30 June 2025
R
B Swartzberg 	8 075 	30/11/2022 	30/09/2027 	1 734 510
38 136 	20/05/2024 	30/09/2026 	8 191 613
DISCOVERY LIMITED LONG-TERM INCENTIVE PLAN
Directors and prescribed officers participation as at 30 June 2025:
Directors and prescribed officers
Outstanding
shares 	Date granted
Final vesting
date
Value at
30 June 2025
R
A Gore 	23 236 	23/10/2020 	30/09/2025 	4 991 093
45 858 	20/10/2021 	30/09/2026 	9 850 298
HD Kallner 	15 584 	23/10/2020 	30/09/2025 	3 347 443
30 757 	20/10/2021 	30/09/2026 	6 606 604
B Swartzberg 	7 792 	23/10/2020 	30/09/2025 	1 673 722
15 379 	20/10/2021 	30/09/2026 	3 303 409
16 017 	30/11/2023 	30/09/2028 	3 440 452
46 799 	30/11/2024 	30/09/2029 	10 052 425
DM Viljoen 	14 702 	23/10/2020 	30/09/2025 	3 157 990
30 132 	20/10/2021 	30/09/2026 	6 472 354
THE VITALITYHEALTH AND VITALITYLIFE PHANTOM SHARE SCHEMES
Directors and prescribed officers participation as at 30 June 2025:
Directors and prescribed officers
Outstanding
shares 	Date granted
Exercise
price GBP
Final vesting
date
Value at
30 June 2025
GBP
NS Koopowitz 	25 216 	01/10/2023 	– 	30/09/2026 	1 312 498
18 247 	01/10/2024 	– 	30/09/2027 	949 756
DIRECTORS’ PARTICIPATION IN SINGLE INCENTIVE PLAN
DISCOVERY LIMITED SINGLE INCENTIVE PLAN
Directors and prescribed officers participation as at 30 June 2025:
Directors and prescribed officers
Outstanding
shares 	Date granted
Final vesting
date
Value at
30 June 2025
R
A Gore 	92 223 	30/11/2022 	30/09/2027 	19 809 500
64 244 	30/11/2023 	30/09/2028 	13 799 611
61 760 	30/11/2024 	30/09/2029 	13 266 048
HD Kallner 	67 823 	30/11/2022 	30/09/2027 	14 568 380
106 440 	30/11/2023 	30/09/2026 	22 863 312
141 234 	30/11/2024 	30/09/2027 	30 337 063
B Swartzberg 	67 999 	30/11/2022 	30/09/2027 	14 606 185
46 453 	30/11/2023 	30/09/2028 	9 978 104
44 153 	30/11/2024 	30/09/2029 	9 484 064
DM Viljoen 	61 054 	30/11/2022 	30/09/2027 	13 114 399
49 864 	30/11/2023 	30/09/2028 	10 710 787
50 910 	30/11/2024 	30/09/2029 	10 935 468
Annexure C – Directorate continued
284
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
DIRECTORS’ INTEREST IN SHARES
According to the Register of Directors’ Interests, maintained by Discovery in accordance with the provisions of section 30(4)(d) of the
Companies Act, directors and prescribed officers of Discovery have disclosed the following interest in the ordinary shares of the Company
at 30 June 2025.
Directors and prescribed officers
Direct
beneficial
Indirect
beneficial 	Total
Indirect
beneficial-
Unvested
shares
Total
2025
30 June 2025
Executive
A Gore1 	31 372 	45 278 935 	45 310 307 	287 321 	45 597 628
B Swartzberg2 	3 146 461 	18 035 115 	21 181 576 	244 592 	21 426 168
DM Viljoen 	100 745 	– 	100 745 	206 662 	307 407
Prescribed officer
HD Kallner3 	100 398 	– 	100 398 	361 838 	462 236
NS Koopowitz 	– 	600 037 	600 037 	– 	600 037
Non-executive
R Farber 	45 000 	– 	45 000 	– 	45 000
FN Khanyile 	1 300 	– 	1 300 	– 	1 300
KC Ramon 	1 326 	4 529 	5 855 	– 	5 855
Total 	3 426 602 	63 918 616 	67 345 218 	1 100 413 	68 445 631
30 June 2024
Executive
A Gore 1 	31 372 	48 311 559 	48 342 931 	290 825 	48 633 756
B Swartzberg2 	3 146 461 	22 635 115 	25 781 576 	172 964 	25 954 540
DM Viljoen 	80 273 	– 	80 273 	197 604 	277 877
Prescribed officer
HD Kallner3 	100 398 	– 	100 398 	317 595 	417 993
NS Koopowitz 	– 	775 037 	775 037 	– 	775 037
Non-executive
R Farber 	52 500 	– 	52 500 	– 	52 500
FN Khanyile 	1 300 	– 	1 300 	– 	1 300
KC Ramon 	1 326 	4 529 	5 855 	– 	5 855
Total 	3 413 630 	71 726 240 	75 139 870 	978 988 	76 118 858
1 Includes 41 300 000 (2024: 41 300 000) ordinary shares which are subject to security.
2 Includes 6 000 000 (2024: 11 500 000) ordinary shares which are subject to security.
3 Includes 100 000 (2024: Nil) ordinary shares which are subject to security.
There has been no change in the directors’ interests in Discovery Limited’s shares between 30 June 2025 and the date of publication of this
annual report.
Annexure C – Directorate continued
285 	285
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
285	284

-- 145 of 155 --

ORDINARY SHAREHOLDERS
Number of
shareholders
% of total
shareholders
Number of
shares
% of
issued
capital
Shareholder spread
1 – 1 000 shares 	36 667 	86.53 	5 153 356 	0.76
1 001 – 10 000 shares 	4 151 	9.80 	11 710 069 	1.72
10 001 – 100 000 shares 	1 084 	2.56 	35 287 016 	5.19
100 001 – 1 000 000 shares 	382 	0.90 	119 409 250 	17.57
1 000 001 shares and over 	92 	0.21 	508 121 150 	74.76
42 376 	100.00 	679 680 841 	100.00
Public/non-public shareholders
Non-public shareholders 	23 	0.05 	170 997 165 	25.16
– Directors of the Company, including their associates1 	9 	0.02 	68 445 631 	10.07
– Employee share trusts2 	2 	— 	10 600 039 	1.56
– Own holdings 	1 	— 	680 268 	0.10
– Key management personnel and trustees of share schemes1 	10 	0.03 	1 320 969 	0.19
– Strategic holdings (more than 10%) 	1 	— 	89 950 258 	13.24
Public shareholders 	42 353 	99.95 	508 683 676 	74.84
42 376 	100.00 	679 680 841 	100.00
1 Includes shares held by directors and prescribed officers in share trusts.
2 Excludes shares held by directors and prescribed officers in share trusts.
Number of
shares 	%
Beneficial shareholders’ holding of 5% or more
Government Employees Pension Fund (including shares managed by Public Investment Corporation) 	89 950 258 	13.24
Remgro Limited 	51 254 365 	7.54
Adrian Gore1 	45 597 628 	6.71
186 802 251 	27.49
1 Includes shares held in share trusts.
B PREFERENCE SHAREHOLDERS
Number of
shareholders
% of total
shareholders
Number of
shares
% of issued
capital
Shareholder spread
1 – 1 000 shares 	2 810 	76.92 	292 727 	3.66
1 001 – 10 000 shares 	713 	19.52 	2 156 691 	26.96
10 001 – 100 000 shares 	119 	3.26 	2 803 966 	35.05
100 001 – 1 000 000 shares 	11 	0.30 	2 746 616 	34.33
3 653 	100.00 	8 000 000 	100.00
Public/non-public shareholders
Public shareholders 	3 653 	100.00 	8 000 000 	100.00
Number of
shares 	%
Beneficial shareholders’ holding of 5% or more
PSG Diversified Income Fund 	715 555 	8.94
OUTsurance Insurance Company Ltd 	500 000 	6.25
Amplify SCI Wealth Protector Fund 	408 206 	5.10
1 623 761 	20.29
Annexure D – Unaudited analysis of shareholders
at 30 June 2025
286
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
INTRODUCTION
We have reviewed the Embedded Value Statement of Discovery Limited and its subsidiaries (together “the Discovery Group”) for the year
ended 30 June 2025 (the Report). The Report is prepared for the purpose of determining the embedded value and performance of the
Discovery Group. The directors of Discovery Limited are responsible for the preparation and presentation of the Report in accordance with
the embedded value basis set out in the Basis of Preparation section of the Report as set out in Table 8, and for determining that the basis
of preparation is acceptable in the circumstances. Our responsibility is to express a conclusion on this Report based on our review.
SCOPE OF REVIEW
We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410: Review of Interim Financial
Information Performed by the Independent Auditor of the Entity. A review of financial information consists of making inquiries, primarily of
persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially
less in scope than an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to
obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express
an audit opinion.
CONCLUSION
Based on our review, nothing has come to our attention that causes us to believe that the Report is not prepared, in all material respects, in
accordance with the embedded value basis set out in Table 8 of the Basis of Preparation section of the Report.
BASIS OF ACCOUNTING AND RESTRICTION ON USE
Without modifying our conclusion, we draw attention to the Basis of Preparation section of the Report as set out in Table 8, which describes
the basis of accounting. The Report is prepared for the purpose of determining the embedded value and performance of the Discovery
Group. As a result, the Report may not be suitable for another purpose. Our report is intended solely for the directors of Discovery Limited
and should not be used by any other parties. We agree to the publication of our report in the Discovery Annual Financial Statements for the
year ended 30 June 2025, provided it is clearly understood by the recipients of the Discovery Annual Financial Statements for the year
ended 30 June 2025 that they enjoy such receipt for information only and that we accept no duty of care to them in respect of our report.
KPMG Inc. 	Deloitte & Touche
Registered Auditor 	Registered Auditors
Per: Mark Danckwerts 	Per: Stephen Munro
Chartered Accountant (SA) 	Chartered Accountant (SA)
Registered Auditor 	Registered Auditor
Director 	Partner
85 Empire Road 	5 Magwa Crescent
Parktown 	Waterfall City
2193 	2090
South Africa 	South Africa
10 September 2025 	10 September 2025
Annexure E – Embedded value statement
Independent auditors’ report on the review of the Embedded
Value Statement of Discovery Limited and its subsidiaries
TO THE DIRECTORS OF DISCOVERY LIMITED
287
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
287	286

-- 146 of 155 --

The embedded value of the Discovery Group consists of the following components:
■ the adjusted net worth attributed to the business at the valuation date;
■ plus: the present value of expected future shareholder cash flows from the in-force covered business;
■ less: the cost of required capital.
The present value of expected future shareholder cash flows from the in-force covered business is calculated as the value of projected
future after-tax shareholder cash flows of the business in-force at the valuation date, discounted at the risk discount rate.
The required capital are the assets attributed to the covered business above the amount required to back covered business liabilities,
whose distribution to shareholders is restricted as they are allocated to cover regulatory and internal capital requirements.
The value of new business is the present value, at the point of sale, of the projected future after-tax shareholder cash flows of the new
business written by the Discovery Group, discounted at the risk discount rate, less an allowance for the reserving strain, initial expenses
and cost of required capital. The value of new business is calculated using the current reporting date assumptions.
The embedded value includes the insurance and administration profits of the covered business in the Discovery Group. Covered business
includes business written in South Africa through Discovery Life (“Life”), Discovery Invest (“Invest”), Discovery Health (“Health”) and Discovery
Vitality (“Vitality”), and in the United Kingdom through VitalityLife and VitalityHealth. For Vitality Group, Ping An Health Insurance, Discovery
Insure, Discovery Bank and Umbrella Funds, no published value has been placed on the current in-force business.
In August 2011, the Discovery Group raised R800 million through the issue of non-cumulative, non-participating, non-convertible
preference shares. For embedded value purposes this capital, net of share issue expenses, has been excluded from the adjusted net worth.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
288
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
TABLE 1: GROUP EMBEDDED VALUE
R millions
30 June
2025
30 June
20241
%
change
Shareholders’ funds 	65 699 	54 451 	21
Adjustment to shareholders’ funds from published basis2 	(40 660) 	(35 163) 	16
Adjusted net worth3 	25 039 	19 288 	30
Value of in-force covered business before cost of required capital 	104 812 	94 258 	11
Cost of required capital 	(3 297) 	(3 192) 	3
Discovery Group embedded value 	126 554 	110 354 	15
Number of shares (millions) 	666.6 	661.0
Embedded value per share 	189.85 	166.95 	14
Diluted number of shares (millions) 	668.7 	665.0
Diluted embedded value per share4 	189.25 	165.94 	14
1 “Shareholders’ funds” and “Adjustments to shareholders’ funds from published basis” have been restated as a result of prior period errors – refer to note 7.5 for more
detail. The restatements do not affect the Group Embedded Value at 30 June 2024 as they relate to Life net assets under insurance contracts, which are eliminated on a
consolidated embedded value basis.
2 A breakdown of the adjustment to shareholders’ funds is shown in the table below. Note that where relevant, adjustments have been converted using the closing exchange
rate of R24.34/GBP (June 2024: R23.07/GBP).
R millions
30 June
2025
30 June
2024
Life net assets under insurance contracts 	(21 333) 	(16 597)
Vitality Life Limited net assets under insurance contracts 	(11 663) 	(11 314)
VitalityHealth Insurance Acquisition Cash Flow (IACF) Asset 	(5 120) 	(4 351)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) 	(7) 	(8)
Goodwill relating to the acquisition of Standard Life Healthcare and the PAC joint venture 	(3 012) 	(2 855)
Intangible assets (net of deferred tax) in covered businesses 	(813) 	(803)
Net preference share capital 	(779) 	(779)
Reversal of 1 Discovery Place IFRS 16 financial lease accounting 	1 550 	1 462
Equity settled share based payment mark-to-market adjustment* 	517 	82
(40 660) 	(35 163)
* The “equity settled share based payment mark-to-market adjustment” reflects the difference between the provision in the IFRS equity and the mark-to-market value of
the equity settled share based payments.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
289
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
289	288

-- 147 of 155 --

3 The following table sets out the capital position of the covered businesses with the required capital on a consistent basis to that used in the embedded value:
R millions
30 June
2025
30 June
2024
Shareholders’ funds 	65 699 	54 451
Adjustment to shareholders’ funds 	(40 660) 	(35 163)
Adjusted net worth 	25 039 	19 288
Excess of available capital over adjusted net worth 	52 419 	48 318
Available capital 	77 458 	67 606
Required capital 	48 446 	44 610
Excess available capital 	29 012 	22 996
The excess of available capital over adjusted net worth reflects the difference between the adjusted net worth for embedded value purposes and the available capital on a
statutory solvency basis for covered business. This includes:
■ The net preference share capital of R779 million which is included as available capital.
■ The difference between Vitality Life Limited’s Solvency UK Pillar 1 Own Funds and its adjusted net worth.
■ The difference between Life’s Pillar 1 Own Funds and its adjusted net worth.
The following table sets out the required capital for each of the covered businesses:
R millions
30 June
2025
30 June
2024
Health and Vitality 	1 286 	1 238
Life and Invest 	29 349 	27 935
VitalityHealth 	4 761 	4 138
VitalityLife 	13 050 	11 299
Total Required Capital 	48 446 	44 610
– For Health and Vitality, the required capital was set equal to two times the monthly renewal expense and Vitality benefit cost.
– For Life and Invest, the required capital was set equal to 1.25 times the SAM Pillar 1 Solvency Capital Requirement.
– For VitalityHealth, the required capital was set equal to 1.55 times the Solvency UK Pillar 1 Solvency Capital Requirement.
– For VitalityLife, the required capital was set equal to 1.4 times the Solvency UK Pillar 1 Solvency Capital Requirement.
4 The diluted embedded value per share adjusts for the effect of vested treasury shares, share options exercised, and vesting of share awards where the impact is dilutive.
This adjustment has been aligned to the diluted number of shares shown elsewhere in the financial statements.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
290
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
TABLE 2: VALUE OF IN-FORCE COVERED BUSINESS
R millions
Value before
cost of
required
capital
Cost of
required
capital
Value after
cost of
required
capital
At 30 June 2025
Health and Vitality 	27 972 	(525) 	27 447
Life and Invest1 	42 869 	(1 614) 	41 255
VitalityHealth2 	18 395 	(526) 	17 869
VitalityLife2 	15 576 	(632) 	14 944
Total 	104 812 	(3 297) 	101 515
At 30 June 2024
Health and Vitality 	27 441 	(527) 	26 914
Life and Invest1 	37 570 	(1 757) 	35 813
VitalityHealth2 	14 353 	(449) 	13 904
VitalityLife2 	14 894 	(459) 	14 435
Total 	94 258 	(3 192) 	91 066
1 Included in the Life and Invest value of in-force covered business is R2 849 million (June 2024: R2 318 million) in respect of investment management services provided on
off balance sheet investment business. The net assets of the investment service provider are included in the adjusted net worth.
2 The value of in-force has been converted using the closing exchange rate of R24.34/GBP (June 2024: R23.07/GBP).
TABLE 3: GROUP EMBEDDED VALUE EARNINGS
Year ended
R millions
30 June
2025
30 June
2024
Embedded value at end of period 	126 554 	110 354
Less: embedded value at beginning of period 	(110 354) 	(98 176)
Increase in embedded value 	16 200 	12 178
Dividends paid 	1 707 	1 269
Employee share option schemes 	(721) 	(683)
Net change in capital 	23 	131
Transfer to hedging reserve 	104 	61
Acquisition of subsidiaries with non-controlling interest 	(1) 	(6)
IFRS 17 impact on non-covered businesses1 	– 	(2)
Embedded value earnings 	17 312 	12 948
Annualised return on opening embedded value 	15.7% 	13.2%
1 In respect of 30 June 2024, the opening embedded value for that period (30 June 2023) was not restated for the transition to IFRS 17. This item represents the difference
between IFRS 4 and IFRS 17 equity on non-covered business, such as Discovery Insure and Ping An Health Insurance, and an opening IFRS balance sheet restatement as a
result of prior period errors. These impacts were not included in the embedded value earnings for 30 June 2024 and so a minor adjustment was required to reconcile the
change from the embedded value at the beginning of the period.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
291
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
291	290

-- 148 of 155 --

TABLE 4: COMPONENTS OF GROUP EMBEDDED VALUE EARNINGS
Year ended
30 June 2025
Year ended
30 June
2024
R millions 	Net worth
Cost of
required
capital
Value of in-
force
covered
business
Embedded
value
Embedded
value
Total profit from new business (at point of sale) 	(6 609) 	(300) 	9 063 	2 154 	1 832
Profit from existing business
– Expected return 	8 856 	(25) 	2 047 	10 878 	10 340
– Change in methodology and assumptions1 	4 169 	162 	(4 735) 	(404) 	2 385
– Experience variances 	331 	113 	2 461 	2 905 	564
Impairment, amortisation and fair value adjustment2 	(62) 	– 	– 	(62) 	(60)
Increase in goodwill and intangibles 	(382) 	– 	– 	(382) 	(308)
Non-covered businesses3 	2 537 	– 	– 	2 537 	1 088
Non-recurring expenses 	(355) 	– 	– 	(355) 	(96)
Acquisition costs4 	(45) 	– 	– 	(45) 	(33)
Finance costs5 	(3 125) 	– 	– 	(3 125) 	(2 796)
Foreign exchange rate movements6 	(113) 	(57) 	1 720 	1 550 	(1 555)
Other7 	(8) 	– 	– 	(8) 	2
Return on shareholders' funds5,8 	1 669 	– 	– 	1 669 	1 585
Embedded value earnings 	6 863 	(107) 	10 556 	17 312 	12 948
1 The changes in methodology and assumptions will vary over time to reflect adjustments to the model and assumptions as a result of changes to the operating and
economic environment. The current period’s changes are described in detail in Table 6 below (for previous periods refer to previous embedded value statements).
2 This item reflects the amortisation of the intangible assets reflecting the banking costs, Cambridge Mobile Telematics system spend and capital expenditure in Vitality
Global.
3 This item includes the profits of non-covered businesses. Head office costs which relate to non-covered business are included in this item, as well as cR171 million of
expenses which are currently incurred by the covered businesses but will be met by non-covered businesses in due course, and hence have not been included in the
relevant covered businesses’ embedded value expense analysis. For June 2025, profits of non-covered segments within the covered businesses of cR267 million, which were
previously reported as experience variances have been included in this item.
4 Acquisition costs relate to commission paid on the Life and Invest business and expenses incurred in writing Health and Vitality business that has been written over the
period but will only be activated and on risk after the valuation date. These policies are not included in the embedded value or the value of new business and therefore the
costs are not deducted from the value of new business.
5 Finance costs and return on shareholders’ funds are shown gross of intercompany charges (R1 351 million at 30 June 2025 and R1 046 million at 30 June 2024).
6 This item includes foreign exchange gains / (losses) emerging through the income statement, in addition to translation impacts on the cost of required capital and value of
in-force.
7 This item includes, among other items, the tangible tax impact from movements in covered business intangible assets, which are excluded from the net worth.
8 The return on shareholders’ funds is shown net of tax and management charges.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
292
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
TABLE 5: EXPERIENCE VARIANCES
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
Year
ended
30 June
2025
Year
ended
30 June
2024
R millions
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force 	Total 	Total
Renewal expenses 	15 	– 	(24) 	6 	(12) 	– 	40 	– 	25 	(55)
Lapses and surrenders1 	12 	(255) 	80 	227 	– 	1 524 	(172) 	167 	1 583 	508
Mortality and morbidity2 	– 	– 	848 	(68) 	(1 204) 	– 	(38) 	– 	(462) 	(681)
Policy alterations3 	– 	(1) 	(562) 	(27) 	– 	– 	19 	(190) 	(761) 	(669)
Backdated cancellations 	– 	– 	– 	– 	– 	– 	– 	– 	– 	–
Premium and fee
income2 	119 	– 	14 	179 	814 	– 	(45) 	19 	1 100 	754
Inflation-linked
indexation4 	– 	– 	(13) 	(218) 	– 	– 	8 	93 	(130) 	(152)
Economic5 	– 	– 	(74) 	592 	198 	– 	3 	– 	719 	269
Tax6 	130 	– 	200 	(159) 	(19) 	– 	308 	23 	483 	147
Reinsurance7 	– 	– 	– 	– 	– 	– 	(162) 	68 	(94) 	(184)
Maintain modelling
term8 	– 	339 	– 	93 	– 	134 	– 	– 	566 	546
Vitality benefits9 	(107) 	– 	– 	– 	– 	– 	(9) 	– 	(116) 	(186)
Other 	– 	(1) 	(12) 	38 	– 	– 	(24) 	(9) 	(8) 	267
Total 	169 	82 	457 	663 	(223) 	1 658 	(72) 	171 	2 905 	564
1 For Health and Vitality, the lapse and surrender experience was driven by the impact of employer groups who have widened the eligible schemes that employees can join
beyond the Discovery Health Medical Scheme. For VitalityHealth, the lapse and surrender experience reflects improved retention rates and higher achieved premium
increases.
2 For Life and Invest, overall claims experience for the period was better than expected for Individual Life, Group Life and Invest lines of business. For VitalityHealth, this item
reflects the difference between the assumed long-term margin for embedded value purposes and the net impact of increasing claims and the associated increased risk
premiums. In light of this, and expected future trends, VitalityHealth have updated their embedded value margin and premium run-off assumptions as part of their
periodic review of the embedded value basis.
3 For Life and Invest, and VitalityLife, the policy alterations experience relates mainly to persistent pressures within the economic environment. This is partially offset by
positive experience on lapses and premium income.
4 For Life and Invest, the experience reflects lower than expected CPI increases on inflation-linked policies on the Individual Life business.
5 For Life and Invest, better than expected unit fund growth in Invest resulted in an improved projected fee income reflected in the value of in-force. For VitalityHealth,
investment return continued to contribute to profitability as interest rates in the UK remain high.
6 The tax variance arises due to the timing difference between the expected tax payments and actual payments.
7 For VitalityLife, the reinsurance experience reflects the better-than-expected retention in the business and higher in-period inflation, which resulted in higher reinsurance
premiums, as well as an increase in provisions related to prior periods.
8 For Health and Vitality, Life and Invest, and VitalityHealth, the projection term is rebased at each reporting period. Therefore, an experience variance arises because the
total term of the in-force covered business is effectively increased by twelve months.
9 For Health and Vitality, the experience is driven by higher benefit costs and utilisation in the Vitality business.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
293
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
293	292

-- 149 of 155 --

TABLE 6: METHODOLOGY AND ASSUMPTION CHANGES
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
Year
ended
30 June
2025
Year
ended
30 June
2024
R millions
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force 	Total 	Total
Modelling changes1 	– 	(51) 	96 	(26) 	– 	– 	(10) 	(108) 	(99) 	2 289
Expenses2 	– 	(267) 	(23) 	(87) 	– 	– 	– 	– 	(377) 	(34)
Lapses3 	– 	(251) 	– 	(345) 	– 	– 	(376) 	(325) 	(1 297) 	(652)
Mortality and morbidity4 	– 	– 	(141) 	262 	– 	487 	99 	327 	1 034 	(501)
Benefit changes 	– 	17 	– 	– 	– 	– 	– 	– 	17 	(57)
Vitality 	– 	– 	– 	– 	– 	– 	– 	– 	– 	–
Tax 	– 	– 	– 	– 	– 	– 	– 	– 	– 	–
Economic assumptions5 	– 	(1 542) 	– 	1 116 	– 	– 	536 	64 	174 	(411)
Premium and fee
income6 	– 	472 	– 	(276) 	– 	– 	– 	– 	196 	198
Reinsurance and
financing7 	– 	– 	647 	(363) 	– 	– 	3 008 	(3 188) 	104 	404
Other8 	– 	(1) 	28 	(201) 	– 	– 	305 	(287) 	(156) 	1 149
Total 	– 	(1 623) 	607 	80 	– 	487 	3 562 	(3 517) 	(404) 	2 385
1 Minor refinements to the modelling environment were introduced.
2 For Health and Vitality, and Life and Invest, the expense assumptions were updated to align to budget.
3 For Health and Vitality, a one-year stressed lapse assumption was implemented to manage expected short term negative variation, allowing time for specific interventions
to take effect. For Life and Invest, the lapse basis for certain plan types was strengthened in line with internal investigations. For VitalityLife, the item includes a
strengthening of the PAC business lapse basis and VitalityLife servicing assumptions.
4 For Life and Invest, refinements to the mortality and morbidity assumptions on the Individual Life business and changes to the interest on lump sum claims reserves on the
Group Life business were implemented. For VitalityHealth, the Margin and Annuity Factor assumptions were revised to align to recent experience and forward-looking
expectations. For VitalityLife, the item reflects a strengthening of the mortality basis, which is more than offset by a weakening of the morbidity basis, to be more in line
with experience.
5 For Health and Vitality, and Life and Invest, the item includes the impact of updating the internally derived yield curves as at 30 June 2025. For Health and Vitality, this also
includes the impact of lower-than-expected inflation applicable to the administration and managed care fee escalation in 2025. For VitalityLife, this item includes the
impact of updating the assumptions relative to the Solvency UK yield curves and the IFRS interest rates.
6 For Health and Vitality, this item represents an additional administration and managed care fee margin effective for 2025. This additional margin is contractually effective
given a defined level of spend to enhance the services rendered by the administrator. For Life and Invest, this item includes assumption changes relating to Vitality status
progressions, decrement rates and integration benefits applied in the shared value model.
7 For Life and Invest, the reinsurance and financing item primarily relates to the impact of internal financing arrangements, where the future expected cash flows arising
from part of the negative reserves are monetised to match other positive policy liabilities. For VitalityLife, this item includes the impact of external financing arrangements,
where future expected cash flows arising from part of the negative reserves are monetised to partially fund new business and support liquidity needs in the business.
8 For Life and Invest, this item mainly relates to a portion of the IAS12 deferred tax liability that has now been recognized in the embedded value. For VitalityLife, the
discretionary margin on the PAC IFRS 4 reserves was removed in line with basis changes approved on the PAC book of business. This item also includes an increase to the
cost of capital for VitalityLife, driven by a reduced allowance for the loss absorbing capacity of deferred taxes on required capital.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
294
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
TABLE 7: VALUE OF NEW BUSINESS
Year ended
R millions
30 June
2025
30 June
2024
%
change
Health and Vitality
Gross profit from new business (at point of sale) 	1 095 	1 103
Cost of required capital 	(45) 	(52)
Present value of future profits from new business (at point of sale) after cost of
required capital 	1 050 	1 051 	0
New business annualised premium income1 	6 093 	7 716 	(21)
Life and Invest
Present value of future profits from new business (at point of sale)2 	535 	560
Cost of required capital 	(74) 	(79)
Present value of future profits from new business (at point of sale) after cost of
required capital 	461 	481 	(4)
New business annualised premium income3 	3 270 	3 214 	2
Annualised profit margin4 	1.8% 	2.0%
Annualised profit margin excluding Invest business 	2.1% 	3.8%
VitalityHealth5
Present value of future profits from new business (at point of sale) 	671 	491
Cost of required capital 	(62) 	(63)
Present value of future profits from new business (at point of sale) after cost of
required capital 	609 	428 	42
New business annualised premium income6 	2 564 	2 443 	5
Annualised profit margin4 	3.1% 	2.6%
VitalityLife
Present value of future profits from new business (at point of sale) 	153 	(58)
Cost of required capital 	(119) 	(70)
Present value of future profits from new business (at point of sale) after cost of
required capital 	34 	(128) 	127
New business annualised premium income7 	2 094 	1 462 	43
Annualised profit margin4 	0.2% 	(1.3%)
1 Health new business annualised premium income is the gross contribution to the medical schemes. The new business annualised premium income shown above excludes
premiums in respect of members who join an existing employer where the member has no choice of medical scheme, as well as premiums in respect of new business
written during the period but only activated after 30 June 2025. The total Health and Vitality new business annualised premium income written over the period was R10
119 million (June 2024: R11 481 million, which included the onboarding of the Sasolmed medical scheme).
2 Included in the Life and Invest embedded value of new business is R49 million (June 2024: R15 million) in respect of investment management services provided on off
balance sheet investment business. Risk business written prior to the valuation date allows certain Invest business to be written at financially advantageous terms, the
impact of which has been recognised in the value of new business.
3 Life new business is defined as Life policies to which Life became contractually bound during the reporting period, including policies whose first premium is due after the
valuation date. Invest new business is defined as business where at least one premium has been received and which has not been refunded after receipt. Invest new
business also includes Discovery Retirement Optimiser policies to which Life and Invest became contractually bound during the reporting period, including policies whose
first premium is due after the valuation date.
The new business annualised premium income of R3 270 million (single premium APE: R1 717 million (June 2024: R1 545 million)) shown above excludes automatic
premium increases, servicing increases in respect of existing business and Umbrella Funds new business annualised premium income. The total new business annualised
premium income written over the period was R6 633 million (single premium APE: R1 806 million (June 2024: R1 626 million)) and is set out in the table below:
R millions
30 June
2025
30 June
2024
New business annualised premium income 	3 270 	3 214
Automatic premium increases 	2 219 	2 249
Servicing increases 	761 	779
Umbrella Funds new business annualised premium income 	383 	626
Total new business annualised premium income 	6 633 	6 868
Single premium Invest business is included at 10% of the value of the single premium. Section 14 transfers for Umbrella Funds are included at 10% of the fund value.
Policy alterations and internal replacement policies, including Discovery Retirement Optimisers added to existing Life Plans, are shown in Table 5 as experience variances and
not included as new business. Term extensions on existing contracts are not included as new business.
4 The annualised profit margin is the value of new business expressed as a percentage of the present value of future premiums.
5 The VitalityHealth value of new business is calculated as the value at point of sale of the new business written premium in-force at the valuation date multiplied by the
Margin multiplied by the Annuity Factor plus the new business cash flows from point of sale to the valuation date. The assumptions for the Margin and Annuity Factor are
shown in Table 8.
6 VitalityHealth new business is defined as individuals and employer groups which incepted during the reporting period. The new business annualised premium income
shown above has been adjusted to exclude premiums in respect of members who join an existing employer group after the first month, as well as premiums in respect of
new business written during the period but only activated after 30 June 2025.
7 VitalityLife new business is defined as policies to which VitalityLife became contractually bound during the reporting period, including policies whose first premium is due
after the valuation date.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
295
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
295	294

-- 150 of 155 --

Basis of preparation
TABLE 8: EMBEDDED VALUE ECONOMIC ASSUMPTIONS
R millions
30 June
2025
30 June
2024
Beta coefficient 	0.75 	0.75
Equity risk premium (%) 	3.5 	3.5
Risk discount rate (%)
– Health and Vitality1 	13.875 	14.875
– Life and Invest1 	14.625 	15.375
– VitalityHealth 	6.573 	6.573
– VitalityLife 	6.734 	6.495
Rand / GBP exchange rate
Closing 	24.34 	23.07
Average 	23.48 	23.55
Margin over expense inflation to derive medical inflation (%)
South Africa 	3.00 	3.00
Expense inflation (%)2
South Africa 	– Health and Vitality 	5.66 	6.87
– Life and Invest 	6.41 	7.05
United Kingdom 	3.72 	4.01
Pre-tax investment return (%)
South Africa 	– Cash 1 	10.50 	11.25
– Life and Invest bonds3 	12.00 	12.75
– Health and Vitality bonds3 	11.25 	12.25
– Equity 	15.50 	16.25
United Kingdom 	– VitalityHealth risk-free rate 	3.95 	3.95
– VitalityLife risk-free rate 	4.11 	3.87
– VitalityLife investment return 	5.26 	4.91
Long-term corporation tax rate (%)
South Africa 	27 	27
United Kingdom 	25 	25
VitalityHealth Margin and Annuity Factor assumptions
– Margin (net of tax and cost of required capital) (%) 	10.56 	12.35
– Annuity Factor 	7.81 	6.42
Projection term
– Health and Vitality 	20 years 	20 years
– Discovery Life 	40 years 	40 years
– Group Life 	20 years 	20 years
– VitalityLife 	No cap 	No cap
– VitalityHealth4 	20 years 	20 years
1 Derived as a margin over (or below for cash) the respective pre-tax investment return for bonds.
2 The inflation assumption is derived as the difference between the nominal and real yield curve at each duration. As an indication, the cash flow weighted average inflation
is shown in the table. For the United Kingdom, the expense inflation assumption is aligned with the long-term market view of inflation.
3 As indications, the cash flow weighted averages derived from the relevant yield curve(s) are shown.
4 The VitalityHealth projection term of 20 years is used in the derivation of the Annuity Factor.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
296
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
The Discovery Group embedded value is calculated based on a risk discount rate using the Capital Asset Pricing Model (CAPM) approach
with specific reference to the Discovery Group beta coefficient. The assumed beta is fixed at 0.75. This has been set such that the risk
discount rate proxies the result of a Weighted Average Cost of Capital approach with reference to the capital structure of the Group and the
observed beta calculated using daily returns over a long time period. The observed beta is calculated with reference to the ALSI. The
assumed beta will only change if the capital structure of the Group and/or the observed beta calculated using daily returns over a long time
period suggest the beta assumption should depart significantly from the assumption at the financial year-end. As beta values reflect the
historic performance of share prices relative to the market, they may not allow fully for non-market related and non-financial risk. Investors
may want to form their own view on an appropriate allowance for these risks which have not been modelled explicitly.
Life and Invest mortality, morbidity and lapse and surrender assumptions were derived from internal experience, where available,
augmented by reinsurance and industry information.
The Health and Vitality lapse assumptions were derived from the results of recent experience investigations.
The VitalityHealth assumptions were derived from internal experience and augmented by future expectations.
VitalityLife assumptions were derived from internal experience, where available, augmented by reinsurance, industry and Discovery Group
information.
Renewal expense assumptions were based on the results of the latest expense and budget information.
The initial expenses included in the calculation of the embedded value of new business are the actual costs incurred excluding expenses of
an exceptional or non-recurring nature.
The South African investment return assumptions for Life, Invest, Health and Vitality were set relative to an internally derived nominal yield
curve, which is consistent with the IFRS 17 reporting basis.
The current and projected tax position of the policyholder funds within the Life company has been taken into account in determining the
net investment return assumption.
The risk-free rate assumption for VitalityHealth was based on the single interest rate derived from the Prudential Regulatory Authority yield
curve. VitalityLife has transitioned to the use of full yield curves to represent its risk-free rate assumption following the implementation of
IFRS 17. For consistency, VitalityLife has also transitioned to the use of a market inflation curve from a long-term market view of inflation.
VitalityHealth calculate the value of in-force at the valuation date as the in-force written premium multiplied by the Margin multiplied by the
Annuity Factor, as set out in the table above. The Annuity Factor assumption is derived from assumed future lapse rates and premium
increases. The Margin assumption reflects assumed profit margins after tax and the cost of required capital. The assumptions underlying
the Annuity Factor and Margin are set at the total book level, taking into account the current experience and future expectations across all
durations of in-force business. The economic components underlying the Annuity Factor are reviewed at each reporting date; the non-
economic components underlying the Annuity Factor and Margin assumptions are reviewed periodically.
The cost of required capital is calculated using the difference between the risk discount rate and the net of tax asset return on tangible
assets. The Vitality Life Limited required capital amount is assumed to earn the investment return assumption, which is set based on the
return on a portfolio of government and corporate bonds assumed to back the required capital. The Life and Invest cost of required capital
is calculated assuming shareholder cash flow is limited to the cash flow available after having met both the required capital amount and an
internally defined liquidity target capital requirement of tangible assets.
The embedded value has been calculated in accordance with the Actuarial Society of South Africa’s Advisory Practice Note (“APN”) 107:
Embedded Value Reporting, except the recommended disclosure of Free Surplus and Required Capital has been adjusted to take into
account the nature of the capital requirements in the covered businesses, as can be seen in Table 1 note 2.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
297
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
297	296

-- 151 of 155 --

BASIS OF PREPARATION
The risk discount rate uses the CAPM approach with specific reference to the Discovery Group beta coefficient. As beta values reflect the
historic performance of share prices relative to the market, they may not allow fully for non-market related and non-financial risk. Investors
may want to form their own view on an appropriate allowance for these risks which have not been modelled explicitly. The sensitivity of the
embedded value and the embedded value of new business at 30 June 2025 to changes in the risk discount rate is included in the tables
below.
For each sensitivity illustrated below, all other assumptions have been left unchanged. No allowance has been made for management
action such as risk premium increases where future experience is worse than the base assumptions.
TABLE 9: EMBEDDED VALUE SENSITIVITY
Discovery
Group 	Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
Embedded
value
%
change	R millions
Adjusted net
worth
Value
of in-force
Cost of
required
capital
Value
of in-force
Cost of
required
capital
Value
of in-force
Cost of
required
capital
Value
of in-force
Cost of
required
capital
Base 	25 039 	27 972 	(525) 	42 869 	(1 614) 	18 395 	(526) 	15 576 	(632) 	126 554
Impact of:
Risk discount rate + 1% 	25 039 	26 448 	(570) 	39 409 	(1 715) 	17 337 	(684) 	14 505 	(720) 	119 049 	(6)
Risk discount rate – 1% 	25 039 	29 656 	(475) 	46 923 	(1 496) 	19 574 	(346) 	16 806 	(499) 	135 182 	7
Lapses – 10% 	24 873 	28 893 	(551) 	46 523 	(1 687) 	20 621 	(589) 	16 586 	(717) 	133 952 	6
Interest rates – 1%1 	25 211 	27 859 	(506) 	43 522 	(1 566) 	19 574 	(559) 	14 994 	(745) 	127 784 	1
Equity and property market value – 10% 	24 981 	27 972 	(525) 	41 937 	(1 602) 	18 395 	(526) 	15 576 	(632) 	125 576 	(1)
Equity and property return + 1% 	25 039 	27 972 	(525) 	43 299 	(1 604) 	18 395 	(526) 	15 576 	(632) 	126 994 	0
Renewal expenses – 10% 	25 150 	30 731 	(486) 	43 625 	(1 580) 	20 251 	(526) 	15 920 	(613) 	132 472 	5
Mortality and Morbidity – 5% 	25 333 	27 972 	(525) 	45 642 	(1 508) 	22 204 	(526) 	16 087 	(607) 	134 072 	6
Projection term + 1 year 	25 039 	28 284 	(530) 	42 943 	(1 616) 	18 618 	(532) 	15 576 	(632) 	127 150 	0
1 All economic assumptions were reduced by 1%.
The following table shows the effect of using different assumptions on the embedded value of new business.
TABLE 10: VALUE OF NEW BUSINESS SENSITIVITY
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
Value of
new business
%
change	R millions
Value
of in-force
Cost of
required
capital
Value
of in-force
Cost of
required
capital
Value
of in-force
Cost of
required
capital
Value
of in-force
Cost of
required
capital
Base 	1 095 	(45) 	535 	(74) 	671 	(62) 	153 	(119) 	2 154
Impact of:
Risk discount rate + 1% 	1 006 	(49) 	362 	(79) 	535 	(78) 	(37) 	(134) 	1 526 	(29)
Risk discount rate – 1% 	1 192 	(40) 	734 	(69) 	823 	(42) 	369 	(95) 	2 872 	33
Lapses – 10% 	1 172 	(49) 	727 	(77) 	1 027 	(72) 	364 	(137) 	2 955 	37
Interest rates – 1%1 	1 102 	(43) 	543 	(72) 	823 	(66) 	268 	(136) 	2 419 	12
Equity and property return + 1% 	1 095 	(45) 	567 	(74) 	671 	(62) 	153 	(119) 	2 186 	1
Renewal expenses – 10% 	1 259 	(42) 	578 	(72) 	862 	(62) 	221 	(116) 	2 628 	22
Mortality and Morbidity – 5% 	1 095 	(45) 	613 	(69) 	1 063 	(62) 	215 	(116) 	2 694 	25
Projection term + 1 year 	1 112 	(45) 	539 	(74) 	697 	(62) 	153 	(119) 	2 201 	2
Acquisition expenses – 10% 	1 132 	(45) 	718 	(74) 	784 	(62) 	396 	(119) 	2 730 	27
1 All economic assumptions were reduced by 1%.
Annexure E – Embedded value statement continued
for the year ended 30 June 2025
298 	299
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Glossary
299	298

-- 152 of 155 --

Group
2021
(IFRS 4)
2022
(IFRS 4)
Restated1
2023
(IFRS 17)
Restated1
2024
(IFRS 17)
2025
(IFRS 17)
Income statement extracts (R million)
Operating profit 	5 304 	7 858 	10 308 	11 390 	14 587
Headline earnings 	2 986 	5 204 	6 720 	7 384 	9 625
Items adjusted for normalised headline earnings 	420 	612 	(320) 	127 	156
Normalised headline earnings 	3 406 	5 816 	6 400 	7 511 	9 781
Diluted normalised headline earnings per share (cents) 	512.9 	877.3 	967.9 	1 129.5 	1 462.8
Statement of financial position extracts
(R million)
Total assets 	246 694 	231 945 	255 339 	279 634 	327 450
Shareholders' funds 	46 415 	40 819 	47 242 	54 451 	65 699
Embedded value
Embedded value (R million) 	74 645 	86 258 	98 176 	110 354 	126 554
Diluted embedded value per share (R) 	112.23 	129.07 	148.45 	165.94 	189.25
Key ratios
Return on average equity (%) 	7.1 	12.6 	14.9 	14.8 	15.9
Return on average assets (%) 	1.4 	2.2 	2.7 	2.8 	3.1
Exchange rates
Rand/USD
– Closing 	14.28 	16.47 	18.87 	18.26 	17.77
– Average 	15.42 	15.22 	17.79 	18.71 	18.16
Rand/GBP
– Closing 	19.74 	20.00 	23.99 	23.07 	24.34
– Average 	20.74 	20.25 	21.43 	23.55 	23.48
Share statistics
Number of ordinary shares in issue
– Weighted average (000’s) 	656 710 	656 901 	658 045 	661 071 	665 168
– Diluted weighted average (000's) 	664 073 	663 082 	661 328 	665 016 	668 715
– End of period (000’s) 	665 769 	668 963 	673 146 	676 374 	679 681
Price/diluted headline earnings (times) 	24.70 	14.60 	15.07 	11.93 	14.68
Share price (cents per share):
– High 	15 738 	18 280 	15 266 	15 878 	22 189
– Low 	10 047 	11 760 	10 241 	10 721 	13 557
– Closing 	12 667 	12 810 	14 585 	13 469 	21 480
Market capitalisation (R million) 	84 333 	85 694 	98 172 	91 104 	146 000
1 The comparative information for the year ended 30 June 2024 has been restated due to correction of a prior period error. Refer to note 7.5 for more detail. In addition,
the closing statement of financial position for 30 June 2023 and relevant key ratios were also restated. All other information for 2023 is consistent with information
previously published.
Annexure F – Unaudited five-year review
for the year ended 30 June 2025
300
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
Abbreviation 	Meaning
AIAV 	AIA Vitality Proprietary Limited
API 	Annualised Premium Income
CAE 	Chief Audit Executive
CCIC 	Capital, Currency and Investment Committee
CEB 	Corporate Employee Benefits
CEO 	Chief Executive Officer
CFC 	Controlled Foreign Company
CFO 	Chief Financial Officer
CGU 	Cash generating unit
CIPC 	Companies and Intellectual Property Commission
CMT 	Cambridge Mobile Telematics
CODM 	Chief Operating Decision-Maker
Companies Act 	South African Companies Act, 71 of 2008
CRO 	Chief Risk Officer
CSM 	Contractual Service Margin (unearned profit)
DAC 	Deferred Acquisition Costs
DHEL 	Discovery Holdings Europe Limited
DHMS 	Discovery Health Medical Scheme
Discovery 	Discovery Limited Group
DLAC 	Discovery Limited Audit Committee
DMTN 	Domestic Medium Term Note
DPF 	Direct Participation Features
DRG 	Discovery Risk Grades
DRO 	Discovery Retirement Optimiser
DSY 	Discovery SA
DVA 	Discovery Vitality Australia Proprietary Limited
ECL 	Expected credit losses
EFCF 	Expected Fulfilment Cash Flows
ESG 	Environmental, Social, and Corporate Governance
FCA 	Finance Conduct Authority
FCC 	Finance and Capital Committee
FEC 	Foreign Exchange Contracts
FGC 	Financial Guarantee Contracts
Financial risk 	The risk of a possible future change in one or more of a specified interest rate, financial instrument price,
commodity price, currency exchange rate, index of prices or rates, credit rating or credit index or other variable,
provided in the case of a non-financial variable that the variable is not specific to a party to the contract.
FinRe 	Financial Reinsurance – with risk transfer
FLR 	Financial Leverage Ratio
FRC 	United Kingdom Financial Reporting Council
FSV 	Financial Soundness Valuation
FVTPL 	Fair value through profit or loss
GIA 	Group Internal Audit
GMM 	General Measurement Model
Glossary
301
Directors’
	responsibility
	statement
Group Chief Executive and
	Group Chief Financial Officer’s
	internal financial control
	responsibility statement
Certificate by
	the Company
	Secretary
Report of the
	Discovery Limited
	Audit Committee
Independent
	auditors’
	report
Directors’
	report
Group statement
	of financial
	position
Group
	income
	statement
Group statement
	of other
	comprehensive
	income
Group
	statement of
	cash flows
Group statement
	of changes in
	equity
Notes to the Group
	annual financial
	statements
Company Annual
	Financial
	Statements
Annexures
 
Glossary
301	300

-- 153 of 155 --

Abbreviation 	Meaning
HAF 	Head of Actuarial Function
IACF 	Initial Acquisition Cash Flows
IASB 	International Accounting Standards Board
IBNR 	incurred but not yet reported claims
ICA 	Individual Capital Assessment
IFA 	Insurance Fund Account
IFIE 	Insurance finance income and expense comprises the change in the carrying amount of the group of insurance
contracts arising from:
■ the effect of the time value of money and changes in the time value of money, and
■ the effect of financial risk and changes in financial risk
IFRS 17 margins 	IFRS 17 margins refers to the contractual service margin plus the risk adjustment
IFRS 17 	IFRS 17 Insurance Contracts (effective for Discovery post 1 July 2023)
IFRS 	IFRS Accounting Standards
INSPRU 	The Prudential Sourcebook for Insurers
IRBA 	South African Independent Regulatory Board of Auditors
ISE 	Insurance Service Expenses
JSE 	JSE Limited
KAM 	Key Audit Matters
LIC 	Liability for Incurred Claims
LRC 	Liability for Remaining Coverage
LTICR 	Long-term Insurance Capital Requirement
LTIP 	Long-term Incentive Plan
Morbidity 	Morbidity claims are claims which arise as a result of an impairment of life due to an illness or disability event
insured by the policyholder
Mortality 	Mortality claims are claims which arise from the death of an insured life
NCAHFS 	Non-current asset held for sale
NCD 	Negotiable certificates of deposits
OCI 	Other Comprehensive Income
OCR 	Outstanding Claims Reserve
ORSA 	Own Risk and Solvency Assessment
PA 	Prudential Authority (South Africa)
PAA 	Premium Allocation Approach
PAC 	Prudential Assurance Company
PAHI 	Ping An Health Insurance Company of China Ltd
PRA 	Prudential Regulatory Authority (United Kingdom)
ROEV 	Return On Opening Embedded Value
SA 	South Africa
SAICA 	South African Institute of Chartered Accountants
SAM 	Solvency Assessment and Management
SAP 	Standard of Actuarial Practice
SCR 	Solvency Capital Requirement
SME 	Small and Medium-sized Enterprises
TCFD 	Task Force on Climate-related Financial Disclosure
TRS 	Total Return equity Swaps
UK 	United Kingdom
VFA 	Variable Fee Approach
VGI 	Vitality Group International Inc.
Vitality 	United Kingdom and Vitality Global
WHT 	Withholding Tax
Glossary continued
302
DISCOVERY ANNUAL FINANCIAL STATEMENTS 2025
302

-- 154 of 155 --

Discovery Limited | +27 11 529 2888 | askthecfo@discovery.co.za | www.discovery.co.za
Copyright 2025. Discovery Ltd is the licensed controlling company of the designated Discovery Insurance Group.

-- 155 of 155 --